<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004905.pub5" GROUP_ID="PREG" ID="469003070622173093" MERGED_FROM="" MODIFIED="2017-04-12 13:28:09 +0100" MODIFIED_BY="Leanne Jones" REVIEW_NO="0422" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="12.0">
<COVER_SHEET MODIFIED="2017-04-12 13:28:08 +0100" MODIFIED_BY="Leanne Jones">
<TITLE>Multiple-micronutrient supplementation for women during pregnancy</TITLE>
<CONTACT MODIFIED="2017-04-12 13:28:08 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="14281" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Zulfiqar</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Bhutta</LAST_NAME><SUFFIX>MBBS, FRCPCH, FAAP, PhD</SUFFIX><POSITION>Robert Harding Chair in Global Child Health &amp; Policy</POSITION><EMAIL_1>Zulfiqar.bhutta@sickkids.ca</EMAIL_1><EMAIL_2>zulfiqar.bhutta@aku.edu</EMAIL_2><ADDRESS><DEPARTMENT>Centre for Global Child Health</DEPARTMENT><ORGANISATION>Hospital for Sick Children</ORGANISATION><CITY>Toronto</CITY><ZIP>M5G A04</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-04-12 13:28:08 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="EF8E590E82E26AA20126CDD16626EA39" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Batool</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Haider</LAST_NAME><POSITION>Researcher</POSITION><EMAIL_1>bah201@mail.harvard.edu</EMAIL_1><EMAIL_2>batoolrehan@yahoo.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Global Health and Population</DEPARTMENT><ORGANISATION>Harvard School of Public Health</ORGANISATION><ADDRESS_1>677 Huntington Avenue</ADDRESS_1><CITY>Boston</CITY><ZIP>02115</ZIP><REGION>MA</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON><PERSON ID="14281" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Zulfiqar</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Bhutta</LAST_NAME><SUFFIX>MBBS, FRCPCH, FAAP, PhD</SUFFIX><POSITION>Robert Harding Chair in Global Child Health &amp; Policy</POSITION><EMAIL_1>Zulfiqar.bhutta@sickkids.ca</EMAIL_1><EMAIL_2>zulfiqar.bhutta@aku.edu</EMAIL_2><ADDRESS><DEPARTMENT>Centre for Global Child Health</DEPARTMENT><ORGANISATION>Hospital for Sick Children</ORGANISATION><CITY>Toronto</CITY><ZIP>M5G A04</ZIP><REGION>ON</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2017-03-16 11:52:02 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="11" MONTH="3" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="11" MONTH="3" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="3" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2004"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-04-07 10:30:54 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-04-07 10:30:39 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="4" YEAR="2017"/>
<DESCRIPTION>
<P>Summary of amendments:</P>
<P>
<U>10 November 2015</U> </P>
<P>We have corrected I² values for footnotes 1 and 2 in the <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
<P>
<U>22 March 2016</U>
</P>
<P>We have corrected the stillbirth data for <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK> and corrected the data for preterm birth, SGA, LBW, stillbirth, perinatal mortality, neonatal mortality, maternal anaemia, caesarian section, and miscarriage for <LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>.</P>
<P>
<U>16 March 2017</U>
</P>
<P>Estimates for Christian 2003 trial were updated.</P>
<P>In response to feedback received from Professor Caroline Fall, all analyses have now been changed to random-effects models, given the clinical heterogeneity amongst the included trials. The Unit of Analysis section has been updated to describe the inclusion of data from trials with more than two intervention groups.</P>
<P>All feedback has been incorporated and addressed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-04-07 10:30:54 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="4" YEAR="2017"/>
<DESCRIPTION>
<P>There have been a number of cumulative amendments since the last published version in 2015. The overall conclusions remain unchanged. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-04-07 10:32:38 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-08-11 10:41:49 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="3" YEAR="2016"/>
<DESCRIPTION>
<P>We have corrected the stillbirth data for <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK> and corrected the data for preterm birth, SGA, LBW, stillbirth, perinatal mortality, neonatal mortality, maternal anaemia, caesarian section, and miscarriage for <LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-04-07 10:32:38 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="11" YEAR="2015"/>
<DESCRIPTION>
<P>We have corrected I² values for footnotes 1 and 2 in the <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-11-10 14:21:50 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>Search updated and two new trials included (<LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK> and <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>) and 51 new studies excluded. Six trials included in previous versions of the review have now been excluded: four trials assessed the effect of fortification with multiple micronutrients (MMN) (<LINK REF="STD-Dieckmann-1944" TYPE="STUDY">Dieckmann 1944</LINK>; <LINK REF="STD-Jarvenpaa-2007" TYPE="STUDY">Jarvenpaa 2007</LINK>; <LINK REF="STD-Tatala-2002" TYPE="STUDY">Tatala 2002</LINK>; <LINK REF="STD-Vadillo_x002d_Ortega-2011" TYPE="STUDY">Vadillo-Ortega 2011</LINK>) and two trials included high-risk women (<LINK REF="STD-Gupta-2007" TYPE="STUDY">Gupta 2007</LINK>; <LINK REF="STD-Rumiris-2006" TYPE="STUDY">Rumiris 2006</LINK>). A 'Summary of findings' table has been added. Two new outcomes, mode of delivery and macrosomia, have been added to the review. The list of primary outcomes has been modified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2015-11-10 14:21:49 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="3" YEAR="2015"/>
<DESCRIPTION>
<P>It is now explicit that the review focuses on oral supplements and trials examining parenteral provision of multiple micronutrients (MMN) or MMN via food fortification are now not included.</P>
<P>The updated review includes 19 studies. There is now evidence to suggest that women who receive MMN are at lower risk of having a stillbirth.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-09-26 20:43:41 +0100" MODIFIED_BY="Batool A Haider">
<DATE DAY="17" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>Search updated. For this update we have added 17 new included studies (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; Gupta 2007a; <LINK REF="STD-Hininger-2004" TYPE="STUDY">Hininger 2004</LINK>; Jarvenpaa 2007; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; Rumiris 2006a; <LINK REF="STD-Sood-1975" TYPE="STUDY">Sood 1975</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; Vadillo-Ortega 2011; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>) and 15 new excluded studies. We have also identified six ongoing studies (<LINK REF="STD-Biggs-2011" TYPE="STUDY">Biggs 2011</LINK>; Cogswell 2006a; <LINK REF="STD-Dewey-2011" TYPE="STUDY">Dewey 2011</LINK>; Fall 2007a; <LINK REF="STD-Moore-2011" TYPE="STUDY">Moore 2011</LINK>; West 2011a).</P>
<P>This review is now comprised of 23 included studies; 64 excluded studies and six ongoing studies.</P>
<P>The methods have been updated.</P>
<P>Conclusions have not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-08-07 11:50:29 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>Review updated. Conclusions not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-03-23 15:41:08 +0000" MODIFIED_BY="Jill Hampson">
<DATE DAY="20" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-10-23 13:48:44 +0100" MODIFIED_BY="Sonja L Henderson">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>The Aga Khan University Hospital</NAME>
<COUNTRY CODE="PK">Pakistan</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2015-10-23 13:48:44 +0100" MODIFIED_BY="Sonja L Henderson">
<SOURCE>
<NAME>Department for International Development</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2015-05-04 00:38:30 +0100" MODIFIED_BY="[Empty name]">
<NAME>United Nations Children's Fund (UNICEF)</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2015-10-23 13:48:44 +0100" MODIFIED_BY="Sonja L Henderson">
<NAME>UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-03-16 12:53:33 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-01-24 11:12:03 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2015-10-22 08:49:25 +0100" MODIFIED_BY="Heather Maxwell">Multiple-micronutrient supplementation for women during pregnancy</TITLE>
<SUMMARY_BODY MODIFIED="2017-01-24 11:12:03 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>What is the issue?</B>
</P>
<P>In low- and middle-income countries, many women have poor diets and are deficient in nutrients and micronutrients which are required for good health. Micronutrients are vitamins and minerals that are needed by the body in very small quantities but are important for normal functioning, growth and development. During pregnancy, these women often become more deficient, with the need to provide nutrition for the baby too, and this can impact on their health and that of their babies.</P>
<P>
<B>Why is this important?</B>
</P>
<P>Combining multiple micronutrients has been suggested as a cost-effective way to achieve multiple benefits for women during pregnancy. Micronutrient deficiencies are known to interact and a greater effect may be achieved by multiple supplementation rather than single-nutrient supplementation, although interactions may also lead to poor absorption of some of the nutrients. High doses of some nutrients may also cause harm to the mother or her baby.</P>
<P>
<B>What evidence did we find?</B>
</P>
<P>We searched Cochrane Pregnancy and Childbirth's Trials Register (11 March 2015). This systematic review included 19 trials involving 138,538 women, but only 17 trials involving 137,791 women contributed data. The included trials compared pregnant women who supplemented their diets with multiple micronutrients with iron and folic acid with pregnant women who received a placebo or supplementation with iron, with or without folic acid. Overall, pregnant women who received multiple-micronutrient supplementation had fewer low birthweight babies and small-for-gestational-age babies than pregnant women who received only iron, with or without folic acid. The evidence for the main outcomes was found to be of high quality.</P>
<P>
<B>What does this mean?</B>
</P>
<P>These findings, consistently observed in several other systematic reviews of evidence, provide a strong basis to guide the replacement of iron and folic acid with multiple-micronutrient supplements for pregnant women in low- and middle-income countries countries where multiple-micronutrient deficiencies are prevalent among women.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-03-10 15:33:26 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2015-10-22 08:48:06 +0100" MODIFIED_BY="Heather Maxwell">
<P>Multiple-micronutrient (MMN) deficiencies often coexist among women of reproductive age in low- to middle-income countries. They are exacerbated in pregnancy due to the increased demands, leading to potentially adverse effects on the mother and developing fetus. Though supplementation with MMNs has been recommended earlier because of the evidence of impact on pregnancy outcomes, a consensus is yet to be reached regarding the replacement of iron and folic acid supplementation with MMNs. Since the last update of this Cochrane review, evidence from a few large trials has recently been made available, the inclusion of which is critical to inform policy.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-04-20 16:22:01 +0100" MODIFIED_BY="[Empty name]">
<P>To evaluate the benefits of oral multiple-micronutrient supplementation during pregnancy on maternal, fetal and infant health outcomes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-03-23 10:00:22 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (11 March 2015) and reference lists of retrieved articles and key reviews. We also contacted experts in the field for additional and ongoing trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-10-02 20:45:47 +0100" MODIFIED_BY="[Empty name]">
<P>All prospective randomised controlled trials evaluating MMN supplementation with iron and folic acid during pregnancy and its effects on the pregnancy outcome were eligible, irrespective of language or the publication status of the trials. We included cluster-randomised trials, but quasi-randomised trials were excluded.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-10-23 12:27:11 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. The quality of the evidence was assessed using the GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-01-24 11:20:13 +0000" MODIFIED_BY="[Empty name]">
<P>Nineteen trials (involving 138,538 women) were identified as eligible for inclusion in this review but only 17 trials (involving 137,791 women) contributed data to the review. Fifteen of these 17 trials were carried out in low and middle-income countries and compared MMN supplements with iron and folic acid versus iron with or without folic acid. Two trials carried out in the UK compared MMN with a placebo.</P>
<P>
<B>MMN with iron and folic acid versus iron, with or without folic acid (15 trials):</B> MMN resulted in a significant decrease in the number of newborn infants identified as low birthweight (LBW) (average risk ratio (RR) 0.88, 95% confidence interval (CI) 0.85 to 0.91; <I>high-quality evidence</I>) or small-for-gestational age (SGA) (average RR 0.92, 95% CI 0.86 to 0.98; <I>moderate-quality evidence</I>). No significant differences were shown for other maternal and pregnancy outcomes: preterm births (average RR 0.96, 95% CI 0.90 to 1.03; <I>high-quality evidence</I>), stillbirth (average RR 0.97, 95% CI 0.87, 1.09; <I>high-quality evidence</I>), maternal anaemia in the third trimester (average RR 1.03, 95% CI 0.85 to 1.24), miscarriage (average RR 0.91, 95% CI 0.80 to 1.03), maternal mortality (average RR 0.97, 95% CI 0.63 to 1.48), perinatal mortality (average RR 1.01, 95% CI 0.91 to 1.13; <I>high-quality evidence)</I>, neonatal mortality (average RR 1.06, 95% CI 0.92 to 1.22; <I>high-quality evidence</I>), or risk of delivery via a caesarean section (average RR 1.04; 95% CI 0.74 to 1.46).</P>
<P>A number of prespecified, clinically important outcomes could not be assessed due to insufficient or non-available data. Single trials reported results for: very preterm birth &lt; 34 weeks, macrosomia, side-effects of supplements, nutritional status of children, and congenital anomalies including neural tube defects and neurodevelopmental outcome: Bayley Scales of Infant Development (BSID) scores. None of these trials reported pre-eclampsia, placental abruption, premature rupture of membranes, cost of supplementation, and maternal well-being or satisfaction.</P>
<P>When assessed according to GRADE criteria, the quality of evidence for the review's primary outcomes overall was good. Pooled results for primary outcomes were based on multiple trials with large sample sizes and precise estimates. The following outcomes were graded to be as of high quality: preterm birth, LBW, perinatal mortality, stillbirth and neonatal mortality. The outcome of SGA was graded to be of moderate quality, with evidence downgraded by one for funnel plot asymmetry and potential publication bias.</P>
<P>We carried out sensitivity analysis excluding trials with high levels of sample attrition (&gt; 20%); results were consistent with the main analysis except for the findings for SGA (average RR 0.91, 95% CI 0.84 to 1.00). We explored heterogeneity through subgroup analyses by maternal height and body mass index (BMI), timing of supplementation and dose of iron. Subgroup differences were observed for maternal BMI for the outcome preterm birth, with significant findings among women with low BMI. Subgroup differences were also observed for maternal BMI and maternal height for the outcome SGA, indicating a significant impact among women with higher maternal BMI and height. The overall analysis of perinatal mortality, although showed a non-significant effect of MMN supplements versus iron with or without folic acid, was found to have substantial statistical heterogeneity. Subgroup differences were observed for timing of supplementation for this outcome, indicating a significantly higher impact with late initiation of supplementation. The findings between subgroups for other primary outcomes were inconclusive.</P>
<P>
<B>MMN versus placebo (two trials):</B> A single trial in the UK found no clear differences between groups for preterm birth, SGA, LBW or maternal anaemia in the third trimester. A second trial reported the number of women with pre-eclampsia; there was no evidence of a difference between groups. Other outcomes were not reported.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-03-10 15:33:26 +0000" MODIFIED_BY="[Empty name]">
<P>Our findings support the effect of MMN supplements with iron and folic acid in improving some birth outcomes. Overall, pregnant women who received MMN supplementation had fewer low birthweight babies and small-for-gestational-age babies. The findings, consistently observed in several systematic evaluations of evidence, provide a basis to guide the replacement of iron and folic acid with MMN supplements containing iron and folic acid for pregnant women in low and middle-income countries where MMN deficiencies are common among women of reproductive age. Efforts could focus on the integration of this intervention in maternal nutrition and antenatal care programs in low and middle-income countries.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-03-16 12:53:33 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-03-10 15:33:57 +0000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2015-10-22 08:50:23 +0100" MODIFIED_BY="Heather Maxwell">
<P>Micronutrient deficiencies are common among women of reproductive age (15 to 49 years of age) (<LINK REF="REF-Black-2013" TYPE="REFERENCE">Black 2013</LINK>). Women in low- and middle-income countries often have limited intake of animal products, fruits, vegetables and fortified foods resulting in multiple-micronutrient (MMN) deficiencies (<LINK REF="REF-FAO_x002f_WHO-2004" TYPE="REFERENCE">FAO/WHO 2004</LINK>; <LINK REF="REF-Huffman-1998" TYPE="REFERENCE">Huffman 1998</LINK>). Pregnant women are at an increased risk of multiple deficiencies. These deficiencies are exacerbated during pregnancy because of the increased requirements of the growing fetus, placenta and maternal tissues. An inability to fulfil the increased requirements/demands results in potentially adverse effects on the mother and the fetus (<LINK REF="REF-Berti-2011" TYPE="REFERENCE">Berti 2011</LINK>).</P>
<P>Anaemia due to iron deficiency is one of the most prevalent micronutrient deficiencies globally. According to 2011 estimates, the worldwide prevalence of anaemia in pregnant women was 38% (95% confidence interval 33% to 43%), translating into 32 (28 to 36) million pregnant women globally (<LINK REF="REF-Stevens-2013" TYPE="REFERENCE">Stevens 2013</LINK>). More than 50% of these cases were due to iron deficiency in regions where fewer other causes were present. The majority of these women live in south Asia, and central and west Africa (<LINK REF="REF-Stevens-2013" TYPE="REFERENCE">Stevens 2013</LINK>). Anaemia during pregnancy has been found to be associated with increased risk of infants with low birthweight (LBW) (<LINK REF="REF-Haider-2013" TYPE="REFERENCE">Haider 2013</LINK>). It is also associated with an increased risk of maternal mortality (<LINK REF="REF-Murray_x002d_Kolb-2013" TYPE="REFERENCE">Murray-Kolb 2013</LINK>). Vitamin A deficiency is another important nutritional deficiency that leads to night blindness. According to the global estimates for the time period between 1995 and 2005, vitamin A deficiency measured using night blindness and low serum retinol levels affected 9.8 million (95% CI 8.7 to 10.8 million) and 19.1 million pregnant women (95% CI 9.30 to 29.0 million), respectively. This corresponds to 7.8% and 15.3% of pregnant women in populations at risk of vitamin A deficiency globally (<LINK REF="REF-WHO-2009" TYPE="REFERENCE">WHO 2009</LINK>). Deficiency of vitamin A was indicated to be associated with poor birth and mortality outcomes; however, supplementation with vitamin A during pregnancy has demonstrated no beneficial effect on these outcomes (<LINK REF="REF-Edmond-2012" TYPE="REFERENCE">Edmond 2012</LINK>; <LINK REF="REF-Tielsch-2008" TYPE="REFERENCE">Tielsch 2008</LINK>).</P>
<P>In the past decade, deficiency of vitamin D has also emerged as an important nutritional problem as women of reproductive age and those pregnant have been found to have low levels of vitamin D. High prevalence has not only been reported in studies conducted in low-income countries but also from high-income countries (<LINK REF="REF-Datta-2002" TYPE="REFERENCE">Datta 2002</LINK>; <LINK REF="REF-Ginde-2010" TYPE="REFERENCE">Ginde 2010</LINK>; <LINK REF="REF-Sachan-2005" TYPE="REFERENCE">Sachan 2005</LINK>). Iodine deficiency is also common among pregnant women. National surveys in several countries found lower than normal urinary iodine levels in pregnant women. The median urinary iodine level in a nationally representative sample of pregnant women in Nepal was reported to be 134 mcg/L (<LINK REF="REF-Benoist-2008" TYPE="REFERENCE">Benoist 2008</LINK>), indicating insufficient iodine intake (<LINK REF="REF-Andersson-2007" TYPE="REFERENCE">Andersson 2007</LINK>). Severe iodine deficiency during pregnancy results in pregnancy loss, mental retardation and cretinism (<LINK REF="REF-Dunn-1993" TYPE="REFERENCE">Dunn 1993</LINK>). Although severe deficiency is now rare, mild to moderate deficiency continues to be a problem (<LINK REF="REF-Andersson-2007" TYPE="REFERENCE">Andersson 2007</LINK>).</P>
<P>Deficiencies of other micronutrients are also common among pregnant women. According to the 2012 estimates, around 17% of the world&#8217;s population have reduced dietary intake of zinc (<LINK REF="REF-Wessells-2012" TYPE="REFERENCE">Wessells 2012</LINK>). Zinc deficiency has been associated with complications of pregnancy and delivery such as pre-eclampsia, premature rupture of membranes, congenital abnormalities in some studies (<LINK REF="REF-Black-2001" TYPE="REFERENCE">Black 2001</LINK>; <LINK REF="REF-Caulfield-1998" TYPE="REFERENCE">Caulfield 1998</LINK>). However, a review of trials of zinc supplementation showed a reduction in the risk of preterm birth only (<LINK REF="REF-Hess-2009" TYPE="REFERENCE">Hess 2009</LINK>; <LINK REF="REF-Ota-2015" TYPE="REFERENCE">Ota 2015</LINK>). Folic acid deficiency can lead to haematological consequences and congenital malformations; however, association with other birth outcomes is equivocal (<LINK REF="REF-Black-2001" TYPE="REFERENCE">Black 2001</LINK>; <LINK REF="REF-De_x002d_Regil-2010" TYPE="REFERENCE">De-Regil 2010</LINK>). Concurrent deficiencies have also been reported in studies conducted among pregnant women (<LINK REF="REF-Jiang-2005" TYPE="REFERENCE">Jiang 2005</LINK>; <LINK REF="REF-Pathak--2004" TYPE="REFERENCE">Pathak 2004</LINK>). These include deficiencies of vitamins A, D, E, riboflavin, B6, B12, folic acid, iron and zinc. Deficiencies of other minerals such as magnesium, selenium, copper and calcium have also been associated with complications of pregnancy, childbirth or fetal development (<LINK REF="REF-Black-2001" TYPE="REFERENCE">Black 2001</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-03-10 15:33:57 +0000" MODIFIED_BY="[Empty name]">
<P>The World Health Organization (WHO) currently recommends iron and folic acid supplementation for women during pregnancy as part of the routine antenatal care (<LINK REF="REF-WHO-2012" TYPE="REFERENCE">WHO 2012</LINK>). The recommended dose of iron ranges from 30 mg to 60 mg. In areas where anaemia is a severe public health problem, defined as a prevalence of 40% or higher; a daily dose of 60 mg of iron is preferred. The standard dose of 60 mg of iron was first recommended in 1959 and was based on maternal requirements during pregnancy (<LINK REF="REF-WHO-1959" TYPE="REFERENCE">WHO 1959</LINK>). Despite its provision as part of national antenatal care programs for the last few decades in most low and middle-income countries, the compliance with the supplement is low. The gastrointestinal side-effects including constipation, nausea, vomiting, and diarrhoea are the most common complaints among women consuming high dose of iron (<LINK REF="REF-Oriji-2011" TYPE="REFERENCE">Oriji 2011</LINK>; <LINK REF="REF-Seck-2008" TYPE="REFERENCE">Seck 2008</LINK>).</P>
<P>Supplementation with iron and folic acid during pregnancy has been found to be associated with reduction in the risk of maternal anaemia and infants with LBW (<LINK REF="REF-Haider-2013" TYPE="REFERENCE">Haider 2013</LINK>; <LINK REF="REF-Pena_x002d_Rosas-2015" TYPE="REFERENCE">Pena-Rosas 2015</LINK>). To overcome other possible maternal micronutrient deficiencies, the United Nations Children's Fund (UNICEF), United Nations University (UNU) and the WHO, in 1999, agreed on the composition of a proposed multiple-micronutrient (MMN) tablet (<LINK REF="REF-UNICEF-1999" TYPE="REFERENCE">UNICEF 1999</LINK>). This UNIMMAP tablet provides one recommended daily allowance of vitamin A, vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid, vitamin C, vitamin D, vitamin E, copper, selenium and iodine with 30 mg of iron and 15 mg of zinc for pregnant women. In contrast to the WHO recommendation, a lower dose of iron was recommended as the absorption of iron was expected to be enhanced due to vitamin C, vitamin A, and riboflavin, and given that the majority of pregnant women suffer from mild anaemia and the potential side-effects associated with higher doses of iron.</P>
</INTERVENTION>
<THEORY MODIFIED="2015-07-27 11:31:04 +0100" MODIFIED_BY="Nancy  Medley">
<P>Vitamins and minerals play critical roles in cellular metabolism, growth and maintenance of normal functioning of the human body. These are also important in many enzymatic processes, signal transduction and transcription pathways (<LINK REF="REF-McArdle-1999" TYPE="REFERENCE">McArdle 1999</LINK>; <LINK REF="REF-WHO-2004" TYPE="REFERENCE">WHO 2004</LINK>). Deficiencies of these micronutrients rarely exist in isolation. Additionally, because of their role at various levels in the biological pathways, it is difficult to assign a clinical or pre-clinical condition to the deficiency of a single micronutrient (<LINK REF="REF-McArdle-1999" TYPE="REFERENCE">McArdle 1999</LINK>). Micronutrient deficiencies are also known to interact. Combining MMN in a single delivery mechanism has been suggested as a cost-effective way to achieve multiple benefits.</P>
</THEORY>
<IMPORTANCE MODIFIED="2015-10-22 08:50:51 +0100" MODIFIED_BY="Heather Maxwell">
<P>The interest of the research community globally in eliminating these deficiencies is because of their significant impact on the health of the women and infants. The health effects during the fetal life may also have consequences later as an adult. Several trials have demonstrated that supplementation with MMN during pregnancy reduces the risk of micronutrient deficiencies (<LINK REF="REF-Haider-2012" TYPE="REFERENCE">Haider 2012</LINK>). The findings of the individual trials regarding the benefit on other maternal and pregnancy outcomes are inconsistent as the individual studies may not have statistical power to evaluate statistically significant effects on these outcomes. Several meta-analyses have systematically reviewed and synthesised the evidence of the effect of supplementation with these micronutrients, with the first such synthesis of evidence being an earlier version of this Cochrane review (<LINK REF="REF-Bhutta-2012" TYPE="REFERENCE">Bhutta 2012</LINK>; <LINK REF="REF-Haider-2006" TYPE="REFERENCE">Haider 2006</LINK>; <LINK REF="REF-Haider-2011" TYPE="REFERENCE">Haider 2011</LINK>; <LINK REF="REF-Haider-2012" TYPE="REFERENCE">Haider 2012</LINK>; <LINK REF="REF-Kawai-2011" TYPE="REFERENCE">Kawai 2011</LINK>; <LINK REF="REF-Ramakrishnan-2012a" TYPE="REFERENCE">Ramakrishnan 2012a</LINK>). On the basis of the evidence, supplementation with MMN during pregnancy has been recommended (<LINK REF="REF-Bhutta-2008" TYPE="REFERENCE">Bhutta 2008</LINK>; <LINK REF="REF-Bhutta-2013" TYPE="REFERENCE">Bhutta 2013</LINK>). However, a consensus is yet to be reached at regarding the replacement of iron and folic acid supplementation with MMN. Since the last update of this Cochrane review (<LINK REF="REF-Haider-2012" TYPE="REFERENCE">Haider 2012</LINK>), evidence from a few large trials has recently been made available, inclusion of which is critical to inform global policy.</P>
<P>This review updates a previously published Cochrane review on MMN supplementation during pregnancy that had demonstrated positive effect of supplementation on birth outcomes (<LINK REF="REF-Haider-2012" TYPE="REFERENCE">Haider 2012</LINK>). The effects of supplementation with individual micronutrients during pregnancy have been evaluated in other Cochrane reviews. The effect of MMN supplementation in HIV-infected pregnant women has been evaluated in another Cochrane review (<LINK REF="REF-Siegfried-2012" TYPE="REFERENCE">Siegfried 2012</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-10-22 08:51:04 +0100" MODIFIED_BY="Heather Maxwell">
<P>To evaluate the benefits of oral multiple-micronutrient (MMN) supplementation during pregnancy on maternal, fetal and infant outcomes.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-01-24 15:40:47 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-10-02 20:45:20 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-10-22 08:51:21 +0100" MODIFIED_BY="Heather Maxwell">
<P>All prospective randomised controlled trials evaluating multiple micronutrient (MMN) supplementation during pregnancy and its effects on the pregnancy outcome were eligible, irrespective of language or publication status of the trials. We included cluster-randomised trials, but quasi-randomised trials were excluded.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-10-22 08:51:26 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women. There was no limit on the length of gestation at the time of enrolment in the study. HIV-infected pregnant women were excluded from the review as this population is at a greater risk of nutritional disorders compared to uninfected women. We also excluded studies recruiting women at high risk of nutritional disorders for other reasons. The effect of MMN supplementation in HIV-infected pregnant women has been evaluated in another Cochrane review (<LINK REF="REF-Siegfried-2012" TYPE="REFERENCE">Siegfried 2012</LINK>).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-10-02 20:45:20 +0100" MODIFIED_BY="[Empty name]">
<P>Since WHO recommends use of iron folic acid supplementation in women during pregnancy as a part of routine antenatal care, we evaluated the effect of MMN supplementation with iron and folic acid in pregnant women versus supplementation with iron, with or without folic acid. Studies comparing the outcomes of providing pregnant women with MMN supplements with iron and folic acid compared to placebo was also included</P>
<P>We evaluated the effects of micronutrients that were different in the two groups and not any co-interventions. Trials that used fewer than three micronutrients in the intervention group were excluded regardless of their outcomes. There were no limits on the duration of supplementation.</P>
<P>The following specific comparisons were included in the review.</P>
<OL>
<LI>Multiple micronutrients with iron and folic acid versus control (iron with or without folic acid)</LI>
<LI>Multiple micronutrients versus control (placebo)</LI>
</OL>
<P>The review focuses on daily oral supplements; trials examining parenteral MMN or food fortification with MMN are not included.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-10-22 08:51:56 +0100" MODIFIED_BY="Heather Maxwell">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-10-22 08:51:45 +0100" MODIFIED_BY="Heather Maxwell">
<OL>
<LI>Preterm births (births before 37 weeks of gestation)</LI>
<LI>Small-for-gestational age (SGA) (as defined by the authors of the trials)</LI>
<LI>Low birthweight (LBW) (birthweight less than 2500 g)</LI>
<LI>Perinatal mortality</LI>
<LI>Stillbirths</LI>
<LI>Neonatal mortality</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-10-22 08:51:56 +0100" MODIFIED_BY="Heather Maxwell">
<OL>
<LI>Maternal anaemia (third trimester haemoglobin (Hb) &lt; 110 g/L)</LI>
<LI>Maternal mortality</LI>
<LI>Miscarriage (loss of pregnancy before 28 weeks of gestation)</LI>
<LI>Premature rupture of membranes</LI>
<LI>Pre-eclampsia</LI>
<LI>Mode of delivery: caesarean section (not prespecified)</LI>
<LI>Macrosomia (not prespecified)</LI>
<LI>Placental abruption</LI>
<LI>Very preterm births (births before 34 weeks of gestation)</LI>
<LI>Neurodevelopmental delay (assessed using Bayley Scale of Infant Development (BSID) at six and 12 months of age)</LI>
<LI>Nutritional status of children (stunting, wasting and underweight at six, 12 and 24 months of age)</LI>
<LI>Cost of supplementation</LI>
<LI>Side-effects of MMN supplements</LI>
<LI>Congenital anomalies (including neural tube defects)</LI>
<LI>Maternal well-being or satisfaction</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-03-23 10:10:05 +0000" MODIFIED_BY="[Empty name]">
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.<BR/>
</P>
<ELECTRONIC_SEARCHES MODIFIED="2015-03-23 10:10:05 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (11 March 2015).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE (Ovid);</LI>
<LI>weekly searches of Embase (Ovid);</LI>
<LI>monthly searches of CINAHL (EBSCO);</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE, Embase and CINAHL, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-03-23 10:09:53 +0000" MODIFIED_BY="[Empty name]">
<P>We searched reference lists of retrieved articles and key reviews. We contacted experts in the field for additional and ongoing trials.</P>
<P>We did not apply any language or date restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-01-24 15:40:47 +0000" MODIFIED_BY="[Empty name]">
<P>For methods used in the previous version of this review, <I>see </I>
<LINK REF="REF-Haider-2012" TYPE="REFERENCE">Haider 2012</LINK>.</P>
<P>For this update, the following methods were used for assessing the reports that were identified as a result of the updated search.</P>
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<STUDY_SELECTION MODIFIED="2015-08-10 11:42:08 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-08-07 11:54:13 +0100" MODIFIED_BY="[Empty name]">
<P>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-10-30 10:45:00 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<A HREF="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716&amp;format=REVMAN_GRAPHS#REF-Higgins-2011">Higgins 2011</A>). Any disagreement was resolved by discussion or by involving a third assessor.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re-include missing data in the analyses which we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We described for each included study any important concerns we had about other possible sources of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <I>Handbook</I> (<A HREF="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716&amp;format=REVMAN_GRAPHS#REF-Higgins-2011">Higgins 2011</A>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of the quality of the evidence using the GRADE approach</HEADING>
<P>For this update, the quality of the evidence was assessed using the GRADE approach as outlined in the <A HREF="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html">GRADE Handbook</A>. We assessed the quality of the body of evidence relating to the following outcomes for the comparison of MMN versus iron and folic acid supplements:</P>
<OL>
<LI>Preterm births</LI>
<LI>Small-for-gestational age (SGA)</LI>
<LI>Low birthweight (LBW)</LI>
<LI>Perinatal mortality</LI>
<LI>Stillbirths</LI>
<LI>Neonatal mortality</LI>
</OL>
<P>We used the <A HREF="http://www.gradepro.org/">GRADEpro</A> Guideline Development Tool to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create a 'Summary of findings' table. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence was downgraded from 'high quality' by one level for serious limitations (or by two levels for very serious), depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. We did not downgrade evidence for heterogeneity with an I² value of less than 60%, though we have noted moderate heterogeneity in the footnotes of the 'Summary of findings' table.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-05-15 09:47:46 +0100" MODIFIED_BY="Leanne V Jones">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>We used the mean difference if outcomes were measured in the same way between trials. In future updates as appropriate, we plan to use the standardised mean difference to combine trials that measure the same outcome, but use different methods.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2017-01-24 11:37:22 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>We included cluster-randomised trials in the analyses along with individually-randomised trials. We extracted cluster-adjusted effect estimates with their confidence intervals, which were analysed along with individually-randomised trials using the generic inverse variance method.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trials with multiple intervention groups</HEADING>
<P>For trials with multiple intervention groups, we selected one pair of interventions and excluded the others. This is one approach recommended by the Cochrane Handbook [16.5.4].</P>
<P>Trials with more than two intervention groups were included in the analysis after selecting the comparison groups (intervention and control groups) that satisfied the "types of intervention" criterion and were relevant to the review. For <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>, data for group 4 (MMN group with iron and folic acid) versus group 2 (control group iron with or without folic acid) were included. Groups 1 (folic acid with vitamin A) and 5 (vitamin A only) were not included since they did not satisfy the inclusion criterion of the review. Further, group 3 (iron, folic acid, vitamin A, and zinc) did not include the majority of micronutrients being considered for inclusion in a MMN supplement for pregnant women and was also not comparable to the UNIMMAP formulation proposed by UNICEF, UNU, and WHO. For <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>, groups 1 (MMN with iron and folic acid) and group 3 (iron and folic acid) were included in the review. The group with one RDA was selected since the MMN supplement in group 1 was comparable to the UNIMMAP formulation. For <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>, data for groups 3 (MMN with iron and folic acid) versus group 2 (iron and folic acid) fit the types of intervention criterion of the review and were included in the analyses. Similarly, data for the comparison of groups 3 (MMN with iron and folic acid) versus 2 (iron and folic acid) were included for <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>. Group 1 in both <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK> and <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK> had received folic acid only and did not satisfy the control definition of the review.</P>
<P>If more than two intervention groups had met the eligibility criteria, we would have combined groups to create a single pair-wise comparison [16.5.4] the Cochrane Handbook<I>.</I>
</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2015-10-22 08:53:12 +0100" MODIFIED_BY="Heather Maxwell">
<P>For included studies, we noted levels of attrition. We assessed the impact of including studies with high levels of missing data (&gt; 20%) in the overall assessment of treatment effect by using sensitivity analysis. For all outcomes, analyses were carried out, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-10-22 08:53:12 +0100" MODIFIED_BY="Heather Maxwell">
<P>We assessed statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. If we identified substantial heterogeneity (above 30%), we explored it by pre-specified subgroup analysis. </P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-05-08 15:12:23 +0100" MODIFIED_BY="[Empty name]">
<P>Where there are 10 or more studies in the meta-analysis, we investigated reporting biases (such as publication bias) using funnel plots. We assessed funnel plot asymmetry visually.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-10-22 08:53:20 +0100" MODIFIED_BY="Heather Maxwell">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar.</P>
<P>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary was treated as the average range of possible treatment effects, and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. If we used random-effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2015-10-22 08:53:25 +0100" MODIFIED_BY="Heather Maxwell">
<P>If we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, we used random-effects analysis to produce it.</P>
<P>We carried out the following subgroup analyses.</P>
<OL>
<LI>Timing of supplementation (categorised as either before or after 20 weeks of gestation)</LI>
<LI>Dose of iron in the MMN and control supplements (30 mg versus 60 mg of iron)</LI>
<LI>Baseline nutritional status of the mother (including body mass index (BMI) and height)</LI>
</OL>
<P>We assessed subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-01-24 15:40:47 +0000" MODIFIED_BY="[Empty name]">
<P>We carried out sensitivity analyses to explore the effect of trial quality assessed by high attrition rates, with poor quality studies being excluded from the analyses in order to assess whether this made any difference to the overall result.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-03-16 12:53:33 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-03-16 12:53:33 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2017-03-16 12:53:33 +0000" MODIFIED_BY="[Empty name]">
<P>For the 2015 update, 81 new reports were assessed for inclusion. We included two new trials in this update (<LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>).</P>
<P>Nineteen trials (involving 138,538 women) were identified as eligible for inclusion in this review but only 17 trials (involving 137,791 women) contributed data to the review. We excluded 97 trials. Two trials are in the <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> section (<LINK REF="STD-Ashorn-2015" TYPE="STUDY">Ashorn 2015</LINK>; <LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>). We have contacted authors to see if separate analyses for HIV- women are available in one trial (<LINK REF="STD-Ashorn-2015" TYPE="STUDY">Ashorn 2015</LINK>) and are seeking clarification on missing group denominators in the second trial (<LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012</LINK>). There are seven ongoing trials (<LINK REF="STD-Biggs-2011" TYPE="STUDY">Biggs 2011</LINK>; <LINK REF="STD-Dewey-2011" TYPE="STUDY">Dewey 2011</LINK>; <LINK REF="STD-Hirschberg-2014" TYPE="STUDY">Hirschberg 2014</LINK>; <LINK REF="STD-Moore-2011" TYPE="STUDY">Moore 2011</LINK>; <LINK REF="STD-Mridha-2014" TYPE="STUDY">Mridha 2014</LINK>; <LINK REF="STD-Ramakrishnan-2012" TYPE="STUDY">Ramakrishnan 2012</LINK>; <LINK REF="STD-Tu-2013" TYPE="STUDY">Tu 2013</LINK>). <I>See</I> <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK> for more information.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-10-02 21:49:47 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 19 trials (involving 138,538 women) were identified as eligible for inclusion in this review. Of these, two studies (<LINK REF="STD-Hininger-2004" TYPE="STUDY">Hininger 2004</LINK>; <LINK REF="STD-Sood-1975" TYPE="STUDY">Sood 1975</LINK>) either did not report outcomes that were of interest in this review or presented data in a format that precluded their inclusion. Hence, these studies did not contribute data to the analyses. A total of 137,791 women participated in the remaining 17 included trials (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>), of which seven were cluster-randomised (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). Three trials were conducted in developed countries (<LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Hininger-2004" TYPE="STUDY">Hininger 2004</LINK>; <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>). Most of the outcomes were defined in the same way across different trials except for anaemia for which different cut-offs were used in two trials (<LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). <I>See</I> the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table for further details of included studies.</P>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>The 17 included trials contributing data to the analysis included 137,791 pregnant women at varying gestational stages, ranging from early pregnancy to 36 weeks of gestation. Pregnant women with a haemoglobin (Hb) of less than 80 g/L, with a serious medical condition or a complication of pregnancy such as cardiac disease, pneumonia and threatened abortion were not eligible for inclusion in the trials. One trial (<LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>) included a subgroup of pregnant women who were HIV-1 infected but the data for this subgroup were not included in the review. Baseline characteristics of the participants in the intervention and the control groups were comparable in the included trials except for minor differences in five trials (<LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>); and these characteristics were not reported in one trial (<LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>). In <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>, a higher proportion of primigravidae were found in the placebo group. In <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>, there was a higher proportion of single mothers and a lower mean BMI in the intervention group. In <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>, more participants in the control group belonged to a specific ethnic background and owned land. In <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>, the Hb level was lower in the intervention group and the BMI was lower in the control group. In <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>, the intervention group had more households and preventive measures against malaria, whereas the placebo group had less education and more poverty.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention</HEADING>
<P>Fourteen trials assessed MMN supplementation versus control (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). Two trials also had a component of nutritional education along with supplementation (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>). Three supplementation trials assessed MMN against a placebo (<LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>); however, in <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK> and <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>, all participants received iron and folic acid supplements. In <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>, participants not taking folic acid were asked to take it daily.</P>
<P>The composition of the MMN supplement was different in all included trials. Fourteen trials included iron and folic acid in the MMN supplement (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). All supplements were given orally to the pregnant women throughout pregnancy from the time of enrolment. However, the duration of supplementation varied because the time of enrolment differed across the trials. Seven trials enrolled participants in the first trimester of pregnancy (<LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>). One trial enrolled participants with a gestation of less than 20 weeks (<LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>), and another less than 28 weeks (<LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). Three trials enrolled participants in the second trimester (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>), one trial enrolled women in both second and third trimester (<LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>), while three trials enrolled pregnant women who were less than 37 weeks' gestation (<LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>). Supplementation was given until delivery in 10 of the included trials (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). Supplementation continued until four weeks after delivery in one trial (<LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>), six weeks after delivery in the <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK> trial, 12 weeks after delivery in four trials (<LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>), and for five weeks after a stillbirth or miscarriage (<LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-10-22 08:54:10 +0100" MODIFIED_BY="Heather Maxwell">
<P>Ninety-seven trials were excluded from the review. Briefly, 36 trials evaluated the effects of a single or two micronutrients or compounds (<LINK REF="STD-Beazley-2002" TYPE="STUDY">Beazley 2002</LINK>; <LINK REF="STD-Bergmann-2006" TYPE="STUDY">Bergmann 2006</LINK>; <LINK REF="STD-Carrasco-1962" TYPE="STUDY">Carrasco 1962</LINK>; <LINK REF="STD-Caulfield-1999" TYPE="STUDY">Caulfield 1999</LINK>; <LINK REF="STD-Caulfield-1999a" TYPE="STUDY">Caulfield 1999a</LINK>; <LINK REF="STD-Chames-2002" TYPE="STUDY">Chames 2002</LINK>; <LINK REF="STD-Goldenberg-1995" TYPE="STUDY">Goldenberg 1995</LINK>; <LINK REF="STD-Gopalan-2004" TYPE="STUDY">Gopalan 2004</LINK>; <LINK REF="STD-Hillman-1963" TYPE="STUDY">Hillman 1963</LINK>; <LINK REF="STD-Holly-1955" TYPE="STUDY">Holly 1955</LINK>; <LINK REF="STD-Hossain-2014" TYPE="STUDY">Hossain 2014</LINK>; <LINK REF="STD-Hunt-1983" TYPE="STUDY">Hunt 1983</LINK>; <LINK REF="STD-Hunt-1984" TYPE="STUDY">Hunt 1984</LINK>; <LINK REF="STD-Hunt-1985" TYPE="STUDY">Hunt 1985</LINK>; <LINK REF="STD-Iannotti-2008" TYPE="STUDY">Iannotti 2008</LINK>; <LINK REF="STD-Lucia-2007" TYPE="STUDY">Lucia 2007</LINK>; <LINK REF="STD-Ma-2008" TYPE="STUDY">Ma 2008</LINK>; <LINK REF="STD-Malvasi-2014" TYPE="STUDY">Malvasi 2014</LINK>; <LINK REF="STD-Marya-1987" TYPE="STUDY">Marya 1987</LINK>; <LINK REF="STD-Mathan-1979" TYPE="STUDY">Mathan 1979</LINK>; <LINK REF="STD-Merialdi-1999" TYPE="STUDY">Merialdi 1999</LINK>; <LINK REF="STD-Muslimatun-2001a" TYPE="STUDY">Muslimatun 2001a</LINK>; <LINK REF="STD-Muslimatun-2001b" TYPE="STUDY">Muslimatun 2001b</LINK>; <LINK REF="STD-Ochoa_x002d_Brust-2007" TYPE="STUDY">Ochoa-Brust 2007</LINK>; <LINK REF="STD-Raqib-2013" TYPE="STUDY">Raqib 2013</LINK>; <LINK REF="STD-Robertson-1991" TYPE="STUDY">Robertson 1991</LINK>; <LINK REF="STD-Sachdeva-1993" TYPE="STUDY">Sachdeva 1993</LINK>; <LINK REF="STD-Sagaonkar-2009" TYPE="STUDY">Sagaonkar 2009</LINK>; <LINK REF="STD-Salzano-2001" TYPE="STUDY">Salzano 2001</LINK>; <LINK REF="STD-Schmidt-2001" TYPE="STUDY">Schmidt 2001</LINK>; <LINK REF="STD-Schmidt-2002" TYPE="STUDY">Schmidt 2002</LINK>; <LINK REF="STD-Semba-2000" TYPE="STUDY">Semba 2000</LINK>; <LINK REF="STD-Semba-2001" TYPE="STUDY">Semba 2001</LINK>; <LINK REF="STD-Suharno-1993" TYPE="STUDY">Suharno 1993</LINK>; <LINK REF="STD-Suprapto-2002" TYPE="STUDY">Suprapto 2002</LINK>; <LINK REF="STD-Tanumihardjo-2002" TYPE="STUDY">Tanumihardjo 2002</LINK>; <LINK REF="STD-Zavaleta-2000" TYPE="STUDY">Zavaleta 2000</LINK>). Twelve trials did not satisfy the study design criteria (<LINK REF="STD-Aguayo-2005" TYPE="STUDY">Aguayo 2005</LINK>; <LINK REF="STD-Biswas-1984" TYPE="STUDY">Biswas 1984</LINK>; <LINK REF="STD-Kubik-2004" TYPE="STUDY">Kubik 2004</LINK>; <LINK REF="STD-Kynast-1986" TYPE="STUDY">Kynast 1986</LINK>; <LINK REF="STD-Itam-2003" TYPE="STUDY">Itam 2003</LINK>; <LINK REF="STD-Menon-1962" TYPE="STUDY">Menon 1962</LINK>; <LINK REF="STD-Patimah-2013" TYPE="STUDY">Patimah 2013</LINK>; <LINK REF="STD-Park-1999" TYPE="STUDY">Park 1999</LINK>; <LINK REF="STD-People_x0027_s-League-1946" TYPE="STUDY">People's League 1946</LINK>; <LINK REF="STD-Sun-2010" TYPE="STUDY">Sun 2010</LINK>; <LINK REF="STD-Thauvin-1992" TYPE="STUDY">Thauvin 1992</LINK>; <LINK REF="STD-Wijaya_x002d_Erhardt-2014" TYPE="STUDY">Wijaya-Erhardt 2014</LINK>), and five trials studied HIV-positive women (<LINK REF="STD-Fawzi-1998" TYPE="STUDY">Fawzi 1998</LINK>; <LINK REF="STD-Khavari-2014" TYPE="STUDY">Khavari 2014</LINK>; <LINK REF="STD-Merchant-2005" TYPE="STUDY">Merchant 2005</LINK>; <LINK REF="STD-Olofin-2014" TYPE="STUDY">Olofin 2014</LINK>; <LINK REF="STD-Webb-2009" TYPE="STUDY">Webb 2009</LINK>) and hence were excluded from the review. In four trials, MMN supplements were given to both groups of patients (<LINK REF="STD-Asemi-2014" TYPE="STUDY">Asemi 2014</LINK>; <LINK REF="STD-Dawson-1987" TYPE="STUDY">Dawson 1987</LINK>; <LINK REF="STD-Dawson-1998" TYPE="STUDY">Dawson 1998</LINK>; <LINK REF="STD-Magon-2014" TYPE="STUDY">Magon 2014</LINK>). <LINK REF="STD-Czeizel-1996" TYPE="STUDY">Czeizel 1996</LINK>, <LINK REF="STD-ICMR-2000" TYPE="STUDY">ICMR 2000</LINK>, <LINK REF="STD-Cooper-2012" TYPE="STUDY">Cooper 2012</LINK>, and <LINK REF="STD-Khulan-2012" TYPE="STUDY">Khulan 2012</LINK> evaluated supplementation in the periconceptional period, and <LINK REF="STD-Nguyen-2012" TYPE="STUDY">Nguyen 2012</LINK> evaluated the effect of pre-conception supplementation. <LINK REF="STD-An-2001" TYPE="STUDY">An 2001</LINK>, <LINK REF="STD-Guldholt-1991" TYPE="STUDY">Guldholt 1991</LINK>, <LINK REF="STD-Graham-2007" TYPE="STUDY">Graham 2007</LINK>, <LINK REF="STD-Fleming-1986" TYPE="STUDY">Fleming 1986</LINK>, and <LINK REF="STD-Wibowo-2012" TYPE="STUDY">Wibowo 2012</LINK> assessed different doses of micronutrients; <LINK REF="STD-Agarwal-2012" TYPE="STUDY">Agarwal 2012</LINK> evaluated different durations of the same micronutrients, while <LINK REF="STD-Feyi_x002d_Waboso-2005" TYPE="STUDY">Feyi-Waboso 2005</LINK> and <LINK REF="STD-Nwagha-2010" TYPE="STUDY">Nwagha 2010</LINK> evaluated parenteral infusion or injection. <LINK REF="STD-Ramirez_x002d_Velez-2011" TYPE="STUDY">Ramirez-Velez 2011</LINK> compared nine versus three micronutrients, and <LINK REF="STD-Ling-1996" TYPE="STUDY">Ling 1996</LINK> evaluated a herbal tonic. <LINK REF="STD-Li-2014" TYPE="STUDY">Li 2014</LINK> evaluated the effect of supplementation with folic acid and milk. Four excluded trials assessed the effect of fortification with MMN (<LINK REF="STD-Dieckmann-1944" TYPE="STUDY">Dieckmann 1944</LINK>; <LINK REF="STD-Jarvenpaa-2007" TYPE="STUDY">Jarvenpaa 2007</LINK>; <LINK REF="STD-Tatala-2002" TYPE="STUDY">Tatala 2002</LINK>; <LINK REF="STD-Vadillo_x002d_Ortega-2011" TYPE="STUDY">Vadillo-Ortega 2011</LINK>). Two trials included high-risk women (<LINK REF="STD-Gupta-2007" TYPE="STUDY">Gupta 2007</LINK>; <LINK REF="STD-Rumiris-2006" TYPE="STUDY">Rumiris 2006</LINK>). Eight trials were excluded because they evaluated the acceptability of different forms of supplementation such as powder, tablet or spread (<LINK REF="STD-Choudhury-2012" TYPE="STUDY">Choudhury 2012</LINK>; <LINK REF="STD-Hambidge-2014" TYPE="STUDY">Hambidge 2014</LINK>; <LINK REF="STD-Lanou-2014" TYPE="STUDY">Lanou 2014</LINK>; <LINK REF="STD-Young-2010" TYPE="STUDY">Young 2010</LINK>); balanced energy protein supplementation (<LINK REF="STD-Huybregts-2009" TYPE="STUDY">Huybregts 2009</LINK>; <LINK REF="STD-Huybregts-2013" TYPE="STUDY">Huybregts 2013</LINK>); weekly food provision (<LINK REF="STD-Wijaya_x002d_Erhardt-2011" TYPE="STUDY">Wijaya-Erhardt 2011</LINK>); or polyunsaturated fatty acids fortification in milk fortified with MMN (<LINK REF="STD-Mardones-2007" TYPE="STUDY">Mardones 2007</LINK>). The cohort of an included study (<LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>) was later randomised to breastfeeding counselling or standard care groups measuring the impact on postnatal growth in children (<LINK REF="STD-Kabir-2009" TYPE="STUDY">Kabir 2009</LINK>) and hence was excluded. <LINK REF="STD-Leroy-2010" TYPE="STUDY">Leroy 2010</LINK> was excluded because it compared a traditional food assisted MCHN program versus a newly designed approach to prevent malnutrition in children. One abstract of a trial was excluded because it was a trial in women with alcohol consumption during pregnancy (<LINK REF="STD-Kable-2012" TYPE="STUDY">Kable 2012</LINK>).</P>
<P>
<LINK REF="STD-Fall-2007" TYPE="STUDY">Fall 2007</LINK> was moved from ongoing to excluded for the 2015 update because it is not a trial of supplementation.</P>
<P>
<I>See </I>the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table for more details.</P>
<P>One abstract comparing MMN supplements versus iron folic acid remains in awaiting assessment due to missing group denominators (<LINK REF="STD-Gathwala-2012" TYPE="STUDY">Gathwala 2012)</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-10-23 12:03:19 +0100" MODIFIED_BY="[Empty name]">
<P>The methodological quality of the included studies was generally good with at least 50% of the judgements at "low risk" for the various domains. It is unlikely that the evidence presented in this review is affected by the biases evaluated.</P>
<P>
<I>See</I> <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table for further details on the methodological quality of the included studies.<BR/>
</P>
<ALLOCATION MODIFIED="2015-10-23 12:02:45 +0100" MODIFIED_BY="[Empty name]">
<P>The included trials were of variable methodological quality. Participants were adequately randomised to the treatment groups in 14 trials (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>;<LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-Sood-1975" TYPE="STUDY">Sood 1975</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>), whereas the method used for generating the randomisation sequence was not described in sufficient detail in the remaining studies to permit judgement.</P>
<P>Allocation of participants in to the intervention and control groups was concealed in nine trials (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>); it was unclear in seven trials (<LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Hininger-2004" TYPE="STUDY">Hininger 2004</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>); whereas allocation was not probably concealed in the remaining three trials (<LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Sood-1975" TYPE="STUDY">Sood 1975</LINK>; <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2015-10-23 12:03:02 +0100" MODIFIED_BY="[Empty name]">
<P>In two trials (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>), the participants and the outcome assessors were blinded to the treatment allocation. Another 15 trials showed blinding of the participants, caregivers and the outcome assessors (<LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Hininger-2004" TYPE="STUDY">Hininger 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). However, <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK> showed blinding of participants only and <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK> indicated blinding only of outcome assessors.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2015-10-23 12:03:19 +0100" MODIFIED_BY="[Empty name]">
<P>Loss to follow-up was less than 5% in two trials (<LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>); between 5% to 9.9% in six trials (<LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>); and between 10% to 19.9% in four trials (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>). It was more than 20% in six trials (<LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Hininger-2004" TYPE="STUDY">Hininger 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Sood-1975" TYPE="STUDY">Sood 1975</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>); and not reported in <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>. In <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>, although attrition was 5% and reasons for it were reported, exclusion was 39.5% and reasons were not reported and so it has been assessed as being at "high risk". Intention-to-treat analysis was used in all of the trials. In this review, an intention-to-treat analysis was conducted for all outcome measures.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2015-01-22 00:10:25 +0000" MODIFIED_BY="[Empty name]">
<P>There was no indication of selective reporting in any of the included trials. All outcomes mentioned in the methods section or the protocol were presented in the various published papers of the trials.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2015-05-15 12:05:17 +0100" MODIFIED_BY="Leanne V Jones">
<P>No other potential sources of bias were identified in most of the included trials.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-03-10 15:34:17 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1: Multiple micronutrients (MMN) versus control (all trials)</HEADING>
<P>Seventeen trials contributed data to this comparison, however, 15 of these 17 trials were carried out in low- and middle-income countries and compared MMN supplements with iron and folic acid versus iron, with or without folic acid. Two trials carried out in the UK compared MMN with a placebo and contributed data to a very limited number of outcomes. In view of the differences in the settings where trials were conducted, and the in control group conditions, we have presented results separately in the forest plots and in the text <I>below</I>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Multiple micronutrients (MMN) with iron and folic acid versus iron, with or without folic acid</HEADING>
<P>In this comparison, we included 15 trials conducted in low and middle-income countries and evaluating UNIMMAP or similar formulations (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). In two trials (<LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>), women received iron and folic acid as separate supplements, and in one trial (<LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>), women in the control group received iron only.</P>
<SUBSECTION>
<HEADING LEVEL="5">Primary outcomes</HEADING>
<P>When MMN supplementation was compared against iron with or without folic acid supplementation, there was a reduction in small-for-gestational age (SGA) (average risk ratio (RR) 0.92, 95% confidence interval (CI) 0.86 to 0.98; studies = 14; random-effects, Tau² = 0.00, I² = 48%; <I>moderate-quality evidence;</I> <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) and low birthweight (LBW) (average RR 0.88, 95% CI 0.85 to 0.91; studies = 15; <I>high-quality evidence;</I> <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). No differences were observed between groups for the other primary outcomes: preterm births (average RR 0.96, 95% CI 0.90 to 1.03; studies = 15; random-effects, Tau² = 0.01, I² = 52%; <I>high-quality evidence;</I> <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>), perinatal mortality (average RR 1.01, 95% CI 0.91 to 1.13; studies = 13; random-effects, Tau² = 0.01, I² = 46%; <I>high-quality evidence; </I>
<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>), stillbirth (average RR 0.97, 95% CI 0.87 to 1.09; studies = 15; random-effects, Tau² = 0.01, I² = 26%; <I>high-quality evidence; </I>
<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>), and neonatal mortality (average RR 1.06, 95% CI 0.92 to 1.22; studies = 11; random-effects, Tau² = 0.01, I² = 31%; <I>high-quality evidence;</I> <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
<P>It should be noted that the data for SGA for the following trials (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>; <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>; <LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-Sunawang-2009" TYPE="STUDY">Sunawang 2009</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>; <LINK REF="STD-Zagre-2007" TYPE="STUDY">Zagre 2007</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>) was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial reports. For this data from the <LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>, the following were excluded: "<I>women known to be HIV-positive, women known to have multiple pregnancy, fetal losses before 28 weeks, stillbirths, infants with gestational age at delivery &lt; 189 or &gt; 314 days, and babies measured &gt; 72 hours after birth. Only one pregnancy (the earliest) was included for each mother</I>."</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary outcomes</HEADING>
<P>MMN supplementation when compared against iron, with or without, folic acid showed no significant impact on maternal anaemia in the third trimester (average RR 1.03, 95% CI 0.85 to 1.24; studies = four; random-effects, Tau² = 0.02, I² = 54%; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). Similarly, no statistically significant difference was seen for the outcomes of miscarriage (average RR 0.91, 95% CI 0.80 to 1.03; studies = eight; random-effects, Tau² = 0.00, I² = 0%; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>), delivery via a caesarean section (average RR 1.04, 95% CI 0.74 to 1.46; studies = four; random-effects, Tau² = 0.00, I² = 0%; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>), and maternal mortality (average RR 0.97, 95% CI 0.63 to 1.48; studies = three; random-effects, Tau² = 0.00, I² = 0%; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P>
<P>A number of prespecified clinically important outcomes could not be assessed due to insufficient data from the included trials. These included the following outcomes, which were measured either only in one trial or in none, or were presented in a format which precluded their inclusion in the analysis: placental abruption, congenital anomalies including neural tube defects (<LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>), pre-eclampsia, very preterm birth (<LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>), side-effects of MMN supplementation (<LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>), and neurodevelopmental delay (<LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>). Additional important outcomes are: macrosomia (<LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>), cost of supplementation, maternal well-being or satisfaction, and nutritional status of the children (<LINK REF="STD-Roberfroid-2008" TYPE="STUDY">Roberfroid 2008</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Multiple micronutrients (MMN) versus placebo</HEADING>
<P>Two trials conducted in the UK (<LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK>) contributed data; in the <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK> trial women in the control group were advised to take folic acid. The <LINK REF="STD-Theobald-1937" TYPE="STUDY">Theobald 1937</LINK> trial contributed data to one outcome only, and showed no clear differences between groups for pre-eclampsia (average RR 0.67, 95% CI 0.12 to 3.74; <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). In the <LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK> trial, 402 women were randomised; women receiving supplements were at reduced risk of anaemia in the third trimester (average RR 0.46, 95% CI 0.29 to 0.73; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>), but there were no clear differences between women receiving supplements and those in the placebo group for any of the other outcomes reported; preterm birth (average RR1.10, 95% CI 0.41 to 2.95; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>); SGA (average RR 0.93, 95% CI 0.53 to1.63; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>); or LBW (average RR 1.63, 95% CI 0.66 to 4.03; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis (Data shown in Comparison 2) multiple micronutrients (MMN) with iron and folic acid versus iron with or without folic acid)</HEADING>
<P>For the trials comparing MNN with iron and folic acid versus iron with or without folic acid (15 trials), we found substantial heterogeneity in the analyses for preterm birth, SGA, and perinatal mortality and explored its presence through subgroup analyses.</P>
<P>For the outcome preterm birth, MMN supplementation led to fewer preterm births for women in a subgroup of trials with mean maternal BMI of less than 20 kg/m² (average RR 0.85, 95% CI 0.80 to 0.90; studies = four), but not for women with a higher BMI (average RR 1.02, 95% CI 0.97 to 1.07; studies = 11); the test for subgroup differences was significant P &lt; 0.00001, I² = 95.6%) <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>. There were no group differences for the subgroups based on the timing of supplementation (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>), maternal height (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>), or for dose of iron for the outcome of preterm birth (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>) (all p&gt;0.05).</P>
<P>Subgroup analysis based on mean maternal BMI showed that the effect of MMN on SGA as compared to iron, with or without folic acid, was significant for the subgroup of trials with mean maternal BMI of at least 20 kg/m² (average RR 0.86, 95% CI 0.81 to 0.92; studies = 10), while it was non-significant for the subgroup with mean maternal BMI of less than 20 kg/m² (average RR 1.00, 95% CI 0.95 to 1.05; studies = four; test for subgroup differences P = 0.001, I² = 90.7%) <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>. Similarly, a significant difference was observed between the subgroup of studies based on maternal height (<LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>). The effect on SGA was significant in the subgroup with mean maternal height of at least 154.9 cm, while it was not significant in the subgroup with mean maternal height of less than 154.9 cm (average RR 0.82, 95% CI 0.76 to 0.89; studies = six) versus (average RR 0.99, 95% CI 0.97 to 1.01; studies = eight; test for subgroup differences P &lt; 0.0001, I² = 94.6%), <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>. Finally, the subgroup differences by the timing of supplementation and different doses of iron were tested and found tobe non-significant (both p&gt;0.05) (<LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>, <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>, respectively).</P>
<P>The overall analysis of perinatal mortality, although showing a non-significant effect of MMN supplements versus iron with or without folic acid, was found to have substantial statistical heterogeneity. Tests for subgroup differences did not show clear differences between subgroups based on mean maternal BMI, mean maternal height, and dose of iron (all P &gt;0.05). However, statistically significant differences were observed between subgroups based on the timing of supplementation. The reduction in perinatal mortality was significantly higher in the subgroup with supplementation after 20 weeks (average RR 0.88, 95% CI 0.80, 0.97; studies = three), while it was non-significant in the subgroup with supplementation before 20 weeks (average RR 1.13, 95% CI 0.96, 1.33; studies = ten), <LINK REF="CMP-002.11" TYPE="ANALYSIS">Analysis 2.11</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis (Data shown in Comparison 3)(multiple micronutrients (MMN) with iron and folic acid versus iron, with or without folic acid)</HEADING>
<P>Sensitivity analysis was undertaken to study the effect of MMN supplementation on various outcomes by excluding trials with loss to follow-up of more than 20% (<LINK REF="STD-Friis-2004" TYPE="STUDY">Friis 2004</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Ramakrishnan-2003" TYPE="STUDY">Ramakrishnan 2003</LINK>; <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>) from the analyses. This exclusion did not affect the significance of the findings for the outcomes.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-03-10 15:35:56 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2016-08-08 22:10:18 +0100" MODIFIED_BY="[Empty name]">
<P>Nineteen trials (involving 138,538 women) were identified as eligible for inclusion in this review. However, only 17 trials (involving 137,791 women) contributed data to the review. This update summarises the current evidence on the effect of multiple-micronutrients (MMN) supplementation during pregnancy on fetal, infant, and maternal outcomes. Overall, MMN supplementation with iron and folic acid versus supplementation with iron (with or without folic acid) showed a 8% reduction in the risk of small-for-gestational age (SGA) births and a 12% reduction in the risk of low birthweight (LBW). A summary of the main findings for trials comparing MMN with iron and folic acid verus iron with or without folic acid is presented in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-03-10 15:35:24 +0000" MODIFIED_BY="[Empty name]">
<P>This review included a total of 19 trials evaluating the effect of MMN supplementation but only 17 contributed data. Trials conducted as early as 1937 were included in the review. All trials evaluating UNIMMAP supplement proposed in 1999 by UNICEF, UNU, and WHO and starting recruitment of participants as early as 2001 were included in the analysis. Inclusion of these and older trials, identified as a result of an extensive search of literature published over the last several decades, represents overall completeness of evidence.</P>
<P>As iron with folic acid are recommended for pregnant women in low and middle-income countries, we primarily evaluated the effect of adding additional micronutrients to the iron and folic acid supplement. Most of the included trials were conducted in low- and middle-income countries and included pregnant women at varying gestational stages, ranging from early pregnancy to 36 weeks of gestation. Pregnant women with serious medical conditions, such as, cardiac disease or respiratory infections, were excluded from the trials.</P>
<P>
<B>Comparison 1: multiple micronutrients (MMN) with iron and folic acid versus control </B>(iron with or without folic acid) resulted in a significant decrease in the number of newborn infants identified as LBW or SGA. No significant differences were shown for other maternal and pregnancy outcomes: preterm births, maternal anaemia in the third trimester, miscarriage, maternal mortality, perinatal mortality, stillbirth, neonatal mortality, or risk of delivery via a caesarean section. A number of prespecified, clinically important outcomes could not be assessed due to insufficient or non-available data. Single trials reported results for: very preterm birth &lt; 34 weeks, macrosomia, side-effects of supplements, nutritional status of children, and congenital anomalies including neural tube defects and neurodevelopmental outcome: Bayley Scales of Infant Development (BSID) scores. No trial reported pre-eclampsia, placental abruption, premature rupture of membranes, cost of supplementation, and maternal well-being or satisfaction.</P>
<P>Supplementation with MMN with iron and folic acid versus iron with or without folic acid reduced the risk of LBW and SGA. One of the postulated pathways for this finding is through an increase in birthweight; higher birthweight resulting in lower proportion of LBW and SGA births. Most of the studies included in these analyses demonstrated an increase in birthweight as a result of supplementation with MMN. During pregnancy, the increase in weight of the fetus occurs during the third trimester and this is a potential window of opportunity to improve birthweight. Importantly, a major proportion of women in these studies were taking supplements in the third trimester as several studies recruited pregnant women in the first trimester with supplementation starting in the second trimester; whereas the others recruited almost 80% of their participants by the end of the second trimester. This provides support to the postulated pathway as the intervention was in place much before the beginning of third trimester. Furthermore, since MMN supplementation did not show an impact on preterm birth, which is an underlying cause of LBW, this finding cannot be attributed to a longer duration of gestation.</P>
<P>Most of the studies included in this review were undertaken in low and middle-income countries with high fertility rates, low maternal body mass index (BMI), a high prevalence of iron-deficiency anaemia, and frequent subclinical micronutrient deficiencies (<LINK REF="REF-Bhutta-2008" TYPE="REFERENCE">Bhutta 2008</LINK>). Studies have shown that a significant proportion of pregnant women suffer from MMN deficiencies at the same time. These have been associated with poor pregnancy outcomes including LBW (<LINK REF="REF-Allen-2005" TYPE="REFERENCE">Allen 2005</LINK>; <LINK REF="REF-Keen-2003" TYPE="REFERENCE">Keen 2003</LINK>). Anaemia, especially as a result of iron deficiency, which is frequent in these women, is also possibly associated with an increased risk of infections (<LINK REF="REF-Oppenheimer-2001" TYPE="REFERENCE">Oppenheimer 2001</LINK>). Whilst the objective of the review was not to measure impact on the immune status or maternal infections, our findings of a significant impact on LBW and SGA as a result of MMN supplementation could be through improved nutritional status and hence better immune system and resistance to maternal infections.</P>
<P>Maternal anthropometry pre-pregnancy and weight gain during pregnancy have also been associated with various neonatal and child outcomes. Maternal height seems to be a stable and easily measurable variable in the setting of low and middle-income countries. Reviews have identified short maternal stature as an important determinant of intrauterine growth retardation and LBW (<LINK REF="REF-Kramer-2003" TYPE="REFERENCE">Kramer 2003</LINK>; <LINK REF="REF-WHO-1995" TYPE="REFERENCE">WHO 1995</LINK>). Short maternal stature (short height) has been found to be significantly associated with an increased risk of child mortality, underweight infants and stunting (<LINK REF="REF-Ozaltin-2010" TYPE="REFERENCE">Ozaltin 2010</LINK>; <LINK REF="REF-Voigt-2010" TYPE="REFERENCE">Voigt 2010</LINK>). Our subgroup analyses indicate that MMN failed to show a significant effect on the SGA outcome in women with poor nutritional status at baseline, defined as maternal height less than 154.9 cm and BMI less than 20 kg/m². MMN showed a significant reduction in SGA babies among women with a mean maternal height at least 154.9 cm as compared to iron with or without folic acid, whereas the effect was non-significant among women with a mean height less than 154.9 cm. Similarly, MMN micronutrients showed a significant reduction in SGA babies among women with a mean BMI at least 20 kg/m², whereas a non-significant effect among those women with a mean BMI less than 20 kg/m². These findings should be interpreted with caution but suggest a possible role of MMN in preventing SGA, but only in women with good nutritional status at baseline, and an absence of similar effects in women with poor nutritional status at the time of conception. On the contrary, the findings for the subgroup analysis for preterm birth indicate a significant effect among women with low BMI but not among those with higher BMI. These differences could be explained by the different underlying causes and mechanisms leading to poor outcomes. The findings further highlight the contribution of maternal malnutrition to poor fetal anthropometry and stunting later in childhood, resulting in an intergenerational transfer of malnutrition. Though supplementation has been suggested to improve child growth and survival, there is currently no evidence that maternal MMN supplementation during pregnancy, compared to iron and folic acid, improves child growth or survival and studies with long-term follow-up are required.</P>
<P>We could not assess a number of prespecified, clinically important outcomes in this review due to insufficient or non-available data. These include placental abruption, congenital anomalies including neural tube defects, premature rupture of membranes, macrosomia, neurodevelopmental delay, very preterm births, macrosomia, cost of supplementation, side-effects of supplements, maternal well-being or satisfaction, and nutritional status or growth during childhood.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-10-22 08:59:40 +0100" MODIFIED_BY="Heather Maxwell">
<P>We evaluated the quality of the available evidence by using the GRADE methodology as outlined in the <A HREF="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html">GRADE Handbook</A>. We created a 'Summary of findings' table for the primary outcomes of preterm birth, SGA, LBW, stillbirths, perinatal and neonatal mortality for Comparison 1: MMN with iron and folic acid versus iron with or without folic acid supplement.</P>
<P>When assessed according to GRADE criteria, the quality of evidence for the review's primary outcomes overall was high. Pooled results for all primary outcomes were based on multiple trials with large sample sizes and precise estimates. For the comparison of MMN versus control (iron and/or folic acid) the following outcomes were graded to be as of high quality: preterm birth, low LBW, perinatal mortality, stillbirth and neonatal mortality. The outcome of SGA was graded to be of moderate quality, downgraded once for funnel plot asymmetry and potential publication bias.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-10-22 08:59:47 +0100" MODIFIED_BY="Heather Maxwell">
<P>This update of the review includes additional data published since the last update. An extensive literature search was conducted to identify any additional studies since the last search. The screening of the updated search, selection of eligible studies and data extraction were conducted independently by two review authors. The risk of bias was also assessed by two review authors. Given the application of the above Cochrane methodology, it is unlikely that the findings of this review are affected by biases in the review process.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2017-03-10 15:35:56 +0000" MODIFIED_BY="[Empty name]">
<P>The significant findings of reduction in the SGA and LBW risk as a result of MMN supplementation in the current review corroborate those of other systematic reviews and meta-analyses conducted since the first version of this Cochrane review (<LINK REF="REF-Bhutta-2012" TYPE="REFERENCE">Bhutta 2012</LINK>; <LINK REF="REF-Kawai-2011" TYPE="REFERENCE">Kawai 2011</LINK>; <LINK REF="REF-Margetts-2009" TYPE="REFERENCE">Margetts 2009</LINK>; <LINK REF="REF-Ramakrishnan-2012a" TYPE="REFERENCE">Ramakrishnan 2012a</LINK>). A recent systematic review and meta-analysis also reports reduction in the LBW and SGA risk; however, the effect on SGA is reported to be marginally significant (<LINK REF="REF-Christian-2015" TYPE="REFERENCE">Christian 2015</LINK>). This review included a smaller number of studies in the SGA analysis (studies = seven) as opposed to the current review (studies = 14), thereby explaining the difference between the estimates reported in the two reviews.</P>
<P>We did not find a significant effect of MMN supplements on perinatal mortality, stillbirth, and neonatal mortality in the main analyses, which are similar to the earlier version of this Cochrane review and other systematic reviews (<LINK REF="REF-Haider-2011" TYPE="REFERENCE">Haider 2011</LINK>; <LINK REF="REF-Ronsmans-2009" TYPE="REFERENCE">Ronsmans 2009</LINK>). <LINK REF="REF-Christian-2015" TYPE="REFERENCE">Christian 2015</LINK> also observed similar findings for neonatal mortality. Previously, concerns were raised regarding the possible harmful effect of MMN supplements by increasing the risk of perinatal and neonatal mortality through increased birth asphyxia in heavier babies (<LINK REF="REF-Christian-2005" TYPE="REFERENCE">Christian 2005</LINK>). Two earlier trials conducted in Nepal by Christian et al and Osrin et al, both had found a non-significant increase in the risk of neonatal and perinatal mortality, but their pooled effect estimate showed a significant increase in the risk of these outcomes (<LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK>). This concern was questioned by other researchers in the field and has not been observed in other studies (<LINK REF="REF-Bhutta-2009b" TYPE="REFERENCE">Bhutta 2009b</LINK>; <LINK REF="REF-Huffman-2005" TYPE="REFERENCE">Huffman 2005</LINK>; <LINK REF="REF-Shrimpton-2005" TYPE="REFERENCE">Shrimpton 2005</LINK>). Importantly, our current findings of no impact on neonatal mortality are supported by those of two MMN supplementation trials that were individually powered to evaluate an effect on early infant mortality (<LINK REF="STD-SUMMIT-2008" TYPE="STUDY">SUMMIT 2008</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>). The recent large trial in Bangladesh did not show an increase in neonatal or early infant mortality risk in the MMN supplementation group verus iron and folic acid (<LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>). The authors, in post-hoc analysis, however report higher neonatal mortality among boys due to birth asphyxia (<LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>). This finding should be interpreted with caution as the cause of death was ascertained by verbal autopsy with parents, which may result in misclassification of the underlying cause of death. Moreover, the trial was not powered to detect a statistically significant difference in cause-specific mortality by gender.</P>
<P>The finding suggesting an increase in the risk of neonatal mortality in some settings is likely due to the absence of skilled care at delivery and the poor standard of care in the health systems in low and middle-income countries, where the majority of births take place at home without the supervision of skilled attendants. This was also observed in a systematic review of MMN supplementation performed using the Child Health Epidemiology Research Group (CHERG) methodology (<LINK REF="REF-Walker-2010" TYPE="REFERENCE">Walker 2010</LINK>). While the current review showed no overall increase in the neonatal mortality risk as a result of MMN supplementation, a significantly increased risk was observed in the subgroup of populations with the majority of births at home while no effect was seen where the majority of births took place in health facilities (<LINK REF="REF-Haider-2011" TYPE="REFERENCE">Haider 2011</LINK>). This finding may be relevant to efforts to improve maternal nutrition and weight gain during pregnancy (and by inference fetal size) in settings where maternal care during pregnancy and childbirth may be sub optimal. We would recommend the use of MMN supplements in pregnancy principally in settings where skilled maternal care during childbirth and facility-based births can be provided.</P>
<P>As noted earlier, the composition of the MMN supplements differed in several of the included trials (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>), and use of folic acid alone or iron with folic acid remains a standard recommendation for pregnant women in many countries globally. In order to identify the effect of a single micronutrient on pregnancy outcomes, each additional micronutrient should be evaluated against a placebo in women receiving iron with folic acid. This would, however, only be of value in populations with single or limited micronutrient deficiencies.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-03-10 15:36:28 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2017-03-10 15:36:13 +0000" MODIFIED_BY="[Empty name]">
<P>Our findings support the effect of multiple-micronutrient (MMN) supplements with iron and folic acid in improving birth outcomes. These findings have been consistently observed in several systematic evaluations of evidence and provide a strong basis to guide the replacement of iron and folic acid with MMN supplements for pregnant women in low and middle-income countries where deficiencies of MMNs exist.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-03-10 15:36:28 +0000" MODIFIED_BY="[Empty name]">
<P>Efforts should focus on the integration of this intervention in maternal nutrition and antenatal care programs in low and middle-income countries where MMN deficiencies are common among women of reproductive age.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-01-24 15:41:59 +0000" MODIFIED_BY="[Empty name]">
<P>This review was prepared in part during the Fellowship Programme organised by the Cochrane Infectious Diseases Group in July 2003 and March 2005. The Department for International Development (UK) supports this programme through the Effective Health Care Research Programme Consortium at the Liverpool Tropical School of Medicine. The views expressed are not necessarily those of the Department for International Development.</P>
<P>This update was made possible through an unrestricted sub-grant under a Program Cooperative Agreement between UNICEF (Headquarters) and the Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canada.</P>
<P>We would like to thank Ms Lynn Hampson for her assistance with the literature search, and Professor James Neilson who provided support and guidance for previous versions of the review. We would also like to thank Nabila Hossain, Anoosh Moin, Nancy Medley, and Nasreen Aflaifel for their assistance with the screening of search results and data extraction, and Roland Kupka from UNICEF for comments on the review. Nancy Medley created the 'Summary of findings' table for the review. We would also like to thank Therese Dowswell for making edits in response to feedback from the Editor.</P>
<P>Nancy Medley and Nasreen Aflaifel's work was financially supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization. The named authors alone are responsible for the views expressed in this publication (2015 update).</P>
<P>As part of the prepublication editorial process, this review has been commented on by three peers (an editor and two referees who are external to the editorial team) and the Group's Statistical Adviser (2015 update).</P>
<P>This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-10-22 09:38:11 +0100" MODIFIED_BY="[Empty name]">
<P>Batool A Haider: none.</P>
<P>Zulfiqar A Bhutta was the principal investigator of the UNIMAPP trial conducted in Pakistan (<LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>). He was not involved in the screening and data extraction for this paper, which was conducted by other review authors acknowledged above.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-03-14 02:09:05 +0000" MODIFIED_BY="[Empty name]">
<P>Batool A Haider (BAH) and Zulfiqar A Bhutta (ZAB) undertook the current 2015 update of the 2012 Cochrane Review. BAH undertook the revised analysis with input from ZAB. Both authors approved the final version of the review.</P>
<P>ZAB was the principal investigator of <LINK REF="STD-Bhutta-2009a" TYPE="STUDY">Bhutta 2009a</LINK>, and data extraction was undertaken by BAH and Arjumand Rizvi for this trial. BAH created the comparisons, did the analysis and wrote the text of the review. ZAB provided guidance and approved the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-10-23 12:44:37 +0100" MODIFIED_BY="[Empty name]">
<P>The methods have been updated to reflect the latest <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The prespecified subgroup analysis 'duration of treatment' has been merged with another prespecified subgroup analysis 'gestational age at which supplementation was started' because it uses the same information. We also deleted a subgroup 'micronutrient interactions'.</P>
<P>Two new secondary outcomes have been included; these are macrosomia and mode of delivery. The list of primary outcomes has been modified so that it now includes some outcomes that were earlier included as secondary outcomes. The changes to the primary and secondary outcomes have been made to address issues identified in the recent literature, by experts in the field and given their importance from the policy perspective.</P>
<P>It is now explicit that the review focuses on oral supplements and trials examining parenteral provision of multiple micronutrients (MMN) or MMN via food fortification are now not included.</P>
<P>A 'Summary of findings' table has been added.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-04-12 13:28:09 +0100" MODIFIED_BY="Leanne Jones">
<STUDIES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-03-11 04:42:24 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Bhutta-2009a" MODIFIED="2016-03-11 04:42:24 +0000" MODIFIED_BY="[Empty name]" NAME="Bhutta 2009a" YEAR="2002">
<REFERENCE MODIFIED="2011-03-23 12:12:09 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bhutta ZA, Rizvi A, Raza F, Hotwani S, Zaidi S, Soofi S, et al</AU>
<TI>A comparative evaluation of multiple micronutrient and iron-folate supplementation during pregnancy in Pakistan: impact on pregnancy outcomes</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>4</NO>
<PG>S496-S505</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879166"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-23 12:22:00 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Persson LA, Eneroth H, Ekstrom EC</AU>
<TI>Multiple micronutrient supplementation during pregnancy: a review of effects on birth size, maternal haemoglobin and perinatal mortality demonstrated in trials in Bangladesh, Guinea-Bissau and Pakistan</TI>
<SO>Report for UNICEF/UNU/WHO</SO>
<YR>2004</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879167"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879165"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brough-2010" MODIFIED="2011-08-04 22:34:59 +0100" MODIFIED_BY="[Empty name]" NAME="Brough 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-08-04 22:34:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brough L, Rees GA, Crawford MA, Morton RH, Dorman EK</AU>
<TI>Effect of multiple-micronutrient supplementation on maternal nutrient status, infant birth weight and gestational age at birth in a low-income, multi-ethnic population</TI>
<SO>British Journal of Nutrition</SO>
<YR>2010</YR>
<VL>104</VL>
<NO>3</NO>
<PG>437-45</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879169"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879168"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Christian-2003" MODIFIED="2015-10-19 15:52:06 +0100" MODIFIED_BY="Heather Maxwell" NAME="Christian 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-03-23 12:12:24 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Darmstadt GL, Wu L, Khatry SK, LeClerq SC, Katz J, et al</AU>
<TI>The effect of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomised, controlled, community trial</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>2008</YR>
<VL>93</VL>
<NO>8</NO>
<PG>660-4</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879171"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-19 15:52:06 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Jiang T, Khatry SK, LeClerq SC, Shrestha SR, West KP Jr</AU>
<TI>Antenatal supplementation with micronutrients and biochemical indicators of status and subclinical infection in rural Nepal</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>83</VL>
<PG>788-94</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879172"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Khatry SK, Katz J, Pradhan EK, LeClerq SC, Shrestha SR, et al</AU>
<TI>Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>326</VL>
<PG>571</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879173"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-29 07:34:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Khatry SK, LeClerq SC, Dali SM</AU>
<TI>Effects of prenatal micronutrient supplementation on complications of labor and delivery and puerperal morbidity in rural Nepal</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2009</YR>
<VL>106</VL>
<NO>1</NO>
<PG>3-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879174"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-16 03:36:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Murray-Kolb LE, Khatry SK, Katz J, Schaefer BA, Cole PM, et al</AU>
<TI>Prenatal micronutrient supplementation and intellectual and motor function in early school-aged children in Nepal</TI>
<SO>JAMA</SO>
<YR>2010</YR>
<VL>304</VL>
<NO>24</NO>
<PG>2716-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879175"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 13:37:43 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="OTHER">
<AU>Christian P, Nanayakkara-Bind A, Schulze K, Wu L, LeClerq SC, Khatry SK</AU>
<TI>Antenatal micronutrient supplementation and third trimester cortisol and erythropoietin concentrations</TI>
<SO>Maternal &amp; Child Nutrition</SO>
<YR>2014 [Epub ahead of print]</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879176"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Shrestha J, LeClerq SC, Khatry SK, Jiang T, Wagner T, et al</AU>
<TI>Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal</TI>
<SO>Journal of Nutrition</SO>
<YR>2003</YR>
<VL>133</VL>
<PG>3492-8</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879177"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-23 12:12:47 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Stewart CP, LeClerq SC, Wu L, Katz J, West KP Jr, et al</AU>
<TI>Antenatal and postnatal iron supplementation and childhood mortality in rural Nepal: a prospective follow-up in a randomized, controlled community trial</TI>
<SO>American Journal of Epidemiology</SO>
<YR>2009</YR>
<VL>170</VL>
<NO>9</NO>
<PG>1127-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879178"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, West KP Jr, Khatry SK, LeClerq SC, Pradhan EK, Katz J, et al</AU>
<TI>Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomised trial in Nepal</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>78</VL>
<PG>1194-202</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879179"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-23 12:13:27 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Katz J, Christian P, Dominici F, Zeger SL</AU>
<TI>Treatment effects of maternal micronutrient supplementation vary by percentiles of the birth weight distribution in rural Nepal</TI>
<SO>Journal of Nutrition</SO>
<YR>2006</YR>
<VL>136</VL>
<PG>1389-94</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879180"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-04 19:55:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kulkarni B, Christian P, LeClerq SC, Khatry SK</AU>
<TI>Determinants of compliance to antenatal micronutrient supplementation and women's perceptions of supplement use in rural Nepal</TI>
<SO>Public Health Nutrition</SO>
<YR>2010</YR>
<VL>13</VL>
<NO>1</NO>
<PG>82-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879181"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:10:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray-Kolb L, Bahnfleth C, Hurley K, Cole P, Khatry S, LeClerq S, et al</AU>
<TI>Micronutrient supplementation during pregnancy and the preschool years and child behavior at 7-9 years of age</TI>
<SO>FASEB Journal</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>1 Suppl</NO>
<PG>Abstract no: 619.3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879182"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:10:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nanayakkara-Bind A, Schulze K, Wu L, Le SC, Khatry SK, Christian P</AU>
<TI>Effects of antenatal micronutrient supplementation on cortisol and erythropoietin in pregnant Nepalese women</TI>
<SO>FASEB Journal</SO>
<YR>2011</YR>
<VL>25</VL>
<PG>Abstract no: 779.15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879183"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-03-18 20:58:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stewart CP, Christian P, LeClerq SC, West KP Jr, Khatry SK</AU>
<TI>Antenatal supplementation with folic acid + iron + zinc improves linear growth and reduces peripheral adiposity in school-age children in rural Nepal</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2009</YR>
<VL>90</VL>
<NO>1</NO>
<PG>132-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879184"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-06 16:09:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stewart CP, Christian P, Schulze KJ, Arguello M, Leclerq SC, Khatry SK, et al</AU>
<TI>Low maternal vitamin B-12 status is associated with offspring insulin resistance regardless of antenatal micronutrient supplementation in rural Nepal</TI>
<SO>Journal of Nutrition</SO>
<YR>2011</YR>
<VL>141</VL>
<NO>10</NO>
<PG>1912-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879185"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-03-18 21:07:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stewart CP, Christian P, Schulze KJ, Leclerq SC, West KP Jr, Khatry SK</AU>
<TI>Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8-year-old children in rural Nepal</TI>
<SO>Journal of Nutrition</SO>
<YR>2009</YR>
<VL>139</VL>
<NO>8</NO>
<PG>1575-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879186"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879170"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fawzi-2007" MODIFIED="2011-03-23 12:14:05 +0000" MODIFIED_BY="Jill Hampson" NAME="Fawzi 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-03-23 12:14:05 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fawzi WW, Msamanga GI, Urassa W, Hertzmark E, Petraro P, Willett WC, et al</AU>
<TI>Vitamins and perinatal outcomes among HIV-negative women in Tanzania</TI>
<SO>New England Journal of Medicine</SO>
<YR>2007</YR>
<VL>356</VL>
<NO>14</NO>
<PG>1423-31</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879188"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879187"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Friis-2004" MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]" NAME="Friis 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Friis H, Gomo E, Nyazema N, Ndhlovu P, Krarup H, Kaestel P, et al</AU>
<TI>Effect of micronutrient supplementation on gestational length and birth size: a randomized, placebo-controlled, double-blind effectiveness trial in Zimbabwe</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>80</VL>
<PG>178-84</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879190"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879189"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hininger-2004" MODIFIED="2015-10-19 16:00:17 +0100" MODIFIED_BY="Heather Maxwell" NAME="Hininger 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-02-24 04:26:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hininger I, Favier M, Arnaud J, Faure H, Thoulon JM, Hariveau E, et al</AU>
<TI>Beneficial effects of a combined micronutrient supplementation on maternal oxidative stress and newborn anthropometric measurements: a randomised double blind, placebo-controlled trial in healthy pregnant women</TI>
<SO>21st Conference on Priorities in Perinatal Care in South Africa; 2002 March 5-8; Eastern Cape, South Africa</SO>
<YR>2002</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879192"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-19 16:00:17 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hininger I, Favier M, Arnaud J, Faure H, Thoulon JM, Hariveau E, et al</AU>
<TI>Effects of a combined micronutrient supplementation on maternal biological status and newborn anthropometric measurements: a randomized double-blind, placebo-controlled trial in apparently healthy pregnant women</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>58</VL>
<PG>52-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879193"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879191"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaestel-2005" MODIFIED="2011-09-14 13:49:57 +0100" MODIFIED_BY="[Empty name]" NAME="Kaestel 2005" YEAR="2003">
<REFERENCE MODIFIED="2011-08-04 19:52:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andersen GS, Friis H, Michaelsen KF, Rodrigues A, Benn CS, Aaby P, et al</AU>
<TI>Effects of maternal micronutrient supplementation on fetal loss and under-2-years child mortality: long-term follow-up of a randomised controlled trial from Guinea-Bissau</TI>
<SO>African Journal of Reproductive Health</SO>
<YR>2010</YR>
<VL>14</VL>
<NO>2</NO>
<PG>17-26</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879195"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:49:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kaestel P, Michaelsen KF, Aaby P, Friis H</AU>
<TI>Effects of prenatal multimicronutrient supplements on birth weight and perinatal mortality: a randomised, controlled trial in Guinea-Bissau</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>59</VL>
<NO>9</NO>
<PG>1081-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879196"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879194"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lui-2013" MODIFIED="2015-10-23 12:00:08 +0100" MODIFIED_BY="[Empty name]" NAME="Lui 2013" YEAR="2006">
<REFERENCE MODIFIED="2014-10-04 17:39:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Cogswell ME</AU>
<TI>Impact of prenatal vitamin/mineral supplements on perinatal mortality (planned trial)</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 21 March 2006)</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879198"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:10:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li HT, Mei Z, Ren A, Serdula M, Cogswell M, Liu JM</AU>
<TI>Impact of iron-containing micronutrient supplementation on high hemoglobin concentration during pregnancy</TI>
<SO>FASEB Journal</SO>
<YR>2012</YR>
<VL>26</VL>
<PG>Abstract no. 1021.2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879199"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-04 17:49:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu JM, Mei Z, Ye R, Serdula M, Li HT, Cogswell M</AU>
<TI>Impact of iron-contained micronutrient supplementation on macrosomia and large for gestational age births</TI>
<SO>FASEB Journal</SO>
<YR>2012</YR>
<VL>26</VL>
<PG>1021.2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879200"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-23 11:58:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Liu JM, Mei Z, Ye R, Serdula MK, Ren A, Cogswell ME</AU>
<TI>Micronutrient supplementation and pregnancy outcomes: Double-blind randomized controlled trial in China</TI>
<SO>JAMA Internal Medicine</SO>
<YR>2013</YR>
<VL>173</VL>
<NO>4</NO>
<PG>276-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879201"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-04 17:44:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mei Z, Serdula MK, Liu JM, Flores-Ayala RC, Wang L, Ye R, et al</AU>
<TI>Iron-containing micronutrient supplementation of Chinese women with no or mild anemia during pregnancy improved iron status but did not affect perinatal anemia</TI>
<SO>Journal of Nutrition</SO>
<YR>2014</YR>
<VL>144</VL>
<NO>6</NO>
<PG>943-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879202"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879197"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osrin-2005" MODIFIED="2015-05-14 23:11:17 +0100" MODIFIED_BY="[Empty name]" NAME="Osrin 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-05-14 23:11:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Devakumar D, Chaube SS, Wells JC, Saville NM, Ayres JG, Manandhar DS, et al</AU>
<TI>Effect of antenatal multiple micronutrient supplementation on anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-blind randomised controlled trial</TI>
<SO>Lancet. Global Health</SO>
<YR>2014</YR>
<VL>2</VL>
<NO>11</NO>
<PG>e654-e663</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879204"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 13:46:23 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="OTHER">
<AU>Devakumar D, Stocks J, Ayres JG, Kirkby J, Yadav SK, Saville NM, et al</AU>
<TI>Effects of antenatal multiple micronutrient supplementation on lung function in mid-childhood: follow-up of a double-blind randomised controlled trial in Nepal</TI>
<SO>European Respiratory Journal</SO>
<YR>2015 [Epub ahead of print]</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879205"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:11:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Devakumar D, Wells JCK, Chaube SS, Saville NM, Manandhar DS, Costello A, et al</AU>
<TI>The phenotypic effects of antenatal multiple micronutrient supplementation in Nepalese children</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>2014</YR>
<VL>99</VL>
<NO>Suppl 1</NO>
<PG>A2, Abstract no: P04</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879206"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-23 12:15:29 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hindle LJ, Gitau R, Filteau SM, Newens KJ, Osrin D, Costello AM, et al</AU>
<TI>Effect of multiple micronutrient supplementation during pregnancy on inflammatory markers in Nepalese women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>84</VL>
<PG>1086-92</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879207"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-02-24 04:43:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>MIRA (Mother Infant Research Unit)</AU>
<TI>MIRA Janakpur. Multiple micronutrient supplementation study. The effects of multiple micronutrient supplementation on birthweight, gestation and infection: a double blind, randomised controlled trial conducted in Nepal</TI>
<SO>Personal communication</SO>
<YR>2003</YR>
<PG>1-18</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879208"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-08-18 19:30:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Osrin D, Vaidya A, Shrestha Y, Baniya RB, Manandhar DS, Adhikari RK, et al</AU>
<TI>Effects of antenatal micronutrient supplementation on birthweight and gestational duration in Nepal: double-blind, randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2005</YR>
<VL>365</VL>
<PG>955-62</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879209"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-29 08:29:02 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vaidya A, Saville N, Shrestha BP, Costello AM, Manandhar DS, Osrin D</AU>
<TI>Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2008</YR>
<VL>371</VL>
<NO>9611</NO>
<PG>492-9</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879210"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879203"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramakrishnan-2003" MODIFIED="2010-03-18 21:52:31 +0000" MODIFIED_BY="[Empty name]" NAME="Ramakrishnan 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-03-18 21:52:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia-Guerra A, Neufeld LM, Hernandez-Cordero S, Rivera J, Martorell R, Ramakrishnan U</AU>
<TI>Prenatal multiple micronutrient supplementation impact on biochemical indicators during pregnancy and postpartum</TI>
<SO>Salud Publica de Mexico</SO>
<YR>2009</YR>
<VL>51</VL>
<NO>4</NO>
<PG>327-35</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879212"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-01 13:19:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramakrishnan U, Cossio TG, Neufeld LM, Rivera J, Martorell R</AU>
<TI>Effect of prenatal multiple micronutrient supplements on maternal weight and skinfold changes: A randomized double-blind clinical trial in Mexico</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2005</YR>
<VL>26</VL>
<NO>3</NO>
<PG>273-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879213"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ramakrishnan U, Gonzalez-Cossio T, Neufeld LM, Rivera J, Martorell R</AU>
<TI>Multiple micronutrient supplementation during pregnancy does not lead to greater infant birth size than does iron-only supplementation: a randomized controlled trial in a semirural community in Mexico</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>77</VL>
<PG>720-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879214"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramakrishnan U, Neufeld LM, Gonzalez-Cossio T, Villalpando S, Garcia-Guerrra A, Juan R, et al</AU>
<TI>Multiple micronutrient supplements during pregnancy do not reduce anemia or improve iron status compared to iron-only supplements in semirural Mexico</TI>
<SO>Journal of Nutrition</SO>
<YR>2004</YR>
<VL>134</VL>
<PG>898-903</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879215"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-02-04 10:53:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Lourdes Flores M, Neufeld LM, Gonzalez-Cossio T, Rivera J, Martorell R, Ramakrishnan U</AU>
<TI>Multiple micronutrient supplementation and dietary energy intake in pregnant women</TI>
<SO>Salud Publica de Mexico</SO>
<YR>2007</YR>
<VL>49</VL>
<NO>3</NO>
<PG>190-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879216"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879211"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roberfroid-2008" MODIFIED="2015-10-19 16:03:26 +0100" MODIFIED_BY="Heather Maxwell" NAME="Roberfroid 2008" YEAR="2004">
<REFERENCE MODIFIED="2015-05-14 23:12:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huybregts L, Roberfroid D, Lanou H, Kolsteren P, Camp J</AU>
<TI>Prenatal lipid-based nutrient supplements increase cord leptin concentration in pregnant women from rural Burkina Faso</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>Suppl 1</NO>
<PG>799, Abstract no: PO1134</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879218"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 14:11:13 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanou H, Huybregts L, Roberfroid D, Kolsteren P</AU>
<TI>Effect of prenatal lipid-based nutrient supplementation on gestational weight gain</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>Suppl 1</NO>
<PG>783, Abstract no: PO1099</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879219"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-22 15:24:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberfroid D, Huybregts L, Habicht JP, Lanou H, Henry MC, Meda N, et al</AU>
<TI>Randomized controlled trial of 2 prenatal iron supplements: is there a dose-response relation with maternal hemoglobin?</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2011</YR>
<VL>93</VL>
<PG>1012-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879220"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-09-28 19:26:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberfroid D, Huybregts L, Lanou H, Habicht JP, Henry MC, Meda N, et al</AU>
<TI>Prenatal micronutrient supplements cumulatively increase fetal growth</TI>
<SO>Journal of Nutrition</SO>
<YR>2012</YR>
<VL>142</VL>
<NO>3</NO>
<PG>548-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879221"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-19 16:03:26 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberfroid D, Huybregts L, Lanou H, Henry MC, Meda N, Kolsteren FP, et al</AU>
<TI>Effect of maternal multiple micronutrient supplements on cord blood hormones: a randomized controlled trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>91</VL>
<NO>6</NO>
<PG>1649-58</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879222"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:50:06 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Roberfroid D, Huybregts L, Lanou H, Henry MC, Meda N, Menten J, et al</AU>
<TI>Effects of maternal multiple micronutrient supplementation on fetal growth: a double-blind randomized controlled trial in rural Burkina Faso</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>88</VL>
<PG>1330-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879223"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-04 18:01:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberfroid D, Huybregts L, Lanou H, Ouedraogo L, Henry MC, Meda N, et al</AU>
<TI>Impact of prenatal multiple micronutrients on survival and growth during infancy: a randomized controlled trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2012</YR>
<VL>95</VL>
<NO>4</NO>
<PG>916-24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879224"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879217"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sood-1975" MODIFIED="2010-05-24 18:38:22 +0100" MODIFIED_BY="[Empty name]" NAME="Sood 1975" YEAR="1975">
<REFERENCE MODIFIED="2010-05-24 17:47:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sood SK, Ramachandran K, Mathur M, Gupta K, Ramalingaswami V, Swarnbai C, et al</AU>
<TI>WHO sponsored collaborative study on nutritional anemia in India</TI>
<SO>Quarterly Journal of Medicine, New Series XLIV</SO>
<YR>1975</YR>
<VL>174</VL>
<PG>241-58</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879226"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879225"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-SUMMIT-2008" MODIFIED="2015-05-14 23:12:54 +0100" MODIFIED_BY="[Empty name]" NAME="SUMMIT 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-09-28 02:55:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prado EL, Alcock KJ, Muadz H, Ullman MT, Shankar AH; for the SUMMIT Study Group</AU>
<TI>Maternal multiple micronutrient supplements and child cognition: a randomized trial in Indonesia</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>130</VL>
<NO>3</NO>
<PG>e536-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879228"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:12:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prado EL, Ullman MT, Muadz H, Alcock KJ, Shankar AH</AU>
<TI>The effect of maternal multiple micronutrient supplementation on cognition and mood during pregnancy and postpartum in Indonesia: a randomized trial</TI>
<SO>PLoS ONE</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>3</NO>
<PG>e32519</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879229"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-06 17:38:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sebayang SK, Dibley MJ, Kelly P, Shankar AV, Shankar AH</AU>
<TI>Modifying effect of maternal nutritional status on the impact of maternal multiple micronutrient supplementation on birthweight in Indonesia</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2011</YR>
<VL>65</VL>
<NO>10</NO>
<PG>1110-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879230"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:12:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shankar AV, Asrilla Z, Kadha JK, Sebayang S, Apriatni M, Sulastri A, et al</AU>
<TI>Programmatic effects of a large-scale multiple-micronutrient supplementation trial in Indonesia: using community facilitators as intermediaries for behavior change</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>2 Suppl</NO>
<PG>S207-S214</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879231"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:50:13 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>The Supplementation with Multiple Micronutrients Intervention Trial (SUMMIT) Study Group, Shankar AH, Jahari AB, Sebayang SK, Aditiawarman, Apriatni M, et al</AU>
<TI>Effect of maternal multiple micronutrient supplementation on fetal loss and infant death in Indonesia: a double-blind cluster-randomised trial</TI>
<SO>Lancet</SO>
<YR>2008</YR>
<VL>371</VL>
<NO>9608</NO>
<PG>215-27</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879232"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879227"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sunawang-2009" MODIFIED="2012-10-01 11:05:26 +0100" MODIFIED_BY="Jill Hampson" NAME="Sunawang 2009" YEAR="2003">
<REFERENCE MODIFIED="2012-10-01 11:05:26 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sunawang, Utomo B, Hidayat A, Kusharisupeni, Subarkah</AU>
<TI>Preventing low birth weight through maternal multiple micronutrient supplementation: a cluster-randomized controlled trial in Indramayu, West Java</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>4</NO>
<PG>S488-S495</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879234"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879233"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Theobald-1937" MODIFIED="2011-03-23 12:21:33 +0000" MODIFIED_BY="Jill Hampson" NAME="Theobald 1937" YEAR="1937">
<REFERENCE MODIFIED="2011-03-23 12:21:33 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Theobald GW, Camb MD</AU>
<TI>Effect of calcium and vitamins A and D on incidence of pregnancy toxaemia</TI>
<SO>Lancet</SO>
<YR>1937</YR>
<VL>2</VL>
<PG>1397-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879236"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879235"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Tofail-2008" MODIFIED="2015-10-19 16:06:13 +0100" MODIFIED_BY="Heather Maxwell" NAME="Tofail 2008" YEAR="2002">
<REFERENCE MODIFIED="2015-05-14 23:13:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ekstrom EC, Eneroth H, Arifeen SE, Persson L</AU>
<TI>Efficacy of micronutrient supplement intake in increasing hemoglobin in pregnancy: dose-effect comparisons with multiple micronutrient in the MINIMat trial in rural Bangladesh</TI>
<SO>FASEB Journal</SO>
<YR>2013</YR>
<VL>27 Suppl</VL>
<PG>Abstract no: 845.25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879238"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-04 20:04:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eneroth H, El Arifeen S, Persson LA, Lonnerdal B, Hossain MB, Stephensen CB, et al</AU>
<TI>Maternal multiple micronutrient supplementation has limited impact on micronutrient status of Bangladeshi infants compared with standard iron and folic acid supplementation</TI>
<SO>Journal of Nutrition</SO>
<YR>2010</YR>
<VL>140</VL>
<NO>3</NO>
<PG>618-24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879239"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-06 15:38:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eneroth H, Persson LA, El Arifeen S, Ekstrom EC</AU>
<TI>Infant anaemia is associated with infection, low birthweight and iron deficiency in rural Bangladesh</TI>
<SO>Acta Paediatrica</SO>
<YR>2011</YR>
<VL>100</VL>
<NO>2</NO>
<PG>220-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879240"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-12 22:26:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hawkesworth S, Wagatsuma Y, Kahn AI, Hawlader MD, Fulford AJ, Arifeen SE, et al</AU>
<TI>Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh</TI>
<SO>Journal of Nutrition</SO>
<YR>2013</YR>
<VL>143</VL>
<NO>5</NO>
<PG>728-34</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879241"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-12 22:35:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan A, Kabir I, Ekstrom EC, Asling-Monemi K, Alam D, Frongillo EA, et al</AU>
<TI>Effects of prenatal food and micronutrient supplementation on child growth from birth to 54 months of age: A randomized trial in Bangladesh</TI>
<SO>Nutrition Journal</SO>
<YR>2011</YR>
<VL>10</VL>
<NO>1</NO>
<PG>134</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879242"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 14:10:50 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan AI, Hawkesworth S, Ekstrom EC, Arifeen S, Moore SE, Frongillo EA, et al</AU>
<TI>Effects of exclusive breastfeeding intervention on child growth and body composition: The MINIMat trial, Bangladesh</TI>
<SO>Acta Paediatrica</SO>
<YR>2013</YR>
<VL>102</VL>
<NO>8</NO>
<PG>815-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879243"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-18 09:34:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan AI</AU>
<TI>Effects of pre- and postnatal nutrition interventions on child growth and body composition: the MINIMat trial in rural Bangladesh</TI>
<SO>Global Health Action</SO>
<YR>2013</YR>
<VL>6</VL>
<PG>22476</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879244"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-12-21 19:23:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moore SE, Fulford AJ, Wagatsuma Y, Persson LA, Arifeen SE, Prentice AM</AU>
<TI>Thymus development and infant and child mortality in rural Bangladesh</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2014</YR>
<VL>43</VL>
<PG>216-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879245"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-12-21 19:49:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Persson LA, Arifeen S, Ekstrom EC, Rasmussen KM, Frongillo EA, Yunus M</AU>
<TI>Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: The MINIMat randomized trial</TI>
<SO>JAMA</SO>
<YR>2012</YR>
<VL>307</VL>
<NO>19</NO>
<PG>2050-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879246"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-19 16:06:13 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Persson LA, Eneroth H, Ekstrom EC</AU>
<TI>Multiple Micronutrient supplementation during pregnancy: A review of effects on birth size, maternal haemoglobin and perinatal mortality demonstrated in trials in Bangladesh, Guinea-Bissau and Pakistan</TI>
<SO>Report for UNICEF/UNU/WHO</SO>
<YR>2004</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879247"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 14:24:15 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaheen R, Persson LA, Ahmed S, Lindholm L</AU>
<TI>Early invitation to prenatal food combined with multiple micronutrients is cost-effective compared to iron-folic acid supplementations: Results from MINIMat trial</TI>
<SO>Tropical Medicine and International Health</SO>
<YR>2013</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>88</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879248"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-12 22:13:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaheen R, Streatfield PK, Naved RT, Lindholm L, Persson LA</AU>
<TI>Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh</TI>
<SO>BMC Public Health</SO>
<YR>2014</YR>
<VL>14</VL>
<PG>5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879249"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:50:57 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tofail F, Persson LA, Arifeen SE, Hamadani JD, Mehrin F, Ridout D, et al</AU>
<TI>Effects of prenatal food and micronutrient supplementation on infant development: a randomized trial from maternal and infant nutrition intervention, Matlab (MINIMat) study</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>87</VL>
<PG>704-11</PG>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879250"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-04-06 07:57:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879237"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-West-2014" MODIFIED="2015-10-19 16:07:26 +0100" MODIFIED_BY="Heather Maxwell" NAME="West 2014" YEAR="2011">
<REFERENCE MODIFIED="2015-05-14 23:13:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Shamim A, Shaikh S, Ali H, Mehra S, Lee W, et al</AU>
<TI>Antenatal multiple micronutrient supplementation and growth in the first two years of life and cognitive function at 24 months in rural Bangladesh</TI>
<SO>FASEB Journal</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>1 Suppl 1</NO>
<PG>Abstract no. 256.5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879252"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:14:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gernand A, Schulze K, Shaikh S, Shamim A, Ali H, Wu L, et al</AU>
<TI>The effect of prenatal multiple micronutrient supplementation on biomarkers of placental angiogenesis in rural Bangladesh</TI>
<SO>FASEB Journal</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>1 Suppl 1</NO>
<PG>Abstract no: 804.2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879253"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-19 16:07:26 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gernand AD, Christian P, Paul RR, Shaikh S, Labrique AB, Schulze KJ, et al</AU>
<TI>Maternal weight and body composition during pregnancy are associated with placental and birth weight in rural Bangladesh</TI>
<SO>Journal of Nutrition</SO>
<YR>2012</YR>
<VL>142</VL>
<NO>11</NO>
<PG>2010-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879254"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-04 17:19:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gernand AD, Christian P, Schulze KJ, Shaikh S, Labrique AB, Shamim AA, et al</AU>
<TI>Maternal nutritional status in early pregnancy is associated with body water and plasma volume changes in a pregnancy cohort in rural Bangladesh</TI>
<SO>Journal of Nutrition</SO>
<YR>2012</YR>
<VL>142</VL>
<NO>6</NO>
<PG>1109-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879255"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:14:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gernand AD, Paul RR, Shaikh S, Shamim AA, Schulze K, Labrique AB, et al</AU>
<TI>Maternal gestational weight and body composition are associated with placental weight in rural Bangladesh</TI>
<SO>FASEB Journal</SO>
<YR>2011</YR>
<VL>25</VL>
<PG>Abstract no: 780.7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879256"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:17:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehra S, Schulze KJ, Merrill RD, Shaikh S, Ali H, Shamim AA, et al</AU>
<TI>Exploration of non-nutritional factors associated with stunting in 24 month old children of rural Bangladesh</TI>
<SO>FASEB Journal</SO>
<YR>2013</YR>
<VL>27 Suppl</VL>
<PG>Abstract no: 618.8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879257"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-12 11:43:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>West KP Jr, Shamim AA, Mehra S, Labrique AB, Ali H, Shaikh S, et al</AU>
<TI>Effect of maternal multiple micronutrient vs iron&#8211;folic acid supplementation on infant mortality and adverse birth outcomes in rural Bangladesh: the JiVitA-3 randomized trial</TI>
<SO>JAMA</SO>
<YR>2014</YR>
<VL>312</VL>
<NO>24</NO>
<PG>2649-58</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879258"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:18:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>West KP, Shamim AA, Labrique AB, Ali H, Shaikh S, Mehra S, et al</AU>
<TI>Efficacy of antenatal multiple micronutrient (MM) vs iron-folic acid (IFA) supplementation in improving gestational and postnatal viability in rural Bangladesh: the JiVitA-3 trial</TI>
<SO>FASEB Journal</SO>
<YR>2013</YR>
<VL>27 Suppl</VL>
<PG>Abstract no: 358.6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879259"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-04 17:17:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>West KP</AU>
<TI>Antenatal micronutrient supplementation and infant survival (JiVitA-3)</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov)</SO>
<YR>(accessed 8 July 2011)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879260"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879251"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zagre-2007" MODIFIED="2011-03-23 12:24:14 +0000" MODIFIED_BY="Jill Hampson" NAME="Zagre 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-03-23 12:24:14 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zagre NM, Desplats G, Adou P, Mamadoultaibou A, Aguayo VM</AU>
<TI>Prenatal multiple micronutrient supplementation has greater impact on birthweight than supplementation with iron and folic acid: a cluster-randomized, double-blind, controlled programmatic study in rural Niger</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2007</YR>
<VL>28</VL>
<NO>3</NO>
<PG>317-27</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879262"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879261"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeng-2008" MODIFIED="2015-05-14 23:19:38 +0100" MODIFIED_BY="[Empty name]" NAME="Zeng 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-05-14 23:18:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cao Y, Wang T, Zeng L</AU>
<TI>Risk of childhood malnutrition at 24 months related to small for gestational age and low birth weight in rural Western China</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>Suppl 1</NO>
<PG>556, Abstract no: PO619</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879264"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-09-28 01:36:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chang S, Zeng L, Brouwer ID, Kok FJ, Yan H</AU>
<TI>Effect of iron deficiency anemia in pregnancy on child mental development in rural china</TI>
<SO>Pediatrics</SO>
<YR>2013</YR>
<VL>131</VL>
<NO>3</NO>
<PG>e755-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879265"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-01 11:05:47 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li Q, Yan H, Zeng L, Cheng Y, Liang W, Dang S, et al</AU>
<TI>Effects of maternal multimicronutrient supplementation on the mental development of infants in rural western China: follow-up evaluation of a double-blind, randomized, controlled trial</TI>
<SO>Pediatrics</SO>
<YR>2009</YR>
<VL>123</VL>
<NO>4</NO>
<PG>e685-e692</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879266"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-09-28 01:42:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang W, Yan H, Zeng L, Cheng Y, Wang D, Li Q</AU>
<TI>No effect of maternal micronutrient supplementation on early childhood growth in rural western China: 30 month follow-up evaluation of a double blind, cluster randomized controlled trial</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2012</YR>
<VL>66</VL>
<NO>2</NO>
<PG>261-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879267"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:54:40 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="OTHER">
<AU>Yan H</AU>
<TI>Impact of iron/folate versus multi-micronutrient supplementation during pregnancy on birth weight: a randomised controlled trial in rural Western China</TI>
<SO>Current Controlled Trials (www.controlled-trials.com)</SO>
<YR>(accessed 15 February 2007)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879268"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-29 08:33:12 +0100" MODIFIED_BY="Jill Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zeng L, Cheng Y, Dang S, Yan H, Dibley MJ, Chang S, et al</AU>
<TI>Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation and perinatal mortality in rural western China: double blind cluster randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>337</VL>
<PG>a2001</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879269"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:19:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeng L, Yan H, Cheng Y, Dang S, Dibley MJ</AU>
<TI>Adherence and costs of micronutrient supplementation in pregnancy in a double-blind, randomized, controlled trial in rural western China</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>4</NO>
<PG>S480-S487</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879270"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 14:29:03 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeng L, Yan H, Cheng Y, Dibley M</AU>
<TI>Modifying effects of maternal nutrition status on the response to multiple micronutrients supplementation on preterm and neonatal mortality in China</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>Suppl 1</NO>
<PG>859-60, Abstract no: PO1241</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879271"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-06 15:41:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeng L, Yan H, Cheng Y, Dibley MJ</AU>
<TI>Modifying effects of wealth on the response to nutrient supplementation in pregnancy on birth weight, duration of gestation and perinatal mortality in rural western China: double-blind cluster randomized controlled trial</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2011</YR>
<VL>40</VL>
<NO>2</NO>
<PG>350-62</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879272"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879263"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-10-19 16:22:48 +0100" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Agarwal-2012" MODIFIED="2014-09-28 00:29:07 +0100" MODIFIED_BY="[Empty name]" NAME="Agarwal 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-28 00:29:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agarwal N, Dora S, Kriplani A, Garg P, Vivekanandhan S, Kulshrestha V</AU>
<TI>Response of therapy with vitamin B6, B12 and folic acid on homocysteine level and pregnancy outcome in hyperhomocysteinemia with unexplained recurrent abortions</TI>
<SO>International Journal of Gynecology and Obstetrics</SO>
<YR>2012</YR>
<VL>119</VL>
<NO>Suppl 3</NO>
<PG>S759</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879274"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879273"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aguayo-2005" MODIFIED="2011-03-23 12:25:51 +0000" MODIFIED_BY="Jill Hampson" NAME="Aguayo 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-03-23 12:25:51 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aguayo VM, Kone D, Bamba SI, Diallo B, Sidibe Y, Traore D, et al</AU>
<TI>Acceptability of multiple micronutrient supplements by pregnant and lactating women in Mali</TI>
<SO>Public Health Nutrition</SO>
<YR>2005</YR>
<VL>8</VL>
<NO>1</NO>
<PG>33-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879276"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879275"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ahn-2006" MODIFIED="2011-06-20 20:19:19 +0100" MODIFIED_BY="[Empty name]" NAME="Ahn 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-06-20 20:19:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ahn E, Pairaudeau N, Pairaudeau N, Cerat Y, Couturier B, Fortier A, et al</AU>
<TI>A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women</TI>
<SO>BMC Pregnancy and Childbirth</SO>
<YR>2006</YR>
<VL>6</VL>
<PG>10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879278"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879277"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-An-2001" MODIFIED="2011-03-23 12:26:16 +0000" MODIFIED_BY="Jill Hampson" NAME="An 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-03-23 12:26:16 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>An H, Yin S, Xu Q</AU>
<TI>Effects of supplementing calcium, iron and zinc on the fetus development and growth during pregnancy</TI>
<SO>Chinese Journal of Preventive Medicine</SO>
<YR>2001</YR>
<VL>35</VL>
<NO>6</NO>
<PG>370-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879280"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879279"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arsenault-2010" MODIFIED="2011-06-20 20:23:48 +0100" MODIFIED_BY="[Empty name]" NAME="Arsenault 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-06-20 20:23:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arsenault JE, Aboud S, Manji KP, Fawzi WW, Villamor E</AU>
<TI>Vitamin supplementation increases risk of subclinical mastitis in HIV-infected women</TI>
<SO>Journal of Nutrition</SO>
<YR>2010</YR>
<VL>140</VL>
<NO>10</NO>
<PG>1788-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879282"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879281"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Asemi-2014" MODIFIED="2014-09-28 00:28:55 +0100" MODIFIED_BY="[Empty name]" NAME="Asemi 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-09-28 00:28:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Asemi Z, Samimi M, Tabassi Z, Ahmad E</AU>
<TI>Multivitamin versus multivitamin-mineral supplementation and pregnancy outcomes: a single-blind randomized clinical trial</TI>
<SO>International Journal of Preventive Medicine</SO>
<YR>2014</YR>
<VL>5</VL>
<NO>4</NO>
<PG>439-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879284"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879283"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beazley-2002" MODIFIED="2015-05-14 23:19:15 +0100" MODIFIED_BY="[Empty name]" NAME="Beazley 2002" YEAR="2002">
<REFERENCE MODIFIED="2015-05-14 23:19:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beazley D, Ahokas R, Livingston J, Griggs M, Scroggs M, Sibai B</AU>
<TI>Effects of vitamin C and E supplementation on total antioxidant status (TAS) and 8-isoprostane (IP) levels in women at high risk for preeclampsia</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2002</YR>
<VL>187</VL>
<NO>6 Pt 2</NO>
<PG>S76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879286"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:55:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Beazley D, Livingston J, Kao L, Sibai L</AU>
<TI>Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind placebo controlled trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2002</YR>
<VL>187</VL>
<NO>6 Pt 2</NO>
<PG>S216</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879287"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879285"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bergmann-2006" MODIFIED="2011-03-23 12:28:19 +0000" MODIFIED_BY="Jill Hampson" NAME="Bergmann 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-03-23 12:28:19 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bergmann RL, Haschke-Becher, Bergmann KE, Dudenhausen JW, Haschke F</AU>
<TI>Low dose docosahexaenoic acid supplementation improves the DHA status of pregnant women</TI>
<SO>Pediatric Academic Societies Annual Meeting; 2006 April 29-May 2; San Francisco, CA, USA</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879289"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879288"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Biswas-1984" NAME="Biswas 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Biswas MK, Pernoll MJ, Mabie WC</AU>
<TI>A placebo controlled comparative trial of various prenatal vitamin formulations in pregnant women</TI>
<SO>Clinical Therapeutics</SO>
<YR>1984</YR>
<VL>6</VL>
<NO>6</NO>
<PG>763-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879291"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879290"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carrasco-1962" MODIFIED="2009-04-01 13:02:56 +0100" MODIFIED_BY="[Empty name]" NAME="Carrasco 1962" YEAR="1962">
<REFERENCE MODIFIED="2009-04-01 13:02:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carrasco EO, Jose FR, Samson GD, Germar E, Padilla B</AU>
<TI>Effect of D-sorbitol on the absorption and transfer of nutrients from mother to fetus</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1962</YR>
<VL>11</VL>
<PG>533-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879293"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879292"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caulfield-1999" MODIFIED="2011-03-23 12:34:31 +0000" MODIFIED_BY="Jill Hampson" NAME="Caulfield 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-03-23 12:34:31 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caulfield LE, Zavaleta N, Figueroa A, Leon Z</AU>
<TI>Maternal zinc supplementation does not affect size at birth or pregnancy duration in Peru</TI>
<SO>Journal of Nutrition</SO>
<YR>1999</YR>
<VL>129</VL>
<NO>8</NO>
<PG>1563-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879295"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879294"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caulfield-1999a" MODIFIED="2011-02-24 01:38:56 +0000" MODIFIED_BY="[Empty name]" NAME="Caulfield 1999a" YEAR="1999">
<REFERENCE MODIFIED="2011-02-24 01:38:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caulfield LE Zavaleta N, Figueroa A</AU>
<TI>Adding zinc to prenatal iron and folate supplements improves maternal and neonatal zinc status in a Peruvian population</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>69</VL>
<PG>1257-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879297"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879296"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chames-2002" MODIFIED="2011-03-23 12:34:39 +0000" MODIFIED_BY="Jill Hampson" NAME="Chames 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-03-23 12:34:39 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chames M, Liu H, Bendich A, Bogden J, Sibai B, Prada J</AU>
<TI>A randomized trial of calcium supplementation effects on blood lead levels in pregnancy</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2002</YR>
<VL>187</VL>
<NO>6 Pt 2</NO>
<PG>S137</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879299"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879298"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choudhury-2012" MODIFIED="2014-09-28 00:29:12 +0100" MODIFIED_BY="[Empty name]" NAME="Choudhury 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-28 00:29:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choudhury N, Aimone A, Hyder SM, Zlotkin SH</AU>
<TI>Relative efficacy of micronutrient powders versus iron-folic acid tablets in controlling anemia in women in the second trimester of pregnancy</TI>
<SO>Food &amp; Nutrition Bulletin</SO>
<YR>2012</YR>
<VL>33</VL>
<NO>2</NO>
<PG>142-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879301"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879300"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Christian-2009" MODIFIED="2011-09-14 13:56:02 +0100" MODIFIED_BY="[Empty name]" NAME="Christian 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-08-04 19:10:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bhutta Z</AU>
<TI>Severe anemia treatment trials, Pakistan (ongoing trial)</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 21 March 2006)</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879303"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:56:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Shahid F, Rizvi A, Klemm RDW, Bhutta ZA</AU>
<TI>Treatment response to standard of care for severe anemia in pregnant women and effect of multivitamins and enhanced anthelminthics</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2009</YR>
<VL>89</VL>
<PG>853-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879304"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879302"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cooper-2012" MODIFIED="2014-09-28 00:26:31 +0100" MODIFIED_BY="[Empty name]" NAME="Cooper 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-28 00:26:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cooper WN, Khulan B, Owens S, Elks CE, Seidel V, Prentice AM, et al</AU>
<TI>DNA methylation profiling at imprinted loci after periconceptional micronutrient supplementation in humans: Results of a pilot randomized controlled trial</TI>
<SO>FASEB Journal</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>5</NO>
<PG>1782-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879306"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879305"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Czeizel-1996" NAME="Czeizel 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Czeizel AE, Dudas I, Fritz G, Tecsoi A, Hanck A, Kunovits G</AU>
<TI>The effect of periconceptional multivitamin -mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>1992</YR>
<VL>251</VL>
<PG>181-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879308"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Czeizel AE, Dudas I, Metneki J</AU>
<TI>Pregnancy outcomes in a randomized controlled trial of periconceptional multivitamin supplementation</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>1994</YR>
<VL>255</VL>
<PG>131-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879309"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Czeizel AE, Dudas I</AU>
<TI>Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation</TI>
<SO>New England Journal of Medicine</SO>
<YR>1992</YR>
<VL>327</VL>
<PG>1832-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879310"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Czeizel AE, Metneki J, Dudas I</AU>
<TI>The effect of preconceptional multivitamin supplementation on fertility</TI>
<SO>International Journal of Vitamin and Nutrition Research</SO>
<YR>1996</YR>
<VL>66</VL>
<PG>55-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879311"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Czeizel AE</AU>
<TI>Controlled studies of multivitamin supplementation on pregnancy outcomes</TI>
<SO>Annals of New York Academy of Sciences</SO>
<YR>1993</YR>
<VL>678</VL>
<PG>266-75</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879312"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Czeizel AE</AU>
<TI>Prevention of congenital abnormalities by periconceptional multivitamin supplementation</TI>
<SO>BMJ</SO>
<YR>1993</YR>
<VL>306</VL>
<PG>1645-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879313"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Czeizel AE</AU>
<TI>Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation</TI>
<SO>American Journal of Medical Genetics</SO>
<YR>1996</YR>
<VL>62</VL>
<PG>179-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879314"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879307"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dawson-1987" NAME="Dawson 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dawson EB, McGanity WJ</AU>
<TI>Protection of maternal iron stores in pregnancy</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1987</YR>
<VL>32</VL>
<NO>6</NO>
<PG>478-87</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879316"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879315"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dawson-1998" MODIFIED="2011-03-23 12:38:38 +0000" MODIFIED_BY="Jill Hampson" NAME="Dawson 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-03-23 12:38:38 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dawson EB, Dawson R, Behrens J, DeVora M, McGanity WJ</AU>
<TI>Iron in prenatal multivitamin/multimineral supplements</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1998</YR>
<VL>43</VL>
<PG>133-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879318"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879317"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dieckmann-1944" MODIFIED="2015-09-26 20:09:38 +0100" MODIFIED_BY="Batool A Haider" NAME="Dieckmann 1944" YEAR="1944">
<REFERENCE MODIFIED="2015-09-26 20:09:38 +0100" MODIFIED_BY="Batool A Haider" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dieckmann WJ, Adair FL, Michel H, Kramer S, Dunkle F, Arthur B, et al</AU>
<TI>Calcium, phosphorus, iron and nitrogen balances in pregnant women</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1944</YR>
<VL>47</VL>
<PG>357-68</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879320"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879319"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fall-2007" MODIFIED="2015-05-18 09:51:30 +0100" MODIFIED_BY="[Empty name]" NAME="Fall 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-05-18 09:51:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Fall C</AU>
<TI>Mumbai maternal nutrition project</TI>
<SO>Current Controlled Trials (http://controlled-trials.com) (accessed 15 February 2007)</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879322"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 14:21:51 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Potdar RD, Sahariah SA, Gandhi M, Kehoe SH, Brown N, Sane H, et al</AU>
<TI>Improving women's diet quality preconceptionally and during gestation: effects on birth weight and prevalence of low birth weight-a randomized controlled efficacy trial in India (Mumbai Maternal Nutrition Project)</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2014</YR>
<VL>100</VL>
<NO>5</NO>
<PG>1257-68</PG>
<EN>ISRCTN62811278</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879323"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879321"/><IDENTIFIER TYPE="ISRCTN" VALUE="ISRCTN62811278"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fawzi-1998" MODIFIED="2015-10-19 16:14:42 +0100" MODIFIED_BY="Heather Maxwell" NAME="Fawzi 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-03-23 12:38:49 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fawzi W, Msamanga G, Antelman G, Xu C, Hertzmark E, Spiegelman D, et al</AU>
<TI>Effect of prenatal vitamin supplementation on lower genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>5</NO>
<PG>716-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879325"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-23 12:38:58 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, et al</AU>
<TI>Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania</TI>
<SO>Journal of Acquired Immune Deficiency Syndromes</SO>
<YR>2000</YR>
<VL>23</VL>
<NO>3</NO>
<PG>246-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879326"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-23 12:39:04 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fawzi WW, Msamanga G, Spiegelman D, Wei R, Kapiga S, Villamor E, et al</AU>
<TI>A randomised trial of multivitamin supplements and HIV disease progression and mortality</TI>
<SO>New England Journal of Medicine</SO>
<YR>2004</YR>
<VL>351</VL>
<NO>1</NO>
<PG>23-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879327"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-19 16:14:42 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fawzi WW, Msamanga GI, Kupka R, Spiegelman D, Villamor E, Mugusi F, et al</AU>
<TI>Multivitamin supplementation improves hematologic status in HIV-infected women and their children in Tanzania</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>85</VL>
<NO>5</NO>
<PG>1335-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879328"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:56:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJN, McGarth N, Mwakagile D, et al</AU>
<TI>Randomized controlled trial of the effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV -1 infected women in Tanzania</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<PG>1477-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879329"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-16 08:23:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kawai K, Kupka R, Mugusi F, Aboud S, Okuma J, Villamor E, et al</AU>
<TI>A randomized trial to determine the optimal dosage of multivitamin supplements to reduce adverse pregnancy outcomes among HIV-infected women in Tanzania</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>91</VL>
<NO>2</NO>
<PG>391-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879330"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-06 15:28:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kawai K, Msamanga G, Manji K, Villamor E, Bosch RJ, Hertzmark E, et al</AU>
<TI>Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania</TI>
<SO>British Journal of Nutrition</SO>
<YR>2010</YR>
<VL>103</VL>
<NO>12</NO>
<PG>1784-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879331"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-04 19:08:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villamor E, Koulinska IN, Aboud S, Murrin C, Bosch RJ, Manji KP, et al</AU>
<TI>Effect of vitamin supplements on HIV shedding in breast milk</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>92</VL>
<NO>4</NO>
<PG>881-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879332"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-16 08:27:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villamor E, Msamanga G, Saathoff E, Manji K, Fawzi WW</AU>
<TI>Effect of vitamin supplements on the incidence of malaria among children born to HIV-infected Women</TI>
<SO>FASEB Journal</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>4 Pt 1</NO>
<PG>A125</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879333"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-02 23:55:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villamor E, Msamanga G, Spiegelman D, Antelman G, Peterson KE, Hunter DJ, et al</AU>
<TI>Effect of multivitamin and vitamin A supplements on weight gain during pregnancy among HIV-1 infected women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>76</VL>
<PG>1082-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879334"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-02 23:56:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villamor E, Saathoff E, Bosch RJ, Hertzmark E, Baylin A, Manji K, et al</AU>
<TI>Vitamin supplementation of HIV-infected women improves postnatal child growth</TI>
<SO>American Journal of Clinial Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<NO>4</NO>
<PG>880-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879335"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879324"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feyi_x002d_Waboso-2005" MODIFIED="2011-02-24 01:39:09 +0000" MODIFIED_BY="[Empty name]" NAME="Feyi-Waboso 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-02-24 01:39:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feyi-Waboso PA, Chris A, Nwaogu GC, Archibong EI, Ejikem EC</AU>
<TI>The role of parenteral multivitamin preparation (Eldervit-12) in the prevention of anaemia in pregnancy</TI>
<SO>Tropical Journal of Obstetrics and Gynaecology</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>2</NO>
<PG>159-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879337"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879336"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fleming-1986" MODIFIED="2011-03-23 12:39:23 +0000" MODIFIED_BY="Jill Hampson" NAME="Fleming 1986" YEAR="1986">
<REFERENCE MODIFIED="2011-03-23 12:39:23 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fleming AF, Ghatoura GBS, Harrison KA, Briggs ND, Dunn DT</AU>
<TI>The prevention of anemia in pregnancy in primigravidae in the Guinea Savana of Nigeria</TI>
<SO>Annals of Tropical Medicine and Parasitology</SO>
<YR>1986</YR>
<VL>80</VL>
<NO>2</NO>
<PG>211-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879339"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879338"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldenberg-1995" MODIFIED="2011-01-24 16:01:11 +0000" MODIFIED_BY="[Empty name]" NAME="Goldenberg 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-01-24 16:01:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldenberg R, Tamura T, Neggers Y, Copper R, Johnston K, DuBard M, et al</AU>
<TI>Maternal zinc supplementation increases birthweight and head circumference</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1995</YR>
<VL>172</VL>
<NO>1 Pt 2</NO>
<PG>368</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879341"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879340"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gopalan-2004" MODIFIED="2012-09-29 08:35:21 +0100" MODIFIED_BY="[Empty name]" NAME="Gopalan 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-09-29 08:35:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gopalan S, Patnaik R, Ganesh K</AU>
<TI>Feasible strategies to combat low birth weight and intra-uterine growth retardation</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>2004</YR>
<VL>39 Suppl 1</VL>
<PG>S37</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879343"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879342"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Graham-2007" MODIFIED="2009-02-06 09:32:02 +0000" MODIFIED_BY="[Empty name]" NAME="Graham 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-02-06 09:32:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Graham JM, Haskell MJ, Pandey P, Shrestha RK, Brown KH, Allen LH</AU>
<TI>Supplementation with iron and riboflavin enhances dark adaptation response to vitamin A-fortified rice in iron-deficient, pregnant, nightblind Nepali women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>85</VL>
<NO>5</NO>
<PG>1375-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879345"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879344"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guldholt-1991" NAME="Guldholt 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guldholt IS, Trolle BG, Hvidman LE</AU>
<TI>Iron supplementation during pregnancy</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1991</YR>
<VL>70</VL>
<PG>9-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879347"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879346"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-2007" MODIFIED="2015-09-26 20:42:58 +0100" MODIFIED_BY="Batool A Haider" NAME="Gupta 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-09-26 20:42:58 +0100" MODIFIED_BY="Batool A Haider" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gupta P, Ray M, Dua T, Radhakrishnan G, Kumar R, Sachdev HP</AU>
<TI>Multimicronutrient supplementation for undernourished pregnant women and the birth size of their offspring: a double-blind, randomized, placebo-controlled trial</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2007</YR>
<VL>161</VL>
<NO>1</NO>
<PG>58-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879349"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879348"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hambidge-2014" MODIFIED="2014-09-28 00:29:30 +0100" MODIFIED_BY="[Empty name]" NAME="Hambidge 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-09-28 00:29:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hambidge KM, Krebs NF, Westcott JE, Garces A, Goudar SS, Kodkany BS, et al</AU>
<TI>Preconception maternal nutrition: a multi-site randomized controlled trial</TI>
<SO>BMC Pregnancy and Childbirth</SO>
<YR>2014</YR>
<VL>14</VL>
<NO>1</NO>
<PG>111</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879351"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879350"/><IDENTIFIER TYPE="CTG" VALUE="NCT01883193"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hillman-1963" MODIFIED="2011-01-24 16:01:11 +0000" MODIFIED_BY="[Empty name]" NAME="Hillman 1963" YEAR="1963">
<REFERENCE MODIFIED="2011-01-24 16:01:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hillman RW, Cabaud PE, Nilsson DE, Arpin PD, Tufano RJ</AU>
<TI>Pyridoxine supplementation during pregnancy</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1963</YR>
<VL>12</VL>
<PG>427-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879353"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879352"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holly-1955" MODIFIED="2012-09-29 08:36:23 +0100" MODIFIED_BY="[Empty name]" NAME="Holly 1955" YEAR="1955">
<REFERENCE MODIFIED="2012-09-29 08:36:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holly RG</AU>
<TI>Anemia in pregnancy</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1955</YR>
<VL>5</VL>
<PG>562-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879355"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879354"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hossain-2014" MODIFIED="2015-05-14 23:21:41 +0100" MODIFIED_BY="[Empty name]" NAME="Hossain 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-05-14 23:21:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hossain N, Kanani FH, Ramzan S, Kausar R, Ayaz S, Khanani R, et al</AU>
<TI>Obstetric and neonatal outcomes of maternal vitamin D supplementation: results of an open label randomized controlled trial of antenatal vitamin D supplementation in Pakistani women</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>2014</YR>
<VL>99</VL>
<NO>7</NO>
<PG>2448-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879357"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879356"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunt-1983" MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" NAME="Hunt 1983" YEAR="1983">
<REFERENCE MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hunt IF, Murphy NJ, Cleaver AE, Faraji B, Swendseid ME, Coulson AH, et al</AU>
<TI>Zinc supplementation during pregnancy: zinc concentration of serum and hair from low-income women of Mexican descent</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>37</VL>
<PG>572-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879359"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879358"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunt-1984" MODIFIED="2011-02-24 01:39:34 +0000" MODIFIED_BY="[Empty name]" NAME="Hunt 1984" YEAR="1984">
<REFERENCE MODIFIED="2011-02-24 01:39:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hunt IF, Murphy NJ, Cleaver AE, Faraji B, Swendseid ME, Coulson AH, et al</AU>
<TI>Zinc supplementation during pregnancy: effects on selected blood constituents and on progress and outcome of pregnancy in low-income women of Mexican descent</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1984</YR>
<VL>40</VL>
<PG>508-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879361"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879360"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hunt-1985" MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" NAME="Hunt 1985" YEAR="1985">
<REFERENCE MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hunt IF, Murphy NJ, Cleaver AE, Faraji B, Swendseid ME, Browdy BL, et al</AU>
<TI>Zinc supplementation during pregnancy in low-income teenagers of Mexican descent: effects on selected blood constituents and on progress and outcome of pregnancy</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1985</YR>
<VL>42</VL>
<PG>815-28</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879363"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879362"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huybregts-2009" MODIFIED="2011-02-24 01:39:46 +0000" MODIFIED_BY="[Empty name]" NAME="Huybregts 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-02-24 01:39:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huybregts L, Roberfroid D, Lanou H, Menten J, Meda N, Van Camp J, et al</AU>
<TI>Prenatal food supplementation fortified with multiple micronutrients increases birth length: a randomized controlled trial in rural Burkina Faso</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2009</YR>
<VL>90</VL>
<NO>6</NO>
<PG>1593-600</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879365"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879364"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huybregts-2013" MODIFIED="2015-04-15 14:04:09 +0100" MODIFIED_BY="Nancy  Medley" NAME="Huybregts 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-04-15 14:04:09 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huybregts L, Roberfroid D, Lanou H, Meda N, Taes Y, Valea I, et al</AU>
<TI>Prenatal lipid-based nutrient supplements increase cord leptin concentration in pregnant women from rural Burkina Faso</TI>
<SO>Journal of Nutrition</SO>
<YR>2013</YR>
<VL>143</VL>
<NO>5</NO>
<PG>576-83</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879367"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879366"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iannotti-2008" MODIFIED="2011-02-24 01:39:50 +0000" MODIFIED_BY="[Empty name]" NAME="Iannotti 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-02-24 01:39:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iannotti LL, Zavaleta N, Leon Z, Shankar AH, Caulfield LE</AU>
<TI>Maternal zinc supplementation and growth in Peruvian infants</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>88</VL>
<NO>1</NO>
<PG>154-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879369"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879368"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-ICMR-2000" NAME="ICMR 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Indian Council of Medical Research (ICMR) Collaborating Centers, Central Technical Co-ordinating Unit</AU>
<TI>Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects in India</TI>
<SO>Indian Journal of Medical Research</SO>
<YR>2000</YR>
<VL>112</VL>
<PG>206-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879371"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879370"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Itam-2003" MODIFIED="2014-10-08 03:22:23 +0100" MODIFIED_BY="[Empty name]" NAME="Itam 2003" YEAR="2003">
<REFERENCE MODIFIED="2014-10-08 03:22:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Itam IH</AU>
<TI>The effect of "Chemiron" on haematological parameters and ferritin levels in pregnant Nigerian women in Calabar</TI>
<SO>Mary Slessor Journal of Medicine</SO>
<YR>2003</YR>
<VL>3</VL>
<NO>2</NO>
<PG>17-24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879373"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879372"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jarvenpaa-2007" MODIFIED="2015-10-19 16:17:47 +0100" MODIFIED_BY="Heather Maxwell" NAME="Jarvenpaa 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-10-19 16:17:42 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jarvenpaa J, Schwab U, Lappalainen T, Pakkila M, Niskanen L, Punnonen K, et al</AU>
<TI>Fortified mineral water improves folate status and decreases plasma homocysteine concentration in pregnant women</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2007</YR>
<VL>35</VL>
<NO>2</NO>
<PG>108-14</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879375"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-19 16:17:47 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Jarvenpaa J, Schwab U, Lappalainen T, Pakkila M, Niskanen L, Punnonen K, et al</AU>
<TI>Mineral water fortified with folic acid and vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in pregnant women</TI>
<SO>35th Nordic Congress of Obstetrics and Gynecology; 2006 May 23-25; Goteburg, Sweden</SO>
<YR>2008</YR>
<PG>55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879376"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879374"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kabir-2009" MODIFIED="2011-08-13 19:48:45 +0100" MODIFIED_BY="[Empty name]" NAME="Kabir 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-08-13 19:48:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kabir I, Khan AI, El Arifeen S, Alam DS, Persson LA</AU>
<TI>Effects of prenatal food and micronutrient supplementation and breastfeeding counseling on postnatal growth of rural Bangladeshi children</TI>
<SO>Pediatric Academic Societies Annual Meeting; 2009 May 2-5; Baltimore, USA</SO>
<YR>2009</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879378"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879377"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kable-2012" MODIFIED="2015-10-12 11:44:30 +0100" MODIFIED_BY="[Empty name]" NAME="Kable 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-05-14 23:23:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chambers C, Yevtushok L, Zymak-Zakutnya N, Wertelecki W, Jones KL, Keen CL, et al</AU>
<TI>Maternal alcohol consumption during pregnancy, nutritional status and impact on infant outcomes</TI>
<SO>Alcohol and Alcoholism</SO>
<YR>2013</YR>
<VL>48 Suppl</VL>
<PG>i21-i22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879380"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 13:35:42 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coles C, Yevtushok L, Zymak-Zakutnya N, Wertelecki W, Keen CL, Y YJ, et al</AU>
<TI>Micronutrient supplements can mitigate the teratogenic effects of prenatal alcohol exposure on Ukrainian infants at 6 months</TI>
<SO>Alcohol and Alcoholism</SO>
<YR>2013</YR>
<VL>48 Suppl</VL>
<PG>i22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879381"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 13:35:13 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coles CD, Chambers CD, Yevtushok L, Zymak-Zakutnya N, Wertelecki W, Keen CL, et al</AU>
<TI>Micronutrient supplements can mitigate the teratogenic effects of prenatal alcohol exposure on Ukrainian infants at six months</TI>
<SO>Birth Defects Research Part A - Clinical and Molecular Teratology</SO>
<YR>2012</YR>
<VL>94</VL>
<NO>5</NO>
<PG>361</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879382"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-12 11:44:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kable J, Coles C, Chambers C, Keen C, Uriu-Adams J, Jones K, et al</AU>
<TI>Preliminary analysis of the impact of micronutrient supplements on neurophysiological encoding and memory in Ukranian infants 12-18 months postpartum</TI>
<SO>Alcoholism: Clinical and Experimental Research</SO>
<YR>2012</YR>
<VL>36</VL>
<NO>S1</NO>
<PG>212A</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879383"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:26:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kable J, Coles C, Chambers C, Keen C, Uriu-Adams J, Jones K, et al</AU>
<TI>The impact of micronutrient supplementation in alcohol-exposed pregnancies on information processing skills in Ukrainian infants</TI>
<SO>Alcohol and Alcoholism</SO>
<YR>2013</YR>
<VL>48 Suppl</VL>
<PG>i22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879384"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879379"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khavari-2014" MODIFIED="2015-04-09 10:09:49 +0100" MODIFIED_BY="[Empty name]" NAME="Khavari 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-09 10:09:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khavari N, Jiang H, Manji K, Msamanga G, Spiegelman D, Fawzi W, et al</AU>
<TI>Maternal multivitamin supplementation reduces the risk of diarrhoea among HIV-exposed children through age 5 years</TI>
<SO>International Health</SO>
<YR>2014</YR>
<VL>6</VL>
<PG>298-305</PG>
<EN>NCT00197743</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879386"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879385"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khulan-2012" MODIFIED="2014-09-28 00:27:19 +0100" MODIFIED_BY="[Empty name]" NAME="Khulan 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-28 00:27:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khulan B, Cooper WN, Skinner BM, Bauer J, Owens S, Prentice AM, et al</AU>
<TI>Periconceptional maternal micronutrient supplementation is associated with widespread gender related changes in the epigenome: A study of a unique resource in the Gambia</TI>
<SO>Human Molecular Genetics</SO>
<YR>2012</YR>
<VL>21</VL>
<NO>9</NO>
<PG>2086-101</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879388"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879387"/><IDENTIFIER TYPE="ISRCTN" VALUE="ISRCTN13687662"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kubik-2004" MODIFIED="2011-09-14 13:57:10 +0100" MODIFIED_BY="[Empty name]" NAME="Kubik 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-08-13 19:10:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chelchowska M, Laskowska-Klita T, Kubik P, Leibschang J</AU>
<TI>The effect of vitamin-mineral supplementation on the level of MDA and activity of glutathione peroxidase and superoxide dismutase in blood of matched maternal-cord pairs</TI>
<TO>Wplyw suplementacji witaminowo-mineralnej na poziom MDA oraz aktywnosc peroksydazy glutationowej i dysmutazy ponadtlenkowej w krwi kobiet ciezarnych i krwi pepowinowej ich dzieci</TO>
<SO>Przeglad Lekarski</SO>
<YR>2004</YR>
<VL>61</VL>
<NO>7</NO>
<PG>760-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879390"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-09-14 13:57:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kubik P, Kowalska B, Laskowska-Klita T, Chelchowska M, Leibschang J</AU>
<TI>Effect of vitamin-mineral supplementation on the status of some microelements in pregnant women</TI>
<SO>Przeglad Lekarski</SO>
<YR>2004</YR>
<VL>61</VL>
<NO>7</NO>
<PG>764-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879391"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-04 22:11:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laskowska-Klita T, Chelchowska M, Ambroszkiewicz J, Kubik P, Leibschang J</AU>
<TI>The effect of vitamin-mineral supplementation on vitamins D, A (beta-carotene) and E concentration in blood of matched maternal-cord pairs</TI>
<TO>Wplyw suplementacji witaminowo-mineralnej na stezenie witamin D, A (beta-karoten) i E w krwi kobiet ciezarnych i krwi pqpowinowej ich dzieci.</TO>
<SO>Przeglad Lekarski</SO>
<YR>2004</YR>
<VL>61</VL>
<NO>7</NO>
<PG>755-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879392"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879389"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kynast-1986" MODIFIED="2011-08-13 19:29:07 +0100" MODIFIED_BY="[Empty name]" NAME="Kynast 1986" YEAR="1986">
<REFERENCE MODIFIED="2011-08-13 19:29:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kynast G, Langner K, Saling E</AU>
<TI>Clinical results of oral application of trace elements in risk pregnancies</TI>
<SO>Proceedings of 10th European Congress of Perinatal Medicine; 1986 Aug 12-16; Leipzig, Germany</SO>
<YR>1986</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879394"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879393"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lanou-2014" MODIFIED="2014-09-28 00:27:35 +0100" MODIFIED_BY="[Empty name]" NAME="Lanou 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-09-28 00:27:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lanou H, Huybregts L, Roberfroid D, Nikiema L, Kouanda S, Van Camp J, et al</AU>
<TI>Prenatal nutrient supplementation and postnatal growth in a developing nation: an RCT</TI>
<SO>Pediatrics</SO>
<YR>2014</YR>
<VL>133</VL>
<NO>4</NO>
<PG>e1001-e1008</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879396"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879395"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leroy-2010" MODIFIED="2015-10-12 11:44:46 +0100" MODIFIED_BY="[Empty name]" NAME="Leroy 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-10-12 11:44:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Leroy JL</AU>
<TI>Preventing malnutrition in children under two years of age approach</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 18 October 2014)</SO>
<YR>2010</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879398"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-15 14:23:46 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="BOOK">
<AU>Richter SM, Leroy JL, Olney D, Quinones E, Ruel M</AU>
<SO>Strengthening and Evaluating the Preventing Malnutrition in Children under 2 Approach in Guatemala: Report of the Enrollment Survey</SO>
<YR>2013</YR>
<PB>FHI 360</PB>
<CY>Washington DC</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879399"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879397"/><IDENTIFIER TYPE="CTG" VALUE="NCT01072279"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2014" MODIFIED="2015-04-09 10:12:01 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-09 10:12:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li YF, Hu NS, Tian XB, Li L, Wang SM, Xu XB, et al</AU>
<TI>Effect of daily milk supplementation on serum and umbilical cord blood folic acid concentrations in pregnant Han and Mongolian women and birth characteristics in China</TI>
<SO>Asia Pacific Journal of Clinical Nutrition</SO>
<YR>2014</YR>
<VL>23</VL>
<NO>4</NO>
<PG>567-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879401"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879400"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindstr_x00f6_m-2011" MODIFIED="2012-07-06 15:34:44 +0100" MODIFIED_BY="[Empty name]" NAME="Lindström 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-07-06 15:34:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindström E, Hossain MB, Lönnerdal B, Raqib R, El Arifeen S, Ekström EC</AU>
<TI>Prevalence of anemia and micronutrient deficiencies in early pregnancy in rural Bangladesh, the MINIMat trial</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2011</YR>
<VL>90</VL>
<NO>1</NO>
<PG>47-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879403"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879402"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ling-1996" MODIFIED="2011-02-24 01:39:56 +0000" MODIFIED_BY="[Empty name]" NAME="Ling 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-02-24 01:39:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ling CD, Zhang ZJ, Chen ZL</AU>
<TI>Studies on nutritional effects of traditional Chinese tonics with strengthened nutrients on pregnant women and rats</TI>
<SO>Chung-Kuo Chung Hsi i Chieh Ho Tsa Chih</SO>
<YR>1996</YR>
<VL>16</VL>
<PG>270-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879405"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879404"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lucia-2007" MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" NAME="Lucia 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lucia Bergmann R, Bergmann KE, Haschke-Becher E, Richter R, Dudenhausen JW, Barclay D, et al</AU>
<TI>Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy?</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2007</YR>
<VL>35</VL>
<NO>4</NO>
<PG>295-300</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879407"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879406"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ma-2008" MODIFIED="2011-03-23 12:41:55 +0000" MODIFIED_BY="Jill Hampson" NAME="Ma 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-03-23 12:41:55 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ma AG, Schouten EG, Zhang FZ, Kok FJ, Yang F, Jiang DC, et al</AU>
<TI>Retinol and riboflavin supplementation decreases the prevalence of anemia in Chinese pregnant women taking iron and folic acid supplements</TI>
<SO>Journal of Nutrition</SO>
<YR>2008</YR>
<VL>138</VL>
<NO>10</NO>
<PG>1946-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879409"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879408"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magon-2014" MODIFIED="2015-04-09 10:12:32 +0100" MODIFIED_BY="[Empty name]" NAME="Magon 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-09 10:12:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magon A, Collin SM, Joshi P, Davys Late G, Attlee A, Mathur B</AU>
<TI>Leaf concentrate fortification of antenatal protein-calorie snacks improves pregnancy outcomes</TI>
<SO>Journal of Health, Population and Nutrition</SO>
<YR>2014</YR>
<VL>32</VL>
<NO>3</NO>
<PG>430-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879411"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879410"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malvasi-2014" MODIFIED="2014-09-28 00:28:32 +0100" MODIFIED_BY="[Empty name]" NAME="Malvasi 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-09-28 00:28:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malvasi A, Casciaro F, Minervini MM, Kosmas I, Mynbaev OA, Pacella E, et al</AU>
<TI>Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation</TI>
<SO>European Review for Medical and Pharmacological Sciences</SO>
<YR>2014</YR>
<VL>18</VL>
<NO>2</NO>
<PG>270-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879413"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879412"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mardones-2007" MODIFIED="2011-03-23 12:42:05 +0000" MODIFIED_BY="Jill Hampson" NAME="Mardones 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-03-23 12:42:05 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mardones F, Urrutia MT, Villarroel L, Rioseco A, Castillo O, Rozowski J, et al</AU>
<TI>Effects of a dairy product fortified with multiple micronutrients and omega-3 fatty acids on birth weight and gestation duration in pregnant Chilean women</TI>
<SO>Public Health Nutrition</SO>
<YR>2007</YR>
<VL>11</VL>
<NO>1</NO>
<PG>30-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879415"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879414"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marya-1987" MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" NAME="Marya 1987" YEAR="1987">
<REFERENCE MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marya RK, Rathee S, Manrow M</AU>
<TI>Effect of calcium and vitamin D supplementation on toxaemia of pregnancy</TI>
<SO>Gynecologic and Obstetric Investigation</SO>
<YR>1987</YR>
<VL>24</VL>
<PG>38-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879417"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879416"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathan-1979" MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" NAME="Mathan 1979" YEAR="1979">
<REFERENCE MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathan BVI, Baker SH, Sood SK, Ramachandran K, Ramalingaswami V</AU>
<TI>WHO sponsored collaborative studies on nutritional anaemia in India. The effects of ascorbic acid and protein supplementation on the response of pregnant women to iron, pteroyglutamic acid and cyanocobalamin therapy</TI>
<SO>British Journal of Nutrition</SO>
<YR>1979</YR>
<VL>42</VL>
<PG>391-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879419"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879418"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Menon-1962" NAME="Menon 1962" YEAR="1962">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Menon MKK, Rajan L</AU>
<TI>Prophylaxis of anaemia in pregnancy</TI>
<SO>British Journal of Obstetrics and Gynaecology of the British Commonwealth</SO>
<YR>1962</YR>
<VL>12</VL>
<PG>382-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879421"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879420"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Merchant-2005" MODIFIED="2011-03-23 12:42:25 +0000" MODIFIED_BY="Jill Hampson" NAME="Merchant 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-03-23 12:42:25 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Merchant AT, Msamanga G, Villamor E, Saathoff E, O'Brien M, Hertzmark E, et al</AU>
<TI>Multivitamin supplementation of HIV- positive women during pregnancy reduces hypertension</TI>
<SO>Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<NO>7</NO>
<PG>1776-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879423"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879422"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Merialdi-1999" MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" NAME="Merialdi 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-01-24 16:01:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Merialdi M, Caulfield LE, Zavaleta N, Figueroa A, DiPietro JA</AU>
<TI>Adding zinc to prenatal iron and folate tablets improves fetal neurobehavioral development</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>2 Pt 1</NO>
<PG>483-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879425"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879424"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muslimatun-2001a" MODIFIED="2015-10-19 16:22:48 +0100" MODIFIED_BY="Heather Maxwell" NAME="Muslimatun 2001a" YEAR="2001">
<REFERENCE MODIFIED="2015-10-19 16:22:48 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Muslimatun S, Schmidt MK, Schultink W, West CE, Hautvast JGAJ, Gross R, et al</AU>
<TI>Weekly supplementation with iron and vitamin A during pregnancy increases hemoglobin concentration but decreases serum ferritin concentration in Indonesian pregnant women</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<NO>1</NO>
<PG>85-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879427"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879426"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muslimatun-2001b" MODIFIED="2011-09-14 13:59:44 +0100" MODIFIED_BY="Jill Hampson" NAME="Muslimatun 2001b" YEAR="2001">
<REFERENCE MODIFIED="2011-03-23 14:44:49 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Muslimatun S, Schmidt MK, West CE, Schultink W, Hautvast JG, Karyadi D</AU>
<TI>Weekly vitamin A and iron supplementation during pregnancy increases vitamin A concentration of breast milk but not iron status in Indonesian lactating women</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<NO>10</NO>
<PG>2664-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879429"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879428"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nguyen-2012" MODIFIED="2014-09-28 00:27:51 +0100" MODIFIED_BY="[Empty name]" NAME="Nguyen 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-28 00:27:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nguyen PH, Lowe AE, Martorell R, Nguyen H, Pham H, Nguyen S, et al</AU>
<TI>Rationale, design, methodology and sample characteristics for the Vietnam pre-conceptual micronutrient supplementation trial (PRECONCEPT): a randomized controlled study</TI>
<SO>BMC Public Health</SO>
<YR>2012</YR>
<VL>12</VL>
<PG>898</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879431"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879430"/><IDENTIFIER TYPE="CTG" VALUE="NCT01665378"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nwagha-2010" MODIFIED="2014-09-28 00:27:51 +0100" MODIFIED_BY="[Empty name]" NAME="Nwagha 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-09-28 00:27:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nwagha UI, Okeji N, Clems-Anunwa O, Ejezie FE, Nwagha TU, Iyare E</AU>
<TI>The role of some micronutrients (eldervit) in the management of the anaemic pregnant Nigerian women: a preliminary report</TI>
<SO>Tropical Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2010</YR>
<VL>27</VL>
<NO>2</NO>
<PG>34-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879433"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879432"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ochoa_x002d_Brust-2007" MODIFIED="2011-02-24 01:40:16 +0000" MODIFIED_BY="[Empty name]" NAME="Ochoa-Brust 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-02-24 01:40:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ochoa-Brust GJ, Fernandez AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernandez B, Vasquez C</AU>
<TI>Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica.</SO>
<YR>2007</YR>
<VL>86</VL>
<NO>7</NO>
<PG>783-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879435"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879434"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olofin-2014" MODIFIED="2015-04-09 10:26:51 +0100" MODIFIED_BY="[Empty name]" NAME="Olofin 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-09 10:26:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olofin IO, Spiegelman D, Aboud S, Duggan C, Danaei G, Fawzi WW</AU>
<TI>Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women</TI>
<SO>Journal of Acquired Immune Deficiency Syndromes (1999)</SO>
<YR>2014</YR>
<VL>67</VL>
<NO>Suppl 4</NO>
<PG>S173-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879437"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879436"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-1999" MODIFIED="2012-09-29 08:39:10 +0100" MODIFIED_BY="[Empty name]" NAME="Park 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-09-29 08:39:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park E, Wagenbichler P, Elmadfa I</AU>
<TI>Effects of multivitamin/mineral supplementation, at nutritional doses, on plasma antioxidant status and DNA damage estimated by sister chromatid exchanges in lymphocytes in pregnant women</TI>
<SO>International Journal for Vitamin and Nutrition Research</SO>
<YR>1999</YR>
<VL>69</VL>
<PG>396-402</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879439"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879438"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patimah-2013" MODIFIED="2014-12-28 02:55:28 +0000" MODIFIED_BY="[Empty name]" NAME="Patimah 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-12-28 02:55:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patimah S, As'ad S, Jusoff K, Hadju V, Razak A, Bahar B</AU>
<TI>The influence of multiple micronutrient supplementations on hemoglobin and serum ferritin levels of pregnant women</TI>
<SO>World Journal of Medical Sciences</SO>
<YR>2013</YR>
<VL>8</VL>
<NO>3</NO>
<PG>177-85</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879441"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879440"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-People_x0027_s-League-1946" MODIFIED="2011-08-13 21:09:53 +0100" MODIFIED_BY="[Empty name]" NAME="People's League 1946" YEAR="1946">
<REFERENCE MODIFIED="2011-08-13 21:09:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>People's League of Health</AU>
<TI>Nutrition of expectant and nursing mothers: interim report</TI>
<SO>Lancet</SO>
<YR>1942</YR>
<VL>2</VL>
<PG>10-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879443"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-13 21:09:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>People's League of Health</AU>
<TI>The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity</TI>
<SO>Journal of Obstetrics and Gynaecology of the British Empire</SO>
<YR>1946</YR>
<VL>53</VL>
<PG>498-509</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879444"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879442"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramirez_x002d_Velez-2011" MODIFIED="2012-07-06 15:53:32 +0100" MODIFIED_BY="[Empty name]" NAME="Ramirez-Velez 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-07-06 15:53:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramirez-Velez R, Romero M, Echeverri I, Ortega JG, Mosquera M, Salazar B, et al</AU>
<TI>A factorial randomized controlled trial to evaluate the effect of micronutrients supplementation and regular aerobic exercise on maternal endothelium-dependent vasodilatation and oxidative stress of the newborn</TI>
<SO>Trials</SO>
<YR>2011</YR>
<VL>12</VL>
<PG>60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879446"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879445"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raqib-2013" MODIFIED="2014-09-28 00:29:48 +0100" MODIFIED_BY="[Empty name]" NAME="Raqib 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-09-28 00:29:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Raqib R</AU>
<TI>Role of vitamin B12 supplementation during pregnancy and postpartum to reduce nutritional anemia and improve immunity in Bangladeshi women and their infants</TI>
<SO>ClinicalTrials.gov (https://clinicaltrials.gov/) (accessed 21 May 2013)</SO>
<YR>2013</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879448"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879447"/><IDENTIFIER TYPE="CTG" VALUE="NCT01795131"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robertson-1991" MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" NAME="Robertson 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robertson JS, Heywood B, Atkinson SM</AU>
<TI>Zinc supplementation during pregnancy</TI>
<SO>Journal of Public Health Medicine</SO>
<YR>1991</YR>
<VL>13</VL>
<PG>227-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879450"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879449"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rumiris-2006" MODIFIED="2015-09-26 20:43:41 +0100" MODIFIED_BY="Batool A Haider" NAME="Rumiris 2006" YEAR="2003">
<REFERENCE MODIFIED="2015-09-26 20:43:41 +0100" MODIFIED_BY="Batool A Haider" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rumiris D, Purwosunu Y, Wibowo N, Farina A, Sekizawa A</AU>
<TI>Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status</TI>
<SO>Hypertension in Pregnancy</SO>
<YR>2006</YR>
<VL>25</VL>
<PG>241-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879452"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879451"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sachdeva-1993" MODIFIED="2011-02-24 01:40:25 +0000" MODIFIED_BY="[Empty name]" NAME="Sachdeva 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-02-24 01:40:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sachdeva R, Mann SK</AU>
<TI>Impact of nutrition education and medical supervision on pregnancy outcome</TI>
<SO>Indian Pediatrics</SO>
<YR>1993</YR>
<VL>30</VL>
<NO>11</NO>
<PG>1309-14</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879454"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879453"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sagaonkar-2009" MODIFIED="2012-07-09 18:32:57 +0100" MODIFIED_BY="[Empty name]" NAME="Sagaonkar 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-07-09 18:32:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sagaonkar S, Sukhija S, Tayal R, Sagaonkar PD</AU>
<TI>Pregnancy induced iron deficiency and the evaluation and comparison of the efficacy and safety of ferrous fumarate and carbonyl iron in its treatment - PERFECT trial</TI>
<SO>Journal of Obstetrics and Gynecology of India</SO>
<YR>2009</YR>
<VL>59</VL>
<NO>6</NO>
<PG>552-62</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879456"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879455"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salzano-2001" MODIFIED="2015-05-14 23:29:24 +0100" MODIFIED_BY="[Empty name]" NAME="Salzano 2001" YEAR="2001">
<REFERENCE MODIFIED="2015-05-14 23:29:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salzano P, Felicetti M, Laboccetta A, Borrelli P, Di Domenico A, Borrelli A</AU>
<TI>Prevention of gestational hypertension with calcium, linoleic acid, mono and polyunsaturated fatty acid supplements</TI>
<SO>Minerva Ginecologica</SO>
<YR>2001</YR>
<VL>53</VL>
<NO>4</NO>
<PG>235-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879458"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879457"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-2001" MODIFIED="2011-03-23 12:43:00 +0000" MODIFIED_BY="Jill Hampson" NAME="Schmidt 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-03-23 12:43:00 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt MK, Muslimatun S, West CE, Schultink W, Hautvast JG</AU>
<TI>Vitamin A and iron supplementation of Indonesian pregnant women benefits vitamin A status of their infants</TI>
<SO>British Journal of Nutrition</SO>
<YR>2001</YR>
<VL>86</VL>
<NO>5</NO>
<PG>607-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879460"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879459"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-2002" MODIFIED="2011-03-23 12:43:12 +0000" MODIFIED_BY="Jill Hampson" NAME="Schmidt 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-03-23 12:43:12 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt MK, Muslimatun S, Schultink W, West CE, Hautvast JG</AU>
<TI>Randomised double-blind trial of the effect of vitamin A supplementation of Indonesian pregnant women on morbidity and growth of their infants during the first year of life</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>56</VL>
<NO>4</NO>
<PG>338-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879462"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879461"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Semba-2000" MODIFIED="2012-07-06 17:53:06 +0100" MODIFIED_BY="[Empty name]" NAME="Semba 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-07-06 17:53:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Semba RD, Kumwenda N, Taha TE, Mtimavalye L, Broadhead R, Miotti PG, et al</AU>
<TI>Plasma and breast milk vitamin A as indicators of vitamin A status in pregnant women</TI>
<SO>International Journal for Vitamin and Nutrition Research</SO>
<YR>2000</YR>
<VL>70</VL>
<NO>6</NO>
<PG>271-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879464"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879463"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Semba-2001" MODIFIED="2011-03-23 12:43:24 +0000" MODIFIED_BY="Jill Hampson" NAME="Semba 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-03-23 12:43:24 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Semba RD, Kumwenda N, Taha TE, Mtimavalye L, Broadhead R, Garrett E, et al</AU>
<TI>Impact of vitamin A supplementation on anaemia and plasma erythropoietin concentrations in pregnant women: a controlled clinical trial</TI>
<SO>European Journal of Haematology</SO>
<YR>2001</YR>
<VL>66</VL>
<NO>6</NO>
<PG>389-95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879466"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879465"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Suharno-1993" MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" NAME="Suharno 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Suharno D, West CE, Muhilal, Karyadi D, Hautvast JGA</AU>
<TI>Supplementation with vitamin A and iron for nutritional anaemia in pregnant women in West Java, Indonesia</TI>
<SO>Lancet</SO>
<YR>1993</YR>
<VL>342</VL>
<PG>1325-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879468"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879467"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2010" MODIFIED="2011-08-13 20:47:09 +0100" MODIFIED_BY="[Empty name]" NAME="Sun 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-08-13 20:47:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun YY, Ma AG, Yang F, Zhang FZ, Luo YB, Jiang DC, et al</AU>
<TI>A combination of iron and retinol supplementation benefits iron status, IL-2 level and lymphocyte proliferation in anemic pregnant women</TI>
<SO>Asia Pacific Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>4</NO>
<PG>513-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879470"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879469"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Suprapto-2002" MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" NAME="Suprapto 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Suprapto B, Widardo, Suhanantyo</AU>
<TI>Effect of low-dosage vitamin A and riboflavin on iron-folate supplementation in anaemic pregnant women</TI>
<SO>Asia Pacific Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>4</NO>
<PG>263-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879472"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879471"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taghizadeh-2014" MODIFIED="2014-09-28 00:52:53 +0100" MODIFIED_BY="[Empty name]" NAME="Taghizadeh 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-09-28 00:52:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taghizadeh M, Samimi M, Tabassi Z, Heidarzadeh Z, Asemi Z</AU>
<TI>Effect of multivitamin-mineral versus multivitamin supplementation on maternal, newborns' biochemical indicators and birth size: a double-blind randomized clinical trial</TI>
<SO>Oman Medical Journal</SO>
<YR>2014</YR>
<VL>29</VL>
<NO>2</NO>
<PG>123-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879474"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879473"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tanumihardjo-2002" MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" NAME="Tanumihardjo 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-01-24 16:01:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tanumihardjo SA</AU>
<TI>Vitamin A and iron status are improved by vitamin A and iron supplementation in pregnant Indonesian women</TI>
<SO>Journal of Nutrition</SO>
<YR>2002</YR>
<VL>132</VL>
<PG>1909-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879476"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879475"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tatala-2002" MODIFIED="2015-10-12 11:45:45 +0100" MODIFIED_BY="[Empty name]" NAME="Tatala 2002" YEAR="2002">
<REFERENCE MODIFIED="2015-09-26 20:10:30 +0100" MODIFIED_BY="Batool A Haider" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Makola D, Ask DM, Tatala SR, Latham MC, Ndossi G, Mehansho H</AU>
<TI>A micronutrient-fortified beverage prevents iron deficiency, reduces anemia and improves the hemoglobin concentration in pregnant Tanzanian women</TI>
<SO>Journal of Nutrition</SO>
<YR>2003</YR>
<VL>133</VL>
<PG>1339-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879478"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-12 11:45:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tatala SR, Ash D, Makola D, Latham M, Ndosi G, Grohn Y</AU>
<TI>Effect of micronutrient fortified beverage on nutritional anaemia during pregnancy</TI>
<SO>East African Medical Journal</SO>
<YR>2002</YR>
<VL>79</VL>
<NO>11</NO>
<PG>598-603</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879479"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879477"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thauvin-1992" MODIFIED="2011-08-13 21:19:30 +0100" MODIFIED_BY="[Empty name]" NAME="Thauvin 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-08-13 21:19:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thauvin E, Fusselier M, Arnaud J, Faure H, Favier M, Coudray C, et al</AU>
<TI>Effects of multivitamin mineral supplement on zinc and copper status during pregnancy</TI>
<SO>Biological Trace Element Research</SO>
<YR>1992</YR>
<VL>32</VL>
<PG>405-14</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879481"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879480"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vadillo_x002d_Ortega-2011" MODIFIED="2015-09-26 20:10:19 +0100" MODIFIED_BY="Batool A Haider" NAME="Vadillo-Ortega 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-09-26 20:10:19 +0100" MODIFIED_BY="Batool A Haider" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, et al</AU>
<TI>Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>342</VL>
<PG>d2901</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879483"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879482"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Webb-2009" MODIFIED="2011-02-24 01:40:34 +0000" MODIFIED_BY="[Empty name]" NAME="Webb 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-02-24 01:40:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Webb AL, Aboud S, Furtado J, Murrin C, Campos H, Fawzi WW, et al</AU>
<TI>Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2009</YR>
<VL>63</VL>
<NO>3</NO>
<PG>332-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879485"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879484"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wibowo-2012" MODIFIED="2014-09-28 00:28:43 +0100" MODIFIED_BY="[Empty name]" NAME="Wibowo 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-28 00:28:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wibowo N, Purwosunu Y, Sekizawa A, Farina A, Idriansyah L, Fitriana I</AU>
<TI>Antioxidant supplementation in pregnant women with low antioxidant status</TI>
<SO>Journal of Obstetrics &amp; Gynaecology Research</SO>
<YR>2012</YR>
<VL>38</VL>
<NO>9</NO>
<PG>1152-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879487"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879486"/><IDENTIFIER TYPE="CTG" VALUE="NCT01232205"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wijaya_x002d_Erhardt-2011" MODIFIED="2014-09-28 00:28:15 +0100" MODIFIED_BY="[Empty name]" NAME="Wijaya-Erhardt 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-09-28 00:28:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wijaya-Erhardt M, Muslimatun S, Erhardt JG</AU>
<TI>Fermented soyabean and vitamin C-rich fruit: a possibility to circumvent the further decrease of iron status among iron-deficient pregnant women in Indonesia</TI>
<SO>Public Health Nutrition</SO>
<YR>2011</YR>
<VL>14</VL>
<NO>12</NO>
<PG>2185-96</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879489"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879488"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wijaya_x002d_Erhardt-2014" MODIFIED="2014-09-28 00:28:19 +0100" MODIFIED_BY="[Empty name]" NAME="Wijaya-Erhardt 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-09-28 00:28:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wijaya-Erhardt M, Muslimatun S, Erhardt G</AU>
<TI>Effect of an educational intervention related to health and nutrition on pregnant women in the villages of Central Java Province, Indonesia</TI>
<SO>Health Education Journal</SO>
<YR>2014</YR>
<VL>73</VL>
<NO>4</NO>
<PG>370-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879491"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879490"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Young-2010" MODIFIED="2015-10-12 11:45:56 +0100" MODIFIED_BY="[Empty name]" NAME="Young 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-05-18 09:54:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hernandez A, Garcia-Guerra A, Dominguez CP, Garcia-Feregrino R, Neufeld LM</AU>
<TI>Effect of three supplements with identical micronutrient content on anemia in pregnant Mexican women</TI>
<SO>FASEB Journal</SO>
<YR>2008</YR>
<VL>22</VL>
<PG>Abstract no: 677.8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879493"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-10-12 11:45:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Young SL, Blanco I, Hernandez-Cordero S, Pelto GH, Neufeld LM</AU>
<TI>Organoleptic properties, ease of use, and perceived health effects are determinants of acceptability of micronutrient supplements among poor Mexican women</TI>
<SO>Journal of Nutrition</SO>
<YR>2010</YR>
<VL>140</VL>
<NO>3</NO>
<PG>605-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879494"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879492"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zavaleta-2000" MODIFIED="2011-01-24 16:01:35 +0000" MODIFIED_BY="[Empty name]" NAME="Zavaleta 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-01-24 16:01:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zavaleta N, Caulfield LE, Garcia T</AU>
<TI>Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<NO>4</NO>
<PG>956-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879496"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879495"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ashorn-2015" MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]" NAME="Ashorn 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adu-Afarwuah S, Lartey A, Okronipa H, Maleta K, Ashorn P, Ashorn U, et al</AU>
<TI>Efficacy of LNS products for pregnant and lactating women: pregnancy outcomes from the iLiNS-dyad studies in Ghana and Malawi</TI>
<SO>Annals of Nutrition and Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<PG>24-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879500"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ashorn P, Alho L, Ashorn U, Cheung YB, Dewey KG, Harjunmaa U, et al</AU>
<TI>The impact of lipid-based nutrient supplement provision to pregnant women on newborn size in rural Malawi: a randomized controlled trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2015</YR>
<VL>101</VL>
<NO>2</NO>
<PG>387-97</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879501"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879499"/><IDENTIFIER TYPE="CTG" VALUE="NCT01239693"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gathwala-2012" MODIFIED="2015-07-27 11:54:24 +0100" MODIFIED_BY="Nancy  Medley" NAME="Gathwala 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-07-27 11:54:24 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gathwala G</AU>
<TI>Effect of antenatal multiple micronutrient supplementation of mothers on the birthweight of their infants</TI>
<SO>Journal of Paediatrics and Child Health</SO>
<YR>2012</YR>
<VL>48</VL>
<NO>Suppl 1</NO>
<PG>47-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879498"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879497"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Biggs-2011" MODIFIED="2015-05-18 09:49:57 +0100" MODIFIED_BY="[Empty name]" NAME="Biggs 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-05-18 09:49:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Biggs BA</AU>
<TI>A randomised controlled trial to compare the impact on birth weight of daily iron-folic acid, twice weekly iron-folic acid and twice weekly multiple micronutrient supplementation for pregnant women in Ha Nam province, Vietnam</TI>
<SO>Australian New Zealand Clinical Trials Registry (www.anzctr.org.au) (accessed 16 February 2011)</SO>
<YR>2011</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879503"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-03-23 09:49:37 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879502"/><IDENTIFIER MODIFIED="2015-03-23 09:49:37 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ACTRN12610000944033"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dewey-2011" MODIFIED="2015-05-18 09:50:12 +0100" MODIFIED_BY="[Empty name]" NAME="Dewey 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-04-16 08:58:22 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adu-Afarwuah S, Lartey A, Okronipa H, Maleta K, Ashorn P, Ashorn U, et al</AU>
<TI>Efficacy of LNS products for pregnant and lactating women: Pregnancy outcomes from the iLiNS-dyad studies in Ghana and Malawi</TI>
<SO>Annals of Nutrition and Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<PG>24-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879505"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:30:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adu-Afarwuah S, Lartey A, Okronipa H, Peerson J, Vosti S, Ashorn P, et al</AU>
<TI>Lipid-based nutrient supplement for pregnant women improve birth outcomes among primiparous but not multiparous women in Ghana</TI>
<SO>FASEB Journal</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>1 Suppl 1</NO>
<PG>Abstract no: 256.7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879506"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-18 09:50:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Dewey KG</AU>
<TI>Efficacy of lipid-based nutrient supplements (LNS) for pregnant and lactating women and their infants</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 15 February 2011)</SO>
<YR>2011</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879507"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:30:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oaks B, Adu-Afarwuah S, Lartey A, Stewart C, Ashorn P, Vosti S, et al</AU>
<TI>Lipid-based nutrient supplementation during pregnancy decreases maternal cortisol in younger women</TI>
<SO>FASEB Journal</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>1 Suppl 1</NO>
<PG>Abstract no. 389.6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879508"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-03-23 09:48:24 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879504"/><IDENTIFIER MODIFIED="2015-03-23 09:48:24 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00970866"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hirschberg-2014" MODIFIED="2015-04-13 16:15:49 +0100" MODIFIED_BY="[Empty name]" NAME="Hirschberg 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-13 16:15:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Hirschberg AL</AU>
<TI>Supplementation with WellnessPack mama during pregnancy and lactation- a randomized double-blind, placebo-controlled study</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 2 September 2014]</SO>
<YR>2014</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879510"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879509"/><IDENTIFIER TYPE="CTG" VALUE="NCT02190565"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moore-2011" MODIFIED="2015-04-15 14:10:05 +0100" MODIFIED_BY="Nancy  Medley" NAME="Moore 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-04-15 14:10:05 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jobarteh ML, Moore S, Kennedy C, Gambling L, McArdle HJ</AU>
<TI>The effect of nutritional supplementation during pregnancy on placental transporter expression in placentas from gambian women</TI>
<SO>Placenta</SO>
<YR>2013</YR>
<VL>34</VL>
<NO>9</NO>
<PG>A81-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879512"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-09-29 08:41:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Moore S</AU>
<TI>Investigating the effects of pre-natal and infancy nutritional supplementation on infant immune development in The Gambia: the Early Nutrition and Immune Development (ENID) trial</TI>
<SO>Current Clinical Trials (http://www.current-trials.com)</SO>
<YR>(accessed 8 July 2011)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879513"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-09-28 20:32:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moore SE, Fulford AJC, Darboe MK, Jobarteh ML, Jarjou LM, Prentice AM</AU>
<TI>A randomized trial to investigate the effects of pre-natal and infant nutritional supplementation on infant immune development in rural Gambia: The ENID trial: Early Nutrition and Immune Development</TI>
<SO>BMC Pregnancy and Childbirth</SO>
<YR>2012</YR>
<VL>12</VL>
<PG>107</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879514"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-03-23 09:45:47 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879511"/><IDENTIFIER MODIFIED="2015-03-23 09:45:47 +0000" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="ISRCTN49289450"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mridha-2014" MODIFIED="2015-05-14 23:36:16 +0100" MODIFIED_BY="[Empty name]" NAME="Mridha 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-05-14 23:35:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Harding KL, Matias SL, Moniruzzaman M, Stewart CP, Mridha MK, Vosti SA, et al</AU>
<SO>Rang-Din Nutrition Study: assessment of participant adherence to lipid-based nutrient and iron-folic acid supplements among pregnant and lactating women in the context of a study on the effectiveness of supplements in Bangladesh</SO>
<YR>2014</YR>
<EN>FHI 360/FANTA</EN>
<PB>US Agency for International Development (USAID)</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879516"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-14 23:36:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mridha M, Chaparro C, Paul R, Hussain S, Vosti S, Matias S, et al</AU>
<TI>Lipid-based nutrient supplements for pregnant women reduce newborn stunting in Bangladesh</TI>
<SO>FASEB Journal</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>1 Suppl</NO>
<PG>Abstract no: 256.6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879517"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-04-16 09:03:24 +0100" MODIFIED_BY="Nancy  Medley"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879515"/><IDENTIFIER MODIFIED="2015-04-16 09:03:19 +0100" MODIFIED_BY="Nancy  Medley" TYPE="CTG" VALUE="NCT01715038"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramakrishnan-2012" MODIFIED="2014-09-28 00:50:27 +0100" MODIFIED_BY="[Empty name]" NAME="Ramakrishnan 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-09-28 00:50:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ramakrishnan U</AU>
<TI>Impact of pre-pregnancy micronutrient supplementation on maternal and child outcomes</TI>
<SO>ClinicalTrials.gov (https://clinicaltrials.gov/) (accessed 20 September 2012)</SO>
<YR>2012</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879519"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879518"/><IDENTIFIER TYPE="CTG" VALUE="NCT01665378"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tu-2013" MODIFIED="2015-05-14 23:36:29 +0100" MODIFIED_BY="[Empty name]" NAME="Tu 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-05-14 23:36:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tu N, King JC, Dean D, Dirren H</AU>
<TI>Effect of food-based supplement prior to and during pregnancy on birth weight and prematurity in rural Vietnam (VINAVAC study)</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>Suppl 1</NO>
<PG>806, Abstract no: PO3314</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879521"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-04-16 10:22:57 +0100" MODIFIED_BY="Nancy  Medley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tu N, King JC, Dirren H, Thu HN, Ngoc QP, Diep AN</AU>
<TI>Effect of animal-source food supplement prior to and during pregnancy on birthweight and prematurity in rural Vietnam: a brief study description</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2014</YR>
<VL>35</VL>
<NO>4 Suppl</NO>
<PG>S205-S208</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2879522"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2879520"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-01-25 16:18:12 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-01-25 16:18:12 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Allen-2005" MODIFIED="2012-10-01 11:07:26 +0100" MODIFIED_BY="Jill Hampson" NAME="Allen 2005" TYPE="JOURNAL_ARTICLE">
<AU>Allen LH</AU>
<TI>Multiple micronutrients in pregnancy and lactation: an overview</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<NO>5</NO>
<PG>1206S&#8211;1212S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Andersson-2007" MODIFIED="2015-10-12 11:55:38 +0100" MODIFIED_BY="[Empty name]" NAME="Andersson 2007" TYPE="JOURNAL_ARTICLE">
<AU>WHO Secretariat, Andersson M, de Benoist B, Delange F, Zupan J</AU>
<TI>Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the technical consultation</TI>
<SO>Public Health Nutrition</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>12A</NO>
<PG>1606-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Benoist-2008" MODIFIED="2015-05-14 23:37:26 +0100" MODIFIED_BY="[Empty name]" NAME="Benoist 2008" TYPE="JOURNAL_ARTICLE">
<AU>de Benoist B, McLean E, Andersson M, Rogers L</AU>
<TI>Iodine deficiency in 2007: global progress since 2003</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2008</YR>
<VL>29</VL>
<NO>3</NO>
<PG>195-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berti-2011" MODIFIED="2015-05-14 23:38:16 +0100" MODIFIED_BY="[Empty name]" NAME="Berti 2011" TYPE="JOURNAL_ARTICLE">
<AU>Berti C, Biesalski HK, Gärtner R, Lapillonne A, Pietrzik K, Poston L, et al</AU>
<TI>Micronutrients in pregnancy: current knowledge and unresolved questions</TI>
<SO>Clinical Nutrition (Edinburgh, Scotland)</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>6</NO>
<PG>689-701</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bhutta-2008" MODIFIED="2010-01-11 00:47:25 +0000" MODIFIED_BY="[Empty name]" NAME="Bhutta 2008" TYPE="JOURNAL_ARTICLE">
<AU>Bhutta ZA, Haider BA</AU>
<TI>Maternal micronutrient deficiencies in developing countries</TI>
<SO>Lancet</SO>
<YR>2008</YR>
<VL>371(9608)</VL>
<PG>186-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bhutta-2009b" MODIFIED="2015-05-14 23:38:28 +0100" MODIFIED_BY="[Empty name]" NAME="Bhutta 2009b" TYPE="JOURNAL_ARTICLE">
<AU>Bhutta ZA, Haider BA</AU>
<TI>Prenatal micronutrient supplementation: Are we there yet?</TI>
<SO>CMAJ : Canadian Medical Association Journal</SO>
<YR>2009</YR>
<VL>180</VL>
<NO>12</NO>
<PG>1188-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bhutta-2012" MODIFIED="2015-05-14 23:38:49 +0100" MODIFIED_BY="[Empty name]" NAME="Bhutta 2012" TYPE="JOURNAL_ARTICLE">
<AU>Bhutta ZA, Imdad A, Ramakrishnan U, Martorell R</AU>
<TI>Is it time to replace iron folate supplements in pregnancy with multiple micronutrients?</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>2012</YR>
<VL>26 Suppl 1</VL>
<PG>27-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bhutta-2013" MODIFIED="2015-05-18 10:06:20 +0100" MODIFIED_BY="[Empty name]" NAME="Bhutta 2013" TYPE="JOURNAL_ARTICLE">
<AU>Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al</AU>
<TI>Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?</TI>
<SO>Lancet</SO>
<YR>2013</YR>
<VL>382</VL>
<NO>9890</NO>
<PG>452-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Black-2001" MODIFIED="2012-10-01 11:08:07 +0100" MODIFIED_BY="[Empty name]" NAME="Black 2001" NOTES="&lt;p&gt;Black RE. Micronutrients in pregnancy. Br J Nutr 2001 May;85 Suppl 2:S193-7&lt;/p&gt;" NOTES_MODIFIED="2012-10-01 11:08:07 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Black RE</AU>
<TI>Micronutrients in pregnancy</TI>
<SO>British Journal of Nutrition</SO>
<YR>2001</YR>
<VL>85 Suppl 2</VL>
<PG>S193-S197</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Black-2013" MODIFIED="2015-05-18 11:03:16 +0100" MODIFIED_BY="[Empty name]" NAME="Black 2013" TYPE="JOURNAL_ARTICLE">
<AU>Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al</AU>
<TI>Maternal and child undernutrition and overweight in low-income and middle-income countries</TI>
<SO>Lancet</SO>
<YR>2013</YR>
<VL>382</VL>
<PG>427-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Caulfield-1998" NAME="Caulfield 1998" NOTES="&lt;p&gt;Caulfield L, Zavaleta N, Shankur AH, Merialdi M. &amp;quot;Potential Contribution of Maternal Zinc Supplementation during Pregnancy to Maternal and Child Survival.&amp;quot; American Journal of Clinical Nutrition 1998; 65: 499S-508S.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Caulfield L, Zavaleta N, Shankur AH, Merialdi M</AU>
<TI>Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1998</YR>
<VL>65</VL>
<PG>S499-S508</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Christian-2005" MODIFIED="2011-03-23 12:48:53 +0000" MODIFIED_BY="Jill Hampson" NAME="Christian 2005" TYPE="JOURNAL_ARTICLE">
<AU>Christian P, Osrin D, Manandhar DS, Khatry SK, de L Costello AM, West KP Jr</AU>
<TI>Antenatal micronutrient supplements in Nepal</TI>
<SO>Lancet</SO>
<YR>2005</YR>
<VL>366</VL>
<PG>711-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Christian-2015" MODIFIED="2015-10-12 11:56:13 +0100" MODIFIED_BY="[Empty name]" NAME="Christian 2015" TYPE="JOURNAL_ARTICLE">
<AU>Christian P</AU>
<TI>Evidence of multiple micronutrient supplementation (MMS) in pregnancy</TI>
<SO>Sight and Life</SO>
<YR>2015</YR>
<VL>29</VL>
<NO>1</NO>
<PG>28-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Datta-2002" MODIFIED="2015-10-19 16:38:36 +0100" MODIFIED_BY="Heather Maxwell" NAME="Datta 2002" TYPE="JOURNAL_ARTICLE">
<AU>Datta S, Alfaham M, Davies DP, Dunstan F, Woodhead S, Evans J, et al</AU>
<TI>Vitamin D deficiency in pregnant women from a non-European ethnic minority population--an interventional study</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2002</YR>
<VL>109</VL>
<NO>8</NO>
<PG>905-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-De_x002d_Regil-2010" MODIFIED="2011-09-14 14:02:57 +0100" MODIFIED_BY="[Empty name]" NAME="De-Regil 2010" TYPE="COCHRANE_REVIEW">
<AU>De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP</AU>
<TI>Effects and safety of periconceptional folate supplementation for preventing birth defects</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2011-09-14 14:02:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2011-09-14 14:02:57 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD007950.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dunn-1993" NAME="Dunn 1993" TYPE="JOURNAL_ARTICLE">
<AU>Dunn JT</AU>
<TI>Iodine supplementation and the prevention of cretinism</TI>
<SO>Annals of New York Academy of Sciences</SO>
<YR>1993</YR>
<VL>678</VL>
<PG>158-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Edmond-2012" MODIFIED="2015-10-19 16:40:31 +0100" MODIFIED_BY="Heather Maxwell" NAME="Edmond 2012" TYPE="JOURNAL_ARTICLE">
<AU>Edmond K, Hurt L, Fenty J, Amenga-Etego S, Zandoh C, Hurt C, et al</AU>
<TI>Effect of vitamin A supplementation in women of reproductive age on cause-specific early and late infant mortality in rural Ghana: ObaapaVitA double-blind, cluster-randomised, placebo-controlled trial</TI>
<SO>BMJ Open</SO>
<YR>2012</YR>
<VL>2</VL>
<NO>1</NO>
<PG>e000658</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fall-2009" MODIFIED="2012-10-01 11:08:30 +0100" MODIFIED_BY="Jill Hampson" NAME="Fall 2009" TYPE="JOURNAL_ARTICLE">
<AU>Fall CH, Fisher DJ, Osmond C, Margetts BM, Maternal Micronutrient Supplementation Study Group</AU>
<TI>Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on birth size and length of gestation</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>4 Suppl</NO>
<PG>S533-S546</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FAO_x002f_WHO-2004" MODIFIED="2015-02-01 23:41:04 +0000" MODIFIED_BY="[Empty name]" NAME="FAO/WHO 2004" TYPE="BOOK">
<AU>FAO/WHO</AU>
<TI>Vitamin and mineral requirements in human nutrition. 2nd ed.World Health Organization and Food and Agriculture Organization of theUnited Nations; 2004.</TI>
<SO>Vitamin and mineral requirements in human nutrition</SO>
<YR>2004</YR>
<EN>2nd</EN>
<PB>World Health Organization and Food and Agriculture Organization of the United Nation</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Food-and-Nutrition-Bulletin-2009" MODIFIED="2017-01-25 16:18:12 +0000" MODIFIED_BY="[Empty name]" NAME="Food and Nutrition Bulletin 2009" TYPE="OTHER">
<AU>Food and Nutrition Bulletin</AU>
<TI>Multiple Micronutrient Supplementation During Pregnancy in Developing Country Settings</TI>
<SO>www.cmamforum.org/Pool/Resources/Multiple-micronutrient-suppl-during-pregnancy-FNB-2009.pdf</SO>
<YR>(accessed 11 March 2015)</YR>
<PG>Table 1: S538</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ginde-2010" MODIFIED="2015-05-14 23:40:08 +0100" MODIFIED_BY="[Empty name]" NAME="Ginde 2010" TYPE="JOURNAL_ARTICLE">
<AU>Ginde AA, Sullivan AF, Mansbach JM, Camargo CA Jr</AU>
<TI>Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2010</YR>
<VL>202</VL>
<NO>5</NO>
<PG>436.e1-436.e8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haider-2011" MODIFIED="2012-09-29 08:44:31 +0100" MODIFIED_BY="[Empty name]" NAME="Haider 2011" TYPE="JOURNAL_ARTICLE">
<AU>Haider BA, Yakoob MY, Bhutta ZA</AU>
<TI>Effect of multiple micronutrient supplementation during pregnancy on maternal and birth outcomes</TI>
<SO>BMC Public Health</SO>
<YR>2011</YR>
<VL>11 Suppl 3</VL>
<PG>S19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haider-2013" MODIFIED="2015-05-18 10:07:21 +0100" MODIFIED_BY="[Empty name]" NAME="Haider 2013" TYPE="JOURNAL_ARTICLE">
<AU>Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW, et al</AU>
<TI>Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis</TI>
<SO>BMJ</SO>
<YR>2013</YR>
<VL>346</VL>
<PG>f3443</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hess-2009" MODIFIED="2015-05-18 10:07:28 +0100" MODIFIED_BY="[Empty name]" NAME="Hess 2009" TYPE="JOURNAL_ARTICLE">
<AU>Hess SY, King JC</AU>
<TI>Effects of maternal zinc supplementation on pregnancy and lactation outcomes</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>1</NO>
<PG>S60-S78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2011-04-21 09:11:20 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huffman-1998" MODIFIED="2015-05-18 10:07:44 +0100" MODIFIED_BY="[Empty name]" NAME="Huffman 1998" NOTES="&lt;p&gt;Huffman SL, Baker J, Shumann J, Zehner ER. The Case for Promoting Multiple Vitamin/Mineral Supplements for Women of Reproductive Age in Developing Countries. The LINKAGES project. 1998&lt;/p&gt;" NOTES_MODIFIED="2015-05-18 10:07:44 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Huffman SL, Baker J, Shumann J, Zehner ER</AU>
<TI>The case for promoting multiple vitamin/mineral supplements for women of reproductive age in developing countries</TI>
<SO>The LINKAGES Project (www.linkagesproject.org) (accessed 26 April 2003)</SO>
<YR>1998</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huffman-2005" MODIFIED="2010-06-04 17:47:11 +0100" MODIFIED_BY="[Empty name]" NAME="Huffman 2005" TYPE="JOURNAL_ARTICLE">
<AU>Huffman SL, Habicht JP, Scrimshaw N</AU>
<TI>Micronutrient supplementation in pregnancy</TI>
<SO>Lancet</SO>
<YR>2005</YR>
<VL>366</VL>
<PG>2001</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jiang-2005" MODIFIED="2015-05-14 23:40:59 +0100" MODIFIED_BY="[Empty name]" NAME="Jiang 2005" TYPE="JOURNAL_ARTICLE">
<AU>Jiang T, Christian P, Khatry SK, Wu L, West KP Jr</AU>
<TI>Micronutrient deficiencies in early pregnancy are common, concurrent, and vary by season among rural Nepali pregnant women</TI>
<SO>Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<NO>5</NO>
<PG>1106-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kawai-2011" MODIFIED="2015-05-14 23:41:41 +0100" MODIFIED_BY="[Empty name]" NAME="Kawai 2011" TYPE="JOURNAL_ARTICLE">
<AU>Kawai K, Spiegelman D, Shankar AH, Fawzi WW</AU>
<TI>Maternal multiple micronutrient supplementation and pregnancy outcomes in developing countries: meta-analysis and meta-regression</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>2011</YR>
<VL>89</VL>
<NO>6</NO>
<PG>402-411B</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keen-2003" MODIFIED="2012-10-01 11:08:51 +0100" MODIFIED_BY="Jill Hampson" NAME="Keen 2003" TYPE="JOURNAL_ARTICLE">
<AU>Keen CL, Clegg MS, Hanna LA, Lanoue L, Rogers JM, Daston GP, et al</AU>
<TI>The plausibility of micronutrient deficiencies being a significant contributing factor to the occurrence of pregnancy complications</TI>
<SO>Journal of Nutrition</SO>
<YR>2003</YR>
<VL>133</VL>
<PG>1597S&#8211;1605S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kramer-2003" MODIFIED="2012-10-01 11:09:05 +0100" MODIFIED_BY="Jill Hampson" NAME="Kramer 2003" TYPE="JOURNAL_ARTICLE">
<AU>Kramer MS</AU>
<TI>The epidemiology of adverse pregnancy outcomes: an overview</TI>
<SO>Journal of Nutrition</SO>
<YR>2003</YR>
<VL>133</VL>
<PG>1592S&#8211;1596S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Margetts-2009" MODIFIED="2012-10-01 11:09:29 +0100" MODIFIED_BY="Jill Hampson" NAME="Margetts 2009" TYPE="JOURNAL_ARTICLE">
<AU>Margetts BM, Fall CH, Ronsmans C, Allen LH, Fisher DJ, Maternal Micronutrient Supplementation Study Group</AU>
<TI>Multiple micronutrient supplementation during pregnancy in low-income countries: review of methods and characteristics of studies included in the meta-analyses</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>4 Suppl</NO>
<PG>S517-S526</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McArdle-1999" MODIFIED="2015-05-14 23:42:06 +0100" MODIFIED_BY="[Empty name]" NAME="McArdle 1999" TYPE="JOURNAL_ARTICLE">
<AU>McArdle HJ, Ashworth CJ</AU>
<TI>Micronutrients in fetal growth and development</TI>
<SO>British Medical Bulletin</SO>
<YR>1999</YR>
<VL>55</VL>
<PG>499-510</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murray_x002d_Kolb-2013" MODIFIED="2015-05-18 11:04:40 +0100" MODIFIED_BY="[Empty name]" NAME="Murray-Kolb 2013" TYPE="OTHER">
<AU>Murray-Kolb LE, Chen L, Chen P, Shapiro M, Caulfield L</AU>
<TI>CHERG iron report: maternal mortality, child mortality, perinatal mortality, child cognition, and estimates of prevalence of anemia due to iron deficiency</TI>
<SO>CHERG Iron Report (cherg.org/publications/iron-report.pdf) (accessed 3 February 2015)</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oppenheimer-2001" MODIFIED="2012-10-01 11:09:42 +0100" MODIFIED_BY="Jill Hampson" NAME="Oppenheimer 2001" TYPE="JOURNAL_ARTICLE">
<AU>Oppenheimer SJ</AU>
<TI>Iron and its relation to immunity and infectious disease</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<PG>616S&#8211;635S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oriji-2011" MODIFIED="2015-05-18 09:36:05 +0100" MODIFIED_BY="[Empty name]" NAME="Oriji 2011" TYPE="JOURNAL_ARTICLE">
<AU>Oriji VK, Enyindah CE, Nyeche S</AU>
<TI>Factors determining compliance to routine iron supplementation in pregnancy at the University of Portharcout Teaching Hospital</TI>
<SO>Nigerian Journal of Medicine</SO>
<YR>2011</YR>
<VL>20</VL>
<NO>1</NO>
<PG>131-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ota-2015" MODIFIED="2015-05-18 10:57:03 +0100" MODIFIED_BY="[Empty name]" NAME="Ota 2015" TYPE="COCHRANE_REVIEW">
<AU>Ota E, Mori R, Middleton P, Tobe-Gai R, Mahomed K, Miyazaki C, et al</AU>
<TI>Zinc supplementation for improving pregnancy and infant outcome</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2015-05-18 09:37:44 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-05-18 09:37:44 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000230.pub5"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ozaltin-2010" MODIFIED="2010-06-14 21:45:23 +0100" MODIFIED_BY="[Empty name]" NAME="Ozaltin 2010" TYPE="JOURNAL_ARTICLE">
<AU>Ozaltin E, Hill K, Subramanian SV</AU>
<TI>Association of maternal stature with offspring mortality, underweight, and stunting in low- to middle-income countries</TI>
<SO>JAMA</SO>
<YR>2010</YR>
<VL>303</VL>
<NO>15</NO>
<PG>1507-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pathak--2004" MODIFIED="2015-05-18 09:38:46 +0100" MODIFIED_BY="[Empty name]" NAME="Pathak  2004" TYPE="JOURNAL_ARTICLE">
<AU>Pathak P, Kapil U, Kapoor SK, Saxena R, Kumar A, Gupta N, et al</AU>
<TI>Prevalence of multiple micronutrient deficiencies amongst pregnant women in a rural area of Haryana</TI>
<SO>Indian Journal of Pediatrics</SO>
<YR>2004</YR>
<VL>71</VL>
<NO>11</NO>
<PG>1007-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pena_x002d_Rosas-2015" MODIFIED="2015-10-23 12:37:16 +0100" MODIFIED_BY="[Empty name]" NAME="Pena-Rosas 2015" TYPE="COCHRANE_REVIEW">
<AU>Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T</AU>
<TI>Daily oral iron supplementation during pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2015</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2015-10-23 12:37:16 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-10-23 12:37:16 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004736.pub5"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ramakrishnan-2012a" MODIFIED="2015-05-18 09:39:40 +0100" MODIFIED_BY="[Empty name]" NAME="Ramakrishnan 2012a" TYPE="JOURNAL_ARTICLE">
<AU>Ramakrishnan U, Grant FK, Goldenberg T, Bui V, Imdad A, Bhutta ZA</AU>
<TI>Effect of multiple micronutrient supplementation on pregnancy and infant outcomes: a systematic review</TI>
<SO>Paediatric and Perinatal Epidemiology</SO>
<YR>2012</YR>
<VL>26(suppl)</VL>
<PG>153-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2014-08-07 11:49:27 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ronsmans-2009" MODIFIED="2012-10-01 11:10:01 +0100" MODIFIED_BY="Jill Hampson" NAME="Ronsmans 2009" TYPE="JOURNAL_ARTICLE">
<AU>Ronsmans C, Fisher DJ, Osmond C, Margetts BM, Fall CH, Maternal Micronutrient Supplementation Study Group</AU>
<TI>Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on stillbirths and on early and late neonatal mortality</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>4 Suppl</NO>
<PG>S547-S555</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sachan-2005" MODIFIED="2015-05-18 09:40:06 +0100" MODIFIED_BY="[Empty name]" NAME="Sachan 2005" TYPE="JOURNAL_ARTICLE">
<AU>Sachan A, Gupta R, Das V, Agarwal A, Awasthi PK, Bhatia V</AU>
<TI>High prevalence of vitamin D deficiency among pregnant womenand their newborns in northern India</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<NO>5</NO>
<PG>1060-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Seck-2008" MODIFIED="2015-05-18 09:40:45 +0100" MODIFIED_BY="[Empty name]" NAME="Seck 2008" TYPE="JOURNAL_ARTICLE">
<AU>Seck BC, Jackson RT</AU>
<TI>Determinants of compliance with iron supplementation among pregnant women in Senegal</TI>
<SO>Public Health Nutrition</SO>
<YR>2008</YR>
<VL>11</VL>
<NO>6</NO>
<PG>596-605</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shrimpton-2005" MODIFIED="2010-06-04 17:48:10 +0100" MODIFIED_BY="[Empty name]" NAME="Shrimpton 2005" TYPE="JOURNAL_ARTICLE">
<AU>Shrimpton R, Dalmiya N, Danton-Hill I, Gross R</AU>
<TI>Micronutrient supplementation in pregnancy</TI>
<SO>Lancet</SO>
<YR>2005</YR>
<VL>366</VL>
<PG>2001-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Siegfried-2012" MODIFIED="2015-05-18 11:05:02 +0100" MODIFIED_BY="[Empty name]" NAME="Siegfried 2012" TYPE="COCHRANE_REVIEW">
<AU>Siegfried N, Irlam JH, Visser ME, Rollins NN</AU>
<TI>Micronutrient supplementation in pregnant women with HIV infection</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2015-05-18 09:41:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-05-18 09:41:23 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009755"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stevens-2013" MODIFIED="2015-05-18 09:41:37 +0100" MODIFIED_BY="[Empty name]" NAME="Stevens 2013" TYPE="JOURNAL_ARTICLE">
<AU>Stevens G, Finucane M, De-Regil L, Paciorek C, Flaxman S, Branca F, et al</AU>
<TI>Global,regional, and national trends in total and severe anaemia prevalence in children and pregnant and non-pregnant women</TI>
<SO>Lancet Global Health</SO>
<YR>2013</YR>
<VL>1</VL>
<NO>1</NO>
<PG>e16-e25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tielsch-2008" MODIFIED="2015-05-18 10:09:35 +0100" MODIFIED_BY="[Empty name]" NAME="Tielsch 2008" TYPE="JOURNAL_ARTICLE">
<AU>Tielsch JM, Rahmathullah L, Katz J, Thulasiraj RD, Coles C, Sheeladevi S, et al</AU>
<TI>Maternal night blindness during pregnancy is associated with low birthweight, morbidity, and poor growth in South India</TI>
<SO>Journal of Nutrition</SO>
<YR>2008</YR>
<VL>138</VL>
<PG>787&#8211;92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-UNICEF-1999" MODIFIED="2011-03-23 14:25:39 +0000" MODIFIED_BY="Jill Hampson" NAME="UNICEF 1999" TYPE="OTHER">
<AU>UNICEF</AU>
<TI>Composition of a multi-micronutrient supplement to be used in pilot programmes among pregnant women in developing countries 1999</TI>
<SO>UNICEF (www.UNICEF.org) (accessed 25 April 2003)</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Voigt-2010" MODIFIED="2011-03-23 14:28:42 +0000" MODIFIED_BY="Jill Hampson" NAME="Voigt 2010" TYPE="JOURNAL_ARTICLE">
<AU>Voigt M, Rochow N, Jährig K, Straube S, Hufnagel S, Jorch G</AU>
<TI>Dependence of neonatal small and large for gestational age rates on maternal height and weight - an analysis of the German Perinatal Survey</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2010</YR>
<VL>38</VL>
<NO>4</NO>
<PG>425-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walker-2010" MODIFIED="2015-05-18 09:46:56 +0100" MODIFIED_BY="[Empty name]" NAME="Walker 2010" TYPE="JOURNAL_ARTICLE">
<AU>Walker N, Fischer-Walker C, Bryce J, Bahl R, Cousens S</AU>
<TI>Standards for CHERG reviews of intervention effects on child survival</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2010</YR>
<VL>39 Suppl 1</VL>
<PG>i21&#8211;i31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wessells-2012" MODIFIED="2015-05-18 09:47:46 +0100" MODIFIED_BY="[Empty name]" NAME="Wessells 2012" TYPE="JOURNAL_ARTICLE">
<AU>Wessells KR, Brown KH</AU>
<TI>Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting</TI>
<SO>PloS One</SO>
<YR>2012</YR>
<VL>7</VL>
<PG>e50568</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1959" MODIFIED="2015-05-18 10:10:35 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 1959" TYPE="OTHER">
<AU>WHO</AU>
<TI>Iron deficiency anaemias: report of a WHO study group</TI>
<SO>WHO Technical Report Series (http://whqlibdoc.who.int/trs/WHO_TRS_182.pdf) (accessed 1 February 2014)</SO>
<YR>1959</YR>
<VL>182</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1995" MODIFIED="2015-05-18 09:48:59 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 1995" TYPE="JOURNAL_ARTICLE">
<AU>Kelly A, Kevanya J, de Onis M, Shah PM</AU>
<TI>A WHO collaborative study of maternal anthropometry and pregnancy outcomes</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1996</YR>
<VL>53</VL>
<PG>219-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2004" MODIFIED="2015-05-18 11:05:33 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2004" TYPE="BOOK">
<AU>FAO/WHO</AU>
<SO>Vitamin and Mineral Requirements in Human Nutrition: Joint FAO/WHO Expert Consultation</SO>
<YR>2004</YR>
<EN>2nd</EN>
<PB>WHO/FAO</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2009" MODIFIED="2015-05-18 11:06:06 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2009" TYPE="BOOK">
<AU>WHO</AU>
<SO>Global Prevalence of Vitamin A Deficiency in Populations at Risk 1995&#8211;2005. WHO Global Database on Vitamin A Deficiency</SO>
<YR>2009</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2012" MODIFIED="2015-05-18 11:06:30 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2012" TYPE="BOOK">
<AU>WHO</AU>
<SO>Guideline: Daily Iron and Folic Acid Supplementation in Pregnant Women</SO>
<YR>2012</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-05-07 14:02:14 +0100" MODIFIED_BY="Nancy L Medley">
<REFERENCE ID="REF-Haider-2006" MODIFIED="2015-05-07 14:02:14 +0100" MODIFIED_BY="Nancy L Medley" NAME="Haider 2006" TYPE="COCHRANE_REVIEW">
<AU>Haider BA, Bhutta ZA.</AU>
<TI>Multiple-micronutrient supplementation for women during pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2015-05-07 14:02:14 +0100" MODIFIED_BY="Nancy L Medley"><IDENTIFIER MODIFIED="2015-05-07 14:02:09 +0100" MODIFIED_BY="Nancy L Medley" TYPE="DOI" VALUE="10.1002/14651858.CD004905.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Haider-2012" MODIFIED="2014-08-07 11:47:24 +0100" MODIFIED_BY="[Empty name]" NAME="Haider 2012" TYPE="COCHRANE_REVIEW">
<AU>Haider BA, Bhutta ZA</AU>
<TI>Multiple-micronutrient supplementation for women during pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2014-08-07 11:47:24 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-08-07 11:47:24 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004905.pub3"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2015-04-15 14:04:09 +0100" MODIFIED_BY="Nancy  Medley"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-02-21 15:05:51 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-02-21 14:59:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bhutta-2009a">
<CHAR_METHODS MODIFIED="2015-03-27 17:12:04 +0000" MODIFIED_BY="[Empty name]">
<P>This cluster-randomised trial was conducted in urban and rural areas in Pakistan.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:00:52 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women with gestational age &lt; 16 weeks were eligible for enrolment. MMN group (n = 1148), iron folic acid group (n = 1230).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 08:00:59 +0100" MODIFIED_BY="Heather Maxwell">
<P>MMN group received vitamin A 800 mcg, D 200 IU, E 10 mg, C 70 mg, B1 1.4 mg, B2 1.4 mg, niacin 18 mg, B6 1.9 mg, B12 2.6 mg, folic acid 400 mcg, iron 30 mg, zinc 15 mg, copper 2 mg, selenium 65 mcg and iodine 150 mcg.</P>
<P>Iron folic acid group received 60 mg iron and 400 mcg folic acid.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 14:59:39 +0000" MODIFIED_BY="[Empty name]">
<P>Size at birth, gestational age at birth, perinatal mortality, maternal anaemia (Hb &lt; 11 g/ dl), mode of delivery (caesarean section).</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-11 15:01:31 +0100" MODIFIED_BY="[Empty name]">
<P>MMN and MMN + nutritional education groups were compared with iron folic acid and iron folic acid + nutritional education group. Iron folic acid given to all participants. Maternal malnutrition, vitamin A deficiency, anaemia and iron deficiency were common. 2 methods of community outreach were implemented that is, basic nutrition along with antenatal care messages and quarterly community-based group sessions conducted by CHWs and social scientist. There was no significant difference in baseline characteristics between 2 groups.</P>
<P>Data for caesarean section were presented (intervention 18/743; control 22/832). It was not included in the analysis as this was a cluster RCT.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-22 09:41:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brough-2010">
<CHAR_METHODS MODIFIED="2012-07-01 20:42:19 +0100" MODIFIED_BY="[Empty name]">
<P>This randomised trial was conducted in a socially deprived, multi-ethnic population in east London, United Kingdom.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-01 20:42:32 +0100" MODIFIED_BY="[Empty name]">
<P>Participants included women aged 16 years or older with a singleton pregnancy. Exclusion criteria included a gestation of greater than 13 weeks of gestation, chronic disease or use of micronutrient supplements (excluding folic acid and iron). MMN group n = 207 and placebo n = 195.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 09:41:34 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were randomised to receive either MMN supplements, known as Pregnacare, or a placebo comprising starch with an iron oxide coating. MMN supplement contained beta-carotene 3 mg, thiamin (as thiamin mononitrate, 3·6 mg) 3 mg, riboflavin 2 mg, niacin (as nicotinamide) 20 mg, vitamin B6 (as pyridoxine HCl) 10mg, vitamin B12 (as cyanocobalamin) 6 mcg, folic acid 400 mcg, vitamin C (as ascorbic acid, 73 mg) 70 mg, vitamin D (as cholecalciferol, 200 IU) 5 mcg, vitamin E (as D-a-tocopheryl acid succinate, 21 mg) 20 mg, vitamin K 70 mcg, Fe (as ferrous fumarate, 63·3 mg) 20 mg, zinc (as zinc sulphate H<SUB>2</SUB>O, 41 mg) 15 mg, Mg (as magnesium hydroxide, 372 mg) 150 mg, Iodine (as potassium iodide, 183 mg) 140 mcg and copper (as copper sulphate H<SUB>2</SUB>O, 2·8 mg) 1 mg.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 08:03:53 +0100" MODIFIED_BY="Heather Maxwell">
<P>Birthweight, preterm birth, SGA, head circumference, Hb.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-09-21 12:27:32 +0100" MODIFIED_BY="[Empty name]">
<P>Women not using folic acid were also given 400 mcg folic acid to take daily until 12 weeks of gestation.</P>
<P>There were no significant differences in age, height, weight, BMI or parity regarding treatment group allocation.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:02:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christian-2003">
<CHAR_METHODS MODIFIED="2015-10-22 08:04:42 +0100" MODIFIED_BY="Heather Maxwell">
<P>This was a double-blind cluster-randomised trial, carried out in rural Nepal from December 1998 to April 2001.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-09-21 12:20:49 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 4926 pregnant women were enrolled in the study. The women were randomised into 5 groups as follows: group 1 (n = 941), group 2 (n = 957), group 3 (n = 999), group 4 (n = 1050) and group 5 (n = 1051).<BR/>Women who were currently pregnant or those who were breastfeeding an infant less than 9 months old were excluded from the study. Also excluded were menopausal, sterilised or widowed women.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-11 14:23:46 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1 received folic acid 400 mcg and vitamin A.</P>
<P>Group 2 received folic acid 400 mcg, iron 60 mg as ferrous fumerate and vitamin A.</P>
<P>Group 3 contained the same minerals as group 2 in addition to 30 mg of zinc as zinc sulphate.</P>
<P>Group 4 received similar micronutrients as group 3 in addition to vitamin D 10 mcg, vitamin E 10 mg, vitamin B1 1.6 mg, vitamin B2 1.8 mg, niacin 20 mg, vitamin B6 2.2 mg, vitamin B12 2.6 mcg, vitamin C 100 mg, vitamin K 65 mcg, copper 2 mg and magnesium 100 mg.</P>
<P>Group 5 (control group) received 1000 mcg of vitamin A only.<BR/>All supplements were given orally from the time of pregnancy detection until 12 weeks after a live birth or 5 weeks after a still birth or a miscarriage.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:02:44 +0000" MODIFIED_BY="[Empty name]">
<P>Preterm births, SGA (weight &lt; 10 percentile of gestational age), LBW (&lt; 2500 g), side-effects, fetal loss, perinatal mortality, neonatal mortality, 3-month infant mortality.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-08 16:26:34 +0100" MODIFIED_BY="[Empty name]">
<P>All women were offered 2, 400 mg single dose albendazole in the second and third trimester of pregnancy because of the high prevalence of hookworm infestation in this population. Hookworm infestation and vitamin A deficiency are one of the major causes of anaemia in this population. Due to this reason, vitamin A was given to all the participants including the control group.</P>
<P>Baseline characteristics did not differ significantly among the various randomisation groups except for ethnicity and land holding.<BR/>
</P>
<P>In this review, we used the group 4 data for the MMN group and group 2 data for the control group. All the estimates were adjusted for the cluster design and provided by the authors.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-22 08:10:02 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Fawzi-2007">
<CHAR_METHODS MODIFIED="2015-10-22 08:08:23 +0100" MODIFIED_BY="Heather Maxwell">
<P>This was a double-blind trial in Dar es Salam, Tanzania. Pregnant women who attended antenatal clinics between August 2001 and July 2004 were included.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-16 05:54:30 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women who attended antenatal clinics, had a negative test for HIV infection, planned to stay in the city until delivery and for 1 year thereafter with gestational age between 12 and 27 weeks according to LMP were included. The study groups were similar with respect to baseline characteristics.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-27 18:54:17 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 4214) received vitamin B1 20 mg, B2 20 mg, B6 25 mg, B12 50 &#956;g, C 500 mg, E 30 mg niacin 100 mg, folic acid 0.8 mg. Control group (n = 4214) received placebo. Women were randomly assigned to receive either MM or control from the time of enrolment until 6 weeks after delivery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 08:10:02 +0100" MODIFIED_BY="Heather Maxwell">
<P>LBW (&lt; 2500 g), preterm delivery (&lt; 37 weeks of gestation), very LBW (&lt; 2000 g), extremely preterm delivery (&lt; 34 weeks of gestation), SGA (&lt; 10th percentile for gestational age), fetal death, death in first 6 weeks, length, head circumference, placental weight, risk of caesarean section, maternal mortality, haematological status (Hb &lt; 11 g/dL and &lt; 8.5 g/dL, immune status (CD4 count &lt; 775 per cubic mm, CD8 count &lt; 480 per cubic mm and CD3 count &lt; 1350 per cubic mm).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-09-20 14:03:10 +0100" MODIFIED_BY="[Empty name]">
<P>All women irrespective of group received iron 60 mg and folic acid 0.25 mg. Malaria prophylaxis (sulphadoxine-pyrimethamine tablets) at 20 and 30 weeks of gestation was given to all. The study groups were similar with respect to baseline characteristics.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:03:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Friis-2004">
<CHAR_METHODS MODIFIED="2012-09-29 06:29:31 +0100" MODIFIED_BY="[Empty name]">
<P>This trial was carried out in Zimbabwe in 1996-1997.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:10:41 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women who were between 22 and 36 weeks of gestation were eligible for enrolment. Participants 1669 were randomised into 2 groups, MMN group n = 837 and placebo n = 832. Out of the 1106 women that were followed, 725 were HIV+ve and 360 were HIV-ve.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 08:11:28 +0100" MODIFIED_BY="Heather Maxwell">
<P>MMN group received daily supplementation of vitamin A 3000 mcg RE, beta carotene 3.5 mg, thiamine 1.5 mg, riboflavin 1.6 mg, B6 2.2 mg, B12 4 mcg, niacin 17 mg, C 80 mg, D 10 mcg, E 10 mg, zinc 15 mg, copper 1.2 mcg and selenium 65 mcg while the other group received a placebo. An iron folic acid supplement was given separately as part of the routine antenatal care and was not part of the MMN tablet. Tablets were given from the day of enrolment until delivery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:03:01 +0000" MODIFIED_BY="[Empty name]">
<P>Gestational age, birthweight, birth length, head circumference, preterm delivery (&lt; 37 weeks of gestation), LBW (&lt; 2500 g), IUGR-LBW (&gt; 37 weeks' gestational age and &lt; 2500 g birthweight).</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-22 08:11:58 +0100" MODIFIED_BY="Heather Maxwell">
<P>Study intervention was approximately the RDA for pregnant or lactating women, except for vitamin A for which a higher amount was given.<BR/>Out of 1106 women who were followed, 725 were HIV-ve whereas 360 were HIV+ve and HIV status of 21 was indeterminate. We have used data of HIV-ve women only in this review.</P>
<P>The intervention and the placebo groups were comparable at baseline except for the higher proportion of primigravida in the placebo group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-22 08:14:06 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Hininger-2004">
<CHAR_METHODS MODIFIED="2015-10-22 08:12:25 +0100" MODIFIED_BY="Heather Maxwell">
<P>A double-blind, randomised placebo-controlled trial. The study was conducted at Obstetric Departments of Grenoble and Lyon Hospitals in France.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-05-24 17:55:07 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 100 apparently healthy women receiving prenatal care between 12 and 16 weeks of gestation were enrolled. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 08:13:34 +0100" MODIFIED_BY="Heather Maxwell">
<P>The intervention group received a MMN supplement and the control group received a placebo. The MMN supplement contained vitamin C (60 mg), b-carotene (4.8 mg), vitamin E (10 mg), thiamin (1.4 mg), riboflavin (1.6 mg), niacin (15 mg), pantothenic acid (6 mg), folic acid (200 mg), cobalamin (1 mg), Zn (15mg as citrate), Mg (87.5 mg as glycerophosphate), Ca (100 mg as carbonate). The supplement was given for an average of 14 ± 2 weeks of gestation till delivery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-09-21 12:18:56 +0100" MODIFIED_BY="[Empty name]">
<P>Effect of MMN supplementation on maternal blood vitamin concentrations, mineral and trace element concentrations and oxidative stress indexes concentrations. Maternal weight gain, gestational age of baby at birth, birthweight and head circumference were also assessed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-22 08:14:06 +0100" MODIFIED_BY="Heather Maxwell">
<P>The MMN supplement was iron-free, due to its oxidative potential effect. Baseline characteristics and vitamin mineral status of the enrolled participants were comparable in both groups. Outcomes measured were presented in a format that precluded its inclusion in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:03:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaestel-2005">
<CHAR_METHODS MODIFIED="2009-04-29 11:00:18 +0100" MODIFIED_BY="[Empty name]">
<P>This study was conducted in Guinea-Bissau. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:15:07 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women with less than 37 weeks of gestation were eligible for enrolment. A total of 2100 women were randomised into 3 groups, MMN RDA group, MMN 2 RDA group and 60 mg iron 400 mcg folic acid group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 08:15:35 +0100" MODIFIED_BY="Heather Maxwell">
<P>15 micronutrients were included in the supplement at RDA level, except for folic acid that was included at 400 mcg level. Supplement consisted of vitamin A 800 mcg, D 200 IU, E 10 mg, C 70 mg, B1 1.4 mg, B2 1.4 mg, niacin 18 mg, B6 1.9 mg, B12 2.6 mg, folic acid 400 mcg, iron 30 mg, zinc 15 mg, copper 2 mg, selenium 65 mcg and iodine 150 mcg. Intervention group (n = 1392) received MMN supplements (supplement RDA n = 695, supplement 2 RDA n = 697) while the other group received folic acid 400 mcg and iron 60 mg n = 708.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:03:12 +0000" MODIFIED_BY="[Empty name]">
<P>Size at birth, gestational age at birth, preterm birth (&lt; 37 weeks of gestation), LBW (&lt; 2500 g), miscarriage (fetal loss before 28 completed weeks of gestation), perinatal mortality (fetal loss between 28 weeks of gestation and first 7 days of life), neonatal mortality (deaths within the first 28 days of life), maternal Hb, anaemia (Hb &lt; 100 g/L) and maternal death (death during pregnancy or within 42 days after termination of pregnancy), childhood mortality.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-10-02 21:25:19 +0100" MODIFIED_BY="[Empty name]">
<P>Malaria is endemic but HIV prevalence is relatively low.<BR/>Iron folic acid given to all participants. There was no significant difference in baseline characteristics between randomisation groups. We used the 1 RDA and control groups in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-04 21:25:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lui-2013">
<CHAR_METHODS MODIFIED="2015-10-22 08:07:02 +0100" MODIFIED_BY="Heather Maxwell">
<P>This was a double </P>
<P>-blind randomised controlled trial conducted in five rural counties in Hebei Provinve, China. Women were enrolled from May 2006 to April 2009.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:07:19 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women who recorded dates of their menstruation for 2 or more months before they became pregnant, were nulliparous, at least 20 years old, not more than 20 weeks' gestation, legally competent, had not consumed micronutrient supplements other than folic acid in the prior 6 months, had a Hb level greater than 10.0 g/dL, resided in and received prenatal care in 1 of 5 counties, and consented to participate were eligible. 18,775 pregnant women with singleton pregnancies were randomised to group A (n = 6261), group B (n = 6252), and group C (n = 6262).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-04 18:49:07 +0100" MODIFIED_BY="[Empty name]">
<P>The study has 3 arms. Group A received folic acid 400 &#956;g, group B received folic acid 400 &#956;g and iron 30 mg, and group C received the UNICEF formulation containing folic acid 400 &#956;g, Fe 30 mg, vitamin A 800 &#956;g, E 10 mg, D 5 mcg, C 70 mg, B1 1.4 mg, B2 1.4 mg, B6 1.9 mg, B12 2.6 &#956;g, niacin 18 mg, Zn 15 mg, Cu 2 mg, iodine 150 &#956;g, selenium 65 &#956;g. Supplements were take from enrolment until delivery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-11 14:49:20 +0100" MODIFIED_BY="[Empty name]">
<P>Perinatal mortality, neonatal mortality, infant mortality, maternal Hb and anaemia at 24 to 28 weeks of gestation, gestational age at birth, preterm birth, LBW, birthweight, low weight for height, low weight for age, low height for age, infant anaemia, gastrointestinal side-effects (nausea, vomiting, or other mild gastrointestinal discomfort) at monthly visits.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-07-04 21:25:44 +0100" MODIFIED_BY="[Empty name]">
<P>There were no significant differences at baseline between the groups</P>
<P>Data for side-effects: 6% (n = 355) in the MMN group while 3.6% (n = 212) in the iron folic acid group.</P>
<P>We used the estimates for the comparison of MMN vs. IFA groups in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:03:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Osrin-2005">
<CHAR_METHODS MODIFIED="2011-08-16 06:02:13 +0100" MODIFIED_BY="[Empty name]">
<P>This study was undertaken in Nepal. All women attending a designated antenatal clinic at Janakpur zonal hospital were considered for enrolment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-29 09:40:41 +0100" MODIFIED_BY="[Empty name]">
<P>Women were eligible for enrolment if an ultrasound examination confirmed a singleton pregnancy, a gestational age between 12 to 20 completed weeks, no notable fetal abnormality, no existing maternal illness of a severity that could compromise the outcome of pregnancy; and the participant lived in an area of Dhanusha or the adjoining district of Mohattari accessible for home visits. Participants received supplements throughout pregnancy until delivery. <BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 08:17:45 +0100" MODIFIED_BY="Heather Maxwell">
<P>The MMN group (n = 600) received tablets containing vitamin A 800 mcg, vitamin E 10 mg, vitamin D 5 mcg, B1 1.4 mg, B2 1.4 mg, niacin 18 mg, B6 1.9 mg, B12 2.6 mcg, folic acid 400 mcg, vitamin C 70 mg, iron 30 mg, zinc 15 mg, copper 2 mg, selenium 65 mcg, and iodine 150 mcg. Control group (n = 600) received tablets containing iron 60 mg and folic acid 400 mcg. There were 2 prespecified deviations from the protocol: if a participant's enrolment blood Hb concentration was less than 70 g/L, she was given an extra 60 mg of iron daily, anthelmintic treatment, and her Hb was rechecked after 1 month; and if a participant described night blindness at any time, she was given 2000 ug of vitamin A daily and referred for medical follow up.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:03:26 +0000" MODIFIED_BY="[Empty name]">
<P>Birthweight, LBW (&lt; 2500 g), gestational duration, preterm delivery (&lt; 37 weeks of gestation), miscarriage, stillbirth, early and late neonatal death, infant length, head circumference.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-22 08:18:21 +0100" MODIFIED_BY="Heather Maxwell">
<P>Infants were followed up to 3 months. Both groups of participants were comparable at baseline.</P>
<P>There is a discrepancy in the number of neonatal deaths reported. Figure: 'Study profile' in the Devakumar 2014 Lancet publication (p e655) reports 12 neonatal deaths in the control group and <LINK REF="STD-Osrin-2005" TYPE="STUDY">Osrin 2005</LINK> reports 11 neonatal deaths in the control group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:03:36 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramakrishnan-2003">
<CHAR_METHODS MODIFIED="2009-04-29 09:15:42 +0100" MODIFIED_BY="[Empty name]">
<P>This randomised controlled trial was carried out during 1997-2000 in Mexico. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:20:09 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women who were less than 13 weeks' pregnant, were not receiving MMN supplementation and who agreed to participate were included in the study. A total of 873 women were randomised into the MMN group (n = 435, mean age 23.09 ± 5.48) and the iron only group (n = 438, mean age 23.00 ± 5.08).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 08:20:20 +0100" MODIFIED_BY="Heather Maxwell">
<P>MMN tablets included the following vitamins and minerals: iron 60 mg as ferrous sulphate, folic acid 215 mcg, vitamin A 2150 IU, vitamin D3 309 IU, vitamin E 5.73 IU, thiamin 0.93 mg, riboflavin 1.87 mg, niacin 15.5 mg, vitamin B6 1.94 mg, vitamin B12 2.04 mcg, vitamin C 66.5 mg, zinc 12.9 mg, magnesium 252 mg.<BR/>The controls were given iron only tablets with 60 mg of iron as iron sulphate.<BR/>All were given orally, from recruitment 6 days a week until delivery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:03:36 +0000" MODIFIED_BY="[Empty name]">
<P>Preterm births (&lt; 37 weeks of gestation), SGA (below the 10th percentile for birthweight-for-gestational age), LBW (&lt; 2500 g), perinatal mortality, mean Hb concentration, mean serum ferritin.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-22 08:21:22 +0100" MODIFIED_BY="Heather Maxwell">
<P>Data on birth outcomes were only available for 656 pregnancies (MMN group n = 328 and control group, iron only n = 326). The 2 groups did not differ significantly in most of the characteristics at recruitment, except for marital status (more single mothers in MMN supplementation group) and mean BMI (significantly lower in the MMN supplementation group).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:04:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roberfroid-2008">
<CHAR_METHODS MODIFIED="2015-10-22 08:22:14 +0100" MODIFIED_BY="Heather Maxwell">
<P>This was a factorial, double-blind, randomised controlled trial from March 2004 to October 2006 in the Hounde health district of Burkina Faso.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-18 20:44:48 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women irrespective of gestational age. Exclusion criterion was if women planned to leave area within 2 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-02 00:48:11 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 714) received vitamin A 800 mcg, D 200 IU, E 10 mg, B1 1.4 mg, B2 1.4 mg, niacin 18 mg, folic acid 400 mg, B6 1.9 mg, B12 2.6 mcg, C 70 mg, zinc 15 mg, iron 30 mg, copper 2 mg, selenium 65 mcg, iodine 150 mcg. Placebo group (n = 712) received folic acid 400 mcg and iron 60 mg.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:04:32 +0000" MODIFIED_BY="[Empty name]">
<P>Stillbirths (fetal death between 28 weeks of gestation till birth), neonatal deaths, perinatal death, gestation age, preterm births (&lt; 37 weeks of gestation), birthweight, LBW (&lt; 2500 g), SGA (birthweight less than 10 percentile of a reference population), LGA, birth length, Rohrer index, arm circumference, chest circumference, head circumference, Hb in cord blood, soluble serum transferrin receptor, stunting, wasting, underweight, and infant mortality during the first year of life.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-22 08:24:18 +0100" MODIFIED_BY="Heather Maxwell">
<P>Supplement intake was observed directly and were given till 3 months after delivery. Participants were also randomly assigned to receive either malaria chemoprophylaxis (300 mg cholorquine/week) or intermittent preventive treatment (1500 mg sulfadoxine and 75 mg pyrimethamine once in the second and third trimester).</P>
<P>All participants received albendazole 400 mg during second and third trimester. Severely anaemic women received ferrous sulphate 200 mg and folic acid 0.25 mg twice daily for 3 months regardless of their allocation groups.</P>
<P>The study groups were similar with respect to baseline characteristics except for small difference in Hb (lower in intervention group) and BMI (lower in control group). Stunting, wasting, underweight, and infant mortality during the first year of life were presented as hazard ratios and could not be included in the analysis of outcome using risk ratios.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-22 08:25:34 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Sood-1975">
<CHAR_METHODS MODIFIED="2010-08-31 17:22:29 +0100" MODIFIED_BY="[Empty name]">
<P>Trial conducted in New Dehli and Tamil Nadu, India.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:25:24 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women with gestational age 22 ± 2 were eligible to participate in the trial. A total of 647 pregnant women participated in the trial. Women with chronic diseases like heart diseases, tuberculosis, leprosy, chronic diarrhoea and a Hb &lt; 5 g/100 mL were excluded from the study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-29 06:43:24 +0100" MODIFIED_BY="[Empty name]">
<P>There were total of 7 study groups. 2 in the control group and 5 in the intervention group. 1 of the control groups received placebo and other received vitamin B12 and folic acid alone. 4 intervention groups received vitamin B12, folic acid and iron in a range of 30 to 240 mg. The fifth intervention group received 120 mg of iron without vitamin B12 and folate. Supplementation was given for 10-12 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 08:25:34 +0100" MODIFIED_BY="Heather Maxwell">
<P>Outcomes were improvement in maternal Hb/haematocrit, iron absorption from maternal gut, fetal birthweight, maternal and fetal Hb 3 months postpartum, hookworm infestation in mother and side-effects of supplementation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-09-20 14:06:35 +0100" MODIFIED_BY="[Empty name]">
<P>None of the outcomes were reported in a format that allowed inclusion of the data in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:04:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-SUMMIT-2008">
<CHAR_METHODS MODIFIED="2015-10-22 08:26:23 +0100" MODIFIED_BY="Heather Maxwell">
<P>A double-blind cluster-randomised trial conducted at Lombok island of Indonesia between July 1, 2001 and April 1, 2004.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-05-06 08:22:56 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women of any gestational age assessed by physical exam and reported LMP. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-11 14:35:44 +0100" MODIFIED_BY="[Empty name]">
<P>MMN group (n = 15804)) received iron 30 mg, folic acid 400 mcg, vitamin A 800 mcg, D 200 IU, E 10 mg, C 70 mg, B1 1.4 mg, B6 1.9 mg, B12 2.6 mcg, zinc 15 mg, copper 2 mg, selenium 65 mcg, iodine 150 mcg and niacin 18 mg. Placebo group (n = 15,486) received iron 30 mg and folic acid 400 mcg.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:04:42 +0000" MODIFIED_BY="[Empty name]">
<P>Early infant mortality (death within 12 weeks of birth), neonatal mortality (death within 28 days of birth), early neonatal mortality (death within 7 days of birth), late neonatal mortality (death between 7 and 28 days of birth), postneonatal mortality (death between 28 days and 12 weeks of birth), fetal loss, abortions (fetal loss before 28 weeks of gestation), still births (death between 28 weeks and before delivery), perinatal mortality (still birth or death within 7 days of birth), maternal mortality related to pregnancy up to 12 weeks postpartum, maternal cognition and mood, and child cognition (motor, cognitive and socioeconomic abilities) at 42 months of age.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-09-29 06:44:53 +0100" MODIFIED_BY="[Empty name]">
<P>Women in both groups received supplements throughout pregnancy until 90 days postpartum. Intervention and placebo groups were comparable in terms of baseline characteristics.</P>
<P>Study was stopped early due to insufficient funds.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:04:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sunawang-2009">
<CHAR_METHODS MODIFIED="2011-09-21 12:39:29 +0100" MODIFIED_BY="[Empty name]">
<P>A cluster-randomised trial conducted in 2 subdistricts of Indramayu district of west Java province of Indonesia from May 2000 till August 2003.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-10-12 18:48:25 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women irrespective of gestational age. Women suffering from diabetes mellitus, coronary heart disease and tuberculosis were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-21 12:49:07 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 432) received RDA of 15 micronutrients according to the UNICEF/UNU/WHO recommended formula, including 30 mg of ferrous fumarate. Control group (n = 411) received ferrous sulphate 60 mg and folic acid 0.25 mg.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:04:54 +0000" MODIFIED_BY="[Empty name]">
<P>Birthweight, birth length, head and chest circumference, Hb, serum ferritin, serum zinc, serum retinol and urinary Iodine, miscarriage, stillbirths, neonatal mortality.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-01 11:14:46 +0100" MODIFIED_BY="[Empty name]">
<P>Study groups were similar with respect to baseline characteristics. Supplements were given from the time of enrolment at 12-20 weeks' gestation and continued up to 30 days postpartum.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-22 08:28:47 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Theobald-1937">
<CHAR_METHODS MODIFIED="2010-08-27 19:21:41 +0100" MODIFIED_BY="[Empty name]">
<P>This study was conducted at St. Mary Abbots hospital, London during 1936.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-10 19:25:03 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women less than 24 weeks of gestation. No baseline characteristics comparison was performed.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-21 12:36:03 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group (n = 50) received calcium lactate 20 grains, vitamin A 11,000 IU, D 450 IU. Placebo group did not receive any intervention.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 08:28:47 +0100" MODIFIED_BY="Heather Maxwell">
<P>Albuminuria + hypertension, hypertension, albuminuria, hyperemeses, oedema, headache, cramps, insomnia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-03-23 11:55:09 +0000" MODIFIED_BY="Jill Hampson">
<P>There was no proof that all the patients in intervention took capsules (vitamin A and D) and tablets (calcium lactate) regularly. Outcomes included in this study were not of review interest.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:05:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tofail-2008">
<CHAR_METHODS MODIFIED="2015-05-11 14:38:37 +0100" MODIFIED_BY="[Empty name]">
<P>The study was conducted in Matlab, a rural subdistrict in the east central plain of Bangladesh from November 2001 till December 2003.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:29:23 +0100" MODIFIED_BY="Heather Maxwell">
<P>Pregnant women with gestational age 6-8 weeks, Hb greater than equal to 80 g/L and no serious disease were eligible for enrolment.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 08:29:32 +0100" MODIFIED_BY="Heather Maxwell">
<P>MMN group (n = 1224) received vitamin A 800 mcg, D 200 IU, E 10 mg, C 70 mg, B1 1.4 mg, B2 1.4 mg, niacin 18 mg, B6 1.9 mg, B12 2.6 mg, folic acid 400 mcg, iron 30 mg, zinc 15 mg, copper 2 mg, selenium 65 mcg and iodine 150 mcg, while the other group received folic acid and iron (60 mg iron 400 mcg folic acid n = 1265 and 30 mg iron 400 mcg folic acid n = 1248).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:05:09 +0000" MODIFIED_BY="[Empty name]">
<P>Size at birth, gestational age at birth, perinatal mortality, maternal Hb at 30 weeks, birthweight, spontaneous abortions, infant mortality, motor development and behavioural development, infant micronutrient status, under 5 child mortality, blood pressure and kidney function in children, child growth outcomes, and adverse effects.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-10-22 08:30:40 +0100" MODIFIED_BY="Heather Maxwell">
<P>Women were divided into 2 groups, that is, early food group and usual food group. Each food group was divided into 3 subgroups of MMN and iron folic acid groups.<BR/>Iron folic acid given to all participants. There was no significant difference in baseline characteristics between randomisation groups. Maternal malnutrition was prevalent. Control group with 30 mg iron is included in this review. Data for child growth outcomes presented in a manner which precluded its inclusion in the analysis. Adverse effects included nausea (MMN supplementation 154/786, 30FeFA 126/763), vomiting (MMN 91/787, 30FeFA 54/762), loose motions (MMN 19/786, 30FeFA 18/763), heartburn (MMN 86/786, 30FeFA 83/763), and constipation (MMN 219/788, 30FeFA 227/762). Other trial (<LINK REF="STD-Gupta-2007" TYPE="STUDY">Gupta 2007</LINK>) measuring this outcome presents data for all side-effects using a composite measure. Analyses for individual side-effects will be presented once additional trials are available.</P>
<P>Cost data are published in Shaheen 2013.</P>
<P>Stunting data relevant to this review are presented in Kahn 2013. The data for the Fe30F group are presented in Figure 1, a line graph, and we will contact the authors to clarify the exact numbers for inclusion in the next update.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-10-22 08:37:41 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-West-2014">
<CHAR_METHODS MODIFIED="2015-10-22 08:31:58 +0100" MODIFIED_BY="Heather Maxwell">
<P>Community-based, cluster-randomised, double-blind trial to examine whether a daily antenatal and postnatal MMN supplement given to women will enhance newborn and infant survival and health and other birth outcomes in a rural setting in northwestern Bangladesh.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-11 14:41:36 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women, aged 12-45 years, consenting to participate were recruited (n = 45,000). Women not interviewed for consent within 12 consecutive weeks after being ascertained as pregnant by urine testing were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-11 14:49:45 +0100" MODIFIED_BY="[Empty name]">
<P>Dietary supplement: MMN containing 15 micronutrients all at an RDA including: vitamin A (770 ug retinol equivalents, vitamin D (5 ug), vitamin E (15 mg), folic acid (600 ug), thiamin (1.4 mg), riboflavin (1.4 mg), niacin (18 mg), vitamin B-12 (2.6 mg), vitamin B-6 (1.9 mg), vitamin C (85 mg), iron (27 mg), zinc (12 mg), iodine (220 ug), copper (1000 ug), selenium (60 ug). Control supplement contained iron (27 mg) - folic acid (600 ug) (providing the current standard of care during pregnancy). Mothers instructed to take 1 tablet per day, from the 1st trimester through 12 weeks postpartum.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 08:37:41 +0100" MODIFIED_BY="Heather Maxwell">
<P>Infant mortality through 6 months of age, perinatal mortality, neonatal mortality, birth size (weight, length, circumferences), gestational age at birth, infant health outcomes, maternal morbidity, obstetric complications, body composition, nutritional status. Christian 2014a reports length-for-age Z score and stunting at 1 and 3 months in an abstract.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-11 14:49:54 +0100" MODIFIED_BY="[Empty name]">
<P>The composition of the MMN supplement followed the UN MMN preparation, except with higher amounts as needed to meet the RDA from the Institute of Medicine.</P>
<P>The substudy area was selected to be representative of the parent trial across a range of factors, including sociodemographic and geographic variations, which were evaluated during an earlier trial in the same area.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:05:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zagre-2007">
<CHAR_METHODS MODIFIED="2015-10-22 08:33:26 +0100" MODIFIED_BY="Heather Maxwell">
<P>This study was a cluster-randomised, double-blind controlled programmatic study in rural Niger aiming to compare MMN supplementation versus iron and folic acid.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:33:40 +0100" MODIFIED_BY="Heather Maxwell">
<P>Women residing in target villages and experiencing amenorrhoea for less than 12 weeks were eligible for recruitment. All villages within the coverage of the 17 health centres of Mayahi district were included. Women with night blindness and/or signs of severe anaemia were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-09-29 06:48:21 +0100" MODIFIED_BY="[Empty name]">
<P>Micronutrient group (n = 1893) received vitamin A 800 mcg, D 200 IU, E 10 mg, C 70 mg, B1 1.4 mg, B2 1.4 mg, B3 18 mg, B6 1.9 mg, B12 2.6 mg, folic acid 400 mcg, iron 30 mg, zinc 15 mg, copper 2 mg, selenium 65 mcg, iodine 150 mcg. Control (n = 1777) received iron and folic acid.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:05:29 +0000" MODIFIED_BY="[Empty name]">
<P>Birthweight and incidence of LBW, miscarriage, stillbirth, maternal mortality.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-07-27 11:34:01 +0100" MODIFIED_BY="Nancy  Medley" NOTES="&lt;p&gt;done&lt;/p&gt;" NOTES_MODIFIED="2015-07-27 11:34:01 +0100" NOTES_MODIFIED_BY="Nancy  Medley">
<P>Study participants received reproductive health services including malaria chemoprophylaxis, behavior change communication activities to increase awareness and adoption of better lifestyles (feeding and rest during pregnancy). Outreach prenatal care sessions were also conducted throughout intervention villages.</P>
<P>Randomisation resulted in comparable groups for most baseline characteristics except for households and more preventive measures against malaria (more in MMN group) and less education and more poverty in iron/folic acid group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-02-21 15:05:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zeng-2008">
<CHAR_METHODS MODIFIED="2015-05-11 14:43:30 +0100" MODIFIED_BY="[Empty name]">
<P>Community-based cluster-randomised trial conducted in 2 poor rural counties in Shaanxi province of north west China between August 2002 and January 2006.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 08:35:39 +0100" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;done&lt;/p&gt;" NOTES_MODIFIED="2015-10-22 08:35:39 +0100" NOTES_MODIFIED_BY="Heather Maxwell">
<P>Pregnant women of less than 28 weeks' gestation between August 2002 and January 2006. Pregnancy was confirmed using last menstrual period (LMP) and urine pregnancy test.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-20 14:08:14 +0100" MODIFIED_BY="[Empty name]">
<P>Group A (n = 2017) received folic acid 0.4 mg. Group B (n = 1912) received iron 60 mg and folic acid 0.4 mg. Group C (n = 1899) received iron 30 mg, folic acid 0.4 mg, zinc 15 mg, copper 2 mg, selenium 0.65 mg, iodine 0.15 mg, vitamin A 0.8 mg, B1 1.4 mg, B2 1.4 mg, B6 1.9, B12 0.026 mg, D 0.05 mg, C 70 mg, E 10 mg, niacin 18 mg.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-02-21 15:05:51 +0000" MODIFIED_BY="[Empty name]">
<P>Birthweight, LBW (&lt; 2500 g), SGA (weight &lt; 10 percentile for gestational age), preterm birth (&lt; 37 weeks of gestation), very preterm birth (&lt; 34 weeks of gestation), gestational age, birth length, head circumference, Hb, anaemia (Hb &lt; 110 g/L in third trimester), neonatal deaths (death within 28 days of delivery), early neonatal deaths (death within 7 days of delivery), perinatal deaths (fetal death after 28 weeks of gestation plus early neonatal deaths); and mental and psychomotor development outcomes until 1 year of age by using the Bayley Scales of Infant Development, and growth outcomes (stunting, underweight, and wasting) in children in the first 30 months of life.</P>
<P>It should be noted that the data for SGA was obtained from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>) and not from the individual trial report.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-11 14:48:17 +0100" MODIFIED_BY="[Empty name]">
<P>For review purpose, MMN and iron folate groups are used. Intervention was administered till 6 weeks postpartum. Baseline characteristics at enrolment and both cluster and individual level baseline characteristics were balanced by treatment groups. Stunting, underweight, and wasting data presented as odds ratio and could not be included in the analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BMI: body mass index<BR/>Hb: haemoglobin<BR/>HIV: human immunodeficiency virus<BR/>IU: international unit<BR/>IUGR: intrauterine growth retardation<BR/>LBW: low birthweight<BR/>LGA: large-for-gestational age<BR/>LMP: last menstrual period<BR/>mcg: microgram<BR/>mg: milligram<BR/>Mg: magnesium<BR/>MMN: multiple micronutrient<BR/>RCT: randomised controlled trial<BR/>RDA: recommended daily allowance<BR/>SGA: small-for-gestational age<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-10-22 09:52:47 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:52:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Agarwal-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:52:23 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only; similar micronutrients given for different durations.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:54:49 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Aguayo-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:54:49 +0100" MODIFIED_BY="Heather Maxwell">
<P>Not a RCT. Assessing acceptability of MMN supplements by pregnant and lactating women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:55:00 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Ahn-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:55:00 +0100" MODIFIED_BY="Heather Maxwell">
<P>Comparing 2 MMN supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:57:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-An-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:57:51 +0100" MODIFIED_BY="[Empty name]">
<P>Compares different doses of iron (35 mg vs 60 mg).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-20 14:09:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arsenault-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-20 14:09:46 +0100" MODIFIED_BY="[Empty name]">
<P>Includes HIV-1 positive women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:53:05 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Asemi-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:53:05 +0100" MODIFIED_BY="Heather Maxwell">
<P>Single-blind trial comparing multivitamin vs multivitamin-mineral. Supplements differed in composition and dose.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:05:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beazley-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:05:47 +0000" MODIFIED_BY="[Empty name]">
<P>Assesses vitamin C and E supplementation only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-24 01:45:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bergmann-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-24 01:45:25 +0000" MODIFIED_BY="[Empty name]">
<P>Assesses docosahexaenoic acid and fructo-oligosaccharide.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-04-08 05:53:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Biswas-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-08 05:53:40 +0100" MODIFIED_BY="[Empty name]">
<P>Cross-over design, measuring only serum iron levels after single doses of different vitamin formulations.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:55:37 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Carrasco-1962">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:55:37 +0100" MODIFIED_BY="Heather Maxwell">
<P>Study has assessed the impact of D-sorbitol on the absorption of MMNs in pregnant women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:06:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caulfield-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:06:27 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-24 04:09:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Caulfield-1999a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-24 04:09:22 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:06:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chames-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:06:47 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses calcium supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:53:17 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Choudhury-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:53:17 +0100" MODIFIED_BY="Heather Maxwell">
<P>Comparing micronutrient powder (home fortification) containing iron, folic acid, vitamin C and zinc vs iron folic acid tablet to study impact on anaemia during pregnancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-29 07:16:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christian-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-29 07:16:34 +0100" MODIFIED_BY="[Empty name]">
<P>Assesses the effectiveness of the standard of care (iron folic acid and single-dose mebendazole) for the treatment of severe anaemia (haemoglobin &lt; 70 g/L) along with enhanced regimens.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:45:47 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Cooper-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:45:47 +0100" MODIFIED_BY="Heather Maxwell">
<P>Evaluates periconceptional MMN supplementation only (no MMNs given during pregnancy) (same as <LINK REF="STD-Khulan-2012" TYPE="STUDY">Khulan 2012</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-28 23:49:24 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Czeizel-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-28 23:49:24 +0000" MODIFIED_BY="[Empty name]">
<P>Assesses periconceptional supplementation of 18 micronutrients against 4 micronutrients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dawson-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Assesses supplementation of 14 micronutrients against 11 micronutrients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dawson-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Assesses supplementation of different doses of 12 to 17 micronutrients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 09:50:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dieckmann-1944">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 09:50:39 +0100" MODIFIED_BY="[Empty name]">
<P>Fortification trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-04-15 15:07:56 +0100" MODIFIED_BY="Nancy  Medley" STUDY_ID="STD-Fall-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-04-15 15:07:56 +0100" MODIFIED_BY="Nancy  Medley">
<P>This is not a trial evaluating micronutrient supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fawzi-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Includes pregnant women who are HIV-1 positive.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-20 14:10:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feyi_x002d_Waboso-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-20 14:10:03 +0100" MODIFIED_BY="[Empty name]">
<P>Parenteral preparation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fleming-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Only assesses iron, folate and vitamin B in different combinations.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:07:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldenberg-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:07:37 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-28 20:30:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gopalan-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-28 20:30:26 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluates effect of soya oil.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:46:34 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Graham-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:46:34 +0100" MODIFIED_BY="Heather Maxwell">
<P>Study has looked at the impact of vitamin A fortified rice with and without iron and riboflavin supplementation in night-blinded women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:57:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guldholt-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:57:55 +0100" MODIFIED_BY="[Empty name]">
<P>Only assesses high-dose vs low-dose iron supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 09:50:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gupta-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 09:50:59 +0100" MODIFIED_BY="[Empty name]">
<P>Women with BMI &lt; 18.5 and/or haemoglobin level of 7-9 g/dL were included.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 09:51:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hambidge-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 09:51:20 +0100" MODIFIED_BY="[Empty name]">
<P>Protocol of a study comparing nutrition intervention (MMN fortified lipid-based supplement) in pre-conceptional and peri-conceptional stage.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:08:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hillman-1963">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:08:06 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses pyridoxine supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:09:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Holly-1955">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:09:41 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses iron and cobalt supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:47:21 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Hossain-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:47:21 +0100" MODIFIED_BY="Heather Maxwell">
<P>Trial evaluates the effect of vitamin D supplementation. Both groups received iron and calcium.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:10:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hunt-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:10:01 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-24 04:31:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hunt-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-24 04:31:51 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:45:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hunt-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:45:27 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:54:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huybregts-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:54:38 +0100" MODIFIED_BY="[Empty name]">
<P>Assesses impact of balanced energy, protein dietary supplement.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-04-15 14:05:18 +0100" MODIFIED_BY="Nancy  Medley" STUDY_ID="STD-Huybregts-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-04-15 14:05:18 +0100" MODIFIED_BY="Nancy  Medley">
<P>Trial compares prenatal LNS vs MMN. Follow-up of primary trial excluded (<LINK REF="STD-Huybregts-2009" TYPE="STUDY">Huybregts 2009</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-24 04:32:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Iannotti-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-24 04:32:06 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-ICMR-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Assesses periconceptional supplementation of folic acid containing vitamins.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:54:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Itam-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:54:49 +0100" MODIFIED_BY="[Empty name]">
<P>Not a randomised trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:47:59 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Jarvenpaa-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:47:59 +0100" MODIFIED_BY="Heather Maxwell">
<P>Fortification trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:48:09 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Kabir-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:48:09 +0100" MODIFIED_BY="Heather Maxwell">
<P>This is the same cohort as <LINK REF="STD-Tofail-2008" TYPE="STUDY">Tofail 2008</LINK>. However, all pregnant women were again randomised to breastfeeding counselling or a control (standard health message) group. Effect was evaluated on anthropometric outcomes in children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:55:43 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Kable-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:55:43 +0100" MODIFIED_BY="Heather Maxwell">
<P>Trial in women consuming alcohol during pregnancy evaluating effect of MMNs in ameliorating the impact of prenatal alcohol exposure in infants.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-04-09 12:11:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khavari-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-04-09 12:11:28 +0100" MODIFIED_BY="[Empty name]">
<P>The trial recruited HIV positive women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:55:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khulan-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:55:03 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluates periconceptional MMN supplementation only (no MMNs given during pregnancy).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-20 14:10:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kubik-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-20 14:10:16 +0100" MODIFIED_BY="[Empty name]">
<P>Original papers in Polish. Translated versions of the papers show that this study is not a randomised trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-13 19:44:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kynast-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-13 19:44:27 +0100" MODIFIED_BY="[Empty name]">
<P>Study presented at a conference. Abstract does not indicate that it as a randomised trial. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:55:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lanou-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:55:11 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluated the effect of a lipid-based nutrient supplement LNS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:57:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leroy-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:57:56 +0100" MODIFIED_BY="[Empty name]">
<P>The study compares a traditional food assisted MCHN program vs a newly designed approach to prevent malnutrition in children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:55:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:55:19 +0100" MODIFIED_BY="[Empty name]">
<P>The study evaluates the effect of supplementation with folic acid and milk.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-29 07:17:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindstr_x00f6_m-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-29 07:17:53 +0100" MODIFIED_BY="[Empty name]">
<P>Describing prevalence of micronutrient deficiencies at baseline and its determinants.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-20 14:10:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ling-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-20 14:10:24 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluating the impact of traditional Chinese tonics with nutrients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:53:56 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Lucia-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:53:56 +0100" MODIFIED_BY="Heather Maxwell">
<P>Evaluating impact of docosahexaenoic acid and fructo-oligosaccharide.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-24 04:40:24 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ma-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-24 04:40:24 +0000" MODIFIED_BY="[Empty name]">
<P>Evaluating retinol and riboflavin supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:55:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Magon-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:55:34 +0100" MODIFIED_BY="[Empty name]">
<P>The trial evaluating the effect of use of fortified snacks during pregnancy. Both groups received the same micronutrients (i.e., iron, folic acid, beta- carotene, and calcium), however, the dose of micronutrients in the intervention group was higher than the control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:54:09 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Malvasi-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:54:09 +0100" MODIFIED_BY="Heather Maxwell">
<P>Study evaluating the effect of myoinositol, d-chiro inositol, folic acid and manganese during pregnancy on maternal blood pressure, glycaemic and cholesterol parameters. Inositol is not an essential nutrient.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-29 07:18:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mardones-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-29 07:18:09 +0100" MODIFIED_BY="[Empty name]">
<P>Impact of fortification of fortified dairy product with polyunsaturated fatty acids.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:11:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marya-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:11:51 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses calcium and vitamin D supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:12:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mathan-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:12:09 +0000" MODIFIED_BY="[Empty name]">
<P>Assesses supplementation of vitamin C and protein.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Menon-1962">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Merchant-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Includes pregnant women who are HIV-1 positive.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:12:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Merialdi-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:12:31 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:12:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Muslimatun-2001a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:12:43 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses vitamin A supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-24 04:45:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Muslimatun-2001b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-24 04:45:40 +0000" MODIFIED_BY="[Empty name]">
<P>Evaluates vitamin A supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:55:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nguyen-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:55:58 +0100" MODIFIED_BY="[Empty name]">
<P>Protocol of a study evaluating pre-conceptional MMN vs IFA supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:56:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nwagha-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:56:02 +0100" MODIFIED_BY="[Empty name]">
<P>Micronutrients given via injection.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-02-24 01:48:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ochoa_x002d_Brust-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-02-24 01:48:46 +0000" MODIFIED_BY="[Empty name]">
<P>Assesses impact of vitamin C only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:50:31 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Olofin-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:50:31 +0100" MODIFIED_BY="Heather Maxwell">
<P>The trial included HIV-positive women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-28 21:37:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Park-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-28 21:37:20 +0100" MODIFIED_BY="[Empty name]">
<P>Study design does not satisfy the eligibility criteria of the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:56:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Patimah-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:56:10 +0100" MODIFIED_BY="[Empty name]">
<P>Not a randomised trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-21 12:16:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-People_x0027_s-League-1946">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-21 12:16:31 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-randomised trial. Women were divided into 2 groups by placing them alternately on separate lists.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-29 07:18:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramirez_x002d_Velez-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-29 07:18:29 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group receives 9 micronutrients and control group receives 3 micronutrients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:56:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Raqib-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:56:18 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluated the effect of vitamin B12 only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:13:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Robertson-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:13:10 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 09:52:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rumiris-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 09:52:26 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women with superoxidedismutase (SOD) levels below 1102 U/gHb included in the study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:56:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sachdeva-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:56:24 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluated calcium supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-29 07:18:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sagaonkar-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-29 07:18:37 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison of 4 micronutrients with 3.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:56:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salzano-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:56:31 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluated supplementation with calcium and fatty acids (linoleic acid, mono and poly unsaturated fatty acids) vs control.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:13:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schmidt-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:13:32 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses vitamin A supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:13:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schmidt-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:13:51 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses vitamin A supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:56:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Semba-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:56:38 +0100" MODIFIED_BY="[Empty name]">
<P>A trial of vitamin A supplementation in HIV-infected women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:14:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Semba-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:14:05 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses vitamin A supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:14:17 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Suharno-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:14:17 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses vitamin A supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-21 12:17:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-21 12:17:09 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-randomised trial. Women were allocated to 4 groups in the order of enrolment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:14:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Suprapto-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:14:48 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses vitamin A and riboflavin supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:55:16 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Taghizadeh-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:55:16 +0100" MODIFIED_BY="Heather Maxwell">
<P>Comparing 2 different MMN supplements (13 micronutrients vs 10 micronutrients).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:14:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tanumihardjo-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:14:57 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses vitamin A and iron supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 09:52:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tatala-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 09:52:47 +0100" MODIFIED_BY="[Empty name]">
<P>Fortification trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-20 14:10:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thauvin-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-20 14:10:43 +0100" MODIFIED_BY="[Empty name]">
<P>Not a randomised trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-09-26 20:10:55 +0100" MODIFIED_BY="Batool A Haider" STUDY_ID="STD-Vadillo_x002d_Ortega-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-09-26 20:10:55 +0100" MODIFIED_BY="Batool A Haider">
<P>Fortification trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-09-29 07:19:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Webb-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-09-29 07:19:01 +0100" MODIFIED_BY="[Empty name]">
<P>Participants include HIV-positive women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:57:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wibowo-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:57:03 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluating effect of milk fortified with different doses of minerals and vitamins.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-10-22 07:52:15 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Wijaya_x002d_Erhardt-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-10-22 07:52:15 +0100" MODIFIED_BY="Heather Maxwell">
<P>Evaluated weekly food provision (optimised diet) vs the control.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-11 14:57:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wijaya_x002d_Erhardt-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-11 14:57:09 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluated educational intervention using a pre-post design.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-23 11:55:33 +0000" MODIFIED_BY="Jill Hampson" STUDY_ID="STD-Young-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-23 11:55:33 +0000" MODIFIED_BY="Jill Hampson">
<P>Study assessed the acceptability of a micronutrient powder (Sprinkles), a fortified food (Nutrivida), and tablets by the participants. All supplements has similar composition of micronutrients.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-24 16:15:36 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zavaleta-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-24 16:15:36 +0000" MODIFIED_BY="[Empty name]">
<P>Only assesses zinc supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>BMI: body mass index<BR/>IFA: iron and folic acid<BR/>LNS: lipid-based nutrient supplement<BR/>MMN: multiple micronutrient<BR/>RCT: randomised controlled trial<BR/>vs: versus</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ashorn-2015">
<CHAR_METHODS MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel randomised trial recruiting at 4 sites in Malawi.</P>
<P>Setting: 1 public district hospital (Mangochi), 1 semiprivate hospital (Malindi), and 2 public health centres (Lungwena and Namwera) in Mangochi District, southern Malawi.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion: ultrasound-confirmed pregnancy of no more than 20 completed gestation weeks, residence in the defined catchment area, availability during the period of the study, and signed or thumb-printed informed consent.</P>
<P>Exclusion: age younger than 15 years, need for frequent medical attention due to a chronic health condition, diagnosed asthma treated with regular medication, severe illness warranting hospital referral, history of allergy toward peanuts, history of anaphylaxis or serious allergic reaction to any substance, requiring emergency medical care, pregnancy complications evident at enrolment visit (moderate to severe edema, blood Hb concentration, 50 g/L, systolic blood pressure .160 mm Hg or diastolic blood pressure .100 mm Hg), earlier participation in the iLiNS-DYAD-M trial (during a previous pregnancy), or concurrent participation in any other clinical trial.</P>
<P>1391 women randomised. (IFA &#8211; 463; MMN 466; LNS &#8211; 462).</P>
<P>Lost to follow-up (IFA 26; MMN 32; LNS 26).</P>
<P>Group demographic characteristics similar.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention:</P>
<P>Group 1: IFA &#8211; 1 capsule containing 60 mg iron and 400 mcg folic acid and 2 doses of intermittent preventive malaria treatment with sulfadoxine-pyrimethamine.</P>
<P>Group 2: MMN &#8211; malaria treatment as above plus 1 capsule containing IFA and 16 micronutrients.</P>
<P>Group 3: LNS &#8211; malaria treatment as above and sachets of SQ-LNS containing the same micronutrients as group 2 plus 4 additional minerals, protein and fat (118 kcal).</P>
<P>All supplements to be taken daily.</P>
<P>Follow-up until 6 weeks postpartum.</P>
<P>Data collectors delivered supplements fortnightly. Participants were invited to antennal care visits at the clinic at 32 and 36 weeks and 1-2 weeks postpartum. Participants were given mobile phones and airtime so that they could inform of deliveries outside of clinics.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: birthweight and newborn length (within 6 weeks of birth). Secondary outcomes: newborn weight, head circumference, mid-upper</P>
<P>arm circumference (MUAC), and the duration of pregnancy, as well as the incidence of maternal or newborn SAEs. Several other maternal and infant outcomes are reported.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]">
<P>Due to testing of LNS products for a bacteria, 160 pregnant women in the LNS group missed out their supplement for 1-20 days during August 2012. 127 of these women were provided with IFA tablets at this time, while 33 were not available for contact.</P>
<P>Adverse events were recorded separately and monitored, and a study physician determined if the participant should continue with the allocated supplement.</P>
<P>Analysis modified ITT = participants with missing data for an outcome were excluded from analysis of that outcome.</P>
<P>12 twin pregnancies were excluded from all analyses.</P>
<P>This trial included women with a + HIV test: IFA = 15.6%; MMN 11.1% and LNS 14.4% We have contacted authors to see if separate analyses for HIV- women are available. Authors have agreed to provide these data for inclusion in the next update of this review.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2015-10-22 09:53:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gathwala-2012">
<CHAR_METHODS MODIFIED="2015-07-27 11:55:49 +0100" MODIFIED_BY="Nancy  Medley">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 09:53:16 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnancy women 12-14 weeks' gestation. Fetal malformation excluded. Total number randomised 560. Group denominators not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 09:53:22 +0100" MODIFIED_BY="[Empty name]">
<P>MMN versus iron 100 mg and folic acid 500 mcg. MMN not described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-07-27 11:57:51 +0100" MODIFIED_BY="Nancy  Medley">
<P>Mean birthweight, low birthweight.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-07-29 19:54:31 +0100" MODIFIED_BY="Batool A Haider">
<P>No usable data due to missing group denominators. Authors contacted (g_gathwala@hotmail.com) in hopes of adding data in next update.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>MMN: multiple micronutrient</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-03-16 12:49:25 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-10-19 16:49:01 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Biggs-2011">
<CHAR_STUDY_NAME MODIFIED="2012-09-29 07:19:45 +0100" MODIFIED_BY="[Empty name]">
<P>A randomised controlled trial to compare the impact on birthweight of daily iron folic acid, twice weekly iron folic acid and twice weekly multiple-micronutrient supplementation for pregnant women in Ha Nam province, Vietnam.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-07-02 00:23:00 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Communes agreeing to participate in the study will be randomly assigned to 1 of the 3 treatment arms. The commune was chosen as the cluster unit of randomisation to reduce the likelihood of interactions between the intervention groups. All eligible women in each commune will be invited to participate in the study. The pharmaceutical manufacturer and the Chairman of the DSMC will retain the allocation code.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-19 16:48:36 +0100" MODIFIED_BY="Heather Maxwell">
<P>Healthy pregnant women 16 weeks' gestation or less were included. Women with complicated pregnancies (e.g. twins, diabetes, other medical conditions), or Hb &#8804; 8.0 will be excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-11 15:19:09 +0100" MODIFIED_BY="[Empty name]">
<P>Study has 3 arms. Group 1 will receive elemental iron 60 mg and folic acid 1.5 mg taken orally twice weekly, group 2 will receive multiple micronutrients (modified 2xUNIMAPP) taken orally twice weekly, and group 3 will receive elemental iron 60 mg and folic acid 0.4 mg taken orally once daily. All supplements will be provided for the duration of pregnancy and 3 months postpartum.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-19 16:49:01 +0100" MODIFIED_BY="Heather Maxwell">
<P>Birthweight, maternal Hb and ferritin, infant cognitive development, infant height, Hb.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-11 14:59:33 +0100" MODIFIED_BY="[Empty name]">
<P>September 2010.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-05-11 14:59:35 +0100" MODIFIED_BY="[Empty name]">
<P>Beverley-Ann Biggs</P>
<P>Department of Medicine<BR/>Royal Melbourne Hospital<BR/>Parkville,<BR/>Victoria, 3050</P>
<P>Australia.</P>
<P>Tel # 61383443256</P>
<P>Email: babiggs@unimelbi.edu.au</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-07-02 00:23:09 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-22 09:57:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dewey-2011">
<CHAR_STUDY_NAME MODIFIED="2015-10-19 17:01:58 +0100" MODIFIED_BY="Heather Maxwell">
<P>ILINS-DYAD - Ghana population.</P>
<P>Protocol identifier: NCT00970866.</P>
<P>Dewey 2011 title (abstract): Efficacy of Lipid-Based Nutrient Supplements (LNS) for pregnant and lactating women and their Infants.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-05-11 15:19:11 +0100" MODIFIED_BY="[Empty name]">
<P>This study will be a community-based, randomised controlled trial with 3 intervention groups.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 09:57:02 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria</P>
<OL>
<LI>At least 18 years of age.</LI>
<LI>No more than 20 weeks of gestation.</LI>
<LI>Given antenatal cards of the Ghana Health Service.</LI>
<LI>Completed the initial routine antenatal examination at the clinics.</LI>
<LI>HIV negative or status unknown (as from the antenatal card).</LI>
<LI>Free from chronic disease, e.g. malignancy requiring frequent medical attention (as from the antenatal card).</LI>
<LI>Residing in the Manya Krobo or Yilo Krobo district.</LI>
<LI>Prepared to sign an informed consent.</LI>
<LI>Living in the area throughout the duration of the study.</LI>
<LI>Acceptance of home visitors.</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>Known asthmatic or history of allergy towards peanut or milk products.</LI>
<LI>Concurrent participation in another clinical trial.</LI>
<LI>Severe illness warranting hospital referral.</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-19 17:05:19 +0100" MODIFIED_BY="Heather Maxwell">
<P>1. Dietary supplement: iron and folic acid (IFA): pregnant women will receive 1 (1) iron (60 mg) and folic acid (400 mcg) (IFA) tablet daily during pregnancy, and a tablet containing calcium (Ca) only (akin to a placebo) during lactation; there will be no supplementation for infants born to the women. The Fe/FA tablets will be taken each day with water after meals.</P>
<P>2. Dietary supplement: multiple micronutrient (MMN) group. Pregnant women will receive 1 (1) multiple-micronutrient tablet daily during pregnancy and the first 6 months of lactation; there will be no supplementation for infants born to the women. The MMN tablets will be taken each day with water after meals.</P>
<P>3. Dietary supplement: lipid-based nutrient supplements (LNS) group. Pregnant women will receive 20 g of LNS-P&amp;L daily during pregnancy and the first 6 months of lactation, whilst infants born to the women will receive 20 g of LNS-20 g daily from 6 to 18 months of age.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 08:40:32 +0100" MODIFIED_BY="Heather Maxwell">
<P>Primary outcome is child length at birth, length-for-age Z-score (LAZ, based on WHO 2006 growth standards) at 18 months of age.</P>
<P>Secondary outcomes include the following.</P>
<P>i. Maternal</P>
<OL>
<LI>Anthropometric status (weight, BMI, mid-upper arm circumference and subscapular skin-fold thickness) at ~ 36 wk gestation and at 6, 12, and 18 months postpartum.</LI>
<LI>Pregnancy outcomes (birthweight, gestational age).</LI>
<LI>Anemia, micronutrient (iron, vitamin A, B-vitamins, zinc) and EFA status, and malarial antigen at ~ 36 wk gestation and 6 mo postpartum.</LI>
<LI>Total plasma cholesterol at ~ 36 wk gestation.</LI>
<LI>Blood pressure and urinary iodine, isoprostane (marker of oxidative stress) and 8-hydroxy-2'deoxyguanosine (8-OHdG) (marker of DNA damage) at 36 wk gestation.</LI>
<LI>Breast milk composition (EFA, vitamin A, B-vitamins, iodine) at 6 mo postpartum.</LI>
<LI>Depressive symptoms (which may be related to EFA status) at 6 mo postpartum.</LI>
</OL>
<P>ii. Child</P>
<OL>
<LI>Anthropometric status (weight, length, head circumference and mid-upper arm circumference) at birth and 3, 6, 12 and 18 mo.</LI>
<LI>Anaemia, micronutrient (iron, vitamin A, B-vitamins, iodine) and EFA status, and malarial antigen at 6 and 18 months.</LI>
<LI>Morbidity between 6 and 18 months.</LI>
<LI>Child feeding practices and maternal report of child sleep patterns at 6, 12 and 18 months.</LI>
<LI>Energy intake from complementary foods at 9 and 15 months.</LI>
<LI>Antibody response to measles vaccination at 12 months.</LI>
<LI>Achievement of 5 motor milestones (sitting without support, standing alone, walking with assistance, walking alone and running) and 4 other developmental milestones (pronouncing single words like mama or dada, waving goodbye, eating by self, drinking from a cup) from 0 to 18 months.</LI>
<LI>Neuro-behavioural development at 18 months of age.</LI>
</OL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-11 15:06:21 +0100" MODIFIED_BY="[Empty name]">
<P>November 2009.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-09-29 07:27:39 +0100" MODIFIED_BY="[Empty name]">
<P>Kathryn G Dewey, UC Davis</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-10-19 17:06:55 +0100" MODIFIED_BY="Heather Maxwell">
<P>Sample size = 864.</P>
<P>For the 2015 update of this review, we identified 3 further reports related to the ILINS-DYAD Ghana trial: Adu-Afarwuah 2013, Adu-Afarwuah 2014 and Oaks 2014. These reports are abstracts; the full report of pregnancy outcome data has not yet been published.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-22 09:58:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hirschberg-2014">
<CHAR_STUDY_NAME MODIFIED="2015-10-19 17:08:34 +0100" MODIFIED_BY="Heather Maxwell">
<P>Protocol identifier: NCT02190565.</P>
<P>Supplementation with WellnessPack mama during pregnancy and lactation - a randomized double-blind, placebo-controlled study.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-04-16 09:37:29 +0100" MODIFIED_BY="Nancy  Medley">
<P>Parallel randomised, double-blind trial investigating food supplementation for the primary prevention of anaemia.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 09:58:25 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria:</P>
<OL>
<LI>Healthy pregnant women aged 18-40 years with a body mass index (BMI) above 18.5 and below 30 kg/m2 who visit prenatal clinics (midwife centres) to register.</LI>
<LI>Nulliparous and multiparous women.</LI>
<LI>The women must be able to understand verbal and written information in Swedish to give an informed consent to participate in the study.</LI>
</OL>
<P>Exclusion criteria:</P>
<OL>
<LI>Women below the age of 18 or above 40 years old.</LI>
<LI>Women with a BMI below 18.5 or above 30 kg/m2.</LI>
<LI>Women with any form of anaemia as diagnosed at the first visit to the prenatal clinic.</LI>
<LI>Women expecting 2 or more babies.</LI>
<LI>Women who have undergone bariatric surgery.</LI>
<LI>Women on medication with pharmaceuticals that could affect the result of the study, e.g. vitamin K antagonists.</LI>
<LI>Women who are allergic to any of the components of WellnessPack mama, e.g. fish.</LI>
<LI>Women who suffer from drug or alcohol abuse.</LI>
<LI>Women who suffer from known severe eating disorders.</LI>
<LI>Women who suffer from chronic diseases that could affect gastrointestinal absorption and metabolism.</LI>
<LI>Women who want to continue or start using similar food supplements in addition to WellnessPack mama/placebo, unless recommended by a physician or midwife, will be excluded from the study.</LI>
</OL>
<P>Upon miscarriage or transfer to prenatal care specialist, the participant is excluded from the study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-11 15:18:59 +0100" MODIFIED_BY="[Empty name]">
<P>Placebo comparator: placebo.</P>
<P>Placebo consisting of 2 sham multivitamin and mineral tablets and 2 capsules of oil.</P>
<P>Active comparator: food supplement.</P>
<P>Food supplement consisting of fish oil (omega 3 fatty acids DHA and EPA) and multivitamin and mineral tablets with extra iron and folic acid.</P>
<P>Intervention: Dietary Supplement: Food supplement.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-22 09:01:45 +0100" MODIFIED_BY="Heather Maxwell">
<P>Primary outcome: prevalence of anaemia in active and placebo groups [Time Frame: pregnancy weeks 28-30] [Designated as safety issue: No]</P>
<P>Blood will be analysed for Hb and ferritin values. We will compare how many women in each group (active vs placebo) are ordinated iron supplementation due to anaemia by mid-pregnancy.</P>
<P>Secondary outcome: Levels of nutritional biomarkers in maternal blood and breast milk [Time Frame: 6-10 weeks after delivery] [ Designated as safety issue: No]</P>
<P>Levels of nutritional biomarkers such as DHA and vitamin D in maternal blood and breast milk will be measured in active and placebo groups.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-11 15:08:59 +0100" MODIFIED_BY="[Empty name]">
<P>October 2014 - January 2016.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-04-16 09:39:59 +0100" MODIFIED_BY="Nancy  Medley">
<P>Professor Angelica Lindén Hirschberg: <A HREF="mailto:Angelica.Hirschberg.Linden%40ki.se">Angelica.Hirschberg.Linden@ki.se</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-04-16 09:39:53 +0100" MODIFIED_BY="Nancy  Medley">
<P>Sudy sponsor: Oriflame Cosmetics AB. Collaborators: Karonlinska Institutet.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-22 10:06:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moore-2011">
<CHAR_STUDY_NAME MODIFIED="2015-05-11 15:09:02 +0100" MODIFIED_BY="[Empty name]">
<P>Investigating the effects of prenatal and infancy nutritional supplementation on infant immune development in The Gambia: The Early Nutrition and Immune Development (ENID) Trial.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-09-29 07:28:18 +0100" MODIFIED_BY="[Empty name]">
<P>A randomised trial to investigate the effects of prenatal and infancy nutritional supplementation on infant immune development.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 10:06:38 +0100" MODIFIED_BY="[Empty name]">
<P>Women (aged 18 to 45 years) resident in rural Kiang West Region, the Gambia, with pregnancy confirmed by urine test and ultrasound examination and with gestational age approximately 10-20 weeks will be recruited. Women currently enrolled in another MRC study or current pregnancy (beyond 20 weeks on ultrasound assessment), with severe anaemia (Hb less than 7 g/dL), reported onset of menopause will be excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-11 15:09:58 +0100" MODIFIED_BY="[Empty name]">
<P>4 pregnancy interventions, to be given daily from 12 weeks' gestation until delivery:<BR/>1. FeFol: Iron-folate, 60 mg iron 400 µg folate, representing the usual standard of care during pregnancy, as per Gambian Government guidelines (control group).<BR/>2. MMN: multiple micronutrients. A combination of 15 micronutrients, specifically designed for use during pregnancy, and as formulated by UNICEF. A single tablet provides the recommended dietary allowance (RDA) for each micronutrient, but we will supplement women in this arm of the trial with 2 daily MMN tablets.<BR/>3. PE + FeFol: protein-energy and iron-folate. A food-based supplement developed by Valid International, providing a comparable level of iron and folate to the FeFol only arm, but with the addition of energy, protein and lipids.<BR/>4. PE + MMN: protein-energy and multiple micronutrients. A micronutrient fortified food-based supplement also developed by Valid International, and providing comparable levels of micronutrients to the MMN arm (including FeFol), in addition to the energy and protein and lipid content.<BR/>
<BR/>From 6 months of age, infants will further be randomised to receive either a lipid-based nutritional supplement, with or without additional MMN, or placebo from 6 to 12 months of age.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-11 15:10:11 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: 1. Thymic index at 1, 8, 24 and 52 weeks of age.<BR/>2. Antibody response to EPI vaccines (diphtheria, tetanus toxoid, HiB, measles).</P>
<P>Secondary outcomes: cellular markers of immunity in a randomly selected subcohort of infants, stratified by treatment group. The secondary outcome measurements will be assessed when the infants are 12, 24 and 52 weeks of age. Subsidiary studies to the main trial will additionally assess the impact of supplementation on infant growth and development to 24 months of age.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-10-22 10:06:52 +0100" MODIFIED_BY="[Empty name]">
<P>October 1, 2009.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-07-09 20:39:53 +0100" MODIFIED_BY="[Empty name]">
<P>Sophie Moore</P>
<P>MRC Keneba<BR/>MRC Laboratories<BR/>Fajara, Banjul<BR/>Gambia<BR/>PO Box 273</P>
<P>Email: <A HREF="mailto:smoore@mrc.gm">smoore@mrc.gm</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-05-11 15:10:17 +0100" MODIFIED_BY="[Empty name]">
<P>800 mother-infant pairs.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-22 09:58:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mridha-2014">
<CHAR_STUDY_NAME MODIFIED="2015-05-11 15:10:23 +0100" MODIFIED_BY="[Empty name]">
<P>Rang-Din Nutrition Study.</P>
<P>Mridha 2014 (abstract) title: Lipid-based nutrient supplements for pregnant women reduce newborn stunting in Bangladesh.</P>
<P>Protocol identifier: NCT01715038.</P>
<P>Harding 2014 documents trial methods and compliance.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-04-16 09:42:31 +0100" MODIFIED_BY="Nancy  Medley">
<P>Cluster-randomised effectiveness trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 09:58:29 +0100" MODIFIED_BY="[Empty name]">
<P>4011 pregnant women recruited.</P>
<P>Inclusion criteria</P>
<OL>
<LI>Gestational age &#8804; 20 weeks.</LI>
<LI>Planning to remain in the study area during pregnancy and the following 3 years (i.e. a permanent resident of the study area).</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>Pregnancy identified and registered in the CHDP program before the beginning of the enrolment.</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 09:58:31 +0100" MODIFIED_BY="[Empty name]">
<P>1. Experimental: Comprehensive</P>
<P>"Comprehensive" LNS: LNS-PLW provided daily to mothers during pregnancy and postpartum lactation (a total of at least 11 months, starting by 20 weeks' gestation and ending at 6 months postpartum) and LNS developed for infants and young children (LNS-child) provided daily to their infants (beginning at 6 months of age for a period of 18 months i.e. from 6-24 months of age).</P>
<P>2. Experimental: child-only LNS</P>
<P>"Child-only" LNS: daily LNS-child supplementation of the child starting at 6 months of age and ending at 24 months of age (18 months total). Women will be provided with iron and folic acid (IFA) tablets during pregnancy and for 3 months postpartum.</P>
<P>3. Experimental: child-only MNP</P>
<P>"Child-only" MNP: daily MNP supplementation of the child starting at 6 months of age and ending at 24 months of age (18 months total). Women will be provided with iron and folic acid (IFA) tablets during pregnancy and for 3 months postpartum.</P>
<P>4. Active comparator: control: IFA.</P>
<P>Control: no additional nutrient supplementation for the child will be provided through the study, but the regular nutrition education and visits provided by the program frontline staff will continue. Women will be provided with IFA tablets during pregnancy and for 3 months postpartum.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-19 17:16:20 +0100" MODIFIED_BY="Heather Maxwell">
<P>Primary outcome measures:</P>
<P>1. Birthweight [Time Frame: Within 48 hours (or back calculated from later measurements).] [Designated as safety issue: No]. Birthweight of the infants (women who received LNS-PLW vs. women who received IFA tablets). Pre-defined tests for interaction will be done for: baseline maternal characteristics (age, height, BMI, education, primiparity, food insecurity, wealth and gestational age at enrolment), time of year when outcome was assessed and child sex.</P>
<P>2. Birth length [Time Frame: Within 48 hours (or back calculated from later measurements)] [Designated as safety issue: No]. Birth length of the infants (women who received LNS-PLW vs. women who received IFA tablets). Pre-defined tests for interaction will be done for: baseline maternal characteristics (age, height, BMI, education, primiparity, food insecurity, wealth and gestational age at enrolment), time of year when outcome was assessed and sex of child.</P>
<P>3. Child linear growth status at 24 months [Time Frame: 24 months] [Designated as safety issue: No]. Linear growth (the "comprehensive" LNS approach vs. the "child-only" LNS approach vs. "child-only" MNP) vis-à-vis one another and vis-à-vis the control group. Pre-defined tests for interaction will be done for: baseline maternal characteristics (age, height, BMI, education, primiparity, food insecurity, wealth and gestational age at enrolment), time of year when outcome was assessed and sex of child.</P>
<P>Secondary outcome measures:</P>
<P>There are many additional maternal and neonatal outcomes listed on the protocol.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-11 15:11:57 +0100" MODIFIED_BY="[Empty name]">
<P>October 2011 - April 2015.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-05-11 15:11:59 +0100" MODIFIED_BY="[Empty name]">
<P>Kathryn Dewey, University of California, Davis.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-04-16 10:00:50 +0100" MODIFIED_BY="Nancy  Medley">
<P>Study sponsors:</P>
<P>University of California, Davis</P>
<P>US Agency for International Development</P>
<P>Family Health International 360</P>
<P>International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)</P>
<P>World Mission Prayer League (LAMB)</P>
<P>FANTA</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-22 10:09:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramakrishnan-2012">
<CHAR_STUDY_NAME MODIFIED="2015-10-19 17:17:59 +0100" MODIFIED_BY="Heather Maxwell">
<P>Impact of pre-pregnancy micronutrient supplementation on maternal and child outcomes.</P>
<P>Protocol identifier: NCT01665378.</P>
<P>Setting: Vietnam.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-04-16 10:14:14 +0100" MODIFIED_BY="Nancy  Medley">
<P>Parallel, double-blind randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-10-22 10:09:32 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria:</P>
<OL>
<LI>18-35 years old.</LI>
<LI>Currently married.</LI>
<LI>Intends to live in the study area for the next 24 months.</LI>
<LI>Plans to have children in the next year.</LI>
<LI>Agrees to participate with informed consent.</LI>
</OL>
<P>Exclusion criteria:</P>
<OL>
<LI>Currently pregnant.</LI>
<LI>Delivered in the previous 6 months.</LI>
<LI>Regularly consumed IFA or MM supplements in the past 2 months.</LI>
<LI>Severe anaemia (Hb &lt; 7 g/L).</LI>
<LI>History of high-risk pregnancy including abruptio placenta, placenta previa, gestational diabetes, pregnancy-induced hypertension, coagulation disorders, thrombocytopenia or chronic vascular, renal or systemic disease and drug use. Chronic haematological diseases, hereditary defects of red cells or Hb.</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-11 15:17:43 +0100" MODIFIED_BY="[Empty name]">
<P>Arms 1 and 2: experimental: multiple micronutrients. Multiple micronutrient groups receive: vitamin A (&#956;g) 800 vitamin D (IU) 600 vitamin E (mg) 10 vitamin C (mg) 70 thiamine (mg) 1.4 riboflavin (mg) 1.4 niacin (mg) 18 vitamin B6 (mg) 1.9 vitamin B12 (&#956;g) 2.6 folic acid (&#956;g)* 2800 Iron (mg)* 60 zinc (mg) 15 copper (mg) 2 selenium (&#956;g) 65 iodine (&#956;g) 150.</P>
<P>Arm 3 and 4: active comparator: iron and folic acid. Iron and folic acid groups receive: iron (60 mg) and folic acid (2800 &#956;g), based on current WHO recommendations for WRA.</P>
<P>Arm 5 and 6: placebo comparator: folic acid. Folic acid groups receive: 2800 &#956;g FA once a week during the pre-pregnancy period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-21 21:40:28 +0100" MODIFIED_BY="Heather Maxwell">
<P>Primary outcomes:</P>
<P>1. Birth Size [Time Frame: At birth] [Designated as safety issue: No]</P>
<P>Infants' weight, length and head circumference will be measured as early as possible within 24 hours after birth using standard procedures. All measurements will be obtained in duplicate by the same data collector. Weight-for-age and length-for-age z scores will be calculated using the 2006 WHO reference data.</P>
<P>2. Gestational Age [Time Frame: At birth] [Designated as safety issue: No]</P>
<P>Gestational age will be calculated based on the date of last menstrual period. This method has been shown to be reliable in previous work and we expect precise estimates since we will be visiting women weekly from baseline during the pre-pregnancy period and will exclude women who may be have delivered in the past 6 months.</P>
<P>Secondary outcomes:</P>
<P>Maternal and infant iron status.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-11 15:17:51 +0100" MODIFIED_BY="[Empty name]">
<P>October 2011 - September 2014.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-05-11 15:17:52 +0100" MODIFIED_BY="[Empty name]">
<P>Dr. Usha Ramakrishnan, Emory University.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-05-11 15:17:53 +0100" MODIFIED_BY="[Empty name]">
<P>Sponsor: Emory University.</P>
<P>Collaborator: MicroNutrient Initiative.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-10-22 10:12:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tu-2013">
<CHAR_STUDY_NAME MODIFIED="2015-05-11 15:17:55 +0100" MODIFIED_BY="[Empty name]">
<P>Effect of animal-source food supplement prior to and during pregnancy on birthweight and prematurity in rural Vietnam.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-05-11 15:01:57 +0100" MODIFIED_BY="[Empty name]">
<P>Cluster-randomised trial recruiting women from 29 communes in Vietnam.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-04-16 10:25:41 +0100" MODIFIED_BY="Nancy  Medley">
<P>Women recruited when registering for marriage.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-10-22 10:12:53 +0100" MODIFIED_BY="[Empty name]">
<P>I) Food supplement 5 days/week from marriage to term (~18 months).</P>
<P>II) Food supplement 5 days/week from 16 weeks' gestation to term (~5 months).</P>
<P>III) Routine prenatal care.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-10-19 17:21:19 +0100" MODIFIED_BY="Heather Maxwell">
<P>The primary outcome is birthweight and the secondary outcome is the prevalence of prematurity.</P>
<P>Other outcomes include maternal micronutrient status (iron, zinc, folic acid, vitamins A and B12), the incidence of infections; infant growth and infections from 0-6 months of age are also assessed. Maternal data and information are measured at recruitment, 16, and 34 weeks' gestation. Infant anthropometric status is measured at birth, 1, 3, and 6 months. Infant gestational age is assessed at birth to determine the prevalence of pre-term deliveries, and the mother&#8217;s activity or physical work during pregnancy is also determined.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-05-11 15:18:17 +0100" MODIFIED_BY="[Empty name]">
<P>Not stated.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-05-11 15:18:18 +0100" MODIFIED_BY="[Empty name]">
<P>N. Tu, Vietnam Nutrition Association, Hanoi, Vietnam. C. King, Children's Hospital Oakland Research Institute, Oakland, CA, USA.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-04-13 16:19:14 +0100" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<FOOTNOTES>
<P>BMI: body mass index<BR/>DHA: docosahexaenoic acid <BR/>EPA: eicosapentaenoic acid <BR/>Hb: haemoglobin<BR/>IFA: iron and folic acid<BR/>ITT: intention-to-treat<BR/>LNS: lipid-based nutrient supplement<BR/>mcg: microgram<BR/>MMN: multiple micronutrient<BR/>RDA: recommended daily allowance<BR/>SAE: serious adverse event<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-10-23 11:18:01 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-10-22 08:31:11 +0100" MODIFIED_BY="Heather Maxwell" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-07-27 11:33:24 +0100" MODIFIED_BY="Nancy  Medley" RESULT="YES" STUDY_ID="STD-Bhutta-2009a">
<DESCRIPTION>
<P>Quote: "a cluster-based allocation strategy of supplements (either IF or MMN supplementation) by respective CHWs was implemented".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:27:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Brough-2010">
<DESCRIPTION>
<P>Quote: "a randomised, double-blind, placebo-controlled trial" and "Participants were randomised to receive either multiple-micronutrient supplements, known as Pregnacare, or a visually identical placebo".</P>
<P>Comment: insufficient information about the sequence generation process to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:29:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2003">
<DESCRIPTION>
<P>Quote: "Randomization was done in blocks of five within each village development community by the senior study investigators, who drew numbered chips from a hat".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:28:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fawzi-2007">
<DESCRIPTION>
<P>Quote: "A list was prepared according to a randomization sequence in blocks of 20; at enrolment, each eligible women was assigned to the next numbered bottle" and computerised random number generator was used (personal communication).</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:29:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friis-2004">
<DESCRIPTION>
<P>Quote: "Allocation to daily supplementation with multimicronutrient or identical-looking placebo tablets was based on simple blocked randomization. The digits 0&#8211;5 in a computer-generated random sequence were replaced by 6 preassigned permuted blocks of 4: AABB, ABAB, ABBA, BABA, BBAA, and BAAB; the digits 6&#8211;9 were deleted".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:21:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hininger-2004">
<DESCRIPTION>
<P>Quote: "Pregnant women were randomly assigned" and "randomized, placebo-controlled trial".</P>
<P>Comment: method used to generate the randomisation sequence is not described in sufficient detail to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:32:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaestel-2005">
<DESCRIPTION>
<P>Quote: "Simple block randomisation with a block size of 150 was managed as follows: at entry, the project midwife randomly drew 1 piece of coloured paper corresponding to the colour code on the tablet containers from envelopes with initially 50 pieces of each of the three colours".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:25:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lui-2013">
<DESCRIPTION>
<P>Quote: "A statistician external to the study randomly assigned ten 4-digit lot numbers to each of the 3 supplement types (masked to the formulation and allocation) and generated the assignment list for each county proportional to the expected number of participants; within each county and block, lot numbers were randomly assigned using RANUNI in SAS statistics<BR/>software (SAS Institute Inc)".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:32:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Osrin-2005">
<DESCRIPTION>
<P>Quote: "Randomly allocated 1200 participant identification numbers by computer into two groups in permuted blocks of 50".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:32:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramakrishnan-2003">
<DESCRIPTION>
<P>Quote: "Randomization was carried out by using 4 color-coded groups (2 per treatment) that were assigned a priori with the use of a computer-generated list".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:33:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberfroid-2008">
<DESCRIPTION>
<P>Quote: "The randomization scheme was generated by a computer program in permuted blocks of 4".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:35:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-SUMMIT-2008">
<DESCRIPTION>
<P>Quote: "Before enrolment, midwife identification numbers were sequentially allocated to computer-generated, randomly permuted blocks of groups numbered one to eight, stratified by community health centre or village health clinic".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:33:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sood-1975">
<DESCRIPTION>
<P>Quote: "By reference to previously prepared random tables the women were allocated to one of the two streams A or B" and "within each stratum subjects were allotted to final treatment groups according to a set of random numbers".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:21:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sunawang-2009">
<DESCRIPTION>
<P>Quote: "We restructured the 157 hamlets into 160 dwelling clusters.", "these 160 clusters (and the pregnant women living within them) were randomly assigned into 4 blocks of 40 clusters each".</P>
<P>Comment: method used for generating the randomisation sequence is not described in sufficient detail to permit judgement.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:34:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Theobald-1937">
<DESCRIPTION>
<P>Quote: "An equal number of blue and white beads were placed in a box. Each women accepted for the experiment was asked to draw a bead from the box. Those who drew blue beads were placed in group A while those who drew white beads were placed in group B."</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-22 08:31:11 +0100" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Tofail-2008">
<DESCRIPTION>
<P>Quote: "individual randomisation was done in blocks of 12" and "After enrolment, women were randomly assigned to 6 intervention groups".</P>
<P>Comment: method used for generating the randomisation sequence was not described in sufficient detail to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:42:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-West-2014">
<DESCRIPTION>
<P>Quote: "Randomized", "study area was divided into 596 sectors of comparable size that were<BR/>used as units of randomization".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:42:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zagre-2007">
<DESCRIPTION>
<P>Quote: "Villages - not individuals were randomly assigned to one treatment group or the other".</P>
<P>Comment: method used for generating the randomisation sequence was not described in sufficient detail to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-29 06:49:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeng-2008">
<DESCRIPTION>
<P>Quote: "The randomisation schedule was generated off site with a pseudo-random number generator in SAS".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-10-22 09:04:55 +0100" MODIFIED_BY="Heather Maxwell" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:24:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhutta-2009a">
<DESCRIPTION>
<P>Comment: "allocated to either the IF or MMN supplements according to their respective location and allocation by the AKU Pharmacy".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:27:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Brough-2010">
<DESCRIPTION>
<P>Quote: "a randomised, double-blind, placebo-controlled trial".</P>
<P>Comment: insufficient information to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-29 07:06:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Christian-2003">
<DESCRIPTION>
<P>Quote: "Randomization was done in blocks of five within each village development community by the senior study investigators, who drew numbered chips from a hat".</P>
<P>Comment: insufficient information to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:30:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fawzi-2007">
<DESCRIPTION>
<P>Quote: "Each eligible women was assigned to the next numbered bottle".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:29:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friis-2004">
<DESCRIPTION>
<P>Quote: "Containers with 110 multimicronutrient or placebo tablets, which were coded A or B, respectively, were delivered by the manufacturer together with the code in 2 sealed envelopes. Duplicate containers, which corresponded to the random sequence, were consecutively numbered from 1 to 1800. The study participants were numbered consecutively at recruitment".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:32:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hininger-2004">
<DESCRIPTION>
<P>Comment: insufficient information to permit judgment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-22 08:16:11 +0100" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-Kaestel-2005">
<DESCRIPTION>
<P>Quote: "at entry, the project midwife randomly drew one piece of coloured paper corresponding to the colour code on the tablet containers from envelopes with initially 50 pieces of each of the three colours".</P>
<P>Comment: probably not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:25:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lui-2013">
<DESCRIPTION>
<P>Quote: " A statistician external to the study randomly assigned ten 4-digit lot numbers to each of the 3 supplement types (masked to the formulation and allocation)".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-29 07:10:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Osrin-2005">
<DESCRIPTION>
<P>Quote: "We did randomisation in advance of recruitment", "The allocation code was kept on file in Kathmandu and London. We allocated every identification number a supplement container to last throughout the trial. Containers were filled with either intervention or control tablets in Kathmandu by a team member who was otherwise uninvolved in the trial; these containers were then marked only with identification numbers and transported to the study centre in Janakpur" and "After screening, consent, and enrolment, one of us (YS) allocated participants sequential identification numbers and the corresponding supplement containers".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:32:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramakrishnan-2003">
<DESCRIPTION>
<P>Quote: "Four colors were used to ensure masking and were assigned at random before the study began to a list of serial numbers from 1 to 1000" and "pregnant women were allocated to the pre-assigned color code as they were added to this list at the time of recruitment".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 13:45:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberfroid-2008">
<DESCRIPTION>
<P>Quote: "Randomization numbers were sealed in opaque envelopes. At each inclusion, the consulting<BR/>physician opened the next sealed envelope and transmitted the randomisation number to a pharmacist managing the allocation sequence and the packaging of drugs in Center Muraz. The pharmacist was also blinded to the intervention. Individual plastic zip bags contained 31 tablets each and were labelled with the participant&#8217;s name, address, and identification numbers only".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:36:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-SUMMIT-2008">
<DESCRIPTION>
<P>Quote: "midwives at village health centres and community health centres were assigned midwife identification numbers" and "Before enrolment, midwife identification numbers were sequentially allocated to computer-generated, randomly permuted blocks of groups numbered one to eight, stratified by community health centre or village health clinic".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:33:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sood-1975">
<DESCRIPTION>
<P>Quote: "By reference to previously prepared random tables the women were allocated to one of the two streams A or B" and "within each stratum subjects were allotted to final treatment groups according to a, set of random numbers".</P>
<P>Comment: probably not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:07:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sunawang-2009">
<DESCRIPTION>
<P>Comment:method used for allocation concealment is not described in sufficient detail to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:34:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Theobald-1937">
<DESCRIPTION>
<P>Comment: probably not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:07:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tofail-2008">
<DESCRIPTION>
<P>Comment: method used for allocation concealment was not described to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-22 09:04:55 +0100" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-West-2014">
<DESCRIPTION>
<P>Quote: "cluster-randomized", "Allocation: Randomized".</P>
<P>Comment: insufficient information to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:08:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zagre-2007">
<DESCRIPTION>
<P>Comment: method used for allocation concealment was not described to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:48:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeng-2008">
<DESCRIPTION>
<P>Quote: "The randomisation schedule was generated off site with a pseudo-random number generator in SAS version 6 (SAS Institute, Cary, NC). A treatment colour code was assigned to each village based on the treatment allocation schedule".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2015-05-14 15:19:15 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-10-23 11:18:01 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-08-17 21:26:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhutta-2009a">
<DESCRIPTION>
<P>Attrition (15.8%) and exclusion (around 1%) along with their reasons were reported. Attrition and exclusions were balanced across the treatment arms.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-08-04 23:18:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brough-2010">
<DESCRIPTION>
<P>Exclusion (8.7%) and attrition (12.2%) was reported along with their reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-08-17 21:45:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2003">
<DESCRIPTION>
<P>Exclusion (1.43%) and attrition (6.9%) was reported along with their reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-09-20 14:03:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fawzi-2007">
<DESCRIPTION>
<P>Exclusion (0.5%) and attrition (5.4%) were reported with reasons in each arm.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-26 19:43:30 +0100" MODIFIED_BY="Batool A Haider" RESULT="NO" STUDY_ID="STD-Friis-2004">
<DESCRIPTION>
<P>Attrition was &gt; 20% and reasons for it were reported. Exclusions were not reported in the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-09-29 06:37:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hininger-2004">
<DESCRIPTION>
<P>Reasons for attrition (35%) were not described in the study. There were no exclusions reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-26 19:44:13 +0100" MODIFIED_BY="Batool A Haider" RESULT="NO" STUDY_ID="STD-Kaestel-2005">
<DESCRIPTION>
<P>Exclusion (3.1%) and attrition (20.4%) data was reported along with their reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-12-22 21:00:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lui-2013">
<DESCRIPTION>
<P>Attrition rate (6.2%) was less than 20% and reasons for attrition and exclusions were provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-10-13 14:25:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Osrin-2005">
<DESCRIPTION>
<P>Attrition was 5% and reasons for it were reported. Exclusion was 39.5% and reasons were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-08-16 06:03:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ramakrishnan-2003">
<DESCRIPTION>
<P>Exclusion was 5.2% but reasons for it were not reported. Attrition (26.2%) along with their reasons were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-09-21 12:15:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberfroid-2008">
<DESCRIPTION>
<P>Attrition was 7.5% and reason for it was provided. Only 1 woman was excluded because of therapeutic abortion.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-08-16 06:06:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-SUMMIT-2008">
<DESCRIPTION>
<P>Exclusion (25.2%) and attrition (5%) were reported along with their reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-26 19:44:26 +0100" MODIFIED_BY="Batool A Haider" RESULT="NO" STUDY_ID="STD-Sood-1975">
<DESCRIPTION>
<P>Attrition was 30% and reasons for it were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-11 14:36:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sunawang-2009">
<DESCRIPTION>
<P>Exclusion (&lt; 1%) and attrition (10.4%) were reported along with their reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-09-20 14:07:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Theobald-1937">
<DESCRIPTION>
<P>No exclusion and attrition were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-09-26 19:44:44 +0100" MODIFIED_BY="Batool A Haider" RESULT="NO" STUDY_ID="STD-Tofail-2008">
<DESCRIPTION>
<P>Attrition was (26%) reported along with their reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-11 14:42:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-West-2014">
<DESCRIPTION>
<P>Complete information was not available as the main trial has not been published; however, attrition is reported to be &lt; 20% (trial presentations).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-10-23 11:18:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zagre-2007">
<DESCRIPTION>
<P>Attrition was 18%. Reasons for attrition were reported. Exclusion data were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-08-28 21:34:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeng-2008">
<DESCRIPTION>
<P>Exclusion (4.8%) and attrition (2.3%) were reported along with their reasons. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-09-26 20:43:41 +0100" MODIFIED_BY="Batool A Haider" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 12:24:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhutta-2009a">
<DESCRIPTION>
<P>Comment: results of all outcomes mentioned in methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:00:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brough-2010">
<DESCRIPTION>
<P>Comment: results of all outcomes mentioned in methods were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-17 21:34:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2003">
<DESCRIPTION>
<P>Comment: results of all outcomes mentioned in methods were presented in the various publications of this trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-18 16:42:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fawzi-2007">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-18 17:10:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friis-2004">
<DESCRIPTION>
<P>Comment: all outcomes in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-18 17:53:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hininger-2004">
<DESCRIPTION>
<P>Comment: all outcomes in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-18 19:29:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaestel-2005">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:26:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lui-2013">
<DESCRIPTION>
<P>Comment: all outcomes mentioned were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-18 19:51:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Osrin-2005">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-18 20:43:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramakrishnan-2003">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the various publications of this trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:06:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberfroid-2008">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:06:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-SUMMIT-2008">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:06:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sood-1975">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:07:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sunawang-2009">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:07:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Theobald-1937">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:07:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tofail-2008">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:42:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-West-2014">
<DESCRIPTION>
<P>Comment: reports from the study are still being published.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:07:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zagre-2007">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-20 14:08:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeng-2008">
<DESCRIPTION>
<P>Comment: all outcomes mentioned in the methods section were presented in the paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-10-22 08:25:52 +0100" MODIFIED_BY="Heather Maxwell" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-08 15:10:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhutta-2009a">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:23:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brough-2010">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:24:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2003">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:28:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fawzi-2007">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:29:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friis-2004">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:31:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hininger-2004">
<DESCRIPTION>
<P>comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:32:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaestel-2005">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:26:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lui-2013">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:32:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Osrin-2005">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:33:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramakrishnan-2003">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:34:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roberfroid-2008">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-12-18 21:40:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-SUMMIT-2008">
<DESCRIPTION>
<P>Study was stopped early due to insufficient funds.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-10-22 08:25:52 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Sood-1975">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:36:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sunawang-2009">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:37:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Theobald-1937">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:39:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tofail-2008">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:42:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-West-2014">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:43:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zagre-2007">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-11 14:48:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeng-2008">
<DESCRIPTION>
<P>Comment: no other bias was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2015-10-22 09:05:56 +0100" MODIFIED_BY="Heather Maxwell" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:02:40 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Bhutta-2009a">
<DESCRIPTION>
<P>Quote: "Both tablets were identical in colour, shape and packaging" and "field staff (medical officers, CHWs, social scientists and data collection team) remained completely blinded as to the supplements allocation. All pregnant women were allocated a unique code and allocated a uniquely labelled and numerically coded specific supplement supply".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:04:23 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Brough-2010">
<DESCRIPTION>
<P>Quote: "Participants were randomised to receive either multiple micronutrient supplements, known as Pregnacare, or visually identical placebo comprising starch with an iron oxide coating. All tablets were provided by Vitabiotics (London, UK) and packaged to allow double blinding. Only Vitabiotics knew the code and it was not broken until statistical analysis had been completed".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-12-18 21:22:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2003">
<DESCRIPTION>
<P>Quote: "participants, investigators, field staff and statisticians did not know supplement codes", "supplements, which were of identical shape,<BR/>size, and color" and "code allocation was kept locked at the Johns Hopkins University, Baltimore".<BR/>Comment: participants and caregivers were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-11 14:28:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fawzi-2007">
<DESCRIPTION>
<P>Quote: "Active tablets and placebo were similar in shape, size and color and were packaged in identical coded bottles" and "Each eligible women was assigned to the next numbered bottle".<BR/>Comment: participants and caregivers were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-12-18 21:24:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friis-2004">
<DESCRIPTION>
<P>Quote: "double blind", "multimicronutrient or identical-looking placebo tablets".<BR/>Comment: study participants and care providers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:14:30 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Hininger-2004">
<DESCRIPTION>
<P>Quote: "The subjects, the hospital staff and the investigators were blinded to the coding scheme until analyses of the data were<BR/>completed".<BR/>Comment: participants and caregivers were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:16:38 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Kaestel-2005">
<DESCRIPTION>
<P>Quote: "three identical-looking micronutrient supplements", "code was kept secret from study participants, study personnel, and data analysts until data cleaning and preliminary data analysis had been carried out." and "the health workers who collected outcome data after delivery did not have any knowledge of intervention group of the women".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-11 14:26:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lui-2013">
<DESCRIPTION>
<P>Quote: "Aside from a pharmaceutical engineer who ensured allocation of lot numbers to the correct supplement formulations, all others (i.e., participants, local physicians, study personnel, and investigators) were masked to the identity of the supplements".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:19:19 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Osrin-2005">
<DESCRIPTION>
<P>Quote: "The allocation code was kept on file in Kathmandu and London" and "Containers were filled with either intervention or control tablets in Kathmandu by a team member who was otherwise uninvolved in the trial; these containers were then marked only with identification numbers and transported to the study centre in Janakpur. Intervention and control supplements were manufactured to look, smell, and taste identical".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:21:50 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Ramakrishnan-2003">
<DESCRIPTION>
<P>Quote: "All study personnel and investigators were blinded to the group assignment, the details of which were kept at Emory University and the INSP in sealed envelopes that were opened only after preliminary data analysis was completed".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:24:48 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Roberfroid-2008">
<DESCRIPTION>
<P>Quote: "double blind", "Intervention and control micronutrient tablets were identical in appearance" and "code was kept secret from study participants and staff until completion of preliminary data analysis" and "Pharmacist was also blinded to the intervention".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:27:16 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-SUMMIT-2008">
<DESCRIPTION>
<P>Quote: "All study scientists and personnel, government staff and enrolees were unaware of the allocation." and "The code to indicate which strip was IFA or MMN was known only by the manufacturing production manager and a quality control officer from UNICEF, Copenhagen, neither of whom had any connection to the study or its personnel".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:26:01 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Sood-1975">
<DESCRIPTION>
<P>Quote: "All the tablets had the same appearance and had the daily folic acid and iron dose divided into two tablets".<BR/>Comment: participants, caregivers probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:28:27 +0100" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Sunawang-2009">
<DESCRIPTION>
<P>Quote: "This study had a single-blind design, since the supplement for the treatment and control group looked different physically. However, participants residing in each cluster received the same supplement, so they were not aware that other participants from other clusters received a different supplement".<BR/>Comment: study participants were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-11 14:37:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Theobald-1937">
<DESCRIPTION>
<P>Quote: "participants were divided into 2 groups, the intervention group received extra vitamins and the control did not receive any intervention".</P>
<P>Comment: probably not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:31:29 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Tofail-2008">
<DESCRIPTION>
<P>Quote: "pills were identical in appearance, and monthly supplies were provided in identical bottles", " the mothers were unaware of their micronutrient supplement" and "double masking was practiced".<BR/>Comment: study participants and caregivers were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-11 14:42:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-West-2014">
<DESCRIPTION>
<P>Quote: "double-masked", "Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)", "received daily supplementation, so treatment effect (still blinded due to the ongoing trial)".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 09:05:56 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Zagre-2007">
<DESCRIPTION>
<P>Quote: "Because the two supplements did not look identical and may have been recognizable, a coding system was put in place by the SONIPHAR pharmaceutical company in Niger. six codes were assigned to the treatments: three for iron/folic acid and three for multimicronutrient supplements. SONIPHAR packaged the supplements in boxes with identical labelling except for the supplement code. Health workers, traditional midwives, and data collectors were informed that each supplement came in two sizes and colors, so that the code letter did not distinguish which supplement was used".<BR/>Comment: participants and caregivers were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-10-22 08:37:05 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Zeng-2008">
<DESCRIPTION>
<P>Quote: "double blind", "treatment colour code was assigned to each village based on the treatment allocation schedule. The treatment codes were opened only once all data had been collected and blinded analysis of the primary hypothesis was completed" and "were of identical appearance and packaged in blister packs".</P>
<P>Comment: participants and caregivers were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-10-22 09:06:03 +0100" MODIFIED_BY="Heather Maxwell" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:02:50 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Bhutta-2009a">
<DESCRIPTION>
<P>Quote: "Both tablets were identical in colour, shape and packaging" and "field staff (medical officers, CHWs, social scientists and data collection team) remained completely blinded as to the supplements allocation".</P>
<P>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:04:31 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Brough-2010">
<DESCRIPTION>
<P>Quote: "All tablets were provided by Vitabiotics (London, UK) and packaged to allow double blinding. Only Vitabiotics knew the code and it was not broken until statistical analysis had been completed".<BR/>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-11 14:24:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Christian-2003">
<DESCRIPTION>
<P>Quote: "participants, investigators, field staff and statisticians did not know supplement codes".<BR/>Comment: outcome assessors were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-11 14:28:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fawzi-2007">
<DESCRIPTION>
<P>Quote: "research assistants who assessed the study outcome were unaware of the intervention group".</P>
<P>Comment: outcome assessors were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-11 14:29:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friis-2004">
<DESCRIPTION>
<P>Quote: "double blind", "multimicronutrient or identical-looking placebo tablets".</P>
<P>Comment: investigators were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:14:39 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Hininger-2004">
<DESCRIPTION>
<P>Quote: "The subjects, the hospital staff and the investigators were blinded to the coding scheme until analyses of the data were<BR/>completed".<BR/>Comment: outcome assessors were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:17:02 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Kaestel-2005">
<DESCRIPTION>
<P>Quote: "three identical-looking micronutrient supplements", "code was kept secret from study participants, study personnel, and data analysts until data cleaning and preliminary data analysis had been carried out." and "the health workers who collected outcome data after delivery did not have any knowledge of intervention group of the women".<BR/>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-11 14:26:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lui-2013">
<DESCRIPTION>
<P>Quote: "Treatment codes were broken after completion of the study and main analyses.", " double blind".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:19:43 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Osrin-2005">
<DESCRIPTION>
<P>Quote: "The allocation code was kept on file in Kathmandu and London" and "Containers were filled with either intervention or control tablets in Kathmandu by a team member who was otherwise uninvolved in the trial; these containers were then marked only with identification numbers and transported to the study centre in Janakpur. Intervention and control supplements were manufactured to look, smell, and taste identical".<BR/>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:22:07 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Ramakrishnan-2003">
<DESCRIPTION>
<P>Quote: "All study personnel and investigators were blinded to the group assignment, the details of which were kept at Emory University and the INSP in sealed envelopes that were opened only after preliminary data analysis was completed".<BR/>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:25:04 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Roberfroid-2008">
<DESCRIPTION>
<P>Quote: "double blind", "Intervention and control micronutrient tablets were identical in appearance" and "code was kept secret from study participants and staff until completion of preliminary data analysis" and "Pharmacist was also blinded to the intervention".<BR/>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:27:38 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-SUMMIT-2008">
<DESCRIPTION>
<P>Quote: "All study scientists and personnel, government staff and enrolees were unaware of the allocation." and "The code to indicate which strip was IFA or MMN was known only by the manufacturing production manager and a quality control officer from UNICEF, Copenhagen, neither of whom had any connection to the study or its personnel".<BR/>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:26:11 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Sood-1975">
<DESCRIPTION>
<P>Quote: "All the tablets had the same appearance and had the daily folic acid and iron dose divided into two tablets".<BR/>Comment: outcome assessors probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-11 14:36:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sunawang-2009">
<DESCRIPTION>
<P>Quote: " This study had a single-blind design" comment: Blinding of outcome assessors probably not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:29:07 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Theobald-1937">
<DESCRIPTION>
<P>Quote: "symptoms were recorded by independent antenatal officers who had no knowledge as to which patients were receiving the additional substances".<BR/>Comment: outcome assessors were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:31:45 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Tofail-2008">
<DESCRIPTION>
<P>Quote: "pills were identical in appearance, and monthly supplies were provided in identical bottles", "the testers were unaware of children&#8217;s groups" and "double masking was practiced".<BR/>Comment: outcome assessors were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-11 14:42:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-West-2014">
<DESCRIPTION>
<P>Quote: "double-masked", "Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)", "received daily supplementation, so treatment effect (still blinded due to the ongoing trial)".</P>
<P>Comment: probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 09:06:03 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Zagre-2007">
<DESCRIPTION>
<P>Quote: "Because the two supplements did not look identical and may have been recognizable, a coding system was put in place by the SONIPHAR pharmaceutical company in Niger. six codes were assigned to the treatments: three for iron/folic acid and three for multimicronutrient supplements. SONIPHAR packaged the supplements in boxes with identical labelling except for the supplement code. Health workers, traditional midwives, and data collectors were informed that each supplement came in two sizes and colors, so that the code letter did not distinguish which supplement was used".<BR/>Comment: outcome assessors were probably blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-10-22 08:37:20 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Zeng-2008">
<DESCRIPTION>
<P>Quote: "double blind", "treatment colour code was assigned to each village based on the treatment allocation schedule. The treatment codes were opened only once all data had been collected and blinded analysis of the primary hypothesis was completed".</P>
<P>Comment: outcome assessors were blinded to the treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-03-16 16:18:21 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-03-16 16:18:21 +0000" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-10-22 08:44:27 +0100" MODIFIED_BY="Heather Maxwell">Multiple micronutrients compared with control (iron and/or folic acid) for women during pregnancy</TITLE>
<TABLE COLS="7" ROWS="19">
<TR>
<TD COLSPAN="7">
<P>
<B>Multiple micronutrients compared with control (iron and/or folic acid) for women during pregnancy</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>Pregnant women<BR/>
<B>Settings: </B>Trials took place in Bangladesh (2), Burkina Faso, China (2), Guinea-Bissau, India, Indonesia (3), Mexico, Nepal (2), Niger, Pakistan, Tanzania and Zimbabwe.<BR/>
<B>Intervention: </B>Multiple micronutrients<BR/>
<B>Comparison: </B>Control (iron with or without folic acid)</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Median control group risk (iron and/or folic acid)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Multiple micronutrients</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Preterm births</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>average RR 0.96<BR/>(0.90 to 1.03)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>90892<BR/>(15 RCTs)</P>
<P/>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Denominators have been taken from individual trial reports or from a series of articles published in the FNB supplement (<LINK REF="REF-Fall-2009" TYPE="REFERENCE">Fall 2009</LINK>). Where different denominators are stated in different reports, we have taken the larger.</P>
<P/>
<P>Both the participant totals and the median control group risk are for illustrative purposes only. In the majority of the trials in this review, the final risk ratio presented will not correspond with raw event and participant data due to adjustments made for the effects of cluster design.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>183 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>176 per 1000<BR/>(163 to 187)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Small-for-gestational age</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>average RR 0.92<BR/>(0.86 to 0.98)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>67036<BR/>(14 RCTs)</P>
<P/>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>118 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>105 per 1000<BR/>(98 to 113)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Low birthweight</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>average RR 0.88<BR/>(0.85 to 0.91)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>70044<BR/>(15 RCTs)</P>
<P/>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>136 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>120 per 1000<BR/>(117 to 124)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Perinatal mortality</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>average RR 1.01<BR/>(0.91 to 1.13)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>94780<BR/>(12 RCTs)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH <SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>40 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>37 per 1000<BR/>(34 to 40)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Stillbirths</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>average RR 0.97<BR/>(0.87 to 1.09)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>98808<BR/>(15 RCTs)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>31 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>28 per 1000<BR/>(26 to 30)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Neonatal mortality</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>average RR 1.06<BR/>(0.92 to 1.22)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>83103<BR/>(11 RCTs)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>31 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>30 per 1000<BR/>(28 to 33)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> is the median control group risk. This rate has been calculated from event and participant raw data, where available. If we found no raw event and participant data in published reports, these trials were not included in the calculation of the median control group risk. We have labelled this risk moderate because it is the median of a range of control group rates.</P>
<P>The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the control group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI: </B>Confidence interval.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Statistical heterogeneity I² = 43%. We have not downgraded evidence for heterogeneity. There is evidence of funnel plot asymmetry for this outcome (-1).</P>
<P>
<SUP>2</SUP>Statistical heterogeneity I² = 45%. We have not downgraded evidence for heterogeneity.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2015-09-28 02:22:32 +0100" MODIFIED_BY="Batool A Haider">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2015-09-28 02:22:32 +0100" MODIFIED_BY="Batool A Haider" NO="1">
<TITLE MODIFIED="2012-07-11 00:50:20 +0100" MODIFIED_BY="[Empty name]">Micronutrients given to women in the intervention group</TITLE>
<TABLE COLS="24" ROWS="20">
<TR>
<TD>
<P>Study ID</P>
</TD>
<TD>
<P>Iron</P>
</TD>
<TD>
<P>Folic acid</P>
</TD>
<TD>
<P>Vit A</P>
</TD>
<TD>
<P>Beta-carotene</P>
</TD>
<TD>
<P>Vit C</P>
</TD>
<TD>
<P>Vit D</P>
</TD>
<TD>
<P>Vit E</P>
</TD>
<TD>
<P>Vit B1</P>
</TD>
<TD>
<P>Vit B2</P>
</TD>
<TD>
<P>Vit B3</P>
</TD>
<TD>
<P>Vit B6</P>
</TD>
<TD>
<P>Vit B12</P>
</TD>
<TD>
<P>Vit K</P>
</TD>
<TD>
<P>Copper</P>
</TD>
<TD>
<P>Selenium</P>
</TD>
<TD>
<P>Zinc</P>
</TD>
<TD>
<P>Iodine</P>
</TD>
<TD>
<P>Magnesium</P>
</TD>
<TD>
<P>Calcium</P>
</TD>
<TD>
<P>Phosphorus</P>
</TD>
<TD>
<P>Biotin</P>
</TD>
<TD>
<P>Potassium</P>
</TD>
<TD>
<P>Manganese</P>
</TD>
</TR>
<TR>
<TD>
<P>Bhutta 2009</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Brough 2010</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Christian 2003</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Cogswell 2013</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fawzi 2007</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Friis 2004</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hininger 2004</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Kaestel 2005</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Osrin 2005</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Ramakrishnan 2003</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Roberfroid 2008</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Sood 1975</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>SUMMIT 2008</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Sunawang 2009</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Theobald 1937</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Tofail 2008</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>West 2014</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Zagre 2007</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Zeng 2008</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P>&#10003;</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-03-10 15:51:58 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-03-10 15:51:58 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Multiple micronutrients vs control</NAME>
<IV_OUTCOME CHI2="29.135417469541864" CI_END="1.0293118576115152" CI_START="0.8981680772167241" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_SIZE="0.9615066572870461" ESTIMABLE="YES" I2="48.51626884810906" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.012546975851311766" LOG_CI_START="-0.046642384738675526" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.01704770444368188" MODIFIED="2017-03-10 15:49:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.015450724473510258" P_Q="0.7887945103363357" P_Z="0.25889082964610943" Q="0.07175773475894402" RANDOM="YES" SCALE="2.6350897893881067" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.006583858127258166" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="1.129016647439579">
<NAME>Preterm births</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="29.03369091142381" CI_END="1.028816242587257" CI_START="0.8974429051638937" DF="14" EFFECT_SIZE="0.9608870056501487" ESTIMABLE="YES" I2="51.780157601349075" ID="CMP-001.01.01" LOG_CI_END="0.01233781212207304" LOG_CI_START="-0.04699317145271025" LOG_EFFECT_SIZE="-0.017327679665318625" MODIFIED="2017-03-10 15:49:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.010341237452898056" P_Z="0.25228403050245485" STUDIES="15" TAU2="0.007017795742971189" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.1448193181178212">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.3963519826118425" CI_START="0.8199900203518332" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.1449949059934276" LOG_CI_START="-0.0861914331437273" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2016-03-02 04:39:47 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.1358" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.770781493742642"/>
<IV_DATA CI_END="1.0367769107215787" CI_START="0.7299955968163363" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.015685316788606636" LOG_CI_START="-0.13667975944685257" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2016-08-08 16:36:22 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.0895" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.082315356306788"/>
<IV_DATA CI_END="1.1200105447124213" CI_START="0.9107943936862798" EFFECT_SIZE="1.0099996658383554" ESTIMABLE="YES" ESTIMATE="0.00995" LOG_CI_END="0.049222111499521" LOG_CI_START="-0.04057965130964631" LOG_EFFECT_SIZE="0.00432123009493732" MODIFIED="2015-10-07 11:15:38 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SE="0.05275" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.393567854604594">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.1346285718957718" CI_START="0.5500724138127263" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.05485371564718746" LOG_CI_START="-0.2595801344163803" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 11:16:03 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SE="0.1847" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.9529743820328678">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.5712331675612452" CI_START="0.7151515733214218" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.1962406381725027" LOG_CI_START="-0.14560190158258352" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="504" SE="0.2008" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.565809431118168"/>
<IV_DATA CI_END="1.061574484908792" CI_START="0.7800843928538019" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.025950471653210985" LOG_CI_START="-0.10785841094016435" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="641" SE="0.0786" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.20458117363942"/>
<IV_DATA CI_END="1.2613885967721832" CI_START="0.6001274827586837" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.10084890055828255" LOG_CI_START="-0.22175648432014786" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SE="0.1895" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.8294184554996735"/>
<IV_DATA CI_END="1.9991571724579433" CI_START="0.6500372058449148" EFFECT_SIZE="1.1399677813119904" ESTIMABLE="YES" ESTIMATE="0.131" LOG_CI_END="0.30084693941470375" LOG_CI_START="-0.18706178515605174" LOG_EFFECT_SIZE="0.05689257712932602" MODIFIED="2015-10-07 11:32:58 +0100" MODIFIED_BY="[Empty name]" ORDER="139" SE="0.2866" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.3623262362541793">
<FOOTNOTE>Control group received iron only</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.4421034736707823" CI_START="0.7500144594720254" EFFECT_SIZE="1.039999258320852" ESTIMABLE="YES" ESTIMATE="0.03922" LOG_CI_END="0.1589964229576192" LOG_CI_START="-0.12493036379712817" LOG_EFFECT_SIZE="0.017033029580245544" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="704" SE="0.16678" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.4869271995999793"/>
<IV_DATA CI_END="1.1925406226853048" CI_START="0.96013055560486" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.0764731817646317" LOG_CI_START="-0.01766970891493137" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="586" SE="0.0553" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.054662784205034"/>
<IV_DATA CI_END="1.482389053805783" CI_START="0.8613494325694755" EFFECT_SIZE="1.1299800751972633" ESTIMABLE="YES" ESTIMATE="0.1222" LOG_CI_END="0.17096219942383498" LOG_CI_START="-0.06482062804668016" LOG_EFFECT_SIZE="0.05307078568857741" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="533" SE="0.1385" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.635923390182702"/>
<IV_DATA CI_END="1.0045232313230552" CI_START="0.5600590623927655" EFFECT_SIZE="0.7500615568648625" ESTIMABLE="YES" ESTIMATE="-0.2876" LOG_CI_END="0.001959985005366867" LOG_CI_START="-0.25176617099611737" LOG_EFFECT_SIZE="-0.12490309299537523" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="241" SE="0.14904" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.155265964175986"/>
<IV_DATA CI_END="0.9030863423844057" CI_START="0.8000645339562924" EFFECT_SIZE="0.8500160902253981" ESTIMABLE="YES" ESTIMATE="-0.1625" LOG_CI_END="-0.044270725623939355" LOG_CI_START="-0.09687498099461747" LOG_EFFECT_SIZE="-0.07057285330927841" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="2213" SE="0.0309" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.234844014553175"/>
<IV_DATA CI_END="1.1308555884511713" CI_START="0.9200102164661593" EFFECT_SIZE="1.0199993601580974" ESTIMABLE="YES" ESTIMATE="0.019802" LOG_CI_END="0.05340714856547824" LOG_CI_START="-0.03620734990418184" LOG_EFFECT_SIZE="0.008599899330648222" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="706" SE="0.05264" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.40824563957007"/>
<IV_DATA CI_END="1.439998930362207" CI_START="0.780326879516213" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.15836216949944154" LOG_CI_START="-0.10772343290952241" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="322" SE="0.1563" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.862356624514717"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="2.95099342003018" CI_START="0.41002306440654096" DF="0" EFFECT_SIZE="1.0999888022722382" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.4699682411340598" LOG_CI_START="-0.3871917128833" LOG_EFFECT_SIZE="0.04138826412537993" MODIFIED="2015-10-08 12:38:21 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8498772299966553" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.18927507447864947">
<NAME>MMN with iron and folic acid vs placebo</NAME>
<IV_DATA CI_END="2.95099342003018" CI_START="0.41002306440654096" EFFECT_SIZE="1.0999888022722382" ESTIMABLE="YES" ESTIMATE="0.0953" LOG_CI_END="0.4699682411340598" LOG_CI_START="-0.3871917128833" LOG_EFFECT_SIZE="0.04138826412537993" MODIFIED="2015-10-07 11:16:23 +0100" MODIFIED_BY="[Empty name]" ORDER="480" SE="0.5035" STUDY_ID="STD-Brough-2010" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Control group advised to take folic acid</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="25.167667351637576" CI_END="0.9811387957284785" CI_START="0.8650766211088081" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_SIZE="0.9212818430033001" ESTIMABLE="YES" I2="44.373072782650766" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.00826955127938617" LOG_CI_START="-0.06294542473050196" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.03560748800494408" MODIFIED="2017-03-10 15:49:57 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.032947788638745035" P_Q="0.9737275093867198" P_Z="0.01068483912528037" Q="0.0010846245751856296" RANDOM="YES" SCALE="3.37" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.004224266413072039" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.00000000000006" Z="2.552840573531179">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="25.132687847939167" CI_END="0.9814125803363282" CI_START="0.8646292154665713" DF="13" EFFECT_SIZE="0.9211720737111079" ESTIMABLE="YES" I2="48.2745336326374" ID="CMP-001.02.01" LOG_CI_END="-0.008148379271722439" LOG_CI_START="-0.06317009392201473" LOG_EFFECT_SIZE="-0.03565923659686861" MODIFIED="2017-03-10 15:49:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.022174155218208536" P_Z="0.011070000332671349" STUDIES="14" TAU2="0.0046265476047913845" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000004" Z="2.540481331425893">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.2061675211454916" CI_START="0.7800104241594188" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.08140762990744277" LOG_CI_START="-0.10789959330354115" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2016-03-05 18:35:18 +0000" MODIFIED_BY="[Empty name]" ORDER="381" SE="0.1112" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.147510255799272"/>
<IV_DATA CI_END="1.158454012644228" CI_START="0.9699736541732841" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.06387879820259258" LOG_CI_START="-0.013240061612673397" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2016-08-08 16:45:09 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.0453" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.640677672333744"/>
<IV_DATA CI_END="0.8915884582738216" CI_START="0.7000178967457131" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="-0.049835562152807676" LOG_CI_START="-0.15489085661638521" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 11:29:46 +0100" MODIFIED_BY="[Empty name]" ORDER="149" SE="0.06171" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.384408276083901">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.2831314648882521" CI_START="0.5113486932766915" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.1082711548555115" LOG_CI_START="-0.2912828495295419" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 11:29:52 +0100" MODIFIED_BY="[Empty name]" ORDER="378" SE="0.2347" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.749410528124842">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.252812239669379" CI_START="0.46107672597089233" EFFECT_SIZE="0.7600280032492344" ESTIMABLE="YES" ESTIMATE="-0.2744" LOG_CI_END="0.09788598768553596" LOG_CI_START="-0.33622679935404054" LOG_EFFECT_SIZE="-0.11917040583425229" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="379" SE="0.255" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.4997286012878681"/>
<IV_DATA CI_END="1.1527853486001205" CI_START="0.5414085788663955" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.061748448147227755" LOG_CI_START="-0.2664748669164207" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="380" SE="0.1928" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.4991016173766227"/>
<IV_DATA CI_END="1.3447248051923095" CI_START="0.5500261885662506" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.12863341607456966" LOG_CI_START="-0.25961663181659045" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 11:33:12 +0100" MODIFIED_BY="[Empty name]" ORDER="156" SE="0.22806" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.844319747053671">
<FOOTNOTE>Control group received iron only</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.0598289305986672" CI_START="0.6500490165412784" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.02523577046031674" LOG_CI_START="-0.1870538944174684" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="707" SE="0.1247" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.177196523669692"/>
<IV_DATA CI_END="1.1317319580675365" CI_START="0.8313127795582369" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.05374357975296" LOG_CI_START="-0.08023554314905836" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="382" SE="0.0787" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.653985603847845"/>
<IV_DATA CI_END="1.2014953054839443" CI_START="0.6300432135741827" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.07972207825568985" LOG_CI_START="-0.20062966201755508" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="723" SE="0.16468" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.290438276607748"/>
<IV_DATA CI_END="1.1738337716075187" CI_START="0.6901301196924974" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.06960660016120053" LOG_CI_START="-0.16106901805002544" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="724" SE="0.1355" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.544278844874666"/>
<IV_DATA CI_END="1.0103366836362089" CI_START="0.9699763148732996" EFFECT_SIZE="0.9899508337158773" ESTIMABLE="YES" ESTIMATE="-0.0101" LOG_CI_END="0.004466121782211678" LOG_CI_START="-0.01323887031665733" LOG_EFFECT_SIZE="-0.00438637426722283" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" SE="0.0104" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.06227433372238"/>
<IV_DATA CI_END="1.067179470837065" CI_START="0.6301362837854216" EFFECT_SIZE="0.8200417708174144" ESTIMABLE="YES" ESTIMATE="-0.1984" LOG_CI_END="0.028237462198471504" LOG_CI_START="-0.2005655126176818" LOG_EFFECT_SIZE="-0.08616402520960519" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="709" SE="0.1344" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.603739243292946"/>
<IV_DATA CI_END="1.0499315419454254" CI_START="0.7544811655591631" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.02116098295128348" LOG_CI_START="-0.12235159723474122" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="323" SE="0.0843" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.902930475924816"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="1.631848901131309" CI_START="0.5299812411258414" DF="0" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.21267994336216606" LOG_CI_START="-0.27573950213451826" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2015-10-07 11:31:54 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8002296972417284" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.25304984315092366">
<NAME>MMN with iron and folic acid vs placebo</NAME>
<IV_DATA CI_END="1.631848901131309" CI_START="0.5299812411258414" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.21267994336216606" LOG_CI_START="-0.27573950213451826" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2015-10-07 11:31:54 +0100" MODIFIED_BY="[Empty name]" ORDER="483" SE="0.2869" STUDY_ID="STD-Brough-2010" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Control group advised to take folic acid</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="11.330486606564948" CI_END="0.9079618709508219" CI_START="0.8541205142800387" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_SIZE="0.8806298088091171" ESTIMABLE="YES" I2="0.0" I2_Q="43.933081773710754" ID="CMP-001.03" LOG_CI_END="-0.041932388905510216" LOG_CI_START="-0.06848084711637153" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.05520661801094086" MODIFIED="2017-03-10 15:50:16 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7288343686149593" P_Q="0.18171010738903792" P_Z="3.598624414609236E-16" Q="1.7835829605685543" RANDOM="YES" SCALE="3.22" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="8.151357201258264">
<NAME>Low birthweight</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="9.546903645996395" CI_END="0.9073383207559119" CI_START="0.8535041001617218" DF="14" EFFECT_SIZE="0.8800096459693055" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="-0.04223074663248788" LOG_CI_START="-0.06879438823016898" LOG_EFFECT_SIZE="-0.0555125674313284" MODIFIED="2017-03-10 15:50:16 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7945036056630276" P_Z="2.572492973023631E-16" STUDIES="15" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="8.191846170989821">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.0843609900114004" CI_START="0.6200278614095005" EFFECT_SIZE="0.8199597707404048" ESTIMABLE="YES" ESTIMATE="-0.1985" LOG_CI_END="0.03517388540464299" LOG_CI_START="-0.20758879472023392" LOG_EFFECT_SIZE="-0.0862074546577955" MODIFIED="2016-03-05 19:53:04 +0000" MODIFIED_BY="[Empty name]" ORDER="171" SE="0.1426" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.1973231429521418"/>
<IV_DATA CI_END="1.219392640427793" CI_START="0.8700949815746023" EFFECT_SIZE="1.0300424345653076" ESTIMABLE="YES" ESTIMATE="0.0296" LOG_CI_END="0.08614356953513534" LOG_CI_START="-0.06043333620646285" LOG_EFFECT_SIZE="0.012855116664336209" MODIFIED="2016-08-08 16:47:40 +0100" MODIFIED_BY="[Empty name]" ORDER="164" SE="0.0861" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.2843098677060945"/>
<IV_DATA CI_END="0.9568163457132325" CI_START="0.7200344738300917" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="-0.01917141404920233" LOG_CI_START="-0.14264670990794934" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 11:30:01 +0100" MODIFIED_BY="[Empty name]" ORDER="166" SE="0.07253" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.6282314924094505">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.2167007142840753" CI_START="0.4500741811165746" EFFECT_SIZE="0.7400037686696985" ESTIMABLE="YES" ESTIMATE="-0.3011" LOG_CI_END="0.08518376301253977" LOG_CI_START="-0.34671590001467806" LOG_EFFECT_SIZE="-0.13076606850106912" MODIFIED="2015-10-07 11:30:06 +0100" MODIFIED_BY="[Empty name]" ORDER="727" SE="0.2537" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.37827661456913825">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.290690004496665" CI_START="0.6000291974225033" EFFECT_SIZE="0.8800293674187135" ESTIMABLE="YES" ESTIMATE="-0.1278" LOG_CI_END="0.11082194675694723" LOG_CI_START="-0.22182761633141845" LOG_EFFECT_SIZE="-0.05550283478723559" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="169" SE="0.1954" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.6376778168703491"/>
<IV_DATA CI_END="1.1570427341288945" CI_START="0.700005292804498" EFFECT_SIZE="0.8999644647935904" ESTIMABLE="YES" ESTIMATE="-0.1054" LOG_CI_END="0.06334939944754178" LOG_CI_START="-0.15489867623274725" LOG_EFFECT_SIZE="-0.045774638392602755" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="643" SE="0.1282" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.4814069496020434"/>
<IV_DATA CI_END="0.9374835213119168" CI_START="0.6001090433027007" EFFECT_SIZE="0.7500615568648625" ESTIMABLE="YES" ESTIMATE="-0.2876" LOG_CI_END="-0.02803635737752464" LOG_CI_START="-0.22176982861322586" LOG_EFFECT_SIZE="-0.12490309299537523" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="170" SE="0.1138" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.8800348678791992"/>
<IV_DATA CI_END="1.5890029442142208" CI_START="0.5800118524306279" EFFECT_SIZE="0.9600211149716509" ESTIMABLE="YES" ESTIMATE="-0.0408" LOG_CI_END="0.20112470189888682" LOG_CI_START="-0.23656313162219209" LOG_EFFECT_SIZE="-0.017719214861652687" MODIFIED="2015-10-07 11:33:20 +0100" MODIFIED_BY="[Empty name]" ORDER="173" SE="0.2571" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.3683377872297236">
<FOOTNOTE>Control group received iron only</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.2739692465668746" CI_START="0.6500165742404088" EFFECT_SIZE="0.9100006183190397" ESTIMABLE="YES" ESTIMATE="-0.09431" LOG_CI_END="0.10515894431996652" LOG_CI_START="-0.18707556949655788" LOG_EFFECT_SIZE="-0.04095831258829568" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="710" SE="0.17166" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.8262514063073496"/>
<IV_DATA CI_END="1.0513052852210514" CI_START="0.7199075191070305" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.02172884774543212" LOG_CI_START="-0.14272329040367807" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="590" SE="0.0966" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.609132744619066"/>
<IV_DATA CI_END="1.814998605988796" CI_START="0.8199723164945201" EFFECT_SIZE="1.219937953908705" ESTIMABLE="YES" ESTIMATE="0.1988" LOG_CI_END="0.25887629581201776" LOG_CI_START="-0.08620080980728481" LOG_EFFECT_SIZE="0.08633774300236645" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="725" SE="0.2027" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.5925744616979483"/>
<IV_DATA CI_END="1.0416909209991074" CI_START="0.7100319724021609" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.017738879024538207" LOG_CI_START="-0.14872209476655904" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="240" SE="0.09778" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.5465391785987532"/>
<IV_DATA CI_END="0.9110945159130742" CI_START="0.8500234322486802" EFFECT_SIZE="0.8800293674187135" ESTIMABLE="YES" ESTIMATE="-0.1278" LOG_CI_END="-0.04043656747233265" LOG_CI_START="-0.07056910210213853" LOG_EFFECT_SIZE="-0.05550283478723559" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="2215" SE="0.0177" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="77.71482892648183"/>
<IV_DATA CI_END="1.1644474055657228" CI_START="0.6500885825698831" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.06611987759511645" LOG_CI_START="-0.18702746135698173" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="711" SE="0.1487" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.1011043820882753"/>
<IV_DATA CI_END="1.2799301780200207" CI_START="0.6327970476828186" EFFECT_SIZE="0.8999644647935904" ESTIMABLE="YES" ESTIMATE="-0.1054" LOG_CI_END="0.10718627892310686" LOG_CI_START="-0.19873555570831236" LOG_EFFECT_SIZE="-0.045774638392602755" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="324" SE="0.1797" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.753970360988635"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.4480833466846268E-32" CI_END="4.025831148473967" CI_START="0.659989478293473" DF="0" EFFECT_SIZE="1.6300325761710857" ESTIMABLE="YES" I2="100.0" ID="CMP-001.03.02" LOG_CI_END="0.6048555557429419" LOG_CI_START="-0.18046298802708416" LOG_EFFECT_SIZE="0.21219628385792885" MODIFIED="2015-10-07 11:32:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.28951756475526524" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.0591805766312596">
<NAME>MMN with iron and folic acid vs placebo</NAME>
<IV_DATA CI_END="4.025831148473967" CI_START="0.6599894782934729" EFFECT_SIZE="1.6300325761710854" ESTIMABLE="YES" ESTIMATE="0.4886" LOG_CI_END="0.6048555557429419" LOG_CI_START="-0.18046298802708421" LOG_EFFECT_SIZE="0.2121962838579288" MODIFIED="2015-10-07 11:32:02 +0100" MODIFIED_BY="[Empty name]" ORDER="485" SE="0.4613" STUDY_ID="STD-Brough-2010" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Control group advised to take folic acid</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="22.26788338765835" CI_END="1.1252890241491618" CI_START="0.9105126057932456" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_SIZE="1.012220253526174" ESTIMABLE="YES" I2="46.110729111098074" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.051264082866919324" LOG_CI_START="-0.04071403714138513" LOG_DATA="YES" LOG_EFFECT_SIZE="0.0052750228627671345" MODIFIED="2017-03-10 15:50:34 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.034624910342454074" P_Q="1.0" P_Z="0.8221261687834951" Q="0.0" RANDOM="YES" SCALE="6.853407090672511" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.012479265625214635" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999997" Z="0.22481117960913866">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="22.26788338765835" CI_END="1.1252890241491618" CI_START="0.9105126057932456" DF="12" EFFECT_SIZE="1.012220253526174" ESTIMABLE="YES" I2="46.110729111098074" ID="CMP-001.04.01" LOG_CI_END="0.051264082866919324" LOG_CI_START="-0.04071403714138513" LOG_EFFECT_SIZE="0.0052750228627671345" MODIFIED="2017-03-10 15:50:34 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.034624910342454074" P_Z="0.8221261687834951" STUDIES="13" TAU2="0.012479265625214635" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999997" Z="0.22481117960913866">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.8139638725879066" CI_START="0.9899365432734446" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.25862863327977703" LOG_CI_START="-0.0043926435736134145" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2016-03-05 19:54:06 +0000" MODIFIED_BY="[Empty name]" ORDER="222" SE="0.1545" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.030556335204372"/>
<IV_DATA CI_END="2.0286475013832126" CI_START="0.9800327244975093" EFFECT_SIZE="1.4100145168847216" ESTIMABLE="YES" ESTIMATE="0.3436" LOG_CI_END="0.3072065904026346" LOG_CI_START="-0.008759422438719943" LOG_EFFECT_SIZE="0.14922358398195734" MODIFIED="2016-08-08 16:49:09 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SE="0.1856" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.220494849065608"/>
<IV_DATA CI_END="1.0131584085904353" CI_START="0.7300278544787893" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.005677353157183769" LOG_CI_START="-0.13666056889920447" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 11:30:16 +0100" MODIFIED_BY="[Empty name]" ORDER="217" SE="0.08361" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.992725545118894">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.2524434964630875" CI_START="0.5500773136538565" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.09775814194222242" LOG_CI_START="-0.25957626589937405" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="220" SE="0.2099" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.1630862958577435"/>
<IV_DATA CI_END="1.380504396872213" CI_START="0.6400244262325874" EFFECT_SIZE="0.9399768797793391" ESTIMABLE="YES" ESTIMATE="-0.0619" LOG_CI_END="0.14003779419462198" LOG_CI_START="-0.19380345105424449" LOG_EFFECT_SIZE="-0.026882828429811306" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1075" SE="0.1961" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.731026567026676"/>
<IV_DATA CI_END="2.0616656156707056" CI_START="0.7101250431105577" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.3142182278508791" LOG_CI_START="-0.1486651713493595" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="221" SE="0.2719" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.378204274428697"/>
<IV_DATA CI_END="4.5216285435348125" CI_START="0.3400467311713735" EFFECT_SIZE="1.2399858893552747" ESTIMABLE="YES" ESTIMATE="0.2151" LOG_CI_END="0.6552948817335159" LOG_CI_START="-0.4684613956187369" LOG_EFFECT_SIZE="0.09341674305738948" MODIFIED="2015-10-07 11:33:29 +0100" MODIFIED_BY="[Empty name]" ORDER="224" SE="0.6601" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.6512706146861071">
<FOOTNOTE>Control group received iron only</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="3.319680512369057" CI_START="0.9544036850549776" EFFECT_SIZE="1.7799762116978486" ESTIMABLE="YES" ESTIMATE="0.5766" LOG_CI_END="0.5210962890077392" LOG_CI_START="-0.02026789247690918" LOG_EFFECT_SIZE="0.25041419826541506" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="716" SE="0.318" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.569528537574786"/>
<IV_DATA CI_END="1.0253122543746036" CI_START="0.7900040518487463" EFFECT_SIZE="0.9000004640921633" ESTIMABLE="YES" ESTIMATE="-0.10536" LOG_CI_END="0.01085614802589345" LOG_CI_START="-0.1023706812525467" LOG_EFFECT_SIZE="-0.04575726661332664" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="227" SE="0.06651" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.26968569264221"/>
<IV_DATA CI_END="1.4390580177117784" CI_START="0.4227438896303208" EFFECT_SIZE="0.7799698608351326" ESTIMABLE="YES" ESTIMATE="-0.2485" LOG_CI_END="0.15807830350168442" LOG_CI_START="-0.3739226610076006" LOG_EFFECT_SIZE="-0.1079221787529581" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1753" SE="0.3125" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.6504332533296644"/>
<IV_DATA CI_END="1.417811995043471" CI_START="0.6500182531456222" EFFECT_SIZE="0.9600019147413544" ESTIMABLE="YES" ESTIMATE="-0.04082" LOG_CI_END="0.15161864627130486" LOG_CI_START="-0.18707444777388635" LOG_EFFECT_SIZE="-0.017727900751290732" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="242" SE="0.19895" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.60708353585954"/>
<IV_DATA CI_END="1.0056182866897758" CI_START="0.8600174811839018" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.002433162188096713" LOG_CI_START="-0.06549272096044882" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2016-05-09 01:44:04 +0100" MODIFIED_BY="[Empty name]" ORDER="358" SE="0.0399" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.744873511155117"/>
<IV_DATA CI_END="1.929864585988086" CI_START="0.9868375549399816" EFFECT_SIZE="1.3800227713344961" ESTIMABLE="YES" ESTIMATE="0.3221" LOG_CI_END="0.28552683666509926" LOG_CI_START="-0.005754331423024438" LOG_EFFECT_SIZE="0.13988625262103743" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="326" SE="0.1711" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.99103098805057"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="18.84065062420012" CI_END="1.0869856978655696" CI_START="0.8698506297769255" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_SIZE="0.9723760557761985" ESTIMABLE="YES" I2="25.6925873779671" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.036223829846252636" LOG_CI_START="-0.060555317764253484" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.012165743959000429" MODIFIED="2017-03-10 15:50:46 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.17112792622327422" P_Q="1.0" P_Z="0.6221825641634822" Q="0.0" RANDOM="YES" SCALE="2.7480261679687805" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.00966868994528844" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000003" Z="0.4927594547689129">
<NAME>Stillbirths</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="18.84065062420012" CI_END="1.0869856978655696" CI_START="0.8698506297769255" DF="14" EFFECT_SIZE="0.9723760557761985" ESTIMABLE="YES" I2="25.6925873779671" ID="CMP-001.05.01" LOG_CI_END="0.036223829846252636" LOG_CI_START="-0.060555317764253484" LOG_EFFECT_SIZE="-0.012165743959000429" MODIFIED="2017-03-10 15:50:46 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.17112792622327422" P_Z="0.6221825641634822" STUDIES="15" TAU2="0.00966868994528844" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000003" Z="0.4927594547689129">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.7400961841283102" CI_START="0.7600733099195451" EFFECT_SIZE="1.150043767101398" ESTIMABLE="YES" ESTIMATE="0.1398" LOG_CI_END="0.24057325465137364" LOG_CI_START="-0.11914451751122442" LOG_EFFECT_SIZE="0.060714368570074576" MODIFIED="2016-03-06 00:56:35 +0000" MODIFIED_BY="[Empty name]" ORDER="239" SE="0.2113" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.949876782160555"/>
<IV_DATA CI_END="2.3564092339238223" CI_START="0.8799070964359363" EFFECT_SIZE="1.4399379177717142" ESTIMABLE="YES" ESTIMATE="0.3646" LOG_CI_END="0.37225071591181896" LOG_CI_START="-0.05556317970796772" LOG_EFFECT_SIZE="0.15834376810192566" MODIFIED="2016-08-08 16:52:09 +0100" MODIFIED_BY="[Empty name]" ORDER="232" SE="0.2513" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.437985192748128"/>
<IV_DATA CI_END="1.0968777589737506" CI_START="0.6901352107546144" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.04015823052706334" LOG_CI_START="-0.16106581428892866" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 11:30:25 +0100" MODIFIED_BY="[Empty name]" ORDER="234" SE="0.1182" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="13.67075827531771">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="10.761306032587841" CI_START="0.3656213931764727" EFFECT_SIZE="1.9835734682721347" ESTIMABLE="YES" ESTIMATE="0.6849" LOG_CI_END="1.0318649821413148" LOG_CI_START="-0.43696840083024047" LOG_EFFECT_SIZE="0.29744829065553713" MODIFIED="2016-03-23 02:45:40 +0000" MODIFIED_BY="[Empty name]" ORDER="235" SE="0.8628" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.4285624841701192">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="0.8891663428095651" CI_START="0.2700551581779206" EFFECT_SIZE="0.4900244456697239" ESTIMABLE="YES" ESTIMATE="-0.7133" LOG_CI_END="-0.051016984804273316" LOG_CI_START="-0.5685475230789057" LOG_EFFECT_SIZE="-0.30978225394158954" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="237" SE="0.304" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.1657613702964333"/>
<IV_DATA CI_END="1.5725057211809816" CI_START="0.5499816594001918" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.19659223419540534" LOG_CI_START="-0.2596517929677575" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1082" SE="0.268" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.965702545154082"/>
<IV_DATA CI_END="1.6401496450050714" CI_START="0.4200474975778983" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.2148834742885866" LOG_CI_START="-0.37670159824573823" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="238" SE="0.3475" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.4778678683927398"/>
<IV_DATA CI_END="4.5216285435348125" CI_START="0.3400467311713735" EFFECT_SIZE="1.2399858893552747" ESTIMABLE="YES" ESTIMATE="0.2151" LOG_CI_END="0.6552948817335159" LOG_CI_START="-0.4684613956187369" LOG_EFFECT_SIZE="0.09341674305738948" MODIFIED="2015-10-07 11:33:38 +0100" MODIFIED_BY="[Empty name]" ORDER="241" SE="0.6601" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.7255843288238674">
<FOOTNOTE>Control group received iron only</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="3.6897038156564257" CI_START="0.8205780992192102" EFFECT_SIZE="1.7400259031788052" ESTIMABLE="YES" ESTIMATE="0.5539" LOG_CI_END="0.5669915053491085" LOG_CI_START="-0.08588007829668613" LOG_EFFECT_SIZE="0.24055571352621116" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="717" SE="0.3835" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.0618465605749825"/>
<IV_DATA CI_END="1.0800591950244371" CI_START="0.7500496686019729" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.033447558605433525" LOG_CI_START="-0.12490997649425833" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="244" SE="0.09302" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.639240748220633"/>
<IV_DATA CI_END="2.314076407180956" CI_START="0.3500740246885221" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.3643776945765052" LOG_CI_START="-0.45584011246533" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="726" SE="0.4818" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.3365420246424684"/>
<IV_DATA CI_END="1.754039957307665" CI_START="0.5701124400466531" EFFECT_SIZE="1.0" ESTIMABLE="YES" ESTIMATE="0.0" LOG_CI_END="0.24403948243969925" LOG_CI_START="-0.2440394824396992" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="246" SE="0.2867" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.517920075396615"/>
<IV_DATA CI_END="0.9780194395116101" CI_START="0.8099568797118069" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="-0.009652512913094278" LOG_CI_START="-0.09153810137036344" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="749" SE="0.0481" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="26.97109648424039"/>
<IV_DATA CI_END="1.7401387679395524" CI_START="0.8001429644354437" EFFECT_SIZE="1.17998296271946" ESTIMABLE="YES" ESTIMATE="0.1655" LOG_CI_END="0.24058388262017258" LOG_CI_START="-0.09683240911019626" LOG_EFFECT_SIZE="0.07187573675498822" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="718" SE="0.1982" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.601900441692149"/>
<IV_DATA CI_END="1.9598837296183116" CI_START="0.9298935610585034" EFFECT_SIZE="1.3499938002062797" ESTIMABLE="YES" ESTIMATE="0.3001" LOG_CI_END="0.2922303075386315" LOG_CI_START="-0.03156675950029972" LOG_EFFECT_SIZE="0.13033177401916585" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="327" SE="0.1902" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.0493548181691565"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="14.443071926373843" CI_END="1.2242273190876736" CI_START="0.9219786619324957" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_SIZE="1.0624083327768377" ESTIMABLE="YES" I2="30.762651803045788" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.08786206671409624" LOG_CI_START="-0.03527913004420963" LOG_DATA="YES" LOG_EFFECT_SIZE="0.026291468334943335" MODIFIED="2017-03-10 15:50:58 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.15372389287705934" P_Q="1.0" P_Z="0.40263146663611926" Q="0.0" RANDOM="YES" SCALE="1.6577234176911515" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.013340282911886273" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.8369308142798836">
<NAME>Neonatal mortality</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="14.443071926373843" CI_END="1.2242273190876736" CI_START="0.9219786619324957" DF="10" EFFECT_SIZE="1.0624083327768377" ESTIMABLE="YES" I2="30.762651803045788" ID="CMP-001.06.01" LOG_CI_END="0.08786206671409624" LOG_CI_START="-0.03527913004420963" LOG_EFFECT_SIZE="0.026291468334943335" MODIFIED="2017-03-10 15:50:58 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.15372389287705934" P_Z="0.40263146663611926" STUDIES="11" TAU2="0.013340282911886273" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.8369308142798836">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="2.182572784942966" CI_START="0.9499894900828798" EFFECT_SIZE="1.4399379177717142" ESTIMABLE="YES" ESTIMATE="0.3646" LOG_CI_END="0.338968735572118" LOG_CI_START="-0.022281199368266846" LOG_EFFECT_SIZE="0.15834376810192566" MODIFIED="2016-03-05 19:55:39 +0000" MODIFIED_BY="[Empty name]" ORDER="179" SE="0.2122" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.9639366090233"/>
<IV_DATA CI_END="2.3873198577669688" CI_START="0.9299993997344395" EFFECT_SIZE="1.4900355816883664" ESTIMABLE="YES" ESTIMATE="0.3988" LOG_CI_END="0.3779106105261896" LOG_CI_START="-0.03151733176015601" LOG_EFFECT_SIZE="0.1731966393830168" MODIFIED="2016-08-08 16:54:01 +0100" MODIFIED_BY="[Empty name]" ORDER="249" SE="0.2405" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.3505647724515315"/>
<IV_DATA CI_END="2.7354654609756652" CI_START="0.5711510272598767" EFFECT_SIZE="1.2499455620426687" ESTIMABLE="YES" ESTIMATE="0.2231" LOG_CI_END="0.437031235581272" LOG_CI_START="-0.24324903775604098" LOG_EFFECT_SIZE="0.09689109891261549" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="632" SE="0.3996" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.0240190633016444"/>
<IV_DATA CI_END="1.3388817700832902" CI_START="0.49005641314542503" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.12674222834327392" LOG_CI_START="-0.30975392301730426" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="1084" SE="0.2564" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.616197450126267"/>
<IV_DATA CI_END="3.240637953596774" CI_START="0.7224043829578354" EFFECT_SIZE="1.5300493656277303" ESTIMABLE="YES" ESTIMATE="0.4253" LOG_CI_END="0.5106305140504214" LOG_CI_START="-0.14121962774351535" LOG_EFFECT_SIZE="0.18470544315345302" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="633" SE="0.3829" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.2710741418693368"/>
<IV_DATA CI_END="5.640190517322974" CI_START="0.7818300850376578" EFFECT_SIZE="2.09992157753265" ESTIMABLE="YES" ESTIMATE="0.7419" LOG_CI_END="0.7512937740586314" LOG_CI_START="-0.10688762181058636" LOG_EFFECT_SIZE="0.32220307612402255" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="719" SE="0.5041" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.9562656275442727"/>
<IV_DATA CI_END="1.0658434881127075" CI_START="0.7600534697012935" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.027693436173301087" LOG_CI_START="-0.11915585406212588" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="253" SE="0.08626" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.177582521899936"/>
<IV_DATA CI_END="1.457807727818968" CI_START="0.2000288343718837" EFFECT_SIZE="0.5400033152990382" ESTIMABLE="YES" ESTIMATE="-0.61618" LOG_CI_END="0.1637002480878219" LOG_CI_START="-0.6989073958061133" LOG_EFFECT_SIZE="-0.2676035738591457" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="720" SE="0.5067" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.9372300673355898"/>
<IV_DATA CI_END="2.3261949529116075" CI_START="0.7719512603210511" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.3666461091137423" LOG_CI_START="-0.11241011940757864" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="634" SE="0.2814" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.654796966139685"/>
<IV_DATA CI_END="1.0913353331712123" CI_START="0.8800275873400117" EFFECT_SIZE="0.9800026531747605" ESTIMABLE="YES" ESTIMATE="-0.0202" LOG_CI_END="0.03795821618804986" LOG_CI_START="-0.0555037132569413" LOG_EFFECT_SIZE="-0.008772748534445691" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="748" SE="0.0549" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="31.992646855809006"/>
<IV_DATA CI_END="2.2397936725193235" CI_START="0.5905011173467205" EFFECT_SIZE="1.150043767101398" ESTIMABLE="YES" ESTIMATE="0.1398" LOG_CI_END="0.3502080134174472" LOG_CI_START="-0.2287792762772979" LOG_EFFECT_SIZE="0.060714368570074576" MODIFIED="2015-10-07 10:36:12 +0100" MODIFIED_BY="[Empty name]" ORDER="328" SE="0.3401" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.055685924499439"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="16.519139117976085" CI_END="1.092348464528174" CI_START="0.7728773380748843" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_SIZE="0.9188315261867772" ESTIMABLE="YES" I2="75.78566309398526" I2_Q="90.0504760098698" ID="CMP-001.07" LOG_CI_END="0.038361202545145724" LOG_CI_START="-0.11188942668231666" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.03676411206858549" MODIFIED="2017-03-10 15:51:13 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0023961063539769123" P_Q="0.0015228834015776904" P_Z="0.33748393388815534" Q="10.050732085193088" RANDOM="YES" SCALE="3.7031987720411483" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.06108088516130154" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="0.9591485366618573">
<NAME>Maternal anaemia (third trimester Hb &lt;110 g/L)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="6.479849352498454" CI_END="1.2399880573614648" CI_START="0.8537766922042631" DF="3" EFFECT_SIZE="1.0289183164794287" ESTIMABLE="YES" I2="53.702627379087424" ID="CMP-001.07.01" LOG_CI_END="0.09341750238240284" LOG_CI_START="-0.06865570545294598" LOG_EFFECT_SIZE="0.01238089846472848" MODIFIED="2017-03-10 15:51:13 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0904607407329101" P_Z="0.7645995034351616" STUDIES="4" TAU2="0.018995931084579067" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.29944634787221686">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="2.1455518682184316" CI_START="0.9800057886888996" EFFECT_SIZE="1.4500528441358083" ESTIMABLE="YES" ESTIMATE="0.3716" LOG_CI_END="0.33153901796389806" LOG_CI_START="-0.008771359013401333" LOG_EFFECT_SIZE="0.1613838294752484" MODIFIED="2016-08-08 16:55:06 +0100" MODIFIED_BY="[Empty name]" ORDER="317" SE="0.1999" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.37340554294005"/>
<IV_DATA CI_END="1.0525421352028739" CI_START="0.7051051634923997" EFFECT_SIZE="0.8614829622951703" ESTIMABLE="YES" ESTIMATE="-0.1491" LOG_CI_END="0.02223949046478338" LOG_CI_START="-0.1517461049683331" LOG_EFFECT_SIZE="-0.06475330725177489" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="335" SE="0.1022" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="30.785660771421114"/>
<IV_DATA CI_END="1.4415852284860429" CI_START="0.8701032804584216" EFFECT_SIZE="1.1199678729169462" ESTIMABLE="YES" ESTIMATE="0.1133" LOG_CI_END="0.15884032356571187" LOG_CI_START="-0.06042919396643501" LOG_EFFECT_SIZE="0.04920556479963841" MODIFIED="2015-10-07 11:33:50 +0100" MODIFIED_BY="[Empty name]" ORDER="336" SE="0.1288" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.469836728826003">
<FOOTNOTE>Control group received iron only</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.199906817194163" CI_START="0.7680934285768597" EFFECT_SIZE="0.9600211149716509" ESTIMABLE="YES" ESTIMATE="-0.0408" LOG_CI_END="0.07914752075619792" LOG_CI_START="-0.11458595047950325" LOG_EFFECT_SIZE="-0.017719214861652687" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="329" SE="0.1138" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="28.37109695681284"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="0.7296980372346311" CI_START="0.28999966187205484" DF="0" EFFECT_SIZE="0.4600132433601723" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="-0.13685682192509793" LOG_CI_START="-0.537602508470652" LOG_EFFECT_SIZE="-0.337229665197875" MODIFIED="2015-10-07 11:32:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="9.715420836650409E-4" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="3.2986406117247236">
<NAME>MMN with iron and folic acid vs placebo</NAME>
<IV_DATA CI_END="0.7296980372346311" CI_START="0.28999966187205484" EFFECT_SIZE="0.4600132433601723" ESTIMABLE="YES" ESTIMATE="-0.7765" LOG_CI_END="-0.13685682192509793" LOG_CI_START="-0.537602508470652" LOG_EFFECT_SIZE="-0.337229665197875" MODIFIED="2015-10-07 11:32:17 +0100" MODIFIED_BY="[Empty name]" ORDER="487" SE="0.2354" STUDY_ID="STD-Brough-2010" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0">
<FOOTNOTE>Control group advised to take folic acid</FOOTNOTE>
</IV_DATA>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="3.087957189287323" CI_END="1.026665051834356" CI_START="0.8004503811035433" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_SIZE="0.9065287816757388" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.011428778683398807" LOG_CI_START="-0.09666558427037737" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.04261840279348929" MODIFIED="2017-03-10 15:51:24 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.8767479825116159" P_Q="1.0" P_Z="0.12222261608086493" Q="0.0" RANDOM="YES" SCALE="2.8159736770166806" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.5455113897027177">
<NAME>Miscarriage (loss before 28 weeks)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="3.087957189287323" CI_END="1.026665051834356" CI_START="0.8004503811035433" DF="7" EFFECT_SIZE="0.9065287816757388" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" LOG_CI_END="0.011428778683398807" LOG_CI_START="-0.09666558427037737" LOG_EFFECT_SIZE="-0.04261840279348929" MODIFIED="2017-03-10 15:51:24 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8767479825116159" P_Z="0.12222261608086493" STUDIES="8" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.5455113897027177">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.3956870047295575" CI_START="0.7899490963830813" EFFECT_SIZE="1.050010327672887" ESTIMABLE="YES" ESTIMATE="0.0488" LOG_CI_END="0.14478803479167573" LOG_CI_START="-0.1024008933579184" LOG_EFFECT_SIZE="0.02119357071687869" MODIFIED="2016-03-05 19:56:49 +0000" MODIFIED_BY="[Empty name]" ORDER="342" SE="0.1452" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="19.122649463665795"/>
<IV_DATA CI_END="1.963413353352378" CI_START="0.4500374554311303" EFFECT_SIZE="0.9400050795087264" ESTIMABLE="YES" ESTIMATE="-0.06187" LOG_CI_END="0.29301174034478866" LOG_CI_START="-0.3467513395354971" LOG_EFFECT_SIZE="-0.026869799595354175" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="334" SE="0.3758" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.854747789059015"/>
<IV_DATA CI_END="1.8806451099278567" CI_START="0.45005977956621307" EFFECT_SIZE="0.9200014802251177" ESTIMABLE="YES" ESTIMATE="-0.08338" LOG_CI_END="0.27430684906368635" LOG_CI_START="-0.34672979686587263" LOG_EFFECT_SIZE="-0.03621147390109315" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="712" SE="0.3648" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.02950474806885"/>
<IV_DATA CI_END="1.1154833971649707" CI_START="0.7101437596808633" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.04746311063662253" LOG_CI_START="-0.14865372492008025" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="325" SE="0.1152" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="30.37920039035708"/>
<IV_DATA CI_END="1.412586079981729" CI_START="0.23001238498183257" EFFECT_SIZE="0.5700107834495196" ESTIMABLE="YES" ESTIMATE="-0.5621" LOG_CI_END="0.15001492227695692" LOG_CI_START="-0.6382487788325927" LOG_EFFECT_SIZE="-0.2441169282778179" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="722" SE="0.46303" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.8804553960933303"/>
<IV_DATA CI_END="1.1342412910207975" CI_START="0.47285619634798665" EFFECT_SIZE="0.7323476105053693" ESTIMABLE="YES" ESTIMATE="-0.3115" LOG_CI_END="0.054705453332692874" LOG_CI_START="-0.3252709155584188" LOG_EFFECT_SIZE="-0.13528273111286293" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="558" SE="0.2232" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.092690218451"/>
<IV_DATA CI_END="1.3961648956331474" CI_START="0.6600965825667234" EFFECT_SIZE="0.9600019147413544" ESTIMABLE="YES" ESTIMATE="-0.04082" LOG_CI_END="0.14493671415706824" LOG_CI_START="-0.18039251565964973" LOG_EFFECT_SIZE="-0.017727900751290732" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="713" SE="0.1911" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.03976738676561"/>
<IV_DATA CI_END="1.1498911581158617" CI_START="0.6888943948593241" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.06065673455645282" LOG_CI_START="-0.1618473488399105" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="325" SE="0.1307" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="23.60098460753932"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.9600388238339785" CI_END="1.4757856220982077" CI_START="0.6322886122505653" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="0.9659826307837077" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.16902327489778793" LOG_CI_START="-0.1990846399189925" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.015030682510602298" MODIFIED="2017-03-10 15:51:35 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.6187714258332966" P_Q="1.0" P_Z="0.8728341528532676" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.16005956513322786">
<NAME>Maternal mortality</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.9600388238339785" CI_END="1.4757856220982077" CI_START="0.6322886122505653" DF="2" EFFECT_SIZE="0.9659826307837077" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.16902327489778793" LOG_CI_START="-0.1990846399189925" LOG_EFFECT_SIZE="-0.015030682510602298" MODIFIED="2017-03-10 15:51:35 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6187714258332966" P_Z="0.8728341528532676" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.16005956513322786">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.8445772074843896" CI_START="0.17001814787947883" EFFECT_SIZE="0.560010357437429" ESTIMABLE="YES" ESTIMATE="-0.5798" LOG_CI_END="0.26589683797577" LOG_CI_START="-0.7695047191907808" LOG_EFFECT_SIZE="-0.25180394060750544" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="715" SE="0.6082" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.639581173099915"/>
<IV_DATA CI_END="1.6573720724073067" CI_START="0.6400984674656505" EFFECT_SIZE="1.029990933731111" ESTIMABLE="YES" ESTIMATE="0.02955" LOG_CI_END="0.21942001647848663" LOG_CI_START="-0.19375321259800446" LOG_EFFECT_SIZE="0.012833401940241088" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="326" SE="0.2427" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="79.37540647555258"/>
<IV_DATA CI_END="5.421456145880456" CI_START="0.2700456011841356" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.7341159491187675" LOG_CI_START="-0.5685628926172479" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="714" SE="0.7652" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.985012351347507"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="2.5398872582188865" CI_START="0.6654314221811357" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="1.30004645702234" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.4048144393679296" LOG_CI_START="-0.17689669526510293" LOG_DATA="YES" LOG_EFFECT_SIZE="0.11395887205141332" MODIFIED="2017-01-24 10:42:42 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.4425317024767108" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.7679250804799532">
<NAME>Very preterm birth (before 34 weeks of gestation)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="2.5398872582188865" CI_START="0.6654314221811357" DF="0" EFFECT_SIZE="1.30004645702234" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.4048144393679296" LOG_CI_START="-0.17689669526510293" LOG_EFFECT_SIZE="0.11395887205141332" MODIFIED="2015-10-07 11:22:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4425317024767108" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.7679250804799532">
<NAME>MMN with iron and FA vs iron with or without folic acid</NAME>
<IV_DATA CI_END="2.5398872582188865" CI_START="0.6654314221811357" EFFECT_SIZE="1.30004645702234" ESTIMABLE="YES" ESTIMATE="0.2624" LOG_CI_END="0.4048144393679296" LOG_CI_START="-0.17689669526510293" LOG_EFFECT_SIZE="0.11395887205141332" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="330" SE="0.3417" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="6.999215421792517" CI_START="0.14003007469789358" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.9900003324950223" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.8450493604309771" LOG_CI_START="-0.8537786795172323" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.004364659543127671" MODIFIED="2017-03-10 15:51:45 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.9919645212097628" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.010071149413768915">
<NAME>Congenital anomalies</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.0" CI_END="6.999215421792517" CI_START="0.14003007469789358" DF="0" EFFECT_SIZE="0.9900003324950223" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.8450493604309771" LOG_CI_START="-0.8537786795172323" LOG_EFFECT_SIZE="-0.004364659543127671" MODIFIED="2017-03-10 15:51:45 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9919645212097628" STUDIES="1" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.010071149413768915">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="6.999215421792517" CI_START="0.14003007469789358" EFFECT_SIZE="0.9900003324950223" ESTIMABLE="YES" ESTIMATE="-0.01005" LOG_CI_END="0.8450493604309771" LOG_CI_START="-0.8537786795172323" LOG_EFFECT_SIZE="-0.004364659543127671" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="337" SE="0.9979" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="0.14538298796028704" CI_END="2.35446618926387" CI_START="-1.8646612352420162" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2449024770109268" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2017-01-24 10:43:19 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.9858835245962707" P_Q="0.9858835245962707" P_Z="0.8200075891196609" Q="0.14538298796028704" RANDOM="YES" SCALE="0.7" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1430" TOTAL_2="1598" UNITS="" WEIGHT="400.0" Z="0.22753521587335293">
<NAME>Neurodevelopmental outcome: BSID scores</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.73654020947602" CI_START="-6.776540209476041" DF="0" EFFECT_SIZE="-0.020000000000010232" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9953709556021343" STUDIES="1" TAU2="0.0" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.00000000000001" Z="0.005801679332248219">
<NAME>Mental development scores at 6 months of age: new subgroup</NAME>
<CONT_DATA CI_END="6.73654020947602" CI_START="-6.776540209476041" EFFECT_SIZE="-0.020000000000010232" ESTIMABLE="YES" MEAN_1="67.6" MEAN_2="67.62" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1477" SD_1="46.14" SD_2="49.5" SE="3.4472777371271905" STUDY_ID="STD-Zeng-2008" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.48215602478623" CI_START="-5.062156024786214" DF="0" EFFECT_SIZE="1.210000000000008" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.02" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7053498866193042" STUDIES="1" TAU2="0.0" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.00000000000001" Z="0.37810864588214904">
<NAME>Mental development scores at 12 months of age</NAME>
<CONT_DATA CI_END="7.48215602478623" CI_START="-5.062156024786214" EFFECT_SIZE="1.210000000000008" ESTIMABLE="YES" MEAN_1="103.65" MEAN_2="102.44" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1478" SD_1="42.06" SD_2="45.21" SE="3.2001384077769734" STUDY_ID="STD-Zeng-2008" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.5877653387217547" CI_START="-3.907765338721755" DF="0" EFFECT_SIZE="-0.16000000000000014" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.03" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.933314840303711" STUDIES="1" TAU2="0.0" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.0" Z="0.08367499274470747">
<NAME>Psychomotor development scores ar 6 months of age</NAME>
<CONT_DATA CI_END="3.5877653387217547" CI_START="-3.907765338721755" EFFECT_SIZE="-0.16000000000000014" ESTIMABLE="YES" MEAN_1="28.16" MEAN_2="28.32" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1479" SD_1="25.6" SD_2="27.45" SE="1.912160309211623" STUDY_ID="STD-Zeng-2008" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.408795627662089" CI_START="-2.728795627662082" DF="0" EFFECT_SIZE="0.3400000000000034" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.04" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.8280917580068696" STUDIES="1" TAU2="0.0" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.0" Z="0.2171496038174762">
<NAME>Psychomotor development scores at 12 months of age</NAME>
<CONT_DATA CI_END="3.408795627662089" CI_START="-2.728795627662082" EFFECT_SIZE="0.3400000000000034" ESTIMABLE="YES" MEAN_1="45.64" MEAN_2="45.3" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1480" SD_1="20.55" SD_2="22.15" SE="1.5657408257847358" STUDY_ID="STD-Zeng-2008" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="0.7593017471803691" CI_END="1.4646816751021197" CI_START="0.743620477659966" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="1.0436317774288195" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.16574324805643403" LOG_CI_START="-0.12864865922790528" LOG_DATA="YES" LOG_EFFECT_SIZE="0.01854729441426434" MODIFIED="2017-03-10 15:51:58 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.8591746902989474" P_Q="1.0" P_Z="0.80493646612451" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.24696350791673355">
<NAME>Mode of delivery: caesarean section</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.7593017471803691" CI_END="1.4646816751021197" CI_START="0.743620477659966" DF="3" EFFECT_SIZE="1.0436317774288195" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.01" LOG_CI_END="0.16574324805643403" LOG_CI_START="-0.12864865922790528" LOG_EFFECT_SIZE="0.01854729441426434" MODIFIED="2017-03-10 15:51:58 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8591746902989474" P_Z="0.80493646612451" STUDIES="4" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.24696350791673355">
<NAME>MMN with iron and folic acid vs iron with or without folic acid</NAME>
<IV_DATA CI_END="1.9258861973909778" CI_START="0.4299930539255249" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.2846306206362058" LOG_CI_START="-0.36653855992315904" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2016-03-05 19:57:34 +0000" MODIFIED_BY="[Empty name]" ORDER="1296" SE="0.3825" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.439207823976798"/>
<IV_DATA CI_END="2.2479537673372394" CI_START="0.4099908790753821" EFFECT_SIZE="0.9600211149716509" ESTIMABLE="YES" ESTIMATE="-0.0408" LOG_CI_END="0.3517873750479163" LOG_CI_START="-0.38722580477122165" LOG_EFFECT_SIZE="-0.017719214861652687" MODIFIED="2015-10-07 11:31:05 +0100" MODIFIED_BY="[Empty name]" ORDER="1297" SE="0.4341" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.868919857948976">
<FOOTNOTE>Iron and folic acid provided as separate supplements</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.6592072693808446" CI_START="0.6900853870218864" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.21990064179633492" LOG_CI_START="-0.16109716894663462" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1299" SE="0.2238" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="59.70445992361815"/>
<IV_DATA CI_END="11.027904249255787" CI_START="0.3700086813127498" EFFECT_SIZE="2.020005026951766" ESTIMABLE="YES" ESTIMATE="0.7031" LOG_CI_END="1.0424929866502415" LOG_CI_START="-0.43178808619788894" LOG_EFFECT_SIZE="0.30535245022617635" MODIFIED="2015-10-07 10:06:07 +0100" MODIFIED_BY="[Empty name]" ORDER="1300" SE="0.866" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.9874123944560824"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="4.002812138890862E-33" CI_END="3.7403246034834092" CI_START="0.12001093683812086" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.669984969788664" ESTIMABLE="YES" I2="99.99999999999999" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.5729092940144621" LOG_CI_START="-0.9207791740189669" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.17393494000225238" MODIFIED="2017-01-24 10:43:30 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="1.0" P_Z="0.6480575943056792" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.45646227490312297">
<NAME>Pre-eclampsia</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours none, placebo,&lt; 2</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="3.7403246034834092" CI_START="0.12001093683812086" EFFECT_SIZE="0.669984969788664" ESTIMABLE="YES" ESTIMATE="-0.4005" LOG_CI_END="0.5729092940144621" LOG_CI_START="-0.9207791740189669" LOG_EFFECT_SIZE="-0.17393494000225238" MODIFIED="2015-10-07 11:09:30 +0100" MODIFIED_BY="[Empty name]" ORDER="1104" SE="0.8774" STUDY_ID="STD-Theobald-1937" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-03-10 15:40:37 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Subgroup analysis for primary outcomes (MMN with iron and folic acid vs iron with or without folic acid))</NAME>
<IV_OUTCOME CHI2="29.033690911423815" CI_END="0.9726677729741693" CI_START="0.9020366390935624" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_SIZE="0.9366866972943727" ESTIMABLE="YES" I2="51.780157601349075" I2_Q="95.55810224272166" ID="CMP-002.01" LOG_CI_END="-0.012035473197558171" LOG_CI_START="-0.044775821844987074" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.028405647521272618" MODIFIED="2016-08-08 17:39:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.010341237452898167" P_Q="2.0874181957397653E-6" P_Z="6.715358382912674E-4" Q="22.51289999553532" RANDOM="YES" SCALE="1.66" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.007017795742971192" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="3.400943997192641">
<NAME>Preterm births: mean maternal BMI</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="0.7833597578182171" CI_END="0.8970627544485834" CI_START="0.8027414308537042" DF="3" EFFECT_SIZE="0.8485926225649272" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="-0.0471771746176333" LOG_CI_START="-0.09542432176621134" LOG_EFFECT_SIZE="-0.07130074819192232" MODIFIED="2016-08-08 16:42:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8534429235724141" P_Z="6.915655303289859E-9" STUDIES="4" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="5.792960072709536">
<NAME>BMI &lt; 20 kg/m<SUP>2</SUP>
</NAME>
<IV_DATA CI_END="1.0367769107215787" CI_START="0.7299955968163363" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.015685316788606636" LOG_CI_START="-0.13667975944685257" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2016-08-08 16:42:44 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.0895" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.027032224303687"/>
<IV_DATA CI_END="1.2613885967721832" CI_START="0.6001274827586837" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.10084890055828255" LOG_CI_START="-0.22175648432014786" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SE="0.1895" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.2366604207636707"/>
<IV_DATA CI_END="1.0045232313230552" CI_START="0.5600590623927655" EFFECT_SIZE="0.7500615568648625" ESTIMABLE="YES" ESTIMATE="-0.2876" LOG_CI_END="0.001959985005366867" LOG_CI_START="-0.25176617099611737" LOG_EFFECT_SIZE="-0.12490309299537523" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="241" SE="0.14904" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.615869912165386"/>
<IV_DATA CI_END="0.9030863423844057" CI_START="0.8000645339562924" EFFECT_SIZE="0.8500160902253981" ESTIMABLE="YES" ESTIMATE="-0.1625" LOG_CI_END="-0.044270725623939355" LOG_CI_START="-0.09687498099461747" LOG_EFFECT_SIZE="-0.07057285330927841" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2213" SE="0.0309" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="84.12043744276725"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="5.737431158070274" CI_END="1.0727398757105937" CI_START="0.9680997066966752" DF="10" EFFECT_SIZE="1.0190776020682888" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.030494424445659477" LOG_CI_START="-0.014079911453784897" LOG_EFFECT_SIZE="0.008207256495937282" MODIFIED="2016-03-05 20:00:49 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8368196559956135" P_Z="0.47044368462176045" STUDIES="11" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.721757343966175">
<NAME>BMI &#8805; 20 kg/m<SUP>2</SUP>
</NAME>
<IV_DATA CI_END="1.3963519826118425" CI_START="0.8199900203518332" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.1449949059934276" LOG_CI_START="-0.0861914331437273" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2016-03-05 20:00:49 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.1358" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.717452492010442"/>
<IV_DATA CI_END="1.1200105447124213" CI_START="0.9107943936862798" EFFECT_SIZE="1.0099996658383554" ESTIMABLE="YES" ESTIMATE="0.00995" LOG_CI_END="0.049222111499521" LOG_CI_START="-0.04057965130964631" LOG_EFFECT_SIZE="0.00432123009493732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SE="0.05275" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="24.637692980754053"/>
<IV_DATA CI_END="1.1346285718957718" CI_START="0.5500724138127263" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.05485371564718746" LOG_CI_START="-0.2595801344163803" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SE="0.1847" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.009607190892662"/>
<IV_DATA CI_END="1.5712331675612452" CI_START="0.7151515733214218" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.1962406381725027" LOG_CI_START="-0.14560190158258352" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="504" SE="0.2008" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.7002686607841404"/>
<IV_DATA CI_END="1.061574484908792" CI_START="0.7800843928538019" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.025950471653210985" LOG_CI_START="-0.10785841094016435" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="641" SE="0.0786" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.096854070722285"/>
<IV_DATA CI_END="1.9991571724579433" CI_START="0.6500372058449148" EFFECT_SIZE="1.1399677813119904" ESTIMABLE="YES" ESTIMATE="0.131" LOG_CI_END="0.30084693941470375" LOG_CI_START="-0.18706178515605174" LOG_EFFECT_SIZE="0.05689257712932602" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="139" SE="0.2866" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.8346273169074615"/>
<IV_DATA CI_END="1.4421034736707823" CI_START="0.7500144594720254" EFFECT_SIZE="1.039999258320852" ESTIMABLE="YES" ESTIMATE="0.03922" LOG_CI_END="0.1589964229576192" LOG_CI_START="-0.12493036379712817" LOG_EFFECT_SIZE="0.017033029580245544" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="704" SE="0.16678" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.464660063346376"/>
<IV_DATA CI_END="1.1925406226853048" CI_START="0.96013055560486" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.0764731817646317" LOG_CI_START="-0.01766970891493137" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="586" SE="0.0553" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.417888477696682"/>
<IV_DATA CI_END="1.482389053805783" CI_START="0.8613494325694755" EFFECT_SIZE="1.1299800751972633" ESTIMABLE="YES" ESTIMATE="0.1222" LOG_CI_END="0.17096219942383498" LOG_CI_START="-0.06482062804668016" LOG_EFFECT_SIZE="0.05307078568857741" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="533" SE="0.1385" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.5739248823656995"/>
<IV_DATA CI_END="1.1308555884511713" CI_START="0.9200102164661593" EFFECT_SIZE="1.0199993601580974" ESTIMABLE="YES" ESTIMATE="0.019802" LOG_CI_END="0.05340714856547824" LOG_CI_START="-0.03620734990418184" LOG_EFFECT_SIZE="0.008599899330648222" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="706" SE="0.05264" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="24.74076964783715"/>
<IV_DATA CI_END="1.439998930362207" CI_START="0.780326879516213" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.15836216949944154" LOG_CI_START="-0.10772343290952241" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="322" SE="0.1563" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.8062542166830386"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="29.03369091142381" CI_END="1.0367536920750076" CI_START="0.9304183261935083" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_SIZE="0.9821479699390354" ESTIMABLE="YES" I2="51.780157601349075" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.01567559064319075" LOG_CI_START="-0.03132174401656882" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.007823076686689039" MODIFIED="2017-01-24 10:59:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.010341237452898056" P_Q="0.428083553501869" P_Z="0.51407680737564" Q="0.62801779101586" RANDOM="YES" SCALE="2.1052342742413432" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0070177957429711875" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="0.6525028989498822">
<NAME>Preterm births: mean maternal height</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="19.854516880551856" CI_END="1.0566069061522847" CI_START="0.8422898213297194" DF="7" EFFECT_SIZE="0.9433818114627585" ESTIMABLE="YES" I2="64.74353900367765" ID="CMP-002.02.01" LOG_CI_END="0.02391344497861924" LOG_CI_START="-0.07453844751818067" LOG_EFFECT_SIZE="-0.025312501269780702" MODIFIED="2016-08-08 16:43:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.005892657249937372" P_Z="0.3135340909442741" STUDIES="8" TAU2="0.013332187373883926" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.0078341734062075">
<NAME>Maternal height &lt; 154.9 cm</NAME>
<IV_DATA CI_END="1.3963519826118425" CI_START="0.8199900203518332" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.1449949059934276" LOG_CI_START="-0.0861914331437273" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2016-03-05 20:01:34 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.1358" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.525768399739015"/>
<IV_DATA CI_END="1.0367769107215787" CI_START="0.7299955968163363" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.015685316788606636" LOG_CI_START="-0.13667975944685257" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2016-08-08 16:43:08 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.0895" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.670372706354454"/>
<IV_DATA CI_END="1.2613885967721832" CI_START="0.6001274827586837" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.10084890055828255" LOG_CI_START="-0.22175648432014786" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SE="0.1895" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.791782981241393"/>
<IV_DATA CI_END="1.9991571724579433" CI_START="0.6500372058449148" EFFECT_SIZE="1.1399677813119904" ESTIMABLE="YES" ESTIMATE="0.131" LOG_CI_END="0.30084693941470375" LOG_CI_START="-0.18706178515605174" LOG_EFFECT_SIZE="0.05689257712932602" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="139" SE="0.2866" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.503067214230921"/>
<IV_DATA CI_END="1.1925406226853048" CI_START="0.96013055560486" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.0764731817646317" LOG_CI_START="-0.01766970891493137" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="586" SE="0.0553" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.405020640083187"/>
<IV_DATA CI_END="1.482389053805783" CI_START="0.8613494325694755" EFFECT_SIZE="1.1299800751972633" ESTIMABLE="YES" ESTIMATE="0.1222" LOG_CI_END="0.17096219942383498" LOG_CI_START="-0.06482062804668016" LOG_EFFECT_SIZE="0.05307078568857741" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="533" SE="0.1385" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.286013694932336"/>
<IV_DATA CI_END="1.0045232313230552" CI_START="0.5600590623927655" EFFECT_SIZE="0.7500615568648625" ESTIMABLE="YES" ESTIMATE="-0.2876" LOG_CI_END="0.001959985005366867" LOG_CI_START="-0.25176617099611737" LOG_EFFECT_SIZE="-0.12490309299537523" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="241" SE="0.14904" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.40900050008332"/>
<IV_DATA CI_END="0.9030863423844057" CI_START="0.8000645339562924" EFFECT_SIZE="0.8500160902253981" ESTIMABLE="YES" ESTIMATE="-0.1625" LOG_CI_END="-0.044270725623939355" LOG_CI_START="-0.09687498099461747" LOG_EFFECT_SIZE="-0.07057285330927841" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2213" SE="0.0309" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="23.408973863335373"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="3.485647952297946" CI_END="1.0570144088838571" CI_START="0.9345363431628324" DF="6" EFFECT_SIZE="0.9938905273463183" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.024080907511870787" LOG_CI_START="-0.029403804688397584" LOG_EFFECT_SIZE="-0.002661448588263396" MODIFIED="2015-10-08 11:53:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7458782280313943" P_Z="0.8453465795927175" STUDIES="7" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.1950592296418882">
<NAME>Maternal height &#8805; 154.9 cm</NAME>
<IV_DATA CI_END="1.1200105447124213" CI_START="0.9107943936862798" EFFECT_SIZE="1.0099996658383554" ESTIMABLE="YES" ESTIMATE="0.00995" LOG_CI_END="0.049222111499521" LOG_CI_START="-0.04057965130964631" LOG_EFFECT_SIZE="0.00432123009493732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SE="0.05275" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="35.47232072868018"/>
<IV_DATA CI_END="1.1346285718957718" CI_START="0.5500724138127263" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.05485371564718746" LOG_CI_START="-0.2595801344163803" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SE="0.1847" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.893348450672381"/>
<IV_DATA CI_END="1.5712331675612452" CI_START="0.7151515733214218" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.1962406381725027" LOG_CI_START="-0.14560190158258352" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="504" SE="0.2008" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.44797576247793"/>
<IV_DATA CI_END="1.061574484908792" CI_START="0.7800843928538019" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.025950471653210985" LOG_CI_START="-0.10785841094016435" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="641" SE="0.0786" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.97678674636905"/>
<IV_DATA CI_END="1.4421034736707823" CI_START="0.7500144594720254" EFFECT_SIZE="1.039999258320852" ESTIMABLE="YES" ESTIMATE="0.03922" LOG_CI_END="0.1589964229576192" LOG_CI_START="-0.12493036379712817" LOG_EFFECT_SIZE="0.017033029580245544" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="704" SE="0.16678" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.548514559479509"/>
<IV_DATA CI_END="1.1308555884511713" CI_START="0.9200102164661593" EFFECT_SIZE="1.0199993601580974" ESTIMABLE="YES" ESTIMATE="0.019802" LOG_CI_END="0.05340714856547824" LOG_CI_START="-0.03620734990418184" LOG_EFFECT_SIZE="0.008599899330648222" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="706" SE="0.05264" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="35.62072620630632"/>
<IV_DATA CI_END="1.439998930362207" CI_START="0.780326879516213" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.15836216949944154" LOG_CI_START="-0.10772343290952241" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="322" SE="0.1563" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.04032754601463"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="29.033690911423818" CI_END="1.0383334197379281" CI_START="0.9342718347075593" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_SIZE="0.9849292711137833" ESTIMABLE="YES" I2="51.78015760134909" I2_Q="65.4702735586727" ID="CMP-002.03" LOG_CI_END="0.016336832415208655" LOG_CI_START="-0.02952674353752001" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.0065949555611556744" MODIFIED="2016-08-08 16:43:23 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.010341237452898278" P_Q="0.0887967424499202" P_Z="0.5729812798323131" Q="2.8960553791215053" RANDOM="YES" SCALE="1.8079929395851924" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.007017795742971191" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="0.5636662694086426">
<NAME>Preterm births: timing of supplementation</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="17.566750250901862" CI_END="1.0131183787052407" CI_START="0.8674112079098951" DF="10" EFFECT_SIZE="0.9374381241598976" ESTIMABLE="YES" I2="43.074274654262766" ID="CMP-002.03.01" LOG_CI_END="0.005660193844731998" LOG_CI_START="-0.061774970587102365" LOG_EFFECT_SIZE="-0.028057388371185144" MODIFIED="2016-08-08 16:43:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06272683055805595" P_Z="0.10290224713348296" STUDIES="11" TAU2="0.005771953458212004" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.6309434749985077">
<NAME>Supplementation started before 20 weeks</NAME>
<IV_DATA CI_END="1.3963519826118425" CI_START="0.8199900203518332" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.1449949059934276" LOG_CI_START="-0.0861914331437273" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2016-03-05 20:02:06 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.1358" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.480205810737963"/>
<IV_DATA CI_END="1.0367769107215787" CI_START="0.7299955968163363" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.015685316788606636" LOG_CI_START="-0.13667975944685257" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2016-08-08 16:43:23 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.0895" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.384904416953685"/>
<IV_DATA CI_END="1.061574484908792" CI_START="0.7800843928538019" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.025950471653210985" LOG_CI_START="-0.10785841094016435" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="641" SE="0.0786" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="13.130561118743831"/>
<IV_DATA CI_END="1.2613885967721832" CI_START="0.6001274827586837" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.10084890055828255" LOG_CI_START="-0.22175648432014786" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SE="0.1895" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.7644139706783855"/>
<IV_DATA CI_END="1.9991571724579433" CI_START="0.6500372058449148" EFFECT_SIZE="1.1399677813119904" ESTIMABLE="YES" ESTIMATE="0.131" LOG_CI_END="0.30084693941470375" LOG_CI_START="-0.18706178515605174" LOG_EFFECT_SIZE="0.05689257712932602" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="139" SE="0.2866" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.7848523231412408"/>
<IV_DATA CI_END="1.4421034736707823" CI_START="0.7500144594720254" EFFECT_SIZE="1.039999258320852" ESTIMABLE="YES" ESTIMATE="0.03922" LOG_CI_END="0.1589964229576192" LOG_CI_START="-0.12493036379712817" LOG_EFFECT_SIZE="0.017033029580245544" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="704" SE="0.16678" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.6716476937219635"/>
<IV_DATA CI_END="1.482389053805783" CI_START="0.8613494325694755" EFFECT_SIZE="1.1299800751972633" ESTIMABLE="YES" ESTIMATE="0.1222" LOG_CI_END="0.17096219942383498" LOG_CI_START="-0.06482062804668016" LOG_EFFECT_SIZE="0.05307078568857741" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="533" SE="0.1385" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.2878812897999365"/>
<IV_DATA CI_END="1.0045232313230552" CI_START="0.5600590623927655" EFFECT_SIZE="0.7500615568648625" ESTIMABLE="YES" ESTIMATE="-0.2876" LOG_CI_END="0.001959985005366867" LOG_CI_START="-0.25176617099611737" LOG_EFFECT_SIZE="-0.12490309299537523" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="241" SE="0.14904" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.606924050951162"/>
<IV_DATA CI_END="0.9030863423844057" CI_START="0.8000645339562924" EFFECT_SIZE="0.8500160902253981" ESTIMABLE="YES" ESTIMATE="-0.1625" LOG_CI_END="-0.044270725623939355" LOG_CI_START="-0.09687498099461747" LOG_EFFECT_SIZE="-0.07057285330927841" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2213" SE="0.0309" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="23.32608690665319"/>
<IV_DATA CI_END="1.1308555884511713" CI_START="0.9200102164661593" EFFECT_SIZE="1.0199993601580974" ESTIMABLE="YES" ESTIMATE="0.019802" LOG_CI_END="0.05340714856547824" LOG_CI_START="-0.03620734990418184" LOG_EFFECT_SIZE="0.008599899330648222" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="706" SE="0.05264" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.36714060955063"/>
<IV_DATA CI_END="1.439998930362207" CI_START="0.780326879516213" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.15836216949944154" LOG_CI_START="-0.10772343290952241" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="322" SE="0.1563" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.1953818090679995"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="2.6933114414923494" CI_END="1.1044779796439166" CI_START="0.9563051329550867" DF="3" EFFECT_SIZE="1.0277246524090689" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.043157061615810885" LOG_CI_START="-0.019403513147666324" LOG_EFFECT_SIZE="0.011876774234072327" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.44136520699248805" P_Z="0.4567698062639002" STUDIES="4" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.7441763391497701">
<NAME>Supplementation after 20 weeks</NAME>
<IV_DATA CI_END="1.1200105447124213" CI_START="0.9107943936862798" EFFECT_SIZE="1.0099996658383554" ESTIMABLE="YES" ESTIMATE="0.00995" LOG_CI_END="0.049222111499521" LOG_CI_START="-0.04057965130964631" LOG_EFFECT_SIZE="0.00432123009493732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SE="0.05275" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="48.53239640931772"/>
<IV_DATA CI_END="1.1346285718957718" CI_START="0.5500724138127263" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.05485371564718746" LOG_CI_START="-0.2595801344163803" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SE="0.1847" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.9586114207854335"/>
<IV_DATA CI_END="1.5712331675612452" CI_START="0.7151515733214218" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.1962406381725027" LOG_CI_START="-0.14560190158258352" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="504" SE="0.2008" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.3492629651638"/>
<IV_DATA CI_END="1.1925406226853048" CI_START="0.96013055560486" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.0764731817646317" LOG_CI_START="-0.01766970891493137" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="586" SE="0.0553" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="44.15972920473306"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="29.033690911423815" CI_END="1.039140760421569" CI_START="0.9081808351902622" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_SIZE="0.9714564960305245" ESTIMABLE="YES" I2="51.780157601349075" I2_Q="0.5308204479457826" ID="CMP-002.04" LOG_CI_END="0.01667438040971131" LOG_CI_START="-0.04182766700115518" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.012576643295721964" MODIFIED="2017-03-10 15:39:30 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.010341237452898167" P_Q="0.36592158679227604" P_Z="0.39939758988370133" Q="2.010673063763796" RANDOM="YES" SCALE="4.898596686484767" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.00701779574297119" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="300.0" Z="0.8426976147656537">
<NAME>Preterm births: dose of iron</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.2936492940352016" CI_END="1.192404810350425" CI_START="0.9238061829542847" DF="5" EFFECT_SIZE="1.0495479676442396" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.07642371937705718" LOG_CI_START="-0.03441913538462069" LOG_EFFECT_SIZE="0.02100229199621824" MODIFIED="2016-03-05 20:02:23 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9355838113704724" P_Z="0.4576388409346698" STUDIES="6" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.7427404498718002">
<NAME>MMN with 30 mg iron vs. supplement with 60 mg iron</NAME>
<IV_DATA CI_END="1.3963519826118425" CI_START="0.8199900203518332" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.1449949059934276" LOG_CI_START="-0.0861914331437273" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2016-03-05 20:02:23 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SE="0.1358" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.98746437470903"/>
<IV_DATA CI_END="1.5712331675612452" CI_START="0.7151515733214218" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.1962406381725027" LOG_CI_START="-0.14560190158258352" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="504" SE="0.2008" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.513884266499963"/>
<IV_DATA CI_END="1.2613885967721832" CI_START="0.6001274827586837" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.10084890055828255" LOG_CI_START="-0.22175648432014786" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SE="0.1895" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.805168232223645"/>
<IV_DATA CI_END="1.4421034736707823" CI_START="0.7500144594720254" EFFECT_SIZE="1.039999258320852" ESTIMABLE="YES" ESTIMATE="0.03922" LOG_CI_END="0.1589964229576192" LOG_CI_START="-0.12493036379712817" LOG_EFFECT_SIZE="0.017033029580245544" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="704" SE="0.16678" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.240621238256237"/>
<IV_DATA CI_END="1.482389053805783" CI_START="0.8613494325694755" EFFECT_SIZE="1.1299800751972633" ESTIMABLE="YES" ESTIMATE="0.1222" LOG_CI_END="0.17096219942383498" LOG_CI_START="-0.06482062804668016" LOG_EFFECT_SIZE="0.05307078568857741" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="533" SE="0.1385" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.099938355052664"/>
<IV_DATA CI_END="1.439998930362207" CI_START="0.780326879516213" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.15836216949944154" LOG_CI_START="-0.10772343290952241" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="322" SE="0.1563" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.35292353325847"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="3.59942672869327" CI_END="1.0601052046140633" CI_START="0.8536853607553274" DF="3" EFFECT_SIZE="0.9513129317104634" ESTIMABLE="YES" I2="16.65339438402417" ID="CMP-002.04.02" LOG_CI_END="0.025348966695111084" LOG_CI_START="-0.0687021659224669" LOG_EFFECT_SIZE="-0.02167659961367793" MODIFIED="2016-08-08 16:43:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.30809407992344295" P_Z="0.3662859202894604" STUDIES="4" TAU2="0.002412477096304881" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.9034522683071475">
<NAME>MMN with 60 mg iron vs. supplement with 60 mg iron</NAME>
<IV_DATA CI_END="1.0367769107215787" CI_START="0.7299955968163363" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.015685316788606636" LOG_CI_START="-0.13667975944685257" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2016-08-08 16:43:35 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.0895" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="29.28342680425034"/>
<IV_DATA CI_END="1.1200105447124213" CI_START="0.9107943936862798" EFFECT_SIZE="1.0099996658383554" ESTIMABLE="YES" ESTIMATE="0.00995" LOG_CI_END="0.049222111499521" LOG_CI_START="-0.04057965130964631" LOG_EFFECT_SIZE="0.00432123009493732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SE="0.05275" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="58.75088348554883"/>
<IV_DATA CI_END="1.1346285718957718" CI_START="0.5500724138127263" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.05485371564718746" LOG_CI_START="-0.2595801344163803" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SE="0.1847" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.355922559615431"/>
<IV_DATA CI_END="1.9991571724579433" CI_START="0.6500372058449148" EFFECT_SIZE="1.1399677813119904" ESTIMABLE="YES" ESTIMATE="0.131" LOG_CI_END="0.30084693941470375" LOG_CI_START="-0.18706178515605174" LOG_EFFECT_SIZE="0.05689257712932602" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="139" SE="0.2866" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.6097671505854136"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="19.73254238006389" CI_END="1.0484812137645643" CI_START="0.8306387813579607" DF="4" EFFECT_SIZE="0.9332251377230004" ESTIMABLE="YES" I2="79.72891722233793" ID="CMP-002.04.03" LOG_CI_END="0.020560653369338235" LOG_CI_START="-0.08058779615344634" LOG_EFFECT_SIZE="-0.030013571392054055" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="5.639162280789423E-4" P_Z="0.2447677910003342" STUDIES="5" TAU2="0.012680929306911295" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.1631521640397806">
<NAME>MMN with 30 mg iron vs. supplement with 30 mg iron</NAME>
<IV_DATA CI_END="1.061574484908792" CI_START="0.7800843928538019" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.025950471653210985" LOG_CI_START="-0.10785841094016435" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="641" SE="0.0786" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.718780537587214"/>
<IV_DATA CI_END="1.1925406226853048" CI_START="0.96013055560486" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.0764731817646317" LOG_CI_START="-0.01766970891493137" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="586" SE="0.0553" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.429314256175235"/>
<IV_DATA CI_END="1.0045232313230552" CI_START="0.5600590623927655" EFFECT_SIZE="0.7500615568648625" ESTIMABLE="YES" ESTIMATE="-0.2876" LOG_CI_END="0.001959985005366867" LOG_CI_START="-0.25176617099611737" LOG_EFFECT_SIZE="-0.12490309299537523" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="241" SE="0.14904" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.116837234746203"/>
<IV_DATA CI_END="0.9030863423844057" CI_START="0.8000645339562924" EFFECT_SIZE="0.8500160902253981" ESTIMABLE="YES" ESTIMATE="-0.1625" LOG_CI_END="-0.044270725623939355" LOG_CI_START="-0.09687498099461747" LOG_EFFECT_SIZE="-0.07057285330927841" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2213" SE="0.0309" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.88898204733178"/>
<IV_DATA CI_END="1.1308555884511713" CI_START="0.9200102164661593" EFFECT_SIZE="1.0199993601580974" ESTIMABLE="YES" ESTIMATE="0.019802" LOG_CI_END="0.05340714856547824" LOG_CI_START="-0.03620734990418184" LOG_EFFECT_SIZE="0.008599899330648222" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="706" SE="0.05264" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.84608592415957"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="25.132687847939167" CI_END="0.9836803745628457" CI_START="0.9039675732817516" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_SIZE="0.9429820576651817" ESTIMABLE="YES" I2="48.2745336326374" I2_Q="90.723908945329" ID="CMP-002.05" LOG_CI_END="-0.0071459931469934485" LOG_CI_START="-0.043847148061565276" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.02549657060427936" MODIFIED="2016-08-08 17:39:43 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.022174155218208536" P_Q="0.001025810654905146" P_Z="0.006465218421041876" Q="10.780403017890261" RANDOM="YES" SCALE="1.73" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.00462654760479139" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="2.723203682826294">
<NAME>Small-for-gestational age: mean maternal BMI</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="4.093049382089727" CI_END="1.0546375751598167" CI_START="0.9458595222911964" DF="3" EFFECT_SIZE="0.9987687385130803" ESTIMABLE="YES" I2="26.705013305548366" ID="CMP-002.05.01" LOG_CI_END="0.023103240534091657" LOG_CI_START="-0.024173359606665678" LOG_EFFECT_SIZE="-5.350595362870362E-4" MODIFIED="2016-08-08 16:45:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.25159029459068005" P_Z="0.9646139916194629" STUDIES="4" TAU2="0.0010122443784242466" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.04436433320437366">
<NAME>BMI &lt; 20 kg/m<SUP>2</SUP>
</NAME>
<IV_DATA CI_END="1.158454012644228" CI_START="0.9699736541732841" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.06387879820259258" LOG_CI_START="-0.013240061612673397" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2016-08-08 16:45:38 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.0453" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.16700437553597"/>
<IV_DATA CI_END="1.1527853486001205" CI_START="0.5414085788663955" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.061748448147227755" LOG_CI_START="-0.2664748669164207" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="552" SE="0.1928" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.0196927061444665"/>
<IV_DATA CI_END="1.1738337716075187" CI_START="0.6901301196924974" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.06960660016120053" LOG_CI_START="-0.16106901805002544" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="550" SE="0.1355" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.980907941096083"/>
<IV_DATA CI_END="1.0103366836362089" CI_START="0.9699763148732996" EFFECT_SIZE="0.9899508337158773" ESTIMABLE="YES" ESTIMATE="-0.0101" LOG_CI_END="0.004466121782211678" LOG_CI_START="-0.01323887031665733" LOG_EFFECT_SIZE="-0.00438637426722283" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" SE="0.0104" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="68.83239497722349"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="6.056134156877606" CI_END="0.9241789555576088" CI_START="0.8082264975452402" DF="9" EFFECT_SIZE="0.8642603313558619" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="-0.03424392500716655" LOG_CI_START="-0.09246691540161091" LOG_EFFECT_SIZE="-0.06335542020438878" MODIFIED="2016-03-05 20:02:59 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7342873195631205" P_Z="1.9947775442712504E-5" STUDIES="10" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="4.265474548275758">
<NAME>BMI &#8805; 20 kg/m<SUP>2</SUP>
</NAME>
<IV_DATA CI_END="1.2061675211454916" CI_START="0.7800104241594188" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.08140762990744277" LOG_CI_START="-0.10789959330354115" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2016-03-05 20:02:59 +0000" MODIFIED_BY="[Empty name]" ORDER="560" SE="0.1112" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.459205151033688"/>
<IV_DATA CI_END="0.8915884582738216" CI_START="0.7000178967457131" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="-0.049835562152807676" LOG_CI_START="-0.15489085661638521" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="554" SE="0.06171" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="30.71518434569871"/>
<IV_DATA CI_END="1.2831314648882521" CI_START="0.5113486932766915" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.1082711548555115" LOG_CI_START="-0.2912828495295419" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="559" SE="0.2347" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.1234304450304613"/>
<IV_DATA CI_END="1.252812239669379" CI_START="0.46107672597089233" EFFECT_SIZE="0.7600280032492344" ESTIMABLE="YES" ESTIMATE="-0.2744" LOG_CI_END="0.09788598768553596" LOG_CI_START="-0.33622679935404054" LOG_EFFECT_SIZE="-0.11917040583425229" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="558" SE="0.255" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.7988040560214993"/>
<IV_DATA CI_END="1.3447248051923095" CI_START="0.5500261885662506" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.12863341607456966" LOG_CI_START="-0.25961663181659045" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="563" SE="0.22806" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.2488784305358602"/>
<IV_DATA CI_END="1.0598289305986672" CI_START="0.6500490165412784" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.02523577046031674" LOG_CI_START="-0.1870538944174684" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="561" SE="0.1247" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.521965065333897"/>
<IV_DATA CI_END="1.1317319580675365" CI_START="0.8313127795582369" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.05374357975296" LOG_CI_START="-0.08023554314905836" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="555" SE="0.0787" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.884902819288335"/>
<IV_DATA CI_END="1.2014953054839443" CI_START="0.6300432135741827" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.07972207825568985" LOG_CI_START="-0.20062966201755508" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="556" SE="0.16468" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.313030232545785"/>
<IV_DATA CI_END="1.067179470837065" CI_START="0.6301362837854216" EFFECT_SIZE="0.8200417708174144" ESTIMABLE="YES" ESTIMATE="-0.1984" LOG_CI_END="0.028237462198471504" LOG_CI_START="-0.2005655126176818" LOG_EFFECT_SIZE="-0.08616402520960519" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="562" SE="0.1344" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.475386292627618"/>
<IV_DATA CI_END="1.0499315419454254" CI_START="0.7544811655591631" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.02116098295128348" LOG_CI_START="-0.12235159723474122" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="557" SE="0.0843" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="16.459213161884136"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="25.132687847939167" CI_END="1.0024992789755522" CI_START="0.9638939358668438" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_SIZE="0.9830071086800025" ESTIMABLE="YES" I2="48.2745336326374" I2_Q="63.16801155438997" ID="CMP-002.06" LOG_CI_END="0.001084068936058733" LOG_CI_START="-0.015970751991348463" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.007443341527644825" MODIFIED="2016-08-08 16:45:50 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.022174155218208536" P_Q="0.06620307878683152" P_Z="0.08711831033869388" Q="5.430062520120003" RANDOM="YES" SCALE="1.2" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.004626547604791381" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="300.0" Z="1.7107985338469447">
<NAME>Small-for-gestational age: dose of iron</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.652142796073375" CI_END="0.9754158201757395" CI_START="0.7944892745564671" DF="5" EFFECT_SIZE="0.8803166517579482" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="-0.010810204906735472" LOG_CI_START="-0.09991196130415758" LOG_EFFECT_SIZE="-0.055361083105446546" MODIFIED="2016-03-05 20:03:42 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8948729988781452" P_Z="0.014869319256122454" STUDIES="6" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999997" Z="2.4355463555136696">
<NAME>MMN with 30 mg iron vs. supplement with 60 mg iron</NAME>
<IV_DATA CI_END="1.2061675211454916" CI_START="0.7800104241594188" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.08140762990744277" LOG_CI_START="-0.10789959330354115" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2016-03-05 20:03:42 +0000" MODIFIED_BY="[Empty name]" ORDER="381" SE="0.1112" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.153286272321385"/>
<IV_DATA CI_END="1.252812239669379" CI_START="0.46107672597089233" EFFECT_SIZE="0.7600280032492344" ESTIMABLE="YES" ESTIMATE="-0.2744" LOG_CI_END="0.09788598768553596" LOG_CI_START="-0.33622679935404054" LOG_EFFECT_SIZE="-0.11917040583425229" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="379" SE="0.255" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.212766354528469"/>
<IV_DATA CI_END="1.1527853486001205" CI_START="0.5414085788663955" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.061748448147227755" LOG_CI_START="-0.2664748669164207" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="380" SE="0.1928" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.369426216275915"/>
<IV_DATA CI_END="1.0598289305986672" CI_START="0.6500490165412784" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.02523577046031674" LOG_CI_START="-0.1870538944174684" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="707" SE="0.1247" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.616305256317723"/>
<IV_DATA CI_END="1.2014953054839443" CI_START="0.6300432135741827" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.07972207825568985" LOG_CI_START="-0.20062966201755508" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="723" SE="0.16468" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.101038292030523"/>
<IV_DATA CI_END="1.0499315419454254" CI_START="0.7544811655591631" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.02116098295128348" LOG_CI_START="-0.12235159723474122" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="323" SE="0.0843" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="38.54717760852597"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="15.434357099915282" CI_END="1.1096941034342886" CI_START="0.7198493425440153" DF="3" EFFECT_SIZE="0.8937631513897534" ESTIMABLE="YES" I2="80.56284443479369" ID="CMP-002.06.02" LOG_CI_END="0.045203278336800795" LOG_CI_START="-0.14275838766347287" LOG_EFFECT_SIZE="-0.04877755466333604" MODIFIED="2016-08-08 16:45:50 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0014806918982992467" P_Z="0.30903327462012964" STUDIES="4" TAU2="0.03130673141362017" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.0172526390985828">
<NAME>MMN with 60 mg iron vs. supplement with 60 mg iron</NAME>
<IV_DATA CI_END="1.158454012644228" CI_START="0.9699736541732841" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.06387879820259258" LOG_CI_START="-0.013240061612673397" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2016-08-08 16:45:50 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.0453" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="36.542905695400755"/>
<IV_DATA CI_END="0.8915884582738216" CI_START="0.7000178967457131" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="-0.049835562152807676" LOG_CI_START="-0.15489085661638521" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="149" SE="0.06171" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="34.71545723874065"/>
<IV_DATA CI_END="1.2831314648882521" CI_START="0.5113486932766915" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.1082711548555115" LOG_CI_START="-0.2912828495295419" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="378" SE="0.2347" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.110622460587555"/>
<IV_DATA CI_END="1.3447248051923095" CI_START="0.5500261885662506" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.12863341607456966" LOG_CI_START="-0.25961663181659045" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="156" SE="0.22806" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.631014605271043"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="2.486184380750357" CI_END="1.0080368377404103" CI_START="0.968334887267209" DF="3" EFFECT_SIZE="0.9879864561999593" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.03" LOG_CI_END="0.0034764032752394422" LOG_CI_START="-0.013974421059372178" LOG_EFFECT_SIZE="-0.005249008892066358" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.4777933168183409" P_Z="0.23837047659415744" STUDIES="4" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.1790696170811596">
<NAME>MMN with 30 mg iron vs. supplement with 30 mg iron</NAME>
<IV_DATA CI_END="1.1317319580675365" CI_START="0.8313127795582369" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.05374357975296" LOG_CI_START="-0.08023554314905836" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="382" SE="0.0787" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.6965147227563606"/>
<IV_DATA CI_END="1.1738337716075187" CI_START="0.6901301196924974" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.06960660016120053" LOG_CI_START="-0.16106901805002544" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="724" SE="0.1355" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.5723062743257225"/>
<IV_DATA CI_END="1.0103366836362089" CI_START="0.9699763148732996" EFFECT_SIZE="0.9899508337158773" ESTIMABLE="YES" ESTIMATE="-0.0101" LOG_CI_END="0.004466121782211678" LOG_CI_START="-0.01323887031665733" LOG_EFFECT_SIZE="-0.00438637426722283" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" SE="0.0104" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="97.1494662831809"/>
<IV_DATA CI_END="1.067179470837065" CI_START="0.6301362837854216" EFFECT_SIZE="0.8200417708174144" ESTIMABLE="YES" ESTIMATE="-0.1984" LOG_CI_END="0.028237462198471504" LOG_CI_START="-0.2005655126176818" LOG_EFFECT_SIZE="-0.08616402520960519" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="709" SE="0.1344" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.5817127197370172"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="25.13268784793916" CI_END="1.0022965424595345" CI_START="0.9176135408372261" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_SIZE="0.9590207918993219" ESTIMABLE="YES" I2="48.27453363263739" I2_Q="69.53992291394388" ID="CMP-002.07" LOG_CI_END="9.96232210198126E-4" LOG_CI_START="-0.03734018635842577" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.01817197707411386" MODIFIED="2016-08-08 16:46:03 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.022174155218208647" P_Q="0.07000153460934222" P_Z="0.06315503023481749" Q="3.282985782257838" RANDOM="YES" SCALE="3.8087773375874416" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.004626547604791382" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="1.8580984830075218">
<NAME>Small-for-gestational age: timing of supplementation</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="10.668754621212225" CI_END="1.0194839716223427" CI_START="0.9284137475173443" DF="9" EFFECT_SIZE="0.9728838238082516" ESTIMABLE="YES" I2="15.641512814385212" ID="CMP-002.07.01" LOG_CI_END="0.008380402168409903" LOG_CI_START="-0.03225843733856895" LOG_EFFECT_SIZE="-0.011939017585079531" MODIFIED="2016-08-08 16:46:03 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2990991593742752" P_Z="0.24948144053615118" STUDIES="10" TAU2="9.201308569373171E-4" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.1516098767302563">
<NAME>Supplementation started before 20 weeks</NAME>
<IV_DATA CI_END="1.2061675211454916" CI_START="0.7800104241594188" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.08140762990744277" LOG_CI_START="-0.10789959330354115" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2016-03-05 20:04:08 +0000" MODIFIED_BY="[Empty name]" ORDER="586" SE="0.1112" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.28921266114939"/>
<IV_DATA CI_END="1.158454012644228" CI_START="0.9699736541732841" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.06387879820259258" LOG_CI_START="-0.013240061612673397" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2016-08-08 16:46:03 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.0453" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="19.172410622571263"/>
<IV_DATA CI_END="1.1527853486001205" CI_START="0.5414085788663955" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.061748448147227755" LOG_CI_START="-0.2664748669164207" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="585" SE="0.1928" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.4959750689769005"/>
<IV_DATA CI_END="1.3447248051923095" CI_START="0.5500261885662506" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.12863341607456966" LOG_CI_START="-0.25961663181659045" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="581" SE="0.22806" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.0765733957603072"/>
<IV_DATA CI_END="1.0598289305986672" CI_START="0.6500490165412784" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.02523577046031674" LOG_CI_START="-0.1870538944174684" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="580" SE="0.1247" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.4598588097360423"/>
<IV_DATA CI_END="1.2014953054839443" CI_START="0.6300432135741827" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.07972207825568985" LOG_CI_START="-0.20062966201755508" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="584" SE="0.16468" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.032289017762893"/>
<IV_DATA CI_END="1.1738337716075187" CI_START="0.6901301196924974" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.06960660016120053" LOG_CI_START="-0.16106901805002544" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="578" SE="0.1355" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.9555764044810924"/>
<IV_DATA CI_END="1.0103366836362089" CI_START="0.9699763148732996" EFFECT_SIZE="0.9899508337158773" ESTIMABLE="YES" ESTIMATE="-0.0101" LOG_CI_END="0.004466121782211678" LOG_CI_START="-0.01323887031665733" LOG_EFFECT_SIZE="-0.00438637426722283" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" SE="0.0104" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="55.41684859466427"/>
<IV_DATA CI_END="1.067179470837065" CI_START="0.6301362837854216" EFFECT_SIZE="0.8200417708174144" ESTIMABLE="YES" ESTIMATE="-0.1984" LOG_CI_END="0.028237462198471504" LOG_CI_START="-0.2005655126176818" LOG_EFFECT_SIZE="-0.08616402520960519" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="583" SE="0.1344" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.0017997827490435"/>
<IV_DATA CI_END="1.0499315419454254" CI_START="0.7544811655591631" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.02116098295128348" LOG_CI_START="-0.12235159723474122" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="582" SE="0.0843" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.099455642148801"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="4.454423563210347" CI_END="0.975478332912532" CI_START="0.7476223241634805" DF="3" EFFECT_SIZE="0.8539844134544755" ESTIMABLE="YES" I2="32.65121833546807" ID="CMP-002.07.02" LOG_CI_END="-0.010782372605732359" LOG_CI_START="-0.12631773897290063" LOG_EFFECT_SIZE="-0.0685500557893165" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.21639207966817464" P_Z="0.020029626462156867" STUDIES="4" TAU2="0.005848550853481023" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.3257924341243386">
<NAME>Supplementation after 20 weeks</NAME>
<IV_DATA CI_END="0.8915884582738216" CI_START="0.7000178967457131" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="-0.049835562152807676" LOG_CI_START="-0.15489085661638521" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="588" SE="0.06171" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="47.695508415147195"/>
<IV_DATA CI_END="1.2831314648882521" CI_START="0.5113486932766915" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.1082711548555115" LOG_CI_START="-0.2912828495295419" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="590" SE="0.2347" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.558838990970516"/>
<IV_DATA CI_END="1.252812239669379" CI_START="0.46107672597089233" EFFECT_SIZE="0.7600280032492344" ESTIMABLE="YES" ESTIMATE="-0.2744" LOG_CI_END="0.09788598768553596" LOG_CI_START="-0.33622679935404054" LOG_EFFECT_SIZE="-0.11917040583425229" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="591" SE="0.255" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.498616422623807"/>
<IV_DATA CI_END="1.1317319580675365" CI_START="0.8313127795582369" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.05374357975296" LOG_CI_START="-0.08023554314905836" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="587" SE="0.0787" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="38.24703617125848"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="25.132687847939163" CI_END="1.0000639365995563" CI_START="0.9628225639956423" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_SIZE="0.9812665915011884" ESTIMABLE="YES" I2="48.27453363263739" I2_Q="94.5931956215059" ID="CMP-002.08" LOG_CI_END="2.7766424743018963E-5" LOG_CI_START="-0.016453740474313115" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.00821298702478504" MODIFIED="2017-03-10 15:40:05 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.02217415521820887" P_Q="1.703331438107636E-5" P_Z="0.05077694362056762" Q="18.495213253461895" RANDOM="YES" SCALE="1.888075957169521" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.004626547604791383" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="1.9533600747387108">
<NAME>Small-for-gestational age: mean maternal height</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="5.229503910060984" CI_END="1.0103999541135629" CI_START="0.971772004399934" DF="7" EFFECT_SIZE="0.9908977690228888" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="0.004493317824167746" LOG_CI_START="-0.01243561660225534" LOG_EFFECT_SIZE="-0.0039711493890438" MODIFIED="2016-08-08 16:46:19 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6319782932322255" P_Z="0.3578197758832984" STUDIES="8" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.9195274296302656">
<NAME>Maternal height &lt; 154.9 cm</NAME>
<IV_DATA CI_END="1.2061675211454916" CI_START="0.7800104241594188" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.08140762990744277" LOG_CI_START="-0.10789959330354115" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2016-03-05 20:04:28 +0000" MODIFIED_BY="[Empty name]" ORDER="566" SE="0.1112" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.7996959104243596"/>
<IV_DATA CI_END="1.158454012644228" CI_START="0.9699736541732841" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.06387879820259258" LOG_CI_START="-0.013240061612673397" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2016-08-08 16:46:19 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.0453" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.818790500707958"/>
<IV_DATA CI_END="1.1527853486001205" CI_START="0.5414085788663955" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="0.061748448147227755" LOG_CI_START="-0.2664748669164207" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="571" SE="0.1928" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.26602373728601525"/>
<IV_DATA CI_END="1.3447248051923095" CI_START="0.5500261885662506" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.12863341607456966" LOG_CI_START="-0.25961663181659045" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="568" SE="0.22806" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.19012367902228566"/>
<IV_DATA CI_END="1.1317319580675365" CI_START="0.8313127795582369" EFFECT_SIZE="0.9699604320672105" ESTIMABLE="YES" ESTIMATE="-0.0305" LOG_CI_END="0.05374357975296" LOG_CI_START="-0.08023554314905836" LOG_EFFECT_SIZE="-0.013245981698049194" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="565" SE="0.0787" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.5965590461579109"/>
<IV_DATA CI_END="1.2014953054839443" CI_START="0.6300432135741827" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.07972207825568985" LOG_CI_START="-0.20062966201755508" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="569" SE="0.16468" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.36463028166024875"/>
<IV_DATA CI_END="1.1738337716075187" CI_START="0.6901301196924974" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.06960660016120053" LOG_CI_START="-0.16106901805002544" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="564" SE="0.1355" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.5385869908415077"/>
<IV_DATA CI_END="1.0103366836362089" CI_START="0.9699763148732996" EFFECT_SIZE="0.9899508337158773" ESTIMABLE="YES" ESTIMATE="-0.0101" LOG_CI_END="0.004466121782211678" LOG_CI_START="-0.01323887031665733" LOG_EFFECT_SIZE="-0.00438637426722283" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" SE="0.0104" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="91.42558985389971"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="1.4079706844162874" CI_END="0.892871744467573" CI_START="0.7561788053066015" DF="5" EFFECT_SIZE="0.821687707723263" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.02" LOG_CI_END="-0.04921092036155921" LOG_CI_START="-0.12137549950374729" LOG_EFFECT_SIZE="-0.08529320993265326" MODIFIED="2015-10-08 11:54:21 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9234394005310965" P_Z="3.6029006716239184E-6" STUDIES="6" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="4.633065738925218">
<NAME>Maternal height &#8805; 154.9 cm</NAME>
<IV_DATA CI_END="0.8915884582738216" CI_START="0.7000178967457131" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="-0.049835562152807676" LOG_CI_START="-0.15489085661638521" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="574" SE="0.06171" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="47.18590376120773"/>
<IV_DATA CI_END="1.2831314648882521" CI_START="0.5113486932766915" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.1082711548555115" LOG_CI_START="-0.2912828495295419" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="572" SE="0.2347" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.2620994064408766"/>
<IV_DATA CI_END="1.252812239669379" CI_START="0.46107672597089233" EFFECT_SIZE="0.7600280032492344" ESTIMABLE="YES" ESTIMATE="-0.2744" LOG_CI_END="0.09788598768553596" LOG_CI_START="-0.33622679935404054" LOG_EFFECT_SIZE="-0.11917040583425229" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="575" SE="0.255" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.7633952678713696"/>
<IV_DATA CI_END="1.0598289305986672" CI_START="0.6500490165412784" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.02523577046031674" LOG_CI_START="-0.1870538944174684" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="576" SE="0.1247" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.555545806701813"/>
<IV_DATA CI_END="1.067179470837065" CI_START="0.6301362837854216" EFFECT_SIZE="0.8200417708174144" ESTIMABLE="YES" ESTIMATE="-0.1984" LOG_CI_END="0.028237462198471504" LOG_CI_START="-0.2005655126176818" LOG_EFFECT_SIZE="-0.08616402520960519" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="573" SE="0.1344" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.947749327552339"/>
<IV_DATA CI_END="1.0499315419454254" CI_START="0.7544811655591631" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.02116098295128348" LOG_CI_START="-0.12235159723474122" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="577" SE="0.0843" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.285306430225866"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="22.26788338765835" CI_END="1.1653533156981826" CI_START="0.9089133301220425" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_SIZE="1.0291769347104507" ESTIMABLE="YES" I2="46.110729111098074" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.06645761617324016" LOG_CI_START="-0.04147752716778989" LOG_DATA="YES" LOG_EFFECT_SIZE="0.012490044502725192" MODIFIED="2016-08-08 16:49:38 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.034624910342454074" P_Q="0.8224577028624873" P_Z="0.6501121278151971" Q="0.05034865114370927" RANDOM="YES" SCALE="1.6109038865520207" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.012479265625214628" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="0.45360642758025643">
<NAME>Perinatal mortality: mean maternal BMI</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="5.602562922223642" CI_END="1.2885577166220048" CI_START="0.8535110055468638" DF="3" EFFECT_SIZE="1.048712635767882" ESTIMABLE="YES" I2="46.453077963659744" ID="CMP-002.09.01" LOG_CI_END="0.11010387608759756" LOG_CI_START="-0.06879087452879336" LOG_EFFECT_SIZE="0.020656500779402148" MODIFIED="2016-08-08 16:49:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.13263142159583718" P_Z="0.6508197666967173" STUDIES="4" TAU2="0.020550635267037935" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.45262365088696155">
<NAME>BMI &lt; 20 kg/m²</NAME>
<IV_DATA CI_END="2.0286475013832126" CI_START="0.9800327244975093" EFFECT_SIZE="1.4100145168847216" ESTIMABLE="YES" ESTIMATE="0.3436" LOG_CI_END="0.3072065904026346" LOG_CI_START="-0.008759422438719943" LOG_EFFECT_SIZE="0.14922358398195734" MODIFIED="2016-08-08 16:49:38 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SE="0.1856" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.078142807478688"/>
<IV_DATA CI_END="2.0616656156707056" CI_START="0.7101250431105577" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.3142182278508791" LOG_CI_START="-0.1486651713493595" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="620" SE="0.2719" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.68770889592383"/>
<IV_DATA CI_END="1.417811995043471" CI_START="0.6500182531456222" EFFECT_SIZE="0.9600019147413544" ESTIMABLE="YES" ESTIMATE="-0.04082" LOG_CI_END="0.15161864627130486" LOG_CI_START="-0.18707444777388635" LOG_EFFECT_SIZE="-0.017727900751290732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="622" SE="0.19895" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.363972905202466"/>
<IV_DATA CI_END="1.0056182866897758" CI_START="0.8600174811839018" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.002433162188096713" LOG_CI_START="-0.06549272096044882" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2016-05-09 02:29:21 +0100" MODIFIED_BY="[Empty name]" ORDER="359" SE="0.0399" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="49.87017539139501"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="16.664273001559504" CI_END="1.1898391003200712" CI_START="0.8712506151030194" DF="8" EFFECT_SIZE="1.0181591467091406" ESTIMABLE="YES" I2="51.993105254268634" ID="CMP-002.09.02" LOG_CI_END="0.07548823654577104" LOG_CI_START="-0.05985690228187928" LOG_EFFECT_SIZE="0.007815667131945916" MODIFIED="2016-03-05 20:05:18 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.033801219513287184" P_Z="0.8209207088383038" STUDIES="9" TAU2="0.02346136927077345" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.2263609351093726">
<NAME>BMI &#8805; 20 kg/m²</NAME>
<IV_DATA CI_END="1.8139638725879066" CI_START="0.9899365432734446" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.25862863327977703" LOG_CI_START="-0.0043926435736134145" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2016-03-05 20:05:18 +0000" MODIFIED_BY="[Empty name]" ORDER="627" SE="0.1545" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="13.35393215212616"/>
<IV_DATA CI_END="1.0131584085904353" CI_START="0.7300278544787893" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.005677353157183769" LOG_CI_START="-0.13666056889920447" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="623" SE="0.08361" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.75604899318057"/>
<IV_DATA CI_END="1.2524434964630875" CI_START="0.5500773136538565" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.09775814194222242" LOG_CI_START="-0.25957626589937405" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="624" SE="0.2099" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.361212132259213"/>
<IV_DATA CI_END="1.380504396872213" CI_START="0.6400244262325874" EFFECT_SIZE="0.9399768797793391" ESTIMABLE="YES" ESTIMATE="-0.0619" LOG_CI_END="0.14003779419462198" LOG_CI_START="-0.19380345105424449" LOG_EFFECT_SIZE="-0.026882828429811306" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="1075" SE="0.1961" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.208303492155762"/>
<IV_DATA CI_END="4.5216285435348125" CI_START="0.3400467311713735" EFFECT_SIZE="1.2399858893552747" ESTIMABLE="YES" ESTIMATE="0.2151" LOG_CI_END="0.6552948817335159" LOG_CI_START="-0.4684613956187369" LOG_EFFECT_SIZE="0.09341674305738948" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="628" SE="0.6601" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.3764641672228155"/>
<IV_DATA CI_END="3.319680512369057" CI_START="0.9544036850549776" EFFECT_SIZE="1.7799762116978486" ESTIMABLE="YES" ESTIMATE="0.5766" LOG_CI_END="0.5210962890077392" LOG_CI_START="-0.02026789247690918" LOG_EFFECT_SIZE="0.25041419826541506" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="626" SE="0.318" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.073334341679009"/>
<IV_DATA CI_END="1.0253122543746036" CI_START="0.7900040518487463" EFFECT_SIZE="0.9000004640921633" ESTIMABLE="YES" ESTIMATE="-0.10536" LOG_CI_END="0.01085614802589345" LOG_CI_START="-0.1023706812525467" LOG_EFFECT_SIZE="-0.04575726661332664" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="630" SE="0.06651" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.66682374021624"/>
<IV_DATA CI_END="1.4390580177117784" CI_START="0.4227438896303208" EFFECT_SIZE="0.7799698608351326" ESTIMABLE="YES" ESTIMATE="-0.2485" LOG_CI_END="0.15807830350168442" LOG_CI_START="-0.3739226610076006" LOG_EFFECT_SIZE="-0.1079221787529581" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="629" SE="0.3125" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.218590294275187"/>
<IV_DATA CI_END="1.929864585988086" CI_START="0.9868375549399816" EFFECT_SIZE="1.3800227713344961" ESTIMABLE="YES" ESTIMATE="0.3221" LOG_CI_END="0.28552683666509926" LOG_CI_START="-0.005754331423024438" LOG_EFFECT_SIZE="0.13988625262103743" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="625" SE="0.1711" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.985290686885039"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="22.267883387658355" CI_END="1.130596083579739" CI_START="0.9092543550084117" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_SIZE="1.0139030588524387" ESTIMABLE="YES" I2="46.11072911109809" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="0.05330747671701155" LOG_CI_START="-0.04131461015052036" LOG_DATA="YES" LOG_EFFECT_SIZE="0.005996433283245557" MODIFIED="2017-03-10 15:40:24 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.03462491034245396" P_Q="0.8086423548099408" P_Z="0.8038129953118252" Q="0.058650114129904146" RANDOM="YES" SCALE="27.509508361265354" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.012479265625214639" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="0.24841543153264375">
<NAME>Perinatal mortality: mean maternal height</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="11.779635269172198" CI_END="1.1368776555312747" CI_START="0.892548496872851" DF="7" EFFECT_SIZE="1.007332339683766" ESTIMABLE="YES" I2="40.575409679115495" ID="CMP-002.10.01" LOG_CI_END="0.05571373083854919" LOG_CI_START="-0.0493681770622055" LOG_EFFECT_SIZE="0.0031727768881718047" MODIFIED="2016-08-08 16:49:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10804270792886983" P_Z="0.905785719001107" STUDIES="8" TAU2="0.00925526658380202" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.1183558341493189">
<NAME>Maternal height &lt; 154.9 cm</NAME>
<IV_DATA CI_END="1.8139638725879066" CI_START="0.9899365432734446" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.25862863327977703" LOG_CI_START="-0.0043926435736134145" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2016-03-05 20:05:42 +0000" MODIFIED_BY="[Empty name]" ORDER="634" SE="0.1545" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.501869692849738"/>
<IV_DATA CI_END="2.0286475013832126" CI_START="0.9800327244975093" EFFECT_SIZE="1.4100145168847216" ESTIMABLE="YES" ESTIMATE="0.3436" LOG_CI_END="0.3072065904026346" LOG_CI_START="-0.008759422438719943" LOG_EFFECT_SIZE="0.14922358398195734" MODIFIED="2016-08-08 16:49:49 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SE="0.1856" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.718134470124504"/>
<IV_DATA CI_END="2.0616656156707056" CI_START="0.7101250431105577" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.3142182278508791" LOG_CI_START="-0.1486651713493595" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="635" SE="0.2719" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.580224085220489"/>
<IV_DATA CI_END="4.5216285435348125" CI_START="0.3400467311713735" EFFECT_SIZE="1.2399858893552747" ESTIMABLE="YES" ESTIMATE="0.2151" LOG_CI_END="0.6552948817335159" LOG_CI_START="-0.4684613956187369" LOG_EFFECT_SIZE="0.09341674305738948" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="632" SE="0.6601" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.8562163353977856"/>
<IV_DATA CI_END="1.0253122543746036" CI_START="0.7900040518487463" EFFECT_SIZE="0.9000004640921633" ESTIMABLE="YES" ESTIMATE="-0.10536" LOG_CI_END="0.01085614802589345" LOG_CI_START="-0.1023706812525467" LOG_EFFECT_SIZE="-0.04575726661332664" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="637" SE="0.06651" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="27.85361836874714"/>
<IV_DATA CI_END="1.4390580177117784" CI_START="0.4227438896303208" EFFECT_SIZE="0.7799698608351326" ESTIMABLE="YES" ESTIMATE="-0.2485" LOG_CI_END="0.15807830350168442" LOG_CI_START="-0.3739226610076006" LOG_EFFECT_SIZE="-0.1079221787529581" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="633" SE="0.3125" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.563744930664928"/>
<IV_DATA CI_END="1.417811995043471" CI_START="0.6500182531456222" EFFECT_SIZE="0.9600019147413544" ESTIMABLE="YES" ESTIMATE="-0.04082" LOG_CI_END="0.15161864627130486" LOG_CI_START="-0.18707444777388635" LOG_EFFECT_SIZE="-0.017727900751290732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="636" SE="0.19895" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.801672859860402"/>
<IV_DATA CI_END="1.0056182866897758" CI_START="0.8600174811839018" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.002433162188096713" LOG_CI_START="-0.06549272096044882" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2016-05-09 02:00:35 +0100" MODIFIED_BY="[Empty name]" ORDER="360" SE="0.0399" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="35.12451925713502"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="10.486004517221946" CI_END="1.3392933332324226" CI_START="0.8115639759891475" DF="4" EFFECT_SIZE="1.0425556208346216" ESTIMABLE="YES" I2="61.85391687147853" ID="CMP-002.10.02" LOG_CI_END="0.12687570699880216" LOG_CI_START="-0.09067723883971783" LOG_EFFECT_SIZE="0.018099234079542195" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.032990362193691225" P_Z="0.7443359060006753" STUDIES="5" TAU2="0.046796440157940815" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.3261169073756721">
<NAME>Maternal height &#8805; 154.9 cm</NAME>
<IV_DATA CI_END="1.0131584085904353" CI_START="0.7300278544787893" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.005677353157183769" LOG_CI_START="-0.13666056889920447" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="639" SE="0.08361" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="30.361780440986283"/>
<IV_DATA CI_END="1.2524434964630875" CI_START="0.5500773136538565" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.09775814194222242" LOG_CI_START="-0.25957626589937405" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="640" SE="0.2099" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.97458765773325"/>
<IV_DATA CI_END="1.380504396872213" CI_START="0.6400244262325874" EFFECT_SIZE="0.9399768797793391" ESTIMABLE="YES" ESTIMATE="-0.0619" LOG_CI_END="0.14003779419462198" LOG_CI_START="-0.19380345105424449" LOG_EFFECT_SIZE="-0.026882828429811306" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="1075" SE="0.1961" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="19.15589053623674"/>
<IV_DATA CI_END="3.319680512369057" CI_START="0.9544036850549776" EFFECT_SIZE="1.7799762116978486" ESTIMABLE="YES" ESTIMATE="0.5766" LOG_CI_END="0.5210962890077392" LOG_CI_START="-0.02026789247690918" LOG_EFFECT_SIZE="0.25041419826541506" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="638" SE="0.318" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.040200236798682"/>
<IV_DATA CI_END="1.929864585988086" CI_START="0.9868375549399816" EFFECT_SIZE="1.3800227713344961" ESTIMABLE="YES" ESTIMATE="0.3221" LOG_CI_END="0.28552683666509926" LOG_CI_START="-0.005754331423024438" LOG_EFFECT_SIZE="0.13988625262103743" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="641" SE="0.1711" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="21.46754112824505"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="22.267883387658358" CI_END="1.0250505260662175" CI_START="0.8652429166543509" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_SIZE="0.9417630842688679" ESTIMABLE="YES" I2="46.11072911109809" I2_Q="84.62314233307723" ID="CMP-002.11" LOG_CI_END="0.010745272856102371" LOG_CI_START="-0.06286194738838045" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.026058337266139042" MODIFIED="2017-01-24 10:58:06 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.03462491034245363" P_Q="0.010767600228460572" P_Z="0.16521986768378147" Q="6.503279289312171" RANDOM="YES" SCALE="5.238808290482777" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.012479265625214644" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="200.0" Z="1.3877280617035277">
<NAME>Perinatal mortality: timing of supplementation</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="18.436582888143718" CI_END="1.3314678341519308" CI_START="0.9594486306088805" DF="9" EFFECT_SIZE="1.1302543917971928" ESTIMABLE="YES" I2="51.18401248971272" ID="CMP-002.11.01" LOG_CI_END="0.12433067913466028" LOG_CI_START="-0.017978272664122996" LOG_EFFECT_SIZE="0.05317620323526866" MODIFIED="2016-08-08 16:50:00 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.03043329527245775" P_Z="0.14298942712448734" STUDIES="10" TAU2="0.028349906938746568" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999" Z="1.4647489403628642">
<NAME>Supplementation before 20 weeks</NAME>
<IV_DATA CI_END="1.8139638725879066" CI_START="0.9899365432734446" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.25862863327977703" LOG_CI_START="-0.0043926435736134145" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2016-03-05 20:05:58 +0000" MODIFIED_BY="[Empty name]" ORDER="645" SE="0.1545" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="13.381397473468956"/>
<IV_DATA CI_END="2.0286475013832126" CI_START="0.9800327244975093" EFFECT_SIZE="1.4100145168847216" ESTIMABLE="YES" ESTIMATE="0.3436" LOG_CI_END="0.3072065904026346" LOG_CI_START="-0.008759422438719943" LOG_EFFECT_SIZE="0.14922358398195734" MODIFIED="2016-08-08 16:50:00 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SE="0.1856" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="11.127533254049023"/>
<IV_DATA CI_END="1.380504396872213" CI_START="0.6400244262325874" EFFECT_SIZE="0.9399768797793391" ESTIMABLE="YES" ESTIMATE="-0.0619" LOG_CI_END="0.14003779419462198" LOG_CI_START="-0.19380345105424449" LOG_EFFECT_SIZE="-0.026882828429811306" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="1075" SE="0.1961" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.459957382680791"/>
<IV_DATA CI_END="2.0616656156707056" CI_START="0.7101250431105577" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.3142182278508791" LOG_CI_START="-0.1486651713493595" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="643" SE="0.2719" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.832049045976452"/>
<IV_DATA CI_END="4.5216285435348125" CI_START="0.3400467311713735" EFFECT_SIZE="1.2399858893552747" ESTIMABLE="YES" ESTIMATE="0.2151" LOG_CI_END="0.6552948817335159" LOG_CI_START="-0.4684613956187369" LOG_EFFECT_SIZE="0.09341674305738948" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="647" SE="0.6601" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.5057226981255691"/>
<IV_DATA CI_END="3.319680512369057" CI_START="0.9544036850549776" EFFECT_SIZE="1.7799762116978486" ESTIMABLE="YES" ESTIMATE="0.5766" LOG_CI_END="0.5210962890077392" LOG_CI_START="-0.02026789247690918" LOG_EFFECT_SIZE="0.25041419826541506" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="646" SE="0.318" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.397061791414731"/>
<IV_DATA CI_END="1.4390580177117784" CI_START="0.4227438896303208" EFFECT_SIZE="0.7799698608351326" ESTIMABLE="YES" ESTIMATE="-0.2485" LOG_CI_END="0.15807830350168442" LOG_CI_START="-0.3739226610076006" LOG_EFFECT_SIZE="-0.1079221787529581" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="642" SE="0.3125" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.54559152584887"/>
<IV_DATA CI_END="1.417811995043471" CI_START="0.6500182531456222" EFFECT_SIZE="0.9600019147413544" ESTIMABLE="YES" ESTIMATE="-0.04082" LOG_CI_END="0.15161864627130486" LOG_CI_START="-0.18707444777388635" LOG_EFFECT_SIZE="-0.017727900751290732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="649" SE="0.19895" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.286593440870108"/>
<IV_DATA CI_END="1.0056182866897758" CI_START="0.8600174811839018" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.002433162188096713" LOG_CI_START="-0.06549272096044882" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2016-05-09 01:54:34 +0100" MODIFIED_BY="[Empty name]" ORDER="361" SE="0.0399" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="23.337806913091654"/>
<IV_DATA CI_END="1.929864585988086" CI_START="0.9868375549399816" EFFECT_SIZE="1.3800227713344961" ESTIMABLE="YES" ESTIMATE="0.3221" LOG_CI_END="0.28552683666509926" LOG_CI_START="-0.005754331423024438" LOG_EFFECT_SIZE="0.13988625262103743" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="644" SE="0.1711" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.126286474473838"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.2666544931651388" CI_END="0.9727565077149011" CI_START="0.7979922030863622" DF="2" EFFECT_SIZE="0.8810517060070934" ESTIMABLE="YES" I2="0.0" ID="CMP-002.11.02" LOG_CI_END="-0.011995855096085717" LOG_CI_START="-0.09800135197397135" LOG_EFFECT_SIZE="-0.05499860353502856" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8751786529810252" P_Z="0.012186174759413373" STUDIES="3" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.5067068046058893">
<NAME>Supplementation after 20 weeks</NAME>
<IV_DATA CI_END="1.0131584085904353" CI_START="0.7300278544787893" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.005677353157183769" LOG_CI_START="-0.13666056889920447" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="651" SE="0.08361" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="36.50994474164511"/>
<IV_DATA CI_END="1.2524434964630875" CI_START="0.5500773136538565" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.09775814194222242" LOG_CI_START="-0.25957626589937405" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="652" SE="0.2099" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.7929895535492975"/>
<IV_DATA CI_END="1.0253122543746036" CI_START="0.7900040518487463" EFFECT_SIZE="0.9000004640921633" ESTIMABLE="YES" ESTIMATE="-0.10536" LOG_CI_END="0.01085614802589345" LOG_CI_START="-0.1023706812525467" LOG_EFFECT_SIZE="-0.04575726661332664" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="650" SE="0.06651" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="57.69706570480559"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="22.26788338765835" CI_END="1.0052511274851377" CI_START="0.888402214160067" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_SIZE="0.9450223952080183" ESTIMABLE="YES" I2="46.110729111098074" I2_Q="59.66020525964342" ID="CMP-002.12" LOG_CI_END="0.0022745688779570402" LOG_CI_START="-0.051390367732410035" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.02455789942722653" MODIFIED="2017-03-10 15:40:37 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.034624910342454074" P_Q="0.08383195872674176" P_Z="0.07284202193916632" Q="4.957883432161265" RANDOM="YES" SCALE="2.0240898622555354" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.012479265625214633" TOTALS="SUB" TOTAL_1="0" TOTAL_2="0" WEIGHT="300.0" Z="1.793819259036355">
<NAME>Perinatal mortality: dose of iron</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="7.6977603341828456" CI_END="1.4819101881446473" CI_START="0.9515826677741692" DF="5" EFFECT_SIZE="1.1875016000984606" ESTIMABLE="YES" I2="35.046042187142554" ID="CMP-002.12.01" LOG_CI_END="0.17082188382204275" LOG_CI_START="-0.021553476847663774" LOG_EFFECT_SIZE="0.07463420348718947" MODIFIED="2016-03-05 20:06:14 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.17369819823396815" P_Z="0.12831492358067895" STUDIES="6" TAU2="0.026056889905710236" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="1.5207805234567136">
<NAME>MMN with 30 mg iron vs. supplement with 60 mg iron</NAME>
<IV_DATA CI_END="1.8139638725879066" CI_START="0.9899365432734446" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.25862863327977703" LOG_CI_START="-0.0043926435736134145" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2016-03-05 20:06:14 +0000" MODIFIED_BY="[Empty name]" ORDER="222" SE="0.1545" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.576281903360712"/>
<IV_DATA CI_END="1.2524434964630875" CI_START="0.5500773136538565" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.09775814194222242" LOG_CI_START="-0.25957626589937405" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="220" SE="0.2099" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.21225740283741"/>
<IV_DATA CI_END="2.0616656156707056" CI_START="0.7101250431105577" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.3142182278508791" LOG_CI_START="-0.1486651713493595" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="221" SE="0.2719" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.771230176685568"/>
<IV_DATA CI_END="3.319680512369057" CI_START="0.9544036850549776" EFFECT_SIZE="1.7799762116978486" ESTIMABLE="YES" ESTIMATE="0.5766" LOG_CI_END="0.5210962890077392" LOG_CI_START="-0.02026789247690918" LOG_EFFECT_SIZE="0.25041419826541506" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="716" SE="0.318" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.040428289216129"/>
<IV_DATA CI_END="1.4390580177117784" CI_START="0.4227438896303208" EFFECT_SIZE="0.7799698608351326" ESTIMABLE="YES" ESTIMATE="-0.2485" LOG_CI_END="0.15807830350168442" LOG_CI_START="-0.3739226610076006" LOG_EFFECT_SIZE="-0.1079221787529581" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="1753" SE="0.3125" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.321867231162523"/>
<IV_DATA CI_END="1.929864585988086" CI_START="0.9868375549399816" EFFECT_SIZE="1.3800227713344961" ESTIMABLE="YES" ESTIMATE="0.3221" LOG_CI_END="0.28552683666509926" LOG_CI_START="-0.005754331423024438" LOG_EFFECT_SIZE="0.13988625262103743" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="326" SE="0.1711" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="23.077934996737664"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="6.079462431853384" CI_END="1.6289749235312991" CI_START="0.7136490406503764" DF="2" EFFECT_SIZE="1.078200533955364" ESTIMABLE="YES" I2="67.10235448580146" ID="CMP-002.12.02" LOG_CI_END="0.21191439882305402" LOG_CI_START="-0.1465153136879198" LOG_EFFECT_SIZE="0.03269954256756712" MODIFIED="2016-08-08 16:50:11 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.047847896073501706" P_Z="0.7206314314931561" STUDIES="3" TAU2="0.07821171812223364" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.3576150274729458">
<NAME>MMN with 60 mg iron vs. supplement with 60 mg iron</NAME>
<IV_DATA CI_END="2.0286475013832126" CI_START="0.9800327244975093" EFFECT_SIZE="1.4100145168847216" ESTIMABLE="YES" ESTIMATE="0.3436" LOG_CI_END="0.3072065904026346" LOG_CI_START="-0.008759422438719943" LOG_EFFECT_SIZE="0.14922358398195734" MODIFIED="2016-08-08 16:50:11 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SE="0.1856" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="39.34748864472491"/>
<IV_DATA CI_END="1.0131584085904353" CI_START="0.7300278544787893" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.005677353157183769" LOG_CI_START="-0.13666056889920447" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="217" SE="0.08361" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="52.0273417995811"/>
<IV_DATA CI_END="4.5216285435348125" CI_START="0.3400467311713735" EFFECT_SIZE="1.2399858893552747" ESTIMABLE="YES" ESTIMATE="0.2151" LOG_CI_END="0.6552948817335159" LOG_CI_START="-0.4684613956187369" LOG_EFFECT_SIZE="0.09341674305738948" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="224" SE="0.6601" STUDY_ID="STD-Ramakrishnan-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.625169555694"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.22692966179589766" CI_END="0.985653595524064" CI_START="0.865264942132687" DF="3" EFFECT_SIZE="0.9234995946366215" ESTIMABLE="YES" I2="0.0" ID="CMP-002.12.03" LOG_CI_END="-0.006275689506441328" LOG_CI_START="-0.06285089220171419" LOG_EFFECT_SIZE="-0.03456329085407774" MODIFIED="2016-05-09 01:57:27 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9731291488905326" P_Z="0.016629982304912663" STUDIES="4" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.394787894125751">
<NAME>MMN with 30 mg iron vs. supplement with 30 mg iron</NAME>
<IV_DATA CI_END="1.380504396872213" CI_START="0.6400244262325874" EFFECT_SIZE="0.9399768797793391" ESTIMABLE="YES" ESTIMATE="-0.0619" LOG_CI_END="0.14003779419462198" LOG_CI_START="-0.19380345105424449" LOG_EFFECT_SIZE="-0.026882828429811306" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="1075" SE="0.1961" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.871919443437252"/>
<IV_DATA CI_END="1.0253122543746036" CI_START="0.7900040518487463" EFFECT_SIZE="0.9000004640921633" ESTIMABLE="YES" ESTIMATE="-0.10536" LOG_CI_END="0.01085614802589345" LOG_CI_START="-0.1023706812525467" LOG_EFFECT_SIZE="-0.04575726661332664" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="227" SE="0.06651" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="24.966263253707698"/>
<IV_DATA CI_END="1.417811995043471" CI_START="0.6500182531456222" EFFECT_SIZE="0.9600019147413544" ESTIMABLE="YES" ESTIMATE="-0.04082" LOG_CI_END="0.15161864627130486" LOG_CI_START="-0.18707444777388635" LOG_EFFECT_SIZE="-0.017727900751290732" MODIFIED="2015-10-07 10:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="242" SE="0.19895" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.790227111548059"/>
<IV_DATA CI_END="1.0056182866897758" CI_START="0.8600174811839018" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.002433162188096713" LOG_CI_START="-0.06549272096044882" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2016-05-09 01:57:27 +0100" MODIFIED_BY="[Empty name]" ORDER="362" SE="0.0399" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="69.37159019130699"/>
</IV_SUBGROUP>
</IV_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2017-03-10 15:41:41 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Sensitivity analysis (all trials) excluding trials with &gt; 20% loss to follow up</NAME>
<IV_OUTCOME CHI2="23.276998893702963" CI_END="1.0409478305556399" CI_START="0.8952044132435548" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_SIZE="0.965329525017086" ESTIMABLE="YES" I2="61.33522177365083" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.01742896441010302" LOG_CI_START="-0.048077785458036655" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.015324410523966823" MODIFIED="2016-08-08 16:43:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.005603310312228271" P_Q="1.0" P_Z="0.3591354849235727" Q="0.0" RANDOM="YES" SCALE="1.2" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.007339732589184013" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.9170136748271116">
<NAME>Preterm births</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.3963519826118425" CI_START="0.8199900203518332" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.1449949059934276" LOG_CI_START="-0.0861914331437273" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2016-03-05 20:06:47 +0000" MODIFIED_BY="[Empty name]" ORDER="247" SE="0.1358" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.743032493017626"/>
<IV_DATA CI_END="1.0367769107215787" CI_START="0.7299955968163363" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.015685316788606636" LOG_CI_START="-0.13667975944685257" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2016-08-08 16:43:55 +0100" MODIFIED_BY="[Empty name]" ORDER="130" SE="0.0895" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.645825956741273"/>
<IV_DATA CI_END="1.1200105447124213" CI_START="0.9107943936862798" EFFECT_SIZE="1.0099996658383554" ESTIMABLE="YES" ESTIMATE="0.00995" LOG_CI_END="0.049222111499521" LOG_CI_START="-0.04057965130964631" LOG_EFFECT_SIZE="0.00432123009493732" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="249" SE="0.05275" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.627439645825772"/>
<IV_DATA CI_END="1.061574484908792" CI_START="0.7800843928538019" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.025950471653210985" LOG_CI_START="-0.10785841094016435" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="641" SE="0.0786" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="10.953293952900545"/>
<IV_DATA CI_END="1.2613885967721832" CI_START="0.6001274827586837" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.10084890055828255" LOG_CI_START="-0.22175648432014786" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="252" SE="0.1895" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.4234293664503235"/>
<IV_DATA CI_END="1.4421034736707823" CI_START="0.7500144594720254" EFFECT_SIZE="1.039999258320852" ESTIMABLE="YES" ESTIMATE="0.03922" LOG_CI_END="0.1589964229576192" LOG_CI_START="-0.12493036379712817" LOG_EFFECT_SIZE="0.017033029580245544" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="254" SE="0.16678" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.211690878136168"/>
<IV_DATA CI_END="1.1925406226853048" CI_START="0.96013055560486" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.0764731817646317" LOG_CI_START="-0.01766970891493137" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="586" SE="0.0553" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.239833313591598"/>
<IV_DATA CI_END="0.9030863423844057" CI_START="0.8000645339562924" EFFECT_SIZE="0.8500160902253981" ESTIMABLE="YES" ESTIMATE="-0.1625" LOG_CI_END="-0.044270725623939355" LOG_CI_START="-0.09687498099461747" LOG_EFFECT_SIZE="-0.07057285330927841" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="2213" SE="0.0309" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.850684218241344"/>
<IV_DATA CI_END="1.1308555884511713" CI_START="0.9200102164661593" EFFECT_SIZE="1.0199993601580974" ESTIMABLE="YES" ESTIMATE="0.019802" LOG_CI_END="0.05340714856547824" LOG_CI_START="-0.03620734990418184" LOG_EFFECT_SIZE="0.008599899330648222" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="258" SE="0.05264" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.644211423086851"/>
<IV_DATA CI_END="1.439998930362207" CI_START="0.780326879516213" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.15836216949944154" LOG_CI_START="-0.10772343290952241" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2015-10-07 10:11:28 +0100" MODIFIED_BY="[Empty name]" ORDER="259" SE="0.1563" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.66055875200849"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="22.05299573977979" CI_END="0.9951656648867293" CI_START="0.8375986382819346" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_SIZE="0.9129892692546066" ESTIMABLE="YES" I2="68.2582807224997" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-0.0021046163826219594" LOG_CI_START="-0.07696403737878718" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.03953432688070459" MODIFIED="2016-08-08 16:46:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0024875199965820327" P_Q="1.0" P_Z="0.038436444924587164" Q="0.0" RANDOM="YES" SCALE="3.37" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.007571677810108789" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="2.0701698145163068">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.158454012644228" CI_START="0.9699736541732841" EFFECT_SIZE="1.0600329579009444" ESTIMABLE="YES" ESTIMATE="0.0583" LOG_CI_END="0.06387879820259258" LOG_CI_START="-0.013240061612673397" LOG_EFFECT_SIZE="0.025319368294959548" MODIFIED="2016-08-08 16:46:35 +0100" MODIFIED_BY="[Empty name]" ORDER="147" SE="0.0453" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.091991932695972"/>
<IV_DATA CI_END="0.8915884582738216" CI_START="0.7000178967457131" EFFECT_SIZE="0.7900176436786672" ESTIMABLE="YES" ESTIMATE="-0.2357" LOG_CI_END="-0.049835562152807676" LOG_CI_START="-0.15489085661638521" LOG_EFFECT_SIZE="-0.10236320938459645" MODIFIED="2015-10-07 10:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="261" SE="0.06171" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="16.99156687701926"/>
<IV_DATA CI_END="1.2831314648882521" CI_START="0.5113486932766915" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.1082711548555115" LOG_CI_START="-0.2912828495295419" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 10:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="383" SE="0.2347" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.0860792543292153"/>
<IV_DATA CI_END="1.0598289305986672" CI_START="0.6500490165412784" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.02523577046031674" LOG_CI_START="-0.1870538944174684" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="264" SE="0.1247" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.362711138302673"/>
<IV_DATA CI_END="1.2014953054839443" CI_START="0.6300432135741827" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.07972207825568985" LOG_CI_START="-0.20062966201755508" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="265" SE="0.16468" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.573770163821089"/>
<IV_DATA CI_END="1.0103366836362089" CI_START="0.9699763148732996" EFFECT_SIZE="0.9899508337158773" ESTIMABLE="YES" ESTIMATE="-0.0101" LOG_CI_END="0.004466121782211678" LOG_CI_START="-0.01323887031665733" LOG_EFFECT_SIZE="-0.00438637426722283" MODIFIED="2015-10-07 10:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="2214" SE="0.0104" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.17770166296076"/>
<IV_DATA CI_END="1.067179470837065" CI_START="0.6301362837854216" EFFECT_SIZE="0.8200417708174144" ESTIMABLE="YES" ESTIMATE="-0.1984" LOG_CI_END="0.028237462198471504" LOG_CI_START="-0.2005655126176818" LOG_EFFECT_SIZE="-0.08616402520960519" MODIFIED="2015-10-07 10:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="267" SE="0.1344" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.542827384736532"/>
<IV_DATA CI_END="1.0499315419454254" CI_START="0.7544811655591631" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.02116098295128348" LOG_CI_START="-0.12235159723474122" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="268" SE="0.0843" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="13.173351586134501"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="8.906635612719244" CI_END="0.9087720950359192" CI_START="0.8537937703017324" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_SIZE="0.8808541044723137" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-0.04154501697414358" LOG_CI_START="-0.06864701834614081" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.05509601766014218" MODIFIED="2016-08-08 17:40:30 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5409866474203298" P_Q="1.0" P_Z="1.6012725910953012E-15" Q="0.0" RANDOM="YES" SCALE="3.22" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000003" Z="7.968873502975821">
<NAME>Low birthweight</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.0843609900114004" CI_START="0.6200278614095005" EFFECT_SIZE="0.8199597707404048" ESTIMABLE="YES" ESTIMATE="-0.1985" LOG_CI_END="0.03517388540464299" LOG_CI_START="-0.20758879472023392" LOG_EFFECT_SIZE="-0.0862074546577955" MODIFIED="2016-03-05 20:07:23 +0000" MODIFIED_BY="[Empty name]" ORDER="269" SE="0.1426" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.2463467307994085"/>
<IV_DATA CI_END="1.219392640427793" CI_START="0.8700949815746023" EFFECT_SIZE="1.0300424345653076" ESTIMABLE="YES" ESTIMATE="0.0296" LOG_CI_END="0.08614356953513534" LOG_CI_START="-0.06043333620646285" LOG_EFFECT_SIZE="0.012855116664336209" MODIFIED="2016-08-08 16:48:23 +0100" MODIFIED_BY="[Empty name]" ORDER="164" SE="0.0861" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.4187837181990774"/>
<IV_DATA CI_END="0.9568538529599047" CI_START="0.7200062495505544" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="-0.019154390018337984" LOG_CI_START="-0.14266373393881362" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 11:26:38 +0100" MODIFIED_BY="[Empty name]" ORDER="201" SE="0.07255" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.815075445977384"/>
<IV_DATA CI_END="1.1570427341288945" CI_START="0.700005292804498" EFFECT_SIZE="0.8999644647935904" ESTIMABLE="YES" ESTIMATE="-0.1054" LOG_CI_END="0.06334939944754178" LOG_CI_START="-0.15489867623274725" LOG_EFFECT_SIZE="-0.045774638392602755" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="643" SE="0.1282" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.5420621571446826"/>
<IV_DATA CI_END="0.9374835213119168" CI_START="0.6001090433027007" EFFECT_SIZE="0.7500615568648625" ESTIMABLE="YES" ESTIMATE="-0.2876" LOG_CI_END="-0.02803635737752464" LOG_CI_START="-0.22176982861322586" LOG_EFFECT_SIZE="-0.12490309299537523" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="275" SE="0.1138" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.9570116264459416"/>
<IV_DATA CI_END="1.2739692465668746" CI_START="0.6500165742404088" EFFECT_SIZE="0.9100006183190397" ESTIMABLE="YES" ESTIMATE="-0.09431" LOG_CI_END="0.10515894431996652" LOG_CI_START="-0.18707556949655788" LOG_EFFECT_SIZE="-0.04095831258829568" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="277" SE="0.17166" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.8600817123859276"/>
<IV_DATA CI_END="1.0513052852210514" CI_START="0.7199075191070305" EFFECT_SIZE="0.8699669992060597" ESTIMABLE="YES" ESTIMATE="-0.1393" LOG_CI_END="0.02172884774543212" LOG_CI_START="-0.14272329040367807" LOG_EFFECT_SIZE="-0.06049722132912297" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="590" SE="0.0966" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.7159619235787558"/>
<IV_DATA CI_END="1.814998605988796" CI_START="0.8199723164945201" EFFECT_SIZE="1.219937953908705" ESTIMABLE="YES" ESTIMATE="0.1988" LOG_CI_END="0.25887629581201776" LOG_CI_START="-0.08620080980728481" LOG_EFFECT_SIZE="0.08633774300236645" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="279" SE="0.2027" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.6168370230207585"/>
<IV_DATA CI_END="0.9110945159130742" CI_START="0.8500234322486802" EFFECT_SIZE="0.8800293674187135" ESTIMABLE="YES" ESTIMATE="-0.1278" LOG_CI_END="-0.04043656747233265" LOG_CI_START="-0.07056910210213853" LOG_EFFECT_SIZE="-0.05550283478723559" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="2215" SE="0.0177" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="80.89681013626537"/>
<IV_DATA CI_END="1.1644474055657228" CI_START="0.6500885825698831" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.06611987759511645" LOG_CI_START="-0.18702746135698173" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="281" SE="0.1487" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.1461883577234748"/>
<IV_DATA CI_END="1.2799301780200207" CI_START="0.6327970476828186" EFFECT_SIZE="0.8999644647935904" ESTIMABLE="YES" ESTIMATE="-0.1054" LOG_CI_END="0.10718627892310686" LOG_CI_START="-0.19873555570831236" LOG_EFFECT_SIZE="-0.045774638392602755" MODIFIED="2015-10-07 10:12:01 +0100" MODIFIED_BY="[Empty name]" ORDER="282" SE="0.1797" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.7848411684592288"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="21.66965220619402" CI_END="1.1721843836840193" CI_START="0.9175542436560029" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_SIZE="1.0370837746279555" ESTIMABLE="YES" I2="58.46726142920072" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.06899593123683476" LOG_CI_START="-0.03736825184521584" LOG_DATA="YES" LOG_EFFECT_SIZE="0.015813839695809417" MODIFIED="2016-08-08 16:51:19 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.009987030536755426" P_Q="1.0" P_Z="0.5600275261768803" Q="0.0" RANDOM="YES" SCALE="5.38" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.016743478181033597" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.00000000000001" Z="0.5828006263568409">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.8139638725879066" CI_START="0.9899365432734446" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.25862863327977703" LOG_CI_START="-0.0043926435736134145" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2016-03-05 20:07:41 +0000" MODIFIED_BY="[Empty name]" ORDER="294" SE="0.1545" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.611544123014044"/>
<IV_DATA CI_END="2.0286475013832126" CI_START="0.9800327244975093" EFFECT_SIZE="1.4100145168847216" ESTIMABLE="YES" ESTIMATE="0.3436" LOG_CI_END="0.3072065904026346" LOG_CI_START="-0.008759422438719943" LOG_EFFECT_SIZE="0.14922358398195734" MODIFIED="2016-08-08 16:51:19 +0100" MODIFIED_BY="[Empty name]" ORDER="215" SE="0.1856" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.625595795708878"/>
<IV_DATA CI_END="1.0131584085904353" CI_START="0.7300278544787893" EFFECT_SIZE="0.8600196853970379" ESTIMABLE="YES" ESTIMATE="-0.1508" LOG_CI_END="0.005677353157183769" LOG_CI_START="-0.13666056889920447" LOG_EFFECT_SIZE="-0.06549160787101034" MODIFIED="2015-10-07 10:12:17 +0100" MODIFIED_BY="[Empty name]" ORDER="296" SE="0.08361" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="16.447241366534318"/>
<IV_DATA CI_END="1.380504396872213" CI_START="0.6400244262325874" EFFECT_SIZE="0.9399768797793391" ESTIMABLE="YES" ESTIMATE="-0.0619" LOG_CI_END="0.14003779419462198" LOG_CI_START="-0.19380345105424449" LOG_EFFECT_SIZE="-0.026882828429811306" MODIFIED="2015-10-07 10:12:17 +0100" MODIFIED_BY="[Empty name]" ORDER="1075" SE="0.1961" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.071918795096152"/>
<IV_DATA CI_END="2.0616656156707056" CI_START="0.7101250431105577" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.3142182278508791" LOG_CI_START="-0.1486651713493595" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:12:17 +0100" MODIFIED_BY="[Empty name]" ORDER="298" SE="0.2719" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.3051433257983645"/>
<IV_DATA CI_END="3.319680512369057" CI_START="0.9544036850549776" EFFECT_SIZE="1.7799762116978486" ESTIMABLE="YES" ESTIMATE="0.5766" LOG_CI_END="0.5210962890077392" LOG_CI_START="-0.02026789247690918" LOG_EFFECT_SIZE="0.25041419826541506" MODIFIED="2015-10-07 10:12:17 +0100" MODIFIED_BY="[Empty name]" ORDER="300" SE="0.318" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.311860459189135"/>
<IV_DATA CI_END="1.0253122543746036" CI_START="0.7900040518487463" EFFECT_SIZE="0.9000004640921633" ESTIMABLE="YES" ESTIMATE="-0.10536" LOG_CI_END="0.01085614802589345" LOG_CI_START="-0.1023706812525467" LOG_EFFECT_SIZE="-0.04575726661332664" MODIFIED="2015-10-07 10:12:17 +0100" MODIFIED_BY="[Empty name]" ORDER="301" SE="0.06651" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.44189377802581"/>
<IV_DATA CI_END="1.4390580177117784" CI_START="0.4227438896303208" EFFECT_SIZE="0.7799698608351326" ESTIMABLE="YES" ESTIMATE="-0.2485" LOG_CI_END="0.15807830350168442" LOG_CI_START="-0.3739226610076006" LOG_EFFECT_SIZE="-0.1079221787529581" MODIFIED="2015-10-07 10:12:17 +0100" MODIFIED_BY="[Empty name]" ORDER="1754" SE="0.3125" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.4122514678913496"/>
<IV_DATA CI_END="1.0056182866897758" CI_START="0.8600174811839018" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.002433162188096713" LOG_CI_START="-0.06549272096044882" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2016-05-09 02:02:23 +0100" MODIFIED_BY="[Empty name]" ORDER="363" SE="0.0399" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="21.28989621426584"/>
<IV_DATA CI_END="1.929864585988086" CI_START="0.9868375549399816" EFFECT_SIZE="1.3800227713344961" ESTIMABLE="YES" ESTIMATE="0.3221" LOG_CI_END="0.28552683666509926" LOG_CI_START="-0.005754331423024438" LOG_EFFECT_SIZE="0.13988625262103743" MODIFIED="2015-10-07 10:12:17 +0100" MODIFIED_BY="[Empty name]" ORDER="303" SE="0.1711" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.482654674476114"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="13.356109366756499" CI_END="1.093560701567256" CI_START="0.879622090289301" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_SIZE="0.9807752801589282" ESTIMABLE="YES" I2="25.127896714516964" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="0.03884289494020855" LOG_CI_START="-0.05570387256922693" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.008430488814509198" MODIFIED="2016-08-08 17:40:52 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.20443731107565632" P_Q="1.0" P_Z="0.7266916338425705" Q="0.0" RANDOM="YES" SCALE="6.71" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0072216087361771" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.3495297593724036">
<NAME>Stillbirths</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.7400961841283102" CI_START="0.7600733099195451" EFFECT_SIZE="1.150043767101398" ESTIMABLE="YES" ESTIMATE="0.1398" LOG_CI_END="0.24057325465137364" LOG_CI_START="-0.11914451751122442" LOG_EFFECT_SIZE="0.060714368570074576" MODIFIED="2016-03-06 01:17:40 +0000" MODIFIED_BY="[Empty name]" ORDER="304" SE="0.2113" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.946455839125049"/>
<IV_DATA CI_END="2.3564092339238223" CI_START="0.8799070964359363" EFFECT_SIZE="1.4399379177717142" ESTIMABLE="YES" ESTIMATE="0.3646" LOG_CI_END="0.37225071591181896" LOG_CI_START="-0.05556317970796772" LOG_EFFECT_SIZE="0.15834376810192566" MODIFIED="2016-08-08 16:52:46 +0100" MODIFIED_BY="[Empty name]" ORDER="232" SE="0.2513" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.382890952680346"/>
<IV_DATA CI_END="1.0968777589737506" CI_START="0.6901352107546144" EFFECT_SIZE="0.8700540002559602" ESTIMABLE="YES" ESTIMATE="-0.1392" LOG_CI_END="0.04015823052706334" LOG_CI_START="-0.16106581428892866" LOG_EFFECT_SIZE="-0.06045379188093267" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="306" SE="0.1182" STUDY_ID="STD-Fawzi-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="14.553894956771156"/>
<IV_DATA CI_END="1.5725057211809816" CI_START="0.5499816594001918" EFFECT_SIZE="0.9299727447357862" ESTIMABLE="YES" ESTIMATE="-0.0726" LOG_CI_END="0.19659223419540534" LOG_CI_START="-0.2596517929677575" LOG_EFFECT_SIZE="-0.03152977938617608" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="1082" SE="0.268" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.902031994851317"/>
<IV_DATA CI_END="1.6401496450050714" CI_START="0.4200474975778983" EFFECT_SIZE="0.8300245502620139" ESTIMABLE="YES" ESTIMATE="-0.1863" LOG_CI_END="0.2148834742885866" LOG_CI_START="-0.37670159824573823" LOG_EFFECT_SIZE="-0.08090906197857582" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="309" SE="0.3475" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.410092631545739"/>
<IV_DATA CI_END="3.6897038156564257" CI_START="0.8205780992192102" EFFECT_SIZE="1.7400259031788052" ESTIMABLE="YES" ESTIMATE="0.5539" LOG_CI_END="0.5669915053491085" LOG_CI_START="-0.08588007829668613" LOG_EFFECT_SIZE="0.24055571352621116" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="311" SE="0.3835" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.9990328640911914"/>
<IV_DATA CI_END="1.0800591950244371" CI_START="0.7500496686019729" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.033447558605433525" LOG_CI_START="-0.12490997649425833" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="312" SE="0.09302" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="19.430017589728575"/>
<IV_DATA CI_END="2.314076407180956" CI_START="0.3500740246885221" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.3643776945765052" LOG_CI_START="-0.45584011246533" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="313" SE="0.4818" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.2886351508647942"/>
<IV_DATA CI_END="0.9780194395116101" CI_START="0.8099568797118069" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="-0.009652512913094278" LOG_CI_START="-0.09153810137036344" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="749" SE="0.0481" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="32.34729090910423"/>
<IV_DATA CI_END="1.7401387679395524" CI_START="0.8001429644354437" EFFECT_SIZE="1.17998296271946" ESTIMABLE="YES" ESTIMATE="0.1655" LOG_CI_END="0.24058388262017258" LOG_CI_START="-0.09683240911019626" LOG_EFFECT_SIZE="0.07187573675498822" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="315" SE="0.1982" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.632394314210962"/>
<IV_DATA CI_END="1.9598837296183116" CI_START="0.9298935610585034" EFFECT_SIZE="1.3499938002062797" ESTIMABLE="YES" ESTIMATE="0.3001" LOG_CI_END="0.2922303075386315" LOG_CI_START="-0.03156675950029972" LOG_EFFECT_SIZE="0.13033177401916585" MODIFIED="2015-10-07 10:12:31 +0100" MODIFIED_BY="[Empty name]" ORDER="316" SE="0.1902" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.107262797026643"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="14.443071926373845" CI_END="1.2242273190876736" CI_START="0.9219786619324957" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_SIZE="1.0624083327768377" ESTIMABLE="YES" I2="30.7626518030458" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.08786206671409624" LOG_CI_START="-0.03527913004420963" LOG_DATA="YES" LOG_EFFECT_SIZE="0.026291468334943335" MODIFIED="2016-08-08 17:40:59 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.15372389287705945" P_Q="1.0" P_Z="0.40263146663611915" Q="0.0" RANDOM="YES" SCALE="1.58" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.013340282911886289" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.8369308142798838">
<NAME>Neonatal mortality</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="2.182572784942966" CI_START="0.9499894900828798" EFFECT_SIZE="1.4399379177717142" ESTIMABLE="YES" ESTIMATE="0.3646" LOG_CI_END="0.338968735572118" LOG_CI_START="-0.022281199368266846" LOG_EFFECT_SIZE="0.15834376810192566" MODIFIED="2016-03-05 20:09:20 +0000" MODIFIED_BY="[Empty name]" ORDER="179" SE="0.2122" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="8.9639366090233"/>
<IV_DATA CI_END="2.3873198577669688" CI_START="0.9299993997344395" EFFECT_SIZE="1.4900355816883664" ESTIMABLE="YES" ESTIMATE="0.3988" LOG_CI_END="0.3779106105261896" LOG_CI_START="-0.03151733176015601" LOG_EFFECT_SIZE="0.1731966393830168" MODIFIED="2016-08-08 16:54:21 +0100" MODIFIED_BY="[Empty name]" ORDER="249" SE="0.2405" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="7.350564772451532"/>
<IV_DATA CI_END="2.7354654609756652" CI_START="0.5711510272598767" EFFECT_SIZE="1.2499455620426687" ESTIMABLE="YES" ESTIMATE="0.2231" LOG_CI_END="0.437031235581272" LOG_CI_START="-0.24324903775604098" LOG_EFFECT_SIZE="0.09689109891261549" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="632" SE="0.3996" STUDY_ID="STD-Kaestel-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.024019063301645"/>
<IV_DATA CI_END="1.3388817700832902" CI_START="0.49005641314542503" EFFECT_SIZE="0.810017035544818" ESTIMABLE="YES" ESTIMATE="-0.2107" LOG_CI_END="0.12674222834327392" LOG_CI_START="-0.30975392301730426" LOG_EFFECT_SIZE="-0.09150584733701515" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1084" SE="0.2564" STUDY_ID="STD-Lui-2013" TOTAL_1="0" TOTAL_2="0" WEIGHT="6.616197450126268"/>
<IV_DATA CI_END="3.240637953596774" CI_START="0.7224043829578354" EFFECT_SIZE="1.5300493656277303" ESTIMABLE="YES" ESTIMATE="0.4253" LOG_CI_END="0.5106305140504214" LOG_CI_START="-0.14121962774351535" LOG_EFFECT_SIZE="0.18470544315345302" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="633" SE="0.3829" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.2710741418693376"/>
<IV_DATA CI_END="5.640190517322974" CI_START="0.7818300850376578" EFFECT_SIZE="2.09992157753265" ESTIMABLE="YES" ESTIMATE="0.7419" LOG_CI_END="0.7512937740586314" LOG_CI_START="-0.10688762181058636" LOG_EFFECT_SIZE="0.32220307612402255" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="719" SE="0.5041" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.9562656275442734"/>
<IV_DATA CI_END="1.0658434881127075" CI_START="0.7600534697012935" EFFECT_SIZE="0.9000544657400421" ESTIMABLE="YES" ESTIMATE="-0.1053" LOG_CI_END="0.027693436173301087" LOG_CI_START="-0.11915585406212588" LOG_EFFECT_SIZE="-0.04573120894441241" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="253" SE="0.08626" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="25.177582521899925"/>
<IV_DATA CI_END="1.457807727818968" CI_START="0.2000288343718837" EFFECT_SIZE="0.5400033152990382" ESTIMABLE="YES" ESTIMATE="-0.61618" LOG_CI_END="0.1637002480878219" LOG_CI_START="-0.6989073958061133" LOG_EFFECT_SIZE="-0.2676035738591457" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="720" SE="0.5067" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="1.9372300673355907"/>
<IV_DATA CI_END="2.3261949529116075" CI_START="0.7719512603210511" EFFECT_SIZE="1.3400407179084461" ESTIMABLE="YES" ESTIMATE="0.2927" LOG_CI_END="0.3666461091137423" LOG_CI_START="-0.11241011940757864" LOG_EFFECT_SIZE="0.12711799485308187" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="634" SE="0.2814" STUDY_ID="STD-Tofail-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.654796966139687"/>
<IV_DATA CI_END="1.0913353331712123" CI_START="0.8800275873400117" EFFECT_SIZE="0.9800026531747605" ESTIMABLE="YES" ESTIMATE="-0.0202" LOG_CI_END="0.03795821618804986" LOG_CI_START="-0.0555037132569413" LOG_EFFECT_SIZE="-0.008772748534445691" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="748" SE="0.0549" STUDY_ID="STD-West-2014" TOTAL_1="0" TOTAL_2="0" WEIGHT="31.992646855808996"/>
<IV_DATA CI_END="2.2397936725193235" CI_START="0.5905011173467205" EFFECT_SIZE="1.150043767101398" ESTIMABLE="YES" ESTIMATE="0.1398" LOG_CI_END="0.3502080134174472" LOG_CI_START="-0.2287792762772979" LOG_EFFECT_SIZE="0.060714368570074576" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="328" SE="0.3401" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="4.05568592449944"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="5.379023485640212" CI_END="1.289047495214675" CI_START="0.7907804377814942" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="1.00963039900104" ESTIMABLE="YES" I2="62.818530067043206" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="0.11026891931588884" LOG_CI_START="-0.10194408274308142" LOG_DATA="YES" LOG_EFFECT_SIZE="0.004162418286403691" MODIFIED="2016-08-08 17:41:09 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.06791426439795589" P_Q="1.0" P_Z="0.9387135939882689" Q="0.0" RANDOM="YES" SCALE="3.7" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.028537721334383447" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.07688680571678777">
<NAME>Maternal anaemia (third trimester Hb &lt;110 g/L)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="2.1455518682184316" CI_START="0.9800057886888996" EFFECT_SIZE="1.4500528441358083" ESTIMABLE="YES" ESTIMATE="0.3716" LOG_CI_END="0.33153901796389806" LOG_CI_START="-0.008771359013401333" LOG_EFFECT_SIZE="0.1613838294752484" MODIFIED="2016-08-08 16:55:38 +0100" MODIFIED_BY="[Empty name]" ORDER="317" SE="0.1999" STUDY_ID="STD-Christian-2003" TOTAL_1="0" TOTAL_2="0" WEIGHT="22.68521995493978"/>
<IV_DATA CI_END="1.0525421352028739" CI_START="0.7051051634923997" EFFECT_SIZE="0.8614829622951703" ESTIMABLE="YES" ESTIMATE="-0.1491" LOG_CI_END="0.02223949046478338" LOG_CI_START="-0.1517461049683331" LOG_EFFECT_SIZE="-0.06475330725177489" MODIFIED="2015-10-07 10:12:55 +0100" MODIFIED_BY="[Empty name]" ORDER="537" SE="0.1022" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="39.861057061027395"/>
<IV_DATA CI_END="1.199906817194163" CI_START="0.7680934285768597" EFFECT_SIZE="0.9600211149716509" ESTIMABLE="YES" ESTIMATE="-0.0408" LOG_CI_END="0.07914752075619792" LOG_CI_START="-0.11458595047950325" LOG_EFFECT_SIZE="-0.017719214861652687" MODIFIED="2015-10-07 10:12:55 +0100" MODIFIED_BY="[Empty name]" ORDER="324" SE="0.1138" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="37.45372298403282"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="2.0914240431848534" CI_END="1.0533450170086402" CI_START="0.8091418592520631" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="0.923203956607784" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.08" LOG_CI_END="0.02257064510846243" LOG_CI_START="-0.0919753309347915" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.034702342913164555" MODIFIED="2017-03-10 15:41:41 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.8363557143746696" P_Q="1.0" P_Z="0.23500522491309306" Q="0.0" RANDOM="YES" SCALE="14.765183233613888" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="1.1875640618449632">
<NAME>Miscarriage (loss before 28 weeks)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.3956870047295575" CI_START="0.7899490963830813" EFFECT_SIZE="1.050010327672887" ESTIMABLE="YES" ESTIMATE="0.0488" LOG_CI_END="0.14478803479167573" LOG_CI_START="-0.1024008933579184" LOG_EFFECT_SIZE="0.02119357071687869" MODIFIED="2016-03-05 20:09:49 +0000" MODIFIED_BY="[Empty name]" ORDER="283" SE="0.1452" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="21.473441118154977"/>
<IV_DATA CI_END="1.8806451099278567" CI_START="0.45005977956621307" EFFECT_SIZE="0.9200014802251177" ESTIMABLE="YES" ESTIMATE="-0.08338" LOG_CI_END="0.27430684906368635" LOG_CI_START="-0.34672979686587263" LOG_EFFECT_SIZE="-0.03621147390109315" MODIFIED="2015-10-07 10:13:15 +0100" MODIFIED_BY="[Empty name]" ORDER="285" SE="0.3648" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.401928793833394"/>
<IV_DATA CI_END="1.1154833971649707" CI_START="0.7101437596808633" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.04746311063662253" LOG_CI_START="-0.14865372492008025" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:13:15 +0100" MODIFIED_BY="[Empty name]" ORDER="287" SE="0.1152" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="34.11378596038487"/>
<IV_DATA CI_END="1.412586079981729" CI_START="0.23001238498183257" EFFECT_SIZE="0.5700107834495196" ESTIMABLE="YES" ESTIMATE="-0.5621" LOG_CI_END="0.15001492227695692" LOG_CI_START="-0.6382487788325927" LOG_EFFECT_SIZE="-0.2441169282778179" MODIFIED="2015-10-07 10:13:15 +0100" MODIFIED_BY="[Empty name]" ORDER="288" SE="0.46303" STUDY_ID="STD-Sunawang-2009" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.11162413974335"/>
<IV_DATA CI_END="1.3961648956331474" CI_START="0.6600965825667234" EFFECT_SIZE="0.9600019147413544" ESTIMABLE="YES" ESTIMATE="-0.04082" LOG_CI_END="0.14493671415706824" LOG_CI_START="-0.18039251565964973" LOG_EFFECT_SIZE="-0.017727900751290732" MODIFIED="2015-10-07 10:13:15 +0100" MODIFIED_BY="[Empty name]" ORDER="289" SE="0.1911" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="12.396911598901129"/>
<IV_DATA CI_END="1.1498911581158617" CI_START="0.6888943948593241" EFFECT_SIZE="0.8900300969766776" ESTIMABLE="YES" ESTIMATE="-0.1165" LOG_CI_END="0.06065673455645282" LOG_CI_START="-0.1618473488399105" LOG_EFFECT_SIZE="-0.05059530714172882" MODIFIED="2015-10-07 10:13:15 +0100" MODIFIED_BY="[Empty name]" ORDER="290" SE="0.1307" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="26.502308388982282"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.04024785970046008" CI_END="1.644922736349804" CI_START="0.6642129463581059" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_SIZE="1.0452650272741077" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="0.21614550352308767" LOG_CI_START="-0.17769266370136344" LOG_DATA="YES" LOG_EFFECT_SIZE="0.019226419910862134" MODIFIED="2016-08-08 17:41:40 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.840996838728908" P_Q="1.0" P_Z="0.8482409516387046" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.19136332490323454">
<NAME>Maternal mortality</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.6573720724073067" CI_START="0.6400984674656505" EFFECT_SIZE="1.029990933731111" ESTIMABLE="YES" ESTIMATE="0.02955" LOG_CI_END="0.21942001647848663" LOG_CI_START="-0.19375321259800446" LOG_EFFECT_SIZE="0.012833401940241088" MODIFIED="2015-10-07 10:13:28 +0100" MODIFIED_BY="[Empty name]" ORDER="292" SE="0.2427" STUDY_ID="STD-SUMMIT-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="90.85969085476871"/>
<IV_DATA CI_END="5.421456145880456" CI_START="0.2700456011841356" EFFECT_SIZE="1.2099753651243128" ESTIMABLE="YES" ESTIMATE="0.1906" LOG_CI_END="0.7341159491187675" LOG_CI_START="-0.5685628926172479" LOG_EFFECT_SIZE="0.08277652825075976" MODIFIED="2015-10-07 10:13:28 +0100" MODIFIED_BY="[Empty name]" ORDER="293" SE="0.7652" STUDY_ID="STD-Zagre-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="9.140309145231292"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="2.5398872582188865" CI_START="0.6654314221811357" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="1.30004645702234" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.10" LOG_CI_END="0.4048144393679296" LOG_CI_START="-0.17689669526510293" LOG_DATA="YES" LOG_EFFECT_SIZE="0.11395887205141332" MODIFIED="2017-01-24 10:43:50 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.4425317024767108" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.7679250804799532">
<NAME>Very preterm birth (before 34 weeks of gestation)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="2.5398872582188865" CI_START="0.6654314221811357" EFFECT_SIZE="1.30004645702234" ESTIMABLE="YES" ESTIMATE="0.2624" LOG_CI_END="0.4048144393679296" LOG_CI_START="-0.17689669526510293" LOG_EFFECT_SIZE="0.11395887205141332" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="330" SE="0.3417" STUDY_ID="STD-Zeng-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.0" CI_END="6.999215421792517" CI_START="0.14003007469789358" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_SIZE="0.9900003324950223" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.11" LOG_CI_END="0.8450493604309771" LOG_CI_START="-0.8537786795172323" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.004364659543127671" MODIFIED="2017-01-24 10:44:32 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.9919645212097628" Q="0.0" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0" Z="0.010071149413768915">
<NAME>Congenital anomalies</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="6.999215421792517" CI_START="0.14003007469789358" EFFECT_SIZE="0.9900003324950223" ESTIMABLE="YES" ESTIMATE="-0.01005" LOG_CI_END="0.8450493604309771" LOG_CI_START="-0.8537786795172323" LOG_EFFECT_SIZE="-0.004364659543127671" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="337" SE="0.9979" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="100.0"/>
</IV_OUTCOME>
<CONT_OUTCOME CHI2="0.14538298796028704" CI_END="2.35446618926387" CI_START="-1.8646612352420162" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2449024770109268" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.12" MODIFIED="2017-01-24 10:44:14 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.9858835245962707" P_Q="0.9858835245962707" P_Z="0.8200075891196609" Q="0.14538298796028704" RANDOM="YES" SCALE="0.7" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1430" TOTAL_2="1598" UNITS="" WEIGHT="400.0" Z="0.22753521587335293">
<NAME>Neurodevelopmental outcome: BSID scores</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.73654020947602" CI_START="-6.776540209476041" DF="0" EFFECT_SIZE="-0.020000000000010232" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.01" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9953709556021343" STUDIES="1" TAU2="0.0" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.00000000000001" Z="0.005801679332248219">
<NAME>Mental development scores at 6 months of age: new subgroup</NAME>
<CONT_DATA CI_END="6.73654020947602" CI_START="-6.776540209476041" EFFECT_SIZE="-0.020000000000010232" ESTIMABLE="YES" MEAN_1="67.6" MEAN_2="67.62" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1477" SD_1="46.14" SD_2="49.5" SE="3.4472777371271905" STUDY_ID="STD-Zeng-2008" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.48215602478623" CI_START="-5.062156024786214" DF="0" EFFECT_SIZE="1.210000000000008" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.02" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7053498866193042" STUDIES="1" TAU2="0.0" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.00000000000001" Z="0.37810864588214904">
<NAME>Mental development scores at 12 months of age</NAME>
<CONT_DATA CI_END="7.48215602478623" CI_START="-5.062156024786214" EFFECT_SIZE="1.210000000000008" ESTIMABLE="YES" MEAN_1="103.65" MEAN_2="102.44" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1478" SD_1="42.06" SD_2="45.21" SE="3.2001384077769734" STUDY_ID="STD-Zeng-2008" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.5877653387217547" CI_START="-3.907765338721755" DF="0" EFFECT_SIZE="-0.16000000000000014" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.03" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.933314840303711" STUDIES="1" TAU2="0.0" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.0" Z="0.08367499274470747">
<NAME>Psychomotor development scores ar 6 months of age</NAME>
<CONT_DATA CI_END="3.5877653387217547" CI_START="-3.907765338721755" EFFECT_SIZE="-0.16000000000000014" ESTIMABLE="YES" MEAN_1="28.16" MEAN_2="28.32" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1479" SD_1="25.6" SD_2="27.45" SE="1.912160309211623" STUDY_ID="STD-Zeng-2008" TOTAL_1="364" TOTAL_2="406" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.408795627662089" CI_START="-2.728795627662082" DF="0" EFFECT_SIZE="0.3400000000000034" ESTIMABLE="YES" I2="0.0" ID="CMP-003.12.04" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.8280917580068696" STUDIES="1" TAU2="0.0" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.0" Z="0.2171496038174762">
<NAME>Psychomotor development scores at 12 months of age</NAME>
<CONT_DATA CI_END="3.408795627662089" CI_START="-2.728795627662082" EFFECT_SIZE="0.3400000000000034" ESTIMABLE="YES" MEAN_1="45.64" MEAN_2="45.3" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1480" SD_1="20.55" SD_2="22.15" SE="1.5657408257847358" STUDY_ID="STD-Zeng-2008" TOTAL_1="351" TOTAL_2="393" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<IV_OUTCOME CHI2="0.7593017471803691" CI_END="1.4646816751021197" CI_START="0.743620477659966" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_SIZE="1.0436317774288195" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.13" LOG_CI_END="0.16574324805643403" LOG_CI_START="-0.12864865922790528" LOG_DATA="YES" LOG_EFFECT_SIZE="0.01854729441426434" MODIFIED="2017-01-24 10:44:50 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.8591746902989474" P_Q="1.0" P_Z="0.80493646612451" Q="0.0" RANDOM="YES" SCALE="37.11409926283001" SHOW_PARTICIPANTS="NO" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="99.99999999999999" Z="0.24696350791673355">
<NAME>Mode of delivery: caesarean section</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours MMN</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours iron and/or folic</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.9258861973909778" CI_START="0.4299930539255249" EFFECT_SIZE="0.9100097183707231" ESTIMABLE="YES" ESTIMATE="-0.0943" LOG_CI_END="0.2846306206362058" LOG_CI_START="-0.36653855992315904" LOG_EFFECT_SIZE="-0.040953969643476626" MODIFIED="2016-03-05 20:10:21 +0000" MODIFIED_BY="[Empty name]" ORDER="1296" SE="0.3825" STUDY_ID="STD-Bhutta-2009a" TOTAL_1="0" TOTAL_2="0" WEIGHT="20.439207823976794"/>
<IV_DATA CI_END="2.2479537673372394" CI_START="0.4099908790753821" EFFECT_SIZE="0.9600211149716509" ESTIMABLE="YES" ESTIMATE="-0.0408" LOG_CI_END="0.3517873750479163" LOG_CI_START="-0.38722580477122165" LOG_EFFECT_SIZE="-0.017719214861652687" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1297" SE="0.4341" STUDY_ID="STD-Friis-2004" TOTAL_1="0" TOTAL_2="0" WEIGHT="15.86891985794897"/>
<IV_DATA CI_END="1.6592072693808446" CI_START="0.6900853870218864" EFFECT_SIZE="1.0700442470478533" ESTIMABLE="YES" ESTIMATE="0.0677" LOG_CI_END="0.21990064179633492" LOG_CI_START="-0.16109716894663462" LOG_EFFECT_SIZE="0.02940173642485013" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1299" SE="0.2238" STUDY_ID="STD-Osrin-2005" TOTAL_1="0" TOTAL_2="0" WEIGHT="59.70445992361814"/>
<IV_DATA CI_END="11.027904249255787" CI_START="0.3700086813127498" EFFECT_SIZE="2.020005026951766" ESTIMABLE="YES" ESTIMATE="0.7031" LOG_CI_END="1.0424929866502415" LOG_CI_START="-0.43178808619788894" LOG_EFFECT_SIZE="0.30535245022617635" MODIFIED="2015-10-07 10:10:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1300" SE="0.866" STUDY_ID="STD-Roberfroid-2008" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.987412394456081"/>
</IV_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-10-23 11:18:02 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-10-23 11:18:02 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-10-23 11:18:02 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVwAAAOPCAIAAAAIQe7TAAAt70lEQVR42u3dv24dxf/GcUtIiMJF
ilwB1+AKWVRQcU+kdBEJytwF4hIQgTKkokOAg4gLCgc6/kT7O8YSP3/tc/bM2Z3PnPnsvh5ZKJzY
jze7M+/5u/OcnBAR3dNARPSvQIGIQIGIQIGIQIGIQIGIQIGIQIGIQIGIQIGIQIFoBZWt+23EoEDU
qJqVfAgKRKsgwuS/BQUiAgWi9XUZzCkQ0f8QoduBAygQgQIoEIECKBB1Vdk6JwIoEBEoEBEoEHVU
2brf6QwKRI1q2t0/mFMgAgWrD0QECkRUyAXDByLKBC9QICJQIGo7akiU4QoKRAQKRAQKRL1UNge3
EtGwbVeCOQUiUAAFItpBAcMHIlMJliSJKDXF3AgiAgUiAgUiAgUiAgWijiub49iIaHDyEhGBAhGB
AhFNmlPwliQRJYSXG0FEoEDUurJt/TMoEK2dCJ1zARSIQAEUiI5Y2aw+EFFKeLkRRAQKRMccPphT
IFo7EfQUiKgRFOp2QECBKDEXttbfmZUaFIiOM6FQpUmPYBAoEBEoEC10YGJOgSj3CKI6EWYOHECB
6DiN+VB10hEUiJYAhYpcAAUiUNhejWvZggLREbjgLUkiygQvUCBaRDWutK4BCkQpq+7WUYk5BaJ8
EwpxzlYf1t7OuCGgAAprx0HJh4QLhg9rL0menTmFqOv0wIiSdhNAQakycACF//GsflIDKOQjgoED
LugpECgscELBnAKBAjUiDiis68EjgrHDXmdzCkSr5gIoEJlTGOOC4cOqS5V7okjsEiisqOdZ/YQ/
IlBYAhRwYQENOygQKHiCez4BBZrOBY8MFECBCBRAgcicwiRnqw+raGES7Zynxj2C6v6KF1EjrIMC
Ee3s3sftaAQFI1Ja+yDCjkZFqtFIlXLNLOgpKFKggAugoEhVfROOephW6HNoCQopC5OnRnG9SMWL
CBRAgeionb66A0BQIMrdnke852pOgQgU4ns0nhkRKIBC1hGp1YdlPMFaoLGjce3tDJGeAoECHVY2
9BRwgdY7fHDEu/JkTkF7Ht5aKF5EuaFgToFoCVyofixKRWdQWO+IlI4+AKy1AbFuH0QJ0/kEMmUD
FDz4Vjgo+XCFz676c/TuAyhUhkLQTrvQapBx7JAFkaCw6jkF7bnBFChQ624t0LTEzWD1gVJAR1J2
rvsMCjkeeZsokThbUAAF0p6DAihQ2/F/iqp7t3QpZg3mFCxJrvF5RyxAaM9TP8GoC/bk0vUUqhcC
RNCLBAU6QiPpnvTfB/GoUjYIWV58uPsHxaxZ7oPhgy5ip+252YqkdwMU1g6FuPYcFJrdDTsaDSDT
bDGyzbnBfbZPgdbbrYV1UKAjcEFhgHVQyNfODBlOWBmcQJ22D+JR6eTTcaqu1QfqDgra86M8wTTw
8sz0FPrv1oLC3q6HHY3GjcmqAS40cDanQP3iBhT2tup93mdQQITYDdSIkO4JgkLKFqbndmZIeIKA
vh4okPa8C753fZ0emDKqPW/cyY/2nPwbFYJ8dVh7Dgr3SkXJh6Cw2CJlR2PEKDo1F8wpgMLaoZA0
6s7BrQQK22tCn6NoAgUd5ty9ZQIFStaeN4BCxjMgpE5TsoFJIvOMg6kGp2zWcgaFlNMKPR8QPtIB
WfM50Yl2joJCPiJUrwbpCgAohD4+UFh7NUi6ozFj1J05BVp72zg4ZOVI99nwYV0PPhcRso9TcjUY
egrUe3ueMequWXdPliRFPfKIPYI9n9SwdQyVMW536HiqGBSSDRzGP+y8PU9RwdJBwZKkTr6TFEGh
SUlT5eAm6WvI6bY5908xUKCoGutMp/ZYHxzxTpQLlCkGJqCgPU92TvSQeRcmKJBJCsOHsXsCClS5
VHXbnkd3mGm8bJhTMCJdY3uuAxJ+b92IdQ5Hh8g8glyzFS1BNliSJL3x6Fux8s1LdjQaNAZuasxy
dku6qLvQbc56CpSm1Y0qrwnnQUCBQMGOxj03pNuhpUelSJnJX+DoEhS0565Z2dBTAIX+17QMH5r0
yEABFOoXhaD1c+Wq5RMEBe1MglOMGk9h9p863fJugAL1BYUGw4et+xQSccGORloXFKLL/a5W1zwL
KKyo0ka3utkPJkh0rHM02b0lSZnmQaJBts6S7DyFtXfyUwxKt5ZRxQwUqPexaPQoN2n+JSiAQtae
wgoLa5uBSd6Wo9ZNdkOpERdWuy0q3f5OUEhctqo7D2nzrNN19+xToMpd8c53NEaH4mbkQpttzpYk
1wuFISzBuWKlDQ3FzXvISnUomGgEhRxQ2Fp7PcQUb694Wim54JAVAgWi/y/uTmoYGZeZU1hda0CL
GT5YkqR+uRA3MGl2KzJONPYOL1UuXSOzzs3ICzjiPfS2GD5Q71BoFhu35r6eiUZKA4UGG6709UDB
CCJkM3LQkQTRfRBFAhQ8+DQj/wZ9EEuSIzfEnAIohDS2dd9QUMwGS5KUotUNfUOBRp6gtySpuy5i
A+c2ATbp9lZET98YPlCOfnL0kqQo+sFEIyVqGxs4p+sseEuSQppfuMkFhSx9EFBYe6ubFGT4+PBu
1Coq7qmueKMTgRSzZCh3I1bIBbkPBAqLmlBIFAProLeW0wqGD7SiwtpgyJP6bphopMBuSLqRlH0K
oLDqqjt43TBPsAooUOIiFT0DUnceJN35Sw1mWGrZgsLaoTC0Wu9UzILOrYhiulq35p6CNxQIFHLP
KThzeVhEKG63Z2GCAuUDmROoR+6GOQVadaub8XC6/u8GKKRscis2NU5/XEDZAIW1P/sh5qTGXBUs
4zbn0HdG7/4Kw4fVEaH6AFKrm3r4EAUvz2y1UBgWsa7hmkHBtEKOVj00wAYXQIGy1gFhMLmuGRRo
cMgKgQK16NMmTbVKjfXB5iXqfKAb94pkyYd6ZKBAPXIhEW7a3OS4EzFAQRex9xaMogdToKBIxRap
RB1mTzC03wQKoNAuUcJDTDEDAgramajaq1zlHqi6EYnmFELz16LPYqf+h2mgQGkK6zjI0i1Jdkte
UKDwIU+0eZbzl4LuDyioY9XKQbNjwppVsHVCYQhaolbl0rW6a37HOSMUhsgD780pgEIOKERPYeZ6
kTyuX2b4sGouBE2q2WK0sAYDFKhOkUp0mjOZU6B2UBg63n6btHfzH21bLtCCwhqHD/0fhZJoEY5A
wbhxJxdC18lAARQoBxSaXfPKN1A3W5IEBVxIM+SJG0lljI3rdpgGClknFNac4LwMpoMC9V5Ynbmc
t98ECpQGChHvayQdPiTCjRua78EPfR/72aDDTC1Kmhux8vY8Rbc2KW7S9W5AARQyjaKjX/fOXjwG
YTCgoA7kvWarD9RpJ38I21RjR2Ob3g0oUIIWrEEnP12hTRTPBwqgkK89X8aOxt67NupGxi5o/wMT
asAFwwdK0+xYI4i+G0HDNFDAhZQXjDVxJcE9VRTanWJkr6Q5BRr6r7ctn/7KoeA4Nlr7MKQlyBKt
PkS/om5JktY4PZFxTqHlnlQ9hZUOH0JnsN1wUFAIkrXnWR4Z1uziQs/zxJ5W1h7+mk8lhJsWKHcj
VDDnKRAo5J5WWHPVXcaSZLfOoIA1KTv56WZYnKdAoNCuyU2UKAkKFFITBu8R5OevI96p2oN3HFt2
pkf0bswpgAIoSLWKv7duxJqhkHfSDiJBwaNK9nJRugAbAgVqMSselz2VAgr9n08BCtS6D5Io1Squ
6kZcZJAzKKScVjDyT43dBpFZoLAuIiSqYBlPi4p7lzHLIAIUQGEhUyHuMyiAwnpfnW4QwZZrHsTm
pfVyIQsR8mZDN1gxiUBkXWdQoKFZ8Oma4QsKtPbBOYECgcJYHwR9zCkQLixkGdXqA5lQSDaTP0S+
VbHOqgEKiWtvlg5Ioncf7FMABSP/lKNoUAAFajQd6K2KIeE7JqCAC+G2Kz8uvdnor9t3okBh7XMK
EVDIu6OxGdbr9nHqOntUax8+5D3iPeI+NFiLefgbe3MGBXMKWY94z3XBoEDJuJAaN0mnFeoOHyo6
g0LWCYWVp07H9RRMgoDC2rse7UfRPXcN5FmDArXrLKw8BnaI3JPqjEYjiDRR9BFL6NGDqWaJj906
g0K+JrdWUbCboOXdAAVK061NuqiR8V+RhQugoBo0bX5X27sJ7YOYUzCnEHtuzwo7zAQKtKWCxR1Y
QqBAiaEwJJxy7/yC41ZMgpxBId+wPG/8Sf/bonRwQCFlkz4EzDbfLQ25ugl1f5cFWlBISYQsDZo3
O6P7ekHOoAAKWbmgrxfkDApZJxf6L6xJu+LRh8dHDHnqOoMC1uTeFjVE5j4MAmYJFHLNVuQ64l1s
HMUOH1ZYWLNDIVlJU+XStedr7oMkbc9BgUCh3YEl+nqWJHEhsLCuebYi6ePTUzChkGnLsPYcFEgn
vzUcU1TdwSErBAo6+c36euYUjCAyLUmmY43qAArJWrDqe/iS9kGq72h0jC0o5IbCkPMtyXVuMXLI
CqWBQoO2Me+OxjWPJkAhJRdW/siSIhIUiOILbvyGq55nKxyyQmkK68ivcNv1FKhm1co11k36vgaE
gcKQqGrdnW0OLRA9Q+HuFWbZ8X1vATVi51JFZ1BIBoXQmhaxiz4akbV+0S6Hus5x11zRGRTy9RSC
WBBnXn1lHhRAARRCoJBukgIUQIFy9xRyQSFuTgEUKGq0H7q81+C9vVr+96z634JpnwItgUHugzKg
EBARKBARKBARKBARKBARKCzhGRC1FSh0DQXOnPtxBgVQ4MwZFECBM2dQAAXOnEEBFDhzBgVQ4MwZ
FNYAheu/ry8uL85fnj/65tHJVyenz0/PXpw9+enJb3/9xplzdWdQ6B0Kz3599vjbx5vn/fBrUw4+
/+VzzpzrOoNC11DYIH/rI7/7tfkezpwrOoNCv1DYtAN7n/rt1642gTPnQ517h8KuXZnlFzwhVmxX
yMKcDydAYTNW3NUz3NpXvPrzijPnmc45oDC/hh/0I1vRM/PDaVC4uLwofOojHUXOnA9yTg+Fke7D
rojugxrzilAY/41bPz9/eb7lAd9q24M/e3HGmfNM59xQGM8dHvnb8sa8FhT2/satH96uMJU/+NPn
p5w5z3ReyJzCoVAovy8zf135b9z+4dZHflcPnj1nzjOdFzKnMAEKha+UT4DCXRyU/0YtGGc9hWNC
oWT4MBKdNGFQMG34YKzL2ZxCNSiMzzhM6OHXmlM4qKdgVpyz1Ye5cwpbu+73UrpHevh7f+P8zQsH
9RSsn3Me7FNYrey042xHI5U+HnvyObd3BoWuoXDbJmyfbf63Z/j01VPOnOs6g0LvUBh2vzO/dazI
mfNMZ1BIAAXOnFs6gwIocOYMCqDAmTMogAJnzqAACpw5gwIocOYMCsuAApHUadKCcdZTIIWVMyiQ
wsoZFEhh5QwKpEhxBgVSpDiDAh0NCm/fXr95c3F1df7q1aOffz65vDx9/frs+vrJ27e/desswTmv
Myj0DoU//nj26tXjTY19+LWpyb///nmHzhKcUzuDQtdQ2DTaWyvt3a/N93Tl7BSj7M6g0C8UNi35
3np7+7WrVW/v7LzD7M45oFC4NzN0VH9QwPTIIdHlv30z2r/bt//665MPPzx5772br08+Ofnuu/u9
/X/+uTq6s5ORsztngkL0fGxhqORwSELU+I/v/e1v3lzcrZzvv39j++WXJ198cfOHDz4o6uo3dpah
kN05PRS2RjxMjocYdoe1jPz28UuaA4Wrq/Ot/fkffri5yHffvf/569dnR3eWtpTdeQlQqJXXtMvq
UCjs/d9yKNyuEd77+v77k48+urnUzz67/1eXl6dHd5bLmN05/ZzCzGDo4fB8+pLfXgsKWxvzjz++
uQOffrp9UvDozhKcszsvZPiwVChsbc/feefmYf3445Z6O7OnUMVZq6unsC4olFf10DmFXV/z5xTm
Oxufm1NIA4VdOdRz0uKjoXBvjeD261blG40aO5vJt/rQ0ZzCcEjc867Vh5H6Xx5FPcTsUxivunP2
KVR0tuaf3TkNFJr1QXq7DDsaOdvR2Lrf0T+bvPvAub2zdx9677D8+y7jo93vMj7t0FmCc2pnUEgw
itl16sHW0X4nzhKc8zqDwpKnNjhzBgVQ4MwZFECBM2dQAAXOnEEBFDhzBgVQ4MwZFFYLBSKp06QF
46ynQAorZ1AghZUzKJDCyhkUSJHiDAqkSHEGBToaFOIyi6VOcwaFfFCIyyyWOs0ZFPJBIe50HScv
cQaFfFCIO4fPGY2cc0Bh13HMc/rehWFwk69tzofj/4S4E3ulTnPOAYXC8KWjTN5GJ800Pttf6jTn
BFAYiU7Ymgd9N7VhJIjh7v+O5zXUTZ0+tP43TgGSOs05JRTuXd/Durf1w5FauvfbqqROV4RCXF6g
1GnO6aEwoULO+ds5AbN7A6zK//lxycJSpzmvBQoj44Jd39YSCp33FKROc042pzC57h06yhjmpU6n
nlOQOs053+rDnJn/NqnTGVcfpE5z7hQKQ8E+hWnDh8ap0+n2KUid5twvFFYrOxo529FIpY/Huw+c
2zuDQtdQGCIzi6VOcwaFlFAYIjOLpU5zBoWUUODMuaUzKIACZ86gAAqcOYMCKHDmDAqgwJkzKIAC
Z86gsAwoEEmdJi0YZz0FUlg5gwIprJxBgRRWzqBAihRnUCBFijMo0NGgIA2Zc0tnUOgdCtKQOTd2
BoWuoeBEIM7tnUGhXyg4O5CzMxqnVKeSbZvzq+icg5v3XqRThjk7zTnB3Oyu39IsS1IeAedB7kNF
KBSmwm19RSQuYPag3AfJRZyHlSdE1e3q3/vz5PipilAojKj8TzIOOQ9rzpKsMqdQUocf/vcgKMxM
nT4MbdKQOa85dTpu+FAIhTZR9HoKnPUUehk+jEOhsPbODLk89F9hrMvZnEJ9KDxcGiypsdVTp6dB
waw4Z6sP9YcPhR3+vasPVVKnD/1XWD/nPNinsFrZacfZjkYqfTz25HNu7wwKXUNhkIbMubkzKPQO
hUEaMue2zqCQAAqcObd0BgVQ4MwZFECBM2dQAAXOnEEBFDhzBgVQ4MwZFJYBBSKp06QF46ynQAor
Z1AghZUzKJDCyhkUSJHiDAqkSHEGBToaFDKmIf99fX15cfHy/PybR4++Ojl5fnr64uzspydP/vpN
NrTUaZoHhYxpyL8+e/bt48dbD/7YMOKXz2VDS52mqVDIeG7Ppjuw95Swzfes5G44eYlqQiHjCX+b
PkLhIcO7+gtOUjyu8zKhUJ7yXP4Pn5M6vfcxLOYs4L+vr3eNGraOI/68cuay05z7mLebYzgnS/Ig
KGRMDbi8uDjEePsgQjrDEZ3XBYW92VB73xJpDIWM+UIvz88PgsKLMzlOEqKOCoWHVbcwQn4+FMZD
7heTRHi7+lj+9fxU4qMsyeZzCoVDgMI7MDlgdgIUMmYWPyyQj/cYy4aWOn3s4cN4Hd57K6ZBYS96
9BS053oKPULh0DWCg6BQuBpiTsHI35xCL1DYO6cwM3V6Qk/B6oM1AqsP/Q4f5qdOT4CCfQrZ74Z9
ClSZYoMdjfnvhh2NVBkKg3cf8t8N7z5QZSgMOdOQN/2FXSsRm89fPZUNLXWaZkBhyJmGvOs8ha3z
CIu/G1KnqTIUOHNu6QwKoMCZMyiAAmfOoAAKnDmDAihw5gwKoMCZMygsAwpEUqdJC8ZZT4EUVs6g
QAorZ1AghZUzKJAixRkUSJHiDAp0NCi8fXv95s3F1dX5q1ePfv755PLy9PXrs+vrJ2/f/tats9Tp
vM6g0DsU/vjj2atXjzc19uHXpib//vvnHTpLnU7tDApdQ2HTaG+ttHe/Nt/TlbOTl7I7g0K/UNi0
5Hvr7e3Xrla9vbMzGrM7dweFkWPRy2Nagi6scer0ZrR/t2//9dcnH3548t57N1+ffHLy3Xf3e/v/
/HN1dGenOWd3TgaFTq6qWcDsmzcXdyvn++/f/PiXX5588cXNHz74oKir39hZ7kN256w9hf9yGUeq
5a4GfNiX9TAe+tgSCldX51v78z/8cOPz7rv3P3/9+uzozhKisjsnhsJ4fvShf7vrGypCYULA7O0a
4b2v778/+eijmyv87LP7f3V5eXp0Z1mS2Z07hcKuFzwnhLjO/LBwHBEEha2N+ccf39yQTz/dPil4
dGep09mdcw8fqkBhBD0VoTAtdXpre/7OOzeX+uOPW+rtzJ5CFWc9BT2F9FA49E5Nnn2ckDq9a+S/
62v+nMJ8Z3MK5hTyQaFkTmHCskhE6vS9NYLbr1uVbzRq7Gz1wepDGigcuvowPtMx8uND2D6F8ao7
Z59CRWf7FLI79wiFo3Cn20uyo/Gu7Dts47wWKJQcVtknp7z7cFfeUGjj7N2H3jsv/77L+Gj3u4xP
O3SWOp3aGRQSjGh2nXqwdbTfibPU6bzOoLDkaQ7OnEEBFDhzBgVQ4MwZFECBM2dQAAXOnEEBFDhz
BoXVQoFI6jRpwTjrKZDCyhkUSGHlDAqksHIGBVKkOIMCKVKcQYGOBoW4zOK4bGip03mdQaF3KMRl
FsdlQ0udTu0MCl1DIe50nbjzkZy8lN0ZFPqFQtw5fHEnKTqjMbtz71AIypudEGA9M3V6Qu5D3Im9
cWcuO805u3M+KNS6zkOhMD91egKG4s72j0tnkPuQ3TkZFOa30iX/W16Ba+VTDs1TgOJynCREZXfO
BIU5kW0jH87JmJ0WG1cOhbi8wLjER1mS2Z3TQKFWLZ3fsM8MmB0OCbCMSxaOy4aWOp3dOQcUdnFh
a2B0Ybjb5ODpyVH0Ez7UU9Ce6ylMqYTThu7TgqcnD2GmQcGcgpG/OYUD6uG0FOk5cwoRSxJWH6w+
WH2osHb4EAcTYqAPXX2Ynzo9YaLRPoU2d4NzMiisRHY0HvducAaFNFAYvPvQ6m5wBoU0UBgiM4vj
sqGlTqd2BoXeoTBEZhbHZUNLnc7rDAoJoMCZc0tnUAAFzpxBARQ4cwYFUODMGRRAgTNnUAAFzpxB
YRlQIJI6TVowznoKpLByBgVSWDmDAimsnEGBFCnOoECKFGdQoKNBQRoy55bOoNA7FKQhc27sDApd
Q8GJQJzbO4NCv1BwdiBnZzR2MZk3M3V6GD0Puvw3OmWY8+A0506gMP6zJQHTJbExe69NHgHnQe5D
eygEBcwWBs+Nfyi5iPMgIWoBUCi53YUfyjjkPMiS7B8KJdmW47MSB1ybNGTOUqeXDQU9Bc56CkuD
Qvn0oTkFzuYU0kNhV3r1+CpjIRSsPnC2+tApFLaeRfUwvXpm6vRgnwLntM7rgkK6Xsxgpx1nOxpB
4aHsyefc3hkUuobCIA2Zc3NnUOgdCoM0ZM5tnUEhARQ4c27pDAqgwJkzKIACZ86gAAqcOYMCKHDm
DAqgwJkzKCwDCkRSp0kLxllPgRRWzqBACitnUCCFlTMokCLFGRRIkeIMCnQ0KGRMQ/77+vry4uLl
+fk3jx59dXLy/PT0xdnZT0+e/PWbbGip0zQPChnTkH999uzbx4+3HvyxYcQvn8uGljpNU6GQ8dye
TXdg7ylhm+9Zyd1w8hLVhELGE/42fYTCQ4Z39RecpHhc5+VAYe/OzZmzOOWp0+Mflh/xnvEs4L+v
r3eNGraOI/68cuay05zjW9qIf0t56nRhhFTJ48mYGnB5cXGI8fZBhHSGIzovBAp7Y1oehjUMD+Kh
//vfvbdiAhTKPe8qY77Qy/Pzg6Dw4kyOk4SotlDYVUUffsPehKiZUJgQBpMxifB29bH86/mpxEdZ
kseDwoSxQPk4ZdqYYs+HCTOLHxbIx3uMZUNLne5m+NASCvufsZ6C9lxPoRkUajXmQ1lsbEUomFMw
8jenUH/1IbSHHz18sPpgjcDqw1wu7AqAnj98OCh1uvzD8cdjn0L2u2GfAtUcAd3Kjsbsd8OORqoM
hcG7D/nvhncfqDIUhpxpyJv+wq6ViM3nr57KhpY6TTOgMORMQ951nsLWeYTF3w2p01QZCpw5t3QG
BVDgzBkUQIEzZ1AABc6cQQEUOHMGBVDgzBkUlgEFIqnTpAXjrKdACitnUCCFlTMokMLKGRRIkeIM
CqRIcQYFOhoUpE5nvxtSp6kmFKROZ78bUqepJhScvJT9bjh5iWpCwRmN2e/Gks9oLN8gGdeLnvO3
Va6tSup0+cU7zTn73Vj4ac6FgStHnGgNhcLMiAe5D3IfFpj7MDnZeWuC6/hP3XMYHiREF/7GYXeW
dOGPj98KCVEPP5QQld25DhRKkp23pjyPWE372eo/flwoyJLMfjcWniVZOKewt26UpDwelOY0oYd/
0AWX/JZCn0PnFKROZ78bC0+dLk9VK4fC1p8qiXgbZofBlV9wRSjoKegpLK2nUKVuTBg+zGnqK84F
DlKnzSmYU5hQHyZAYXzYH1HVD7rg8qlWqw9WH6w+nDwcLU8YPoz/VOjwYZA6bZ8C58lQoFDZ0bjU
uyF1mipDYfDuQ/674d0HqgyFQep0/rshdZoqQ2GQOp3/bkidpspQ4My5pTMogAJnzqAACpw5gwIo
cOYMCqDAmTMogAJnzqCwDCgQSZ0mLRhnPQVSWDmDAimsnEGBFFbOoECKFGdQIEWKMyjQ0aAgDZlz
S2dQ6B0K0pA5N3YGha6h4EQgzu2dQaFfKDg7kPPyz2g8NL168oUV/qMOimaQOs3Zac4tmsSIgPmZ
/5zqEQ/ryX3gnN25OyiUh0GPf+e9WIfyWLqHYRMj/4RoKEgu4jz0nBDVAAoHZUmXf+ecnOvjQkHG
Ieeh5yzJBnMKoQlx5VAYYgJmJ8wpSEPmPPScOh3RU5ic17oVKz1DQU+Bs55C6fBhfh2b3G5PgMIc
iplT4GxOoRoUqkdRT5tTkDrN2epDytWH8T7F5NUHqdOc7VOgprLTjrPUaSp9PPbkc27vDApdQ2GQ
hsy5uTMo9A6FQRoy57bOoJAACpw5t3QGBVDgzBkUQIEzZ1AABc6cQQEUOHMGBVDgzBkUlgEFIqnT
pAXjrKdACitnUCCFlTMokMLKGRRIkeIMCqRIcQYFOhoU4jKL/76+vry4eHl+/s2jR1+dnDw/PX1x
dvbTkyd//davs2zoaGdQ6B0KcZnFvz579u3jx1uP59jU5F8+79FZNnQDZ1DoGgpxp+tsGu29Z3lt
vqcrZ+cjtXEGhX6hEHcO36YlLzwKeFer3t7ZSYptnJcDhfIk68lVdOSU562Xsevzwt8Yd2LvZrS/
q2+/tbf/59XxnZ253MZ5OVAYiZOoBYWtp7bv/ZHCS2p8tv/lxcUhxtu7+o2dpTO0cV4FFA6NZhh2
h1McBIVyIgzNU4Benp8fVHVfnB3fWY5TG+fFQmG8Zu6NipoTG7frfyeEwcTlBd6uEZZ/PT89vrPE
xzbOy59TqJjsNlLzx0cWw9TYuLhk4YfF5vEe4+M7y4Zu47zY1YeKqZMlE40HTWr0kDqtp8B5vXMK
0VCoNadoTsHI35xCv1CYP6cwYdLR6oM1AqsPjeYUaq0+jA8fSsYOXaVO26fAebCjMenqiR2Nbe4G
Z1BIA4XBuw+t7gZnUEgDhSEys3jTqu9aL9h8/uppj86yoRs4g0LvUBgiM4t3nXqwdbTfibNs6Ghn
UEgABc6cWzqDAihw5gwKoMCZMyiAAmfOoAAKnDmDAihw5gwKy4ACkdRp0oJx1lMghZUzKJDCyhkU
SGHlDAqkSHEGBVKkOIMCHQ0K0pDbOL99e/3mzcXV1fmrV49+/vnk8vL09euz6+snb99KnaaeoCAN
uY3zH388e/Xq8YYFD782jPj9d6nT1AcUnAjUxnnTHdiKg7tfm+9Zyd0AhX6h4OzANs6bPsJeItx+
7eovOKOxUT0ZT3y698mcvyrZAVrlqOhOTnPmfG8e4e6o4euvTz788OS9926+Pvnk5Lvv7o8j/vnH
ac4dtJyF1fthrmzJX5XcppmhMr3lPnC+qzdvLu5W+/ffvykeX3558sUXN3/44IOiQYTch9VBYe/F
REBBclEb56ur860jhR9+uPF+9937n79+LSGqpzF2yUBgeJAcv/ev+oSCjMM2zrerj/e+vv/+5KOP
brw/++z+X11eypJMNacQDYVpkdbT5hSkIbdx3tpN+PjjG8tPP90+3bjgu5Fm9eGgKcMOoaCnkK6n
8M47N8Y//riFCHoKmeYUoqFQEjBrTmExcwq7vswp9AWFg9rqg/5QcpvqLklYI+hz9eH261blW5is
PhxtTmFkfB4KhV1bGOxTWIDzvX0K41CwT4GOvNpi32EbZzsaQSENFAZvKLRy9u4DKKSBwiANuZXz
v29JPtr9lqTUaeoGCoM05FbOu85T2DqPsOC7AQoJoMCZc0tnUAAFzpxBARQ4cwYFUODMGRRAgTNn
UAAFzpxBYRlQIJI6TVowznoKpLByBgVSWDmDAimsnEGBFCnOoECKFGdQoKNBIS4NWc5yG+dcTxAU
eodCXBqynOU2zumeICh0DYW4E4GcNdTGOeMTBIV+oRB3dqBTCds4Z3yCraFQssWy23rbOHU6Lg1Z
znIb54xPsDUUJgQ3dtiSN8uSjEtDlrPcxjnjE+wFCiMVaW+TW5INszWQcpfzUJwTFQ2FuDRkOctt
nDM+wSNDoaQy761d41CY4Lz3bjSDQlwaspzlNs4Zn2AvcwozK9JIVOTMylzIr3LzXbe6cRqynOU2
zhmf4JFXH6bV0odYGYfCru9vCYW9Y5PGachylo/YU+j8CSaYUzho9mEYDZWeD4XJqdP7G6u2achy
lo87p9DzE+wOCuXteckApIrzyB1svPpQMQ1ZzvJRVh9SPMFe5hS29q4P6oeP1LqZzg8vu1nqdFwa
spzlo+xTSPEEjzynkGJXwnF/ox2N2Z3taMwNgiNutfTuw4KdvftA9fsmcWnIcpbbOKd7gqCQYMAS
l4YsZ7mNc64nCApLnsXgzBkUQIEzZ1AABc6cQQEUOHMGBVDgzBkUQIEzZ1BYLRSIpE6TFoyzngIp
rJxBgRRWzqBACitnUCBFijMokCLFGRToaFCIS0P++/r68uLi5fn5N48efXVy8vz09MXZ2U9Pnvz1
mzzrHPc54ppBoXcoxKUh//rs2bePH289UmRTdn/5XJ517/c56JpBoWsoxJ0ItGmm9p4/tvmeCc7O
dGpzn+OuGRT6hULc2YGbtqvw+OJd7ZjTH497n+Ou+chQ2LX1cub1lP94+YHrw+gpz+Mf7t1b2viU
4c34dldvdmv/9s8redZ93ee4a+6op1A3kDoCClsr/8M/VwyDicsjuLy4OMR4e+dWnvUR73PcNfcO
hcmRCuU/Xp77MJQlRO3tWZSzKS656OX5+UGF9cWZPOu+7nPcNXcNhZLI6WFeYvVwYOr0TCgURlT+
p7iMw9tVsfKv56fyrPu6z3HXnGP4EBr9XiVLciTwag4U4tKQHxabx3uM5Vn3dZ/jrjkfFGZGSI/8
+AQoDAdmSa+2p7DaPGs9haY9hep9imlQKB8+jN/hxc8prDPP2pxCX8OHwlmD6nMKhbG3K1l9WHme
tdWHcCjUWn0YqcPjuyQm71OYBoUF7FNYeZ61fQpUjYn/yY7GNnfDjkZQSAOFwbsPre6Gdx9AIQ0U
hsg05E07tmuGfPP5q6fyrHu/z0HXDAq9Q2GITEPe9Z7/1vHtQc7yrNvc54hrBoUEUODMuaUzKIAC
Z86gAAqcOYMCKHDmDAqgwJkzKIACZ86gsAwoEEmdJi0YZz0FUlg5gwIprJxBgRRWzqBAihRnUCBF
ijMo0NGgEJfgHOecK2eZMyhkgkJcgnOcc7qcZc6gkAYKcacYxTlnPGuIMyjkgELceYdxzhlPJeS8
KCgctHlzKDvBfSRgdlq25a4Pxx9PXIJznHPG84s5L7anUPJPKPxnjie+hcbY3VVcgnOcc8akA84r
gsLDhLiR/93bU2gPhbgE5zjnjJlInNcChQkhcb1BIS7BOc45Y3oiZ1DYX8kLMyOnZduWj2viEpzj
nDPmLHMGhS0zlNFQqNhTqJLgHOesp6CnsK7hQ90U3Mkj//kJznHO5hTMKaSHQnlPofqSxKFrBBUT
nOOcrT5Yfci0+jDsy5gegcKufRAt9ylUTHCOc7ZPIbvzoqCwMKLdyo7Gu7LvsI0zKHQNhcG7D/8r
byi0cQaFrqEwRCY4xzmny1nmDAqZoDBEJjjHOefKWeYMCsmgwJlzS2dQAAXOnEEBFDhzBgVQ4MwZ
FECBM2dQAAXOnEFhGVAgkjpNWjDOegqksHIGBVJYOYMCKaycQYEUKc6gQIoUZ1Cgo0EhLrM4LnVa
gnNeZ1DoHQpxmcVxqdMSnFM7g0LXUIg7XSfu5CWnGGV3BoV+oRB3Dl/cGY3OO8zuvBAojJzvPmGq
Zmbq9FCcHDH+edyJvXGp005Gzu68TCjcO7i9ChQmJMTtutHlUIg72z8udVqGQnbnVUDh0JiGkndF
9pKiChTiUoDiUqelLWV3XtScwq5qOTMk+lAojPc1DoJCXF5gXOq0XMbszguEQnmXYXz6oLxLEgeF
uGThuNRpCc7ZnVcHhcLot+pQODS69ig9hSqp01pdPYWsPYXycUHhosZeKIyfbNHJnML81Gnjc3MK
XS9MljTsc8YUBw0fJnzebPWhYuq0mXyrD5mgMBTvNRj5npLU6SHbPoWKqdPW/LM7Lw0KS8LZrexo
5GxHIyjcl3cfOLd3BoWuoTBEZhbHpU5LcE7tDAq9Q2GIzCyOS52W4JzXGRQSQIEz55bOoAAKnDmD
Aihw5gwKoMCZMyiAAmfOoAAKnDmDwjKgQCR1mrRgnPUUSGHlDAqksHIGBVJYOYMCKVKcQYEUKc6g
QEeDQlw2dEZn2dDRzqDQOxTisqEzOsuGbuAMCl1DIe58pIzOzkdq4wwK/UIh7iTFjM5OUmzjnBsK
5ds2K/6uCR9Oy32Iy4bO6OzM5TbOi+opRBPh4Z8PiqKe8GFcNnRGZ+kMbZyXA4XyBnwYjaItuRVz
oHBQ7kNcNnRGZzlObZyXCYXxuvowdb6whZ8PhcKIyv8Ulw2d0VniYxvnhUChpLIdVIHnBMxWhEJc
NnRGZ9nQbZyXAIVdQ/R7Y4GSClz4nnkzKMRlQ2d01p7rKUyHQsVJwb0zF1V6H0PzbOiMzkb+5hRm
dRNGpgxK5hHmpE5XhEJcNnRGZ2sEVh+KiLBrn8LDhYaR1YfxNYvxwcVBmxcOhUJcNnRGZ7sJ2jgv
Z/Wh1sRkb5dkR+Nd2XfYxnktUGiz6zGCU959uCtvKLRx9u5D752XuGzojM6yoRs4g0KCEU1cNnRG
Z9nQ0c6gsORpDs6cQQEUOHMGBVDgzBkUQIEzZ1AABc6cQQEUOHMGhdVCgUjqNGnBOOspkMLKGRRI
YeUMCqSwcgYFUqQ4gwIpUpxBgY4GBWnInFs6g0LvUJCGzLmxMyh0DQUnAnFu7wwK/ULB2YGcndE4
q16FJlDPSZ0e9gVVOmWYs9OcjzxvN8dwQsDMtChqeQScB7kPEUTYGtYw/G8qzN3vHAICZqdBQXIR
50FCVFyrPhQkRz382+NCQcYh50GWZEQ3oVa9LSfOrm84dE5BGjLnQep09amEXaFyjaGgp8BZT6Ej
KMyZNWzWDTHW5WxOodGKw4R6O5IxW3dJwqw4Z6sPsUQYT6AuSYgfWX2okjptnwJn+xQW1ek4ym+0
046zHY1d9DW6wpA9+ZzbO4NC730TacicGzuDQoIBizRkzi2dQWHJsxicOYMCKHDmDAqgwJkzKIAC
Z86gAAqcOYMCKHDmDAqrhQKR1Gki6ruVciOICBSICBSICBSICBSICBSICBSIKBAKRET/6f8AO65M
kHWqHVkAAAAASUVORK5CYII=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2017-03-16 13:15:20 +0000" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2017-03-16 13:15:20 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-03-09 15:16:18 +0000" MODIFIED_BY="[Empty name]">Professor Caroline Fall</TITLE>
<DATE_SUBMITTED>
<DATE DAY="31" MONTH="5" YEAR="2016"/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2017-03-16 13:14:48 +0000" MODIFIED_BY="[Empty name]">
<P>Our comments relate mainly to the stillbirth analysis. We believe a fixed-effect model is inappropriate for this analysis. While there was no statistical heterogeneity, the Cochrane handbook and the methods section of the review state that clinical (contextual) heterogeneity should be the main driver of the choice of model, rather than statistical heterogeneity. Contextual heterogeneity was evident in a number of aspects of these trials, including their design (individual or cluster randomized), interventions (composition of multiple micronutrient supplements and duration of supplementation), co-interventions (for example early or late food supplementation), comparison groups (iron alone, IFA, and different doses of these, especially iron), participants (geographic location, phenotype, and gestational age at randomization) and outcome definition (definition of stillbirths varied from &#8805;24 weeks to &#8805;28 weeks gestation, including or excluding multiple births). There is inconsistency in the use of fixed or random-effects models within the review; for example, for perinatal mortality (of which stillbirths form a sub-set, <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>), including 12 of the 15 trials contributing to the stillbirth analysis, a random effects meta-analysis was used.</P>
<P>We think that three eligible trials have been omitted from the review (<LINK REF="STD-Ashorn-2015" TYPE="STUDY">Ashorn 2015</LINK>
<SUP>1</SUP>; Hanieh 2013<SUP>2</SUP> [protocol of this trial is cited as <LINK REF="STD-Biggs-2011" TYPE="STUDY">Biggs 2011</LINK>]; and Adu-Afarwuah 2015<SUP>3</SUP> [protocol cited as <LINK REF="STD-Dewey-2011" TYPE="STUDY">Dewey 2011</LINK>). These are all listed in the review as &#8216;ongoing trials&#8217;, but they were published before the stated search date of March 2015. Inclusion of these trials makes little difference to the overall results, but a Cochrane review is expected to be complete.</P>
<P>The Methods section under &#8220;Unit of analysis issues&#8221; does not clearly define the strategy for comparisons in trials with factorial designs. Further, the comparisons made are unclear in places and inconsistent across studies. This issue potentially applies to 4 studies (<LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>), all of which had more than one eligible intervention and/or control group.</P>
<P>A reduction in stillbirths is the only direct benefit to health that has been reported as a result of multiple micronutrient supplements in pregnancy (as opposed to &#8216;metric&#8217; outcomes like birth weight and rates of preterm birth), and is currently the only evidence sufficient to justify changing routine supplementation from IFA to MMN. A significant increase in birth weight might be expected to lead to significant health benefits (eg. reduced infant mortality) but until this review, there was no apparent effect of MMN supplementation in pregnancy on mortality. The soundness of the stillbirth evidence is therefore crucial to the policy review, and we believe that the evidence remains inconclusive.<BR/>
</P>
<P>Finally, we are curious to know how the review authors presented data for smallness for gestational age (SGA) as an outcome (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) because data for SGA were not published for some of the trials.</P>
<P>(Summary of feedback from Harshpal Singh Sachdev, Delanjathan Devakumar, Caroline Fall, Clive Osmond, David Osrin, Jonathan Broad, Barrie Margetts, May 2016).</P>
<P>
<B>References</B>
</P>
<OL>
<LI>Ashorn P, Alho L, Ashorn U, Cheung YB, Dewey KG, Harjunmaa U, et al. The impact of lipid-based nutrient supplement provision to pregnant women on newborn size in rural Malawi: a randomized controlled trial. The American Journal of Clinical Nutrition 2015; 101: 387-97.</LI>
<LI>Hanieh S, Ha TT, Simpson JA, Casey GJ, Khuong NC, Thoang DD, et al. The effect of intermittent antenatal iron supplementation on maternal and infant outcomes in rural Viet Nam: a cluster randomised trial. PLoS Med 2013; 10: e1001470.</LI>
<LI>Adu-Afarwuah S, Lartey A, Okronipa H, Ashorn P, Zeilani M, Peerson JM, et al. Lipid-based nutrient supplement increases the birth size of infants of primiparous women in Ghana. The American Journal of Clinical Nutrition 2015; 101: 835-46.</LI>
</OL>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2017-03-16 13:15:20 +0000" MODIFIED_BY="[Empty name]">
<P>We would like to thank you and your colleagues for the detailed comments and queries on our review. We have made edits to the review to address the specific queries. We also plan to update this important review over the coming year, since the search will become out of date in March 2017.</P>
<P>
<B>1. Random-effects versus fixed-effect model &#8211; stillbirth analysis</B>
</P>
<P>Regarding the comment about the inconsistent use of fixed or random effects model in the review, please note we had not used these inconsistently. While we agree regarding the presence of contextual differences between the included trials, the decision to select fixed or random effects model for stillbirth analysis was based on the values of I², Tau² and/or p value, as per the methodological guidelines of Cochrane Pregnancy and Childbirth reviews: &#8220;We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.&#8221; We have taken on board your comments and changed the stillbirth results to RR 0.97, 95% CI 0.87 to 1.09, using a random effects model. However, as our group statistician has advised, this is a very conservative approach and an interpretation of a possible reduction in stillbirth would also be valid.</P>
<P>
<B>2. Omission of trials </B>
</P>
<P>Regarding the omission of three eligible trials, namely Hanieh 2013, <LINK REF="STD-Ashorn-2015" TYPE="STUDY">Ashorn 2015</LINK>, and Adu-Afarwuah 2015, we consulted the Information Specialist of Cochrane Pregnancy and Childbirth. The Information Specialist has informed us that one of the trials, Adu-Afarwuah 2015 was not identified in the literature search conducted on 11<SUP>th</SUP> March 2015 &#8211; and had not been added to the Cochrane Pregnancy and Childbirth group trials register at that time. Regarding <LINK REF="STD-Ashorn-2015" TYPE="STUDY">Ashorn 2015</LINK>, this was in <LINK TAG="ONGOING_STUDIES" TYPE="SECTION">Ongoing studies</LINK>, but has now been moved to <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>. The review authors have requested additional data from the trial authors for <LINK REF="STD-Ashorn-2015" TYPE="STUDY">Ashorn 2015</LINK>, as stated in the notes section of the <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK> table. This trial included HIV+ patients: &#8220;This trial included women with a + HIV test: IFA = 15.6%; MMN 11.1% and LNS 14.4%. We have contacted authors to see if separate analyses for HIV- women are available.&#8221; Hanieh 2013 had been assigned to another review on intermittent iron, but will be re-assessed at next update. The review authors will assess all three of these studies in the next update of this review.</P>
<P>
<B>3. Unit of analysis issues - Trials with multiple intervention groups</B>
</P>
<P>We appreciate that our methods section had not detailed clearly how unit of analysis issues for trials with multiple intervention groups had been dealt with. We have made edits to address this issue, as detailed in the Unit of analysis issues section for <LINK REF="STD-Christian-2003" TYPE="STUDY">Christian 2003</LINK>; <LINK REF="STD-Kaestel-2005" TYPE="STUDY">Kaestel 2005</LINK>; <LINK REF="STD-Lui-2013" TYPE="STUDY">Lui 2013</LINK>; <LINK REF="STD-Zeng-2008" TYPE="STUDY">Zeng 2008</LINK>. For trials with multiple intervention groups, we selected one pair of interventions and excluded the others. This is one approach recommended by the Cochrane Handbook [16.5.4]. If more than two intervention groups had met the eligibility criteria, we would have combined groups to create a single pair-wise comparison as per [16.5.4] of the Cochrane Handbook.</P>
<P>4. <B>Source of data for Small for gestational age (SGA) Unit of analysis issues - Trials with multiple intervention groups</B>
</P>
<P>We have spoken to the Research Associate, Cochrane Pregnancy and Childbirth, who helped with the last update. The SGA data for all but three trials, came from a separate report (<LINK REF="REF-Food-and-Nutrition-Bulletin-2009" TYPE="REFERENCE">Food and Nutrition Bulletin 2009</LINK>). Only in three trials were we able to extract SGA data directly from the trial reports (<LINK REF="STD-Brough-2010" TYPE="STUDY">Brough 2010</LINK>; <LINK REF="STD-Fawzi-2007" TYPE="STUDY">Fawzi 2007</LINK>; <LINK REF="STD-West-2014" TYPE="STUDY">West 2014</LINK>).</P>
<P>(Reply from Batool A Haider, Zulfiqar A Bhutta, Philippa Middleton, March 2017).</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2017-03-16 11:40:06 +0000" MODIFIED_BY="[Empty name]">
<P>Harshpal Singh Sachdev MD, Senior Consultant in Pediatrics and Clinical Epidemiology, Sitaram Bhartia Institute of Science and Research, New Delhi, India<BR/>Delanjathan Devakumar PhD, NIHR Clinical Lecturer in Public Health, Institute for Global Health, Faculty of Population Health Sciences, University College London, London, UK<BR/>Caroline Fall DM, Professor of International Paediatric Epidemiology, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK<BR/>Clive Osmond PhD, Professor of Biostatistics, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK<BR/>David Osrin PhD, Professor of Global Health, Institute for Global Health, Faculty of Population Health Sciences, University College London, London, UK<BR/>Jonathan Broad MBChB, Honorary research fellow, University of Bristol, Academic Foundation Doctor, Peninsula Deanery<BR/>Barrie Margetts PhD, Emeritus Professor, Population Health Sciences Research Group, Faculty of Medicine, University of Southampton, Southampton, UK</P>
<P>Batool A Haider, Researcher, Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA</P>
<P>Zulfiqar A Bhutta, Robert Harding Chair in Global Child Health &amp; Policy, Centre for Global Child Health, Hospital for Sick Children, Toronto, Canada</P>
<P>Philippa Middleton, Editor, Australian Satellite of Cochrane Pregnancy and Childbirth/Principal Research Fellow, Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Women's and Children's Hospital, Adelaide, Australia</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2014-08-07 11:48:32 +0100" MODIFIED_BY="[Empty name]"/>
<EXTENSIONS MODIFIED="2009-04-06 07:57:50 +0100" MODIFIED_BY="[Empty name]"/>
</COCHRANE_REVIEW>